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Abstract 
 
This thesis describes the study of new methodologies for the asymmetric synthesis of N-
Boc heterocycles using lithiation chemistry, with the main focus on N-Boc pyrrolidine. 
 
The “high” temperature asymmetric lithiation-trapping of five-membered heterocycles 
N-Boc pyrrolidine and N-Boc imidazolidine and six-membered heterocycles N-Boc 
piperidine and N-Boc piperazine is described in Chapter Two. It was found that lithiated 
N-Boc pyrrolidine is configurationally stable for 1 hour at 40 °C and 30 °C giving 
high ers (90:10 er). With N-Boc imidazolidine, yields above 50% can be achieved using 
THF as solvent and are supported by VT 
1
H NMR spectroscopy studies as well as 
ReactIR™ spectroscopy studies. 
 
In Chapter Three, attempts towards the elucidation of the instability of α-amino 
sulfoxides are described. The synthetic strategies planned to clarify the possible 
mechanism causing the elimination of the sulfoxide group were unsuccessful and 
ultimately, we were unable to understand which process was at the basis of the 
elimination. As part of these studies, the development of the asymmetric lithiation-
trapping of 4-phenyl N-Boc pyrrolidine is also described.  
  
Chapter Four describes the development of the asymmetric synthesis of α,α' tri- and 
tetra-substituted pyrrolidines. The use of ReactIR™ spectroscopy experiments was 
fundamental for the studies into the interconversion of N-Boc rotamers and to achieve 
good yields of the trapped products. An interesting match/mismatch mechanism for the 
formation of tri-substituted pyrrolidines is shown, which can give ers of >99:1 er. 
Finally, the synthesis of several new tetra-substituted pyrrolidines in 70:30-91:9 dr is 
presented. 
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Chapter One: Introduction 
 
Pyrrolidines are a widespread motif in both natural products and pharmaceutically 
active compounds. An example of a natural compound showing a substituted 
pyrrolidine core is (‒)-kainic acid, which is an agonist for a subtype of glutamate 
receptors ultimately involved in neuronal apoptosis.
1
 The pyrrolidine ring also appears 
in important pharmaceutical products such as Pfizer’s anti-migraine drug eletriptan 
(Relpax
®
)
2
 and (+)-RP 66803 a cholecystokinin antagonist (Figure 1.1).
3
 Different 
synthetic strategies have been employed to access these substituted pyrrolidines. 
However, the asymmetric lithiation-trapping methodology represents one of the most 
efficient and straightforward transformations available to synthetic chemists. The 
importance of the lithiation chemistry is shown by the possibility of introducing a 
stereogenic centre using a single synthetic transformation. 
 
Figure 1.1 
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1.1 Brief Overview of Lithiation-Trapping of N-Boc Heterocycles 
 
In 1989, Beak and Lee reported that α-substituted nitrogen heterocycles could be easily 
accessed via lithiation chemistry of N-Boc protected substrates.
4
 They described the 
lithiation of N-Boc pyrrolidine 1 using s-BuLi and TMEDA in Et2O at ‒78 °C for 3.5 
hours which generated lithiated intermediate rac-2. Trapping with Me3SiCl gave silyl 
pyrrolidine rac-3 in 81% yield (Scheme 1.1). 
 
Scheme 1.1 
 
More than a decade later, our group discovered that the racemic lithiation-trapping 
methodology could also be successfully performed at ‒30 °C without TMEDA, if THF 
was used as the solvent.
5
 Lithiation of N-Boc pyrrolidine 1 with s-BuLi in THF at ‒30 
°C and trapping with Me3SiCl afforded rac-3 in 71% yield (Scheme 1.2). The lithiation-
trapping chemistry has been also developed on six-membered N-Boc heterocycles such 
as N-Boc piperidine
4,6,7
 and N-Boc piperazine.
8,9
  
 
Scheme 1.2 
 
The racemic lithiation-trapping protocol was soon followed by the development of 
asymmetric lithiation-trapping methodology with the employment of chiral ligands. 
Beak and Kerrick showed that the use of (‒)-sparteine in the lithiation of N-Boc 
pyrrolidine 1 with s-BuLi and trapping with Me3SiCl gave silyl pyrrolidine (S)-3 (76% 
yield) in 98:2 er (Scheme 1.3).
10,11
 The key intermediate was a configurationally stable 
chiral organolithium species. Chiral ligands other than (‒)-sparteine were also 
developed. Our group first presented the (+)-sparteine surrogate and subsequently 
diamine (R,R)-4, which could afford a 95:5 er of silyl pyrrolidine (R)-3 and (S)-3 
Chapter One: Introduction 
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respectively.
12,13
 These methodologies with related synthetic applications have also 
been independently reviewed by Beak and Maes.
14,15
 
 
Scheme 1.3 
 
These results shown in this section are just a brief overview of the lithiation-trapping 
methodology of N-Boc heterocycles. More details are presented at the relevant points in 
later chapters. 
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1.2 Synthetic Applications of N-Boc α-Lithiation Methodology 
 
There are numerous applications of Beak’s N-Boc α-lithiation-trapping methodology. In 
this section, some selected examples are presented with a focus on the synthetic 
applications. Researchers at Boehringer Ingelheim Pharmaceuticals described the 
synthesis of dipeptides based on proline boronic acids, such as 6, which could have 
potential applications in the treatment of human immunodeficiency virus.
16
 The 
common intermediate in the synthetic pathway, boronic pyrrolidine rac-5, was accessed 
in 81% yield by lithiating N-Boc pyrrolidine 1 with s-BuLi and TMEDA in Et2O at ‒40 
°C for 3 hours and trapping with trimethyl borate (Scheme 1.4). 
 
Scheme 1.4 
 
The use of the lithiation chemistry has been applied to other N-Boc heterocycles. 
Chackalamannil et al. lithiated 2-methyl N-Boc piperidine (S)-7 with s-BuLi and 
TMEDA in Et2O and trapped with DMF to synthesise (2R,6S)-8 in 86% yield and 95:5 
dr (Scheme 1.5).
17
 The trans geometry between methyl group and the aldehyde was due 
to allylic A1,3 strain
18
 which forced the α-substituent to be axial. Subsequent equatorial 
lithiation gave the observed relative stereochemistry.
7
 Aldehyde (2R,6S)-8 was further 
processed to ultimately give (+)-himbacine, studied for the treatment of Alzheimer’s 
disease. 
 
Scheme 1.5 
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The same substrate, but the opposite enantiomer, (R)-7, was used by Sorensen to form 
allyl derivative (2R,6S)-9 (96:4 dr), in synthetic studies towards the citrinadins core 
architecture 10 (Scheme 1.6).
19
 In this case, the lithiation of (R)-7 with s-BuLi/TMEDA 
in Et2O was followed by transmetallation to an organocuprate intermediate with a 
mixture of CuCN∙2LiCl. Final trapping with allyl bromide gave (2R,6S)-9, with the 
electrophile introduced trans to the methyl group. Allyl (2R,6S)-9 was further processed 
without purification and the dr was determined in subsequent products. 
 
Scheme 1.6 
 
A similar lithiation-copper transmetallation sequence was employed in a synthesis of 
the natural alkaloid (+)-myrtine.
20
 Lithiation-transmetallation of ketal N-Boc piperidine 
(R)-11 and trapping of the organocuprate intermediate with 1-chloro-4-iodobutane gave 
piperidine (R,R)-12 in 62% and >99:1 dr, which was then deprotected and cyclised to 
(+)-myrtine in 50% yield (Scheme 1.7) 
 
Scheme 1.7 
 
Racemic lithiation-trapping was applied to N-Boc piperazine (S)-13 by Guerrini et al. in 
the synthesis of (S)-16, an antagonist of neuropeptide S receptor (NPSR) which is 
involved in the regulation of several functions in the central nervous system.
21
 
Lithiation of N-Boc piperazine (S)-13 with s-BuLi and TMEDA in THF and trapping 
with benzophenone gave two separable diastereoisomers (1R,7S)-14 (45% yield) and 
Chapter One: Introduction 
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(1S,7S)-15 (40% yield) (Scheme 1.8). Since the stereogenic centre was far from the 
lithiation position, there was little diastereoselectivity in this reaction. 
 
Scheme 1.8 
 
Interestingly, the lithiation-trapping procedure has been successfully employed with an 
azabicyclic substrate by researchers at AstraZeneca in the synthesis of (R)-20, a GlyT1 
uptake receptor inhibitor.
22
 N-Boc azabicycle 17 was lithiated with s-BuLi and TMEDA 
at ‒25 °C and then trapped with sulfinamide (SS)-18 to give (R,SS)-19 (50% yield) 
(Scheme 1.9). In this case, diastereoselective addition of the organolithium to the imine 
was controlled by the sulfinamide chiral auxiliary. Further elaboration of (R,SS)-19 
formed the active compound, (R)-20.  
 
Scheme 1.9 
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The asymmetric lithiation-trapping methodology represents an attractive alternative to 
the racemic protocol for the total synthesis of natural products. As an example, the 
Dieter group reported the asymmetric lithiation of N-Boc pyrrolidine 1 with s-BuLi and 
(‒)-sparteine followed by CuCN∙2LiCl transmetallation and trapping with ethyl 3-
iodopropenoate 21. Vinyl pyrrolidine (R)-22 was isolated in 85% yield and 96:4 er 
(Scheme 1.10). Subsequent deprotection and cyclisation gave (‒)-pyrrolam A.23 A range 
of bicyclic alkaloids were also synthesised using a similar procedure, as described by 
the same group.
24
 
 
Scheme 1.10 
 
The lithiation-allylation procedure was used by our group in the synthesis of alkaloid (‒
)-indolizidine 167B.
13
 Allyl intermediate (S)-23 was obtained in 78% yield and 85:15 
er, by treatment of N-Boc pyrrolidine 1 with s-BuLi and chiral diamine (S,S)-4 at ‒78 
°C followed by lithium-copper transmetallation and allylation (Scheme 1.11). 
 
Scheme 1.11 
 
Another interesting natural product, with a poly-substituted pyrrolidine core, is (‒)-
kainic acid.
25
 Fukuyama showed that asymmetric lithiation of substituted N-Boc 
Chapter One: Introduction 
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pyrrolidine 24 with s-BuLi and the (+)-sparteine surrogate followed by trapping with 
CO2 gave an 81:19 mixture of regioisomers 25 and 26 in 71% yield (Scheme 1.12).
1
 
Further processing of 25 subsequently gave (‒)-kainic acid. 
 
Scheme 1.12 
 
More recently, Altmann et al. reported the synthesis of the hygrolines and 
pseudohygrolines via the asymmetric lithiation-trapping methodology by combining 
chiral ligands and chiral epoxides.
26
 As an example, lithiation of N-Boc pyrrolidine 1 
with s-BuLi and (‒)-sparteine and trapping with propylene oxide (S)-27 afforded 
alcohol (1R,2S)-28 (60% yield) in 94.5:5.5 dr. Subsequent reduction of the Boc group 
with LiAlH4 gave (+)-pseudohygroline in 93% yield, 96:4 dr and >99:1 er (Scheme 
1.13). The use of epoxides as electrophiles in the lithiation-trapping of N-Boc 
pyrrolidine 1 was first revealed by Mani and Deng.
27
 
 
Scheme 1.13 
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In 2009, our group described the formation of piperidine heterocycles via a ring 
expansion procedure from α-substituted pyrrolidines.28 These pyrrolidine intermediates 
were attained using a lithiation-trapping methodology which used 0.3 eq. of (‒)-
sparteine. Hence, N-Boc pyrrolidine 1 was lithiated with s-BuLi and (‒)-sparteine (0.3 
eq.) in the presence of an additive (LiDMAE). Trapping with PhCHO gave alcohols 
(1R,2R)-29 (90:10 er) and (1S,2R)-30 (89:11 er) in 64% and 25% yield respectively 
(Scheme 1.14). Alcohol (1R,2R)-29 was then converted into piperidine (+)-L-733,060 
which is a potent substance P-NK1 receptor antagonist. 
 
Scheme 1.14 
 
Campos at Merck was the first to show that the lithiation-trapping chemistry could be 
useful to access α-arylated products such as glucokinase activator (R)-33.29 The 
synthesis of (R)-33 was achieved by elaboration of arylated pyrrolidine (R)-32. In this 
case, the lithiation of N-Boc pyrrolidine 1 was performed on a 7.2 mol scale. Pyrrolidine 
(R)-32 (63% yield and 96:4 er) was formed using the lithiation of N-Boc pyrrolidine 1 
with s-BuLi and (‒)-sparteine in TBME, followed by treatment with ZnCl2 and Pd-
Negishi catalysed reaction with bromo aniline 31 (Scheme 1.15). 
Chapter One: Introduction 
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Scheme 1.15 
 
This lithiation-transmetallation-Negishi coupling sequence also allowed the total 
synthesis of natural products such as (S)-nicotine, (R)-crispine A and (R)-maackiamine, 
as shown by our group in collaboration with Campos in a subsequent report (Figure 
1.2).
30
  
 
Figure 1.2 
 
The examples reviewed in this section are not an exhaustive list of the synthetic 
applications of the lithiation-trapping methodology. However, the versatility of the 
lithiation chemistry is demonstrated through the selection of representative examples. It 
was shown that lithiation-trapping methodology has been successfully used by 
pharmaceutical companies for the synthesis of potential drug compounds. In one case, it 
has been also employed in a large-scale reaction by process chemists at Merck. 
Moreover, several academic groups have applied the lithiation chemistry in the total 
synthesis of natural products. 
Chapter One: Introduction 
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1.3 Outline of the Project 
 
In the first part of the project (Chapter Two), we planned to explore the asymmetric 
lithiation-trapping of N-Boc heterocycles at temperatures > ‒78 °C. In particular, our 
interest was to discover the effect of “high” temperatures on the enantioselective 
outcome of the asymmetric lithiation methodology. The initial investigation was 
developed with N-Boc pyrrolidine 1 and then extended to N-Boc piperidine 34, N-Boc 
piperazine 35 and N-Boc imidazolidine 36 (Scheme 1.16). 
 
 
Scheme 1.16 
 
One of the major limitations of the asymmetric α-lithiation and electrophilic trapping 
methodology of N-Boc heterocycles is the impossibility of accessing enantiopure 
products. Typically, enantioselectivities of ≤95:5 er are obtained with this chemistry. To 
overcome this limitation, our group has put some effort into the synthesis of stable α-
amino sulfoxides such as anti-(R,R,SS)-37, with the aim to access N-Boc heterocycles 
39 in >99:1 er using asymmetric lithiation chemistry.
31
 The enantiopure sulfoxide anti-
(R,R,SS)-37 would act as a precursor for chiral Grignard reagent (R,R)-38 via sulfoxide-
magnesium exchange (Scheme 1.17). 
 
Scheme 1.17 
 
Chapter One: Introduction 
21 
In order to explore other N-Boc α-amino sulfoxides, the attempted syntheses of 
sulfoxides 40-43 are described in Chapter Three (Figure 1.3). 
 
Figure 1.3 
 
Ultimately, we planned to use the asymmetric lithiation-trapping methodology for the 
synthesis of α,α'-tetra-substituted pyrrolidines 44. We proposed that such compounds 
could be accessed via two sequential asymmetric lithiation-Negishi coupling reactions 
and benzylic lithiation steps (Scheme 1.18). ReactIR™ spectroscopy studies were 
planned in order to optimise the lithiation-trapping of di- and tri-substituted 
pyrrolidines.  
 
Scheme 1.18 
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Chapter Two: Asymmetric Synthesis of N-Boc 
Heterocycles at Temperatures Above ‒78 °C 
 
An exploration of the asymmetric lithiation of N-Boc heterocycles performed at 
temperatures above ‒78 °C will be presented in this chapter. The ultimate objective of 
this part of the project was to investigate whether the asymmetric lithiation could be 
performed successfully at temperatures ≥ ‒40 °C with high levels of enantioselectivity 
(Scheme 2.1). The selection of ‒40 °C as the lowest temperature in this study, was due 
to the fact that cooling down a process-scale reaction to temperatures below ‒40 °C 
vastly increases the energetic cost of the process.
32
 Thus, temperatures of ‒78 °C could 
make the lithiation methodology unsuitable for use in process-scale reactions. In 
addition, higher temperatures might allow shorter lithiation times to be used and this 
could further reduce the energy cost and increase the sustainability of the process. 
Finally, the aim of this investigation was to find the highest temperature which could 
give products in high enantioselectivities, ideally ≥80:20 er, and good yields. 
 
Scheme 2.1 
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2.1 Asymmetric Synthesis of N-Boc Pyrrolidines Using Organolithium 
Methodology 
 
Enantioenriched α-substituted N-Boc pyrrolidines can be accessed using lithiation 
chemistry via two predominant mechanisms: asymmetric deprotonation and asymmetric 
substitution. 
 
2.1.1 Asymmetric Lithiation-Trapping of N-Boc Pyrrolidine 1 
 
The conditions for the asymmetric lithiation of N-Boc pyrrolidine 1 were first reported 
by Beak and Kerrick in 1991
10
 and then in full in 1994.
11
 In their protocol, the lithiation 
of 1 was performed with s-BuLi and ()-sparteine in Et2O for 4 hours at ‒78 °C to give 
the configurationally stable lithiated intermediate (S)-2∙L* (Scheme 2.2). Subsequent 
trapping with a range of electrophiles gave products in moderate to good yields (35-
88%) and high enantioselectivity (79:21-98:2 er). For example, trapping with Me3SiCl 
gave silylated product (S)-3 in 87% yield and 98:2 er. 
 
Scheme 2.2 
 
The enantioselectivity of the lithiation originated from asymmetric deprotonation of N-
Boc pyrrolidine 1. This was proven with mechanistic studies using tin-lithium 
transmetallation experiments with stannyl pyrrolidines (S)-47 and rac-47. With 
enantioenriched (S)-47 (98:2 er), transmetallation with n-BuLi gave lithiated 
intermediate (S)-2, which was then trapped with Me3SiCl to afford silylated pyrrolidine 
(S)-3 in 97:3 er (Scheme 2.3). 
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Scheme 2.3 
 
In contrast, when the racemic stannane rac-47 was treated with n-BuLi and then ()-
sparteine was added with the electrophile, trapped silylated product (S)-3 was isolated 
almost as a racemate (52:48 er) (Scheme 2.4). This showed that ()-sparteine did not 
affect the substitution step and the enantioselectivity of the reaction was established 
during the deprotonation. 
 
Scheme 2.4 
 
Kinetic studies carried out by Beak and Gallagher suggested that the lithiation reaction 
proceeds via the formation of a pre-lithiation complex 48.
33
 Thus, 48 is formed by 
coordination of the carbonyl oxygen of N-Boc pyrrolidine 48 with the chiral base 
complex, arising from s-BuLi and the chiral ligand (Scheme 2.5). In this example, the 
stereochemistry depicted is that obtained using (‒)-sparteine. Subsequent deprotonation 
of the pseudo equatorial proton leads to lithiated intermediate (S)-2∙L*. 
 
Scheme 2.5 
 
The opposite enantiomeric series could be successfully accessed with the use of a (+)-
sparteine surrogate described by our group in 2002.
12
 Deprotonation of N-Boc 
pyrrolidine 1 with s-BuLi and the (+)-sparteine surrogate in Et2O at 78 °C for 5 hours 
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and trapping with Me3SiCl gave silylated product (R)-3 in 84% yield and 95:5 er 
(Scheme 2.6). This result showed that the (+)-sparteine surrogate was as effective as 
()-sparteine in the asymmetric lithiation of 1, inducing high levels of enantioselectivity 
with the opposite sense of induction. 
 
Scheme 2.6 
 
In 2008, O’Brien and Stead reported the use of the cyclohexyl diamine chiral ligand 
(R,R)-4,
13
 whose synthesis was developed by the Alexakis group.
34-36
 The result in 
Scheme 2.7 showed that the use of (R,R)-4 in the asymmetric lithiation of N-Boc 
pyrrolidine 1 was as effective as (‒)-sparteine. In fact, trapping with Me3SiCl gave (S)-3 
(72% yield) in high enantioselectivity (95:5 er).  
 
Scheme 2.7 
 
More recently, the asymmetric lithiation of N-Boc pyrrolidine 1 with s-BuLi and ()-
sparteine at 78 °C in Et2O followed by trapping with PhCHO was reported by our 
group.
37,38
 The reaction with this electrophile gave two diastereoisomeric alcohols 
(1R,2R)-29 and (1S,2R)-30 in 63% and 23% yield respectively and a high 97:3 er for 
both (Scheme 2.8). In the same paper, it was also shown that the use of (+)-sparteine 
surrogate gave access to the opposite enantiomeric alcohols in high er: (1S,2S)-29 (58% 
yield) and (1R,2S)-30 (23% yield) were isolated in 95:5 er and 94:6 er respectively. 
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Scheme 2.8 
 
Interestingly, a solvent effect in the asymmetric lithiation of 1 was also observed. The 
lithiation of N-Boc pyrrolidine 1 was performed under the standard conditions (s-BuLi, 
chiral ligand, 3 hours at 78 °C) in different solvents such as TBME, THF and 2-
methyl-THF. The reaction carried out with (+)-sparteine surrogate in THF gave (1S,2S)-
29 (45% yield) and (1R,2S)-30 (20% yield) in a high 95:5 er for both the alcohols 
(Scheme 2.9). Similar results were also obtained with TBME and 2-methyl-THF. 
 
Scheme 2.9 
 
In contrast, the use of ()-sparteine in THF afforded alcohols (1S,2S)-29 (50% yield) 
and (1R,2S)-30 (14% yield) both in a low 51:49 er. Similarly, 2-Methyl-THF gave 
comparable low enantioselectivities, while the data with TBME matched those obtained 
with Et2O. 
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These results were rationalised with 
6
Li NMR spectroscopy studies performed using i-
PrLi and the chiral diamines at 80 °C. The experiments carried out in Et2O-d10 showed 
that both ()-sparteine and the (+)-sparteine surrogate formed a complex with i-PrLi. In 
contrast, when THF-d8 was used as solvent, the (+)-sparteine surrogate was still able to 
complex i-PrLi, but ()-sparteine did not form a complex and the organolithium was 
solvated by THF molecules. 
 
The asymmetric lithiation-trapping methodology of N-Boc pyrrolidine 1 has been used 
by Dieter for the formation of several vinylic and allylic N-Boc pyrrolidines in high er 
via an asymmetric lithiation-copper transmetallation procedure.
39
 However, the use of 
allyl bromide as electrophile resulted in a slightly lower er of allylic pyrrolidine (R)-23 
(89:11 er) than Beak had observed with other electrophiles (Scheme 2.10). Furthermore, 
with diamine (S,S)-4 an even lower 85:15 er of (S)-23 was observed.
13
 
 
Scheme 2.10 
 
Interestingly, when a bulky electrophile such as Ph3SiCl was used, a very low er (52:48 
er) of silylated product (S)-49 (66% yield) was obtained (Scheme 2.11).
40
 Problems 
with the reactivity of Ph3SiCl were also reported by Strohmann, who was unable to 
synthesise (S)-49 via asymmetric lithiation-trapping of N-Boc pyrrolidine 1.
41
 However, 
the use of Ph3SiF improved both the yield and the er of (S)-49, which was isolated in 
93% yield and 96:4 er.
42
 
 
Scheme 2.11 
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The low er and moderate yield achieved with Ph3SiCl were ascribed to the steric 
hindrance of the phenyl groups, which reduced the reactivity of the electrophile. It was 
assumed that the electrophilic trapping would happen only on warming of the reaction 
to a temperature where the lithiated intermediate was configurationally unstable, 
generating (S)-49 in 52:48 er. This problem was not observed with Ph3SiF which 
presumably is a faster reacting electrophile. 
 
The allylation and silylation examples showed that slow reacting electrophiles and 
transmetallations can represent a limitation of the lithiation-trapping methodology. 
 
The asymmetric lithiation-trapping methodology was also extended and applied to other 
five-membered ring heterocycles. Coldham reported the synthesis of α-substituted N-
Boc imidazolidines in good er from N-Boc imidazolidine 36 using s-BuLi and ()-
sparteine in Et2O at 78 °C.
43,44
 When Bu3SnCl was used as electrophile, stannane (S)-
50 (40% yield) was isolated in 94:6 er (Scheme 2.12).   
 
Scheme 2.12 
 
In 1997, Beak et al. showed that N-Boc indoline 51 could be lithiated with s-BuLi/()-
sparteine in cumene.
45
 Trapping with carbon dioxide gave carboxylic acid (R)-52 in a 
high 90% yield and 89:11 er (Scheme 2.13). In this substrate, the chlorine atom was 
needed to block ortho lithiation on the aromatic moiety. 
 
Scheme 2.13 
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Another example of asymmetric lithiation-trapping on pyrrolidine-like substrates was 
reported by Metallinos.
46
 Lithiation of unsaturated urea 53 with i-PrLi and ()-sparteine 
in TBME and trapping with Me2SO4 afforded methylated (S)-54 (63% yield, 97:3 er) 
(Scheme 2.14). 
 
Scheme 2.14 
 
From these reports, it is possible to conclude that the asymmetric lithiation-trapping 
methodology can be successfully applied to a range of five-membered substrates with a 
high level of enantioselectivity. 
 
2.1.2 Asymmetric Synthesis of N-Boc Pyrrolidines via Dynamic Resolution  
 
Enantioenriched 2-substituted N-Boc pyrrolidines can also be accessed via an 
asymmetric substitution process, which has been named dynamic resolution. This 
process relies on the configurational instability of the lithiated intermediate and has 
been extensively studied by the Coldham group in the past decade.
47-50
 In this approach, 
the racemic lithiated intermediate rac-2, generated by tin-lithium exchange for example, 
is treated with a chiral ligand to form a mixture of diastereomeric complexes, (S)-2∙L* 
and (R)-2∙L* (Scheme 2.15). The mixture is then trapped with an electrophile to give 
product (S)-55 or (R)-55 with high er. Depending on the rate of interconversion of (S)-
2∙L* and (R)-2∙L*, kinv, and the rates of trapping, k1 and k2, the observed er can arise via 
two principal mechanisms, a dynamic kinetic resolution and a dynamic thermodynamic 
resolution.
51
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Scheme 2.15 
 
The dynamic kinetic resolution process requires the rate of interconversion of the 
diastereomeric complexes (S)-2∙L* and (R)-2∙L* to be faster than the rates of trapping 
with the electrophile, under the reaction conditions. In other words, kinv > k1 and k2, and 
at the same time k1 > k2, or vice versa, for high enantioselectivity. An example of this 
mechanism was reported by Coldham et al. using N-Boc stannane rac-47 (Scheme 
2.16).
49,50
 Stannane rac-47 was transmetallated with n-BuLi at 78 °C followed by the 
addition of a mixture of chiral ligand (S,S)-56 and additional n-BuLi. The mixture was 
then warmed to 20 °C for 20 minutes. Finally, slow addition of Me3SiCl over 90 
minutes at 20 °C gave a 54% yield of (S)-3 in 96:4 er.  
 
Scheme 2.16 
 
The slow addition of the electrophile was needed to allow the diastereomeric complexes 
(S)-2∙L* and (R)-2∙L* time to interconvert and equilibrate. In this case, the electrophile 
reacted preferentially with the (S)-2∙L* complex and thus, the er of this reaction 
depended on the rate of trapping of the diastereomeric complexes and was independent 
of the rate of interconversion of (S)-2∙L* and (R)-2∙L*. However, experiments within 
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this exploration showed that a combination of both dynamic kinetic and dynamic 
thermodynamic resolution mechanisms could be at the origin of the observed 
enantioselectivities. In addition, these results showed that the lithiated intermediate was 
chemically stable at 20 °C for at least 20 minutes. Moreover, with the dynamic kinetic 
resolution high er of the products could be achieved only when slow trapping 
electrophiles were used, thus limiting the application of this methodology. 
 
On the other hand, the dynamic thermodynamic resolution process requires the rate of 
interconversion between (S)-2∙L* and (R)-2∙L* to be slower than the rate of trapping, 
kinv < k1 and k2. This would allow the formation of the most stable diastereomeric 
complex, in thermodynamic equilibrium, which would be frozen by cooling to a lower 
temperature before trapping with the electrophile. Therefore, (S)-2∙L* and (R)-2∙L* do 
not equilibrate on the reaction timescale with the electrophile and the er of the product 
would reflect the diastereomeric ratio of (S)-2∙L* and (R)-2∙L*. To date, there are no 
reported examples of dynamic thermodynamic resolution using an N-Boc pyrrolidine. 
However, Coldham showed that high enantioselectivities could be obtained starting 
from stannane 57 with an alkyl group.
50
 Transmetallation of 57 with n-BuLi at room 
temperature was followed by treatment with a mixture of (S,S)-56 and n-BuLi and the 
complexes formed were left to equilibrate for 1 hour. The temperature was then lowered 
to 20 °C before the addition of the electrophile and (S)-58 was isolated in 75% yield 
and 97:3 er (Scheme 2.17). 
 
Scheme 2.17 
 
Although several electrophiles were successfully used in the trapping of the lithiated 
intermediate (>85:15 er), the dynamic thermodynamic resolution gave high er only 
when N-isobutyl or N-allyl pyrrolidines were used as substrates. It is worth noting that 
removal of the N-isobutyl group was not possible and that the N-allyl group could only 
be cleaved under harsh conditions. 
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To conclude this section, the mechanism of the asymmetric lithiation-trapping of N-Boc 
pyrrolidine 1 has been studied in detail and has been successfully applied to other 
substrates. In addition, both enantiomeric series of trapped products can be easily 
accessed in high er (~95:5 er) by choosing the appropriate chiral ligand. In contrast, 
both of the dynamic resolution processes showed major drawbacks which make this 
methodology not easy to expand. Hence, the asymmetric lithiation-trapping remains the 
most useful methodology for the synthesis of α-substituted N-Boc pyrrolidines using 
lithium chemistry. 
  
Chapter Two: Asymmetric Synthesis of N-Boc Heterocycles at Temperatures Above ‒78 °C 
33 
2.2 High Temperature α-Lithiation and Electrophilic Trapping of N-
Boc Pyrrolidine 1 
 
When considering temperatures above 78 °C for the asymmetric α-lithiation-trapping 
of N-Boc pyrrolidine 1, higher temperatures will clearly influence the outcome of the 
reaction. Specifically, we identified four main factors which depend on the temperature 
and would affect the yield and the er of the products.  
 
We start by considering the factors which could influence the yield of the lithiation-
trapping process. First, the time for full lithiation. It is known, from the results of the 
racemic high temperature lithiation-trapping of N-Boc pyrrolidine 1, that complete 
lithiation of 1 could be achieved in short reaction times.
5
 In that work, a 5 minute 
lithiation was enough to achieve products in 49-77% yield, upon treatment of 1 with s-
BuLi in THF at 30 °C and trapping with a range of electrophiles. For example, 
trapping with Me3SiCl gave silyl pyrrolidine rac-3 in 71% yield (Scheme 2.18). 
Therefore, it is reasonable to expect that the time for full lithiation of 1 will be 
considerably shorter at higher temperatures than at 78 °C. 
 
Scheme 2.18 
 
Second, high temperatures may affect the chemically stability of the lithiated N-Boc 
pyrrolidine 2. It is possible that 2 could undergo a decomposition pathway similar to the 
one reported for THF with organolithiums.
52,53
 Lithiated intermediate rac-2 could be 
subjected to a reverse [3+2] cycloaddition to form ethylene 59 and lithium imidate 60 
(Scheme 2.19). These intermediates would eventually react further with the 
organolithium (i.e. s-BuLi),
54
 or with the electrophile.
5
 Ultimately, if temperatures 
higher than 78 °C accelerate the rate of decomposition of 2, the yield of the trapped 
product between 1 and the electrophile will be reduced. 
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Scheme 2.19 
 
Next, we consider the factors which could influence the er of the product. The er could 
be affected by the kinetic selectivity arising from the interaction between the s-
BuLi/chiral ligand complex and N-Boc pyrrolidine 1. Hence, the kinetic selectivity is 
the expression of the asymmetric deprotonation rates of 1 which selectively forms (R)-
2∙L* over (S)-2∙L* (Scheme 2.20), or vice versa, and will be dependent on the 
temperature. 
 
Scheme 2.20 
 
Undoubtedly, (R)-2∙L* and (S)-2∙L* could interconvert and this introduces the second 
important factor affecting the er: the configurational stability of the lithiated 
intermediate.
55
 Once the mixture of (R)-2∙L* and (S)-2∙L* is formed from the 
asymmetric deprotonation, the C-Li bond could break and the generated carbanion 
could invert and attach to the lithium on the opposite face, creating an equilibrium 
between (R)-2∙L* and (S)-2∙L* via the mechanism shown in Scheme 2.21. It is 
reasonable to think that at temperatures > 40 °C the rate of interconversion of (R)-2∙L* 
and (S)-2∙L* will be faster than at 78 °C, thus reducing the er of the final product. 
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Scheme 2.21 
 
To the best of our knowledge, the only asymmetric lithiation-trapping reaction of N-Boc 
pyrrolidine 1 performed at a temperature above 78 °C was reported by Beak in 1994.11 
Lithiation of 1 with s-BuLi and ()-sparteine at 40 °C for 2 hours, followed by 
electrophilic trapping with Me3SiCl afforded (S)-3 (54% yield) in 82:18 er (Scheme 
2.22). Similar results were obtained when the reaction was carried out in pentane for 4 
hours. 
 
Scheme 2.22 
 
The 82:18 er was considerably lower than the 98:2 er achieved when the reaction was 
carried out at 78 °C (see Scheme 2.2) and could be due to a partial configurational 
instability of the lithiated intermediate at 40 °C over 2 hours. In addition, the moderate 
yield reported could result from some chemical instability of the organolithium under 
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the reaction conditions. Nevertheless, the enantioselectivity reported was an 
encouraging result and it was reasonable to believe that high er could be achieved by 
modulating the lithiation time. 
 
2.2.1 Optimising the Asymmetric Lithiation-Trapping of N-Boc Pyrrolidine 1 at 
Temperatures ≥ ‒40 °C Using s-BuLi/(‒)-Sparteine 
 
The exploration of the asymmetric α-lithiation-trapping of N-Boc pyrrolidine 1 at 
“high” temperature commenced with ‒40 °C as the reaction temperature. s-BuLi and 
()-sparteine in Et2O were selected as lithiation conditions and PhCHO trapping was 
used as it was known to give two separable diastereoisomers in good yield (86% total 
yield) and high enantioselectivity (97:3 er) at ‒78 °C (see Scheme 2.8). As shown in 
Scheme 2.23 and Table 2.1, N-Boc pyrrolidine 1 was lithiated with s-BuLi and ()-
sparteine in Et2O at ‒40 °C and then trapped with PhCHO. Reaction times of 1 second, 
2 minutes, 20 minutes and 1 hour were investigated. The 1 second lithiation was used to 
have information on the kinetic selectivity of the chiral base at this temperature, since 
we assumed that, over such a short time, the lithiated intermediate would be 
configurationally stable. Longer times of 2 and 20 minutes were selected to explore the 
time required for full lithiation and finally, the 1 hour reaction should give an indication 
of the configurationally stability of the lithiated intermediate. In addition, a 1 hour 
reaction time should be favourable for process-scale reactions where longer times for 
the addition of the s-BuLi are likely to be necessary. 
 
Hence, addition of the electrophile after 1 second gave alcohols (1R,2R)-29 (6% yield) 
and (1S,2R)-30 (4% yield) in 92:8 er and 91:9 er respectively (Entry 1); unreacted 
starting 1 was also recovered (73% yield). The 2 minute lithiation afforded (1R,2R)-29 
(93:7 er) and (1S,2R)-30 (91:9 er) in 84% total yield (Entry 2), while with the 20 
minutes lithiation time a 92:8 er for both of the alcohols (87% total yield) was achieved 
(Entry 3). In Entry 4, electrophilic trapping after 1 hour gave (1R,2R)-29 (52% yield) 
and (1S,2R)-30 (27% yield) in 92:8 er and 90:10 er respectively. 
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Scheme 2.23 
Table 2.1: Study of the Asymmetric Lithiation-Trapping of N-Boc Pyrrolidine 1 with 
()-Sparteine at 40 °C 
Entry Time 
Yield of 
(1R,2R)-29 (%)
a 
er
b 
Yield of 
(1S,2R)-30 (%)
a 
er
b 
Total 
yield (%) 
1 1 s 6 92:8 4 91:9 10 
2 2 min 58 93:7 26 91:9 84 
3 20 min 58 92:8 29 92:8 87 
4 1 h 52 92:8 27 90:10 79 
a
Yield after purification by chromatography. 
b
er determined by CSP-HPLC. 
 
We were very pleased to observe that a high level of enantioselectivity (90:10-93:7 er) 
could be achieved at ‒40 °C. For the 1 second lithiation (Entry 1), the enantioselectivity 
of the reaction was due to a lower selectivity of the chiral base (s-BuLi/()-sparteine) 
with N-Boc pyrrolidine 1, which was ~92:8 er, compared to the ‒78 °C reaction (97:3 
er). Clearly, the low yield (10% total yield) reflected the incomplete lithiation of 1 and 
was accompanied by recovery of a large amount of starting material. The 
configurational stability of the lithiated intermediate over a longer period was studied 
with the longer reaction times (Entry 2-4). Analysing the level of enantioselectivity 
achieved under these conditions (90:10-93:7 er) and that obtained with the 1 second 
reaction (~92:8 er), we could establish that the lithiated intermediate was 
configurationally stable for at least 1 hour at ‒40 °C. Moreover, the high yields obtained 
in these examples (79-87% total yield) indicated a chemical stability of the lithiated N-
Boc pyrrolidine under all the reaction conditions. 
 
Inspired by the high er at ‒40 °C, higher temperatures were then investigated. A 
lithiation temperature of ‒30 °C and reaction times of 1 second, 2 minutes, 20 minutes 
and 1 hour were explored (Scheme 2.24 and Table 2.2). In Entry 1, 1 second lithiation 
gave alcohols (1R,2R)-29 and (1S,2R)-30 (19% total yield) in 89:11 er for both 
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diastereoisomers; unreacted starting 1 was also recovered in 51% yield. This revealed a 
kinetic selectivity of ~89:11 er at ‒30 °C, which was slightly lower than that observed at 
‒40 °C (~92:8 er). Electrophilic trapping after 2 minutes afforded (1R,2R)-29 (90:10 er) 
and (1S,2R)-30 (89:11 er) in a high 92% total yield (Entry 2). In the 20 minute reaction, 
alcohols (1R,2R)-29 (49% yield) and (1S,2R)-30 (28% yield) were obtained in 88:12 er 
and 87:13 er respectively (Entry 3) and the 1 hour reaction gave a 72% total yield of 
(1R,2R)-29 (87:13 er) and (1S,2R)-30 (84:16 er) (Entry 4). 
 
Scheme 2.24 
Table 2.2: Study of the Asymmetric Lithiation-Trapping of N-Boc Pyrrolidine 1 with 
()-Sparteine at 30 °C 
Entry Time 
Yield of 
(1R,2R)-29 (%)
a 
er
b 
Yield of 
(1S,2R)-30 (%)
a 
er
b 
Total 
yield (%) 
1 1 s 12 89:11 7 89:11 19 
2 2 min 58 90:10 34 89:11 92 
3 20 min 49 88:12 28 87:13 77 
4 1 h 42 87:13 30 84:16 72 
a
Yield after purification by chromatography. 
b
er determined by CSP-HPLC. 
 
Increasing the temperature resulted in a progressive, although small, reduction of 
enantioselectivity from ~90:10 er to ~85:15 er. This was attributed to a lack of 
configurational stability of the lithiated intermediate over longer reaction times at ‒30 
°C. However, the results of the 2 minute lithiation (Entry 2) showed that the lithiated N-
Boc pyrrolidine was configurationally stable for 2 minutes. Furthermore, the 92% total 
yield obtained with only a 2 minute reaction represented the highest yield achieved with 
a “high” temperature asymmetric lithiation-trapping of N-Boc pyrrolidine 1 using ()-
sparteine. Nevertheless, the isolated yields of alcohols (1R,2R)-29 and (1S,2R)-30 
diminished with the longer reaction times (Entries 3 and 4), suggesting that the lithiated 
intermediate was chemically unstable at ‒30 °C. 
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Next, to test the limits of the “high” temperature lithiation, even higher temperatures 
were explored. Thus, lithiation of 1 with s-BuLi and ()-sparteine in Et2O was carried 
out at 20 °C, 10 °C and 0 °C (Scheme 2.25 and Table 2.3). When the reaction was 
performed at 20 °C followed by trapping with PhCHO after 1 minute, alcohols 
(1R,2R)-29 and (1S,2R)-30 (86% total yield) were isolated in 86:14 er and 85:15 er 
respectively (Entry 1). Similar yields (82% total yield) and er (87:13-85:15 er) were 
obtained with the 2 minute lithiation at 20 °C (Entry 2). At 10 °C, a 30 second 
lithiation time afforded (1R,2R)-29 (43% yield) and (1S,2R)-30 (29% yield), both in 
80:20 er (Entry 3). Finally, a reaction temperature of 0 °C was explored (Entries 4 and 
5). The 10 second lithiation gave 75:25 er of (1R,2R)-29 and (1S,2R)-30 (67% total 
yield), while in the 1 minute reaction, alcohols (60% total yield) were obtained in a low 
65:35 er for (1R,2R)-29 and 62:38 er for (1S,2R)-30. 
 
Scheme 2.25 
Table 2.3: Exploration of the Asymmetric Lithiation-Trapping of N-Boc Pyrrolidine 1 
with ()-Sparteine at 20 - 0 °C 
Entry 
Temp 
(ᵒC) 
Time 
Yield of 
(1R,2R)-29 
(%)
a 
er
b 
Yield of 
(1S,2R)-30 
(%)
a 
er
b 
Total 
yield (%) 
1 20 1 min 53 86:14 33 85:15 86 
2 20 2 min 51 87:13 31 85:15 82 
3 10 30 s 43 80:20 29 80:20 72 
4 0 10 s 40 75:25 27 75:25 67 
5 0 1 min 35 65:35 25 62:38 60 
a
Yield after purification by chromatography. 
b
er determined by CSP-HPLC. 
 
With these higher temperatures, the kinetic selectivity was not determined using the 1 
second lithiation. However, it was assumed to be close to the value observed with the 
shortest reaction time at each temperature. At 20 °C, a slight loss of kinetic selectivity 
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(~85:15 er) compared with the 40 °C reactions (~92:8 er) or with the 30 °C reactions 
(~89:11 er) was observed. Nonetheless, the lithiated intermediate was configurationally 
stable at 20 °C for at least 2 minutes. The results at 0 °C indicate that at this 
temperature there was a significant decrease in the kinetic selectivity (~75:25 er) and 
the lithiated intermediate was configurationally labile. In fact, the er reduced to ~65:35 
er after only 1 minute. Thus, 0 °C is not a suitable temperature for use in the asymmetric 
lithiation protocol. 
 
In the exploration of the asymmetric α-lithiation-trapping of N-Boc pyrrolidine 1 with 
()-sparteine at “high” temperature, one of the most surprising aspects was the yield in 
relation to the reaction time. In fact, the 2 minute reactions at 30 °C and at 40 °C 
gave overall yields of 92% and 84% respectively and an 86% total yield was obtained 
after only 1 minute at 20 °C. 
 
2.2.2 Asymmetric Lithiation-Trapping of N-Boc Pyrrolidine 1 at Temperatures     
≥  ‒40 °C Using s-BuLi/(S,S)-4 
 
Next, the α-lithiation of N-Boc pyrrolidine 1 was explored using Alexakis diamine 
(S,S)-4, which was known to give excellent results in the asymmetric lithiation protocol 
(see Scheme 2.7).
13
 Unfortunately, the lithiation of 1 with s-BuLi and diamine (S,S)-4 
followed by trapping with PhCHO gave poor yields of isolated products (<20% yield). 
Hence, the lithiation of 1 was performed using s-BuLi and diamine (S,S)-4 in Et2O and 
benzophenone was used for the electrophilic trapping (Scheme 2.26 and Table 2.4). 
First, the reaction was performed at 78 °C as a reference. Thus, a 60 minute lithiation 
at 78 °C gave alcohol (S)-62 in excellent yield and enantioselectivity (82% yield, 95:5 
er) (Entry 1). Then, high temperatures of 40 °C and 30 °C were explored (Entries 2-
5). A 1 second reaction at 40 °C afforded (S)-62 (15% yield) in 86:14 er and recovered 
starting pyrrolidine 1 (50% yield) (Entry 2), while trapping after 2 minutes gave (S)-62 
in 49% yield (86:14 er) (Entry 3). In Entry 4, alcohol (S)-62 (14% yield) was obtained 
in 80:20 er with the lithiation at 30 °C for 1 second; starting 1 was also recovered in 
55% yield. Finally, a 2 minute reaction at 30 °C gave (S)-62 in 45% yield and 81:19 er 
with 15% yield of recovered N-Boc pyrrolidine 1 (Entry 5). 
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Scheme 2.26 
Table 2.4: Exploration of the Asymmetric Lithiation-Trapping of N-Boc Pyrrolidine 1 
with Alexakis Diamine (S,S)-4 
Entry Temp (ᵒC) Time Yield of (S)-62 (%)a erb 
Yield of rec. 
SM 1 (%)
a 
1 78 60 min 82 95:5 - 
2 40 1 s 15 86:14 50 
3 40 2 min 49 86:14 - 
4 30 1 s 14 80:20 55 
5 30 2 min 45 81:19 15 
a
Yield after purification by chromatography. 
b
er determined by CSP-HPLC 
 
With diamine (S,S)-4 as chiral ligand, the kinetic selectivity at 40 °C and at 30 °C 
was considerably lower compared to ()-sparteine. With the 1 second lithiation at 40 
°C, 86:14 er was achieved with (S,S)-4, while ()-sparteine gave ~92:8 er. At 30 °C, 
80:20 er was obtained with (S,S)-4, whereas an 89:11 er was attained with ()-sparteine 
under the same conditions. Furthermore, the yields of the 2 minute lithiations were 
significantly lower using benzophenone as electrophile. Due to these considerations, we 
concluded that Alexakis diamine (S,S)-4 was not an effective chiral ligand for the 
asymmetric α-lithiation at high temperatures and thus, use of diamine (S,S)-4 was not 
further investigated. 
 
2.2.3 s-BuLi/(+)-Sparteine Surrogate-Mediated Lithiation-Trapping of N-Boc 
Pyrrolidine 1  at Temperatures ≥ ‒40 °C 
 
The exploration of the asymmetric lithiation-trapping of N-Boc pyrrolidine 1 was 
continued using the (+)-sparteine surrogate, which has a more sparteine-like structure 
and hence, good results were anticipated. First, the lithiation was performed using 40 
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°C and the lithiated intermediate was trapped with PhCHO (Scheme 2.27 and Table 
2.5). A 2 minute lithiation gave a high 95% total yield of alcohols (1S,2S)-29 (90:10 er) 
and (1R,2S)-30 (92:8 er) (Entry 1), while electrophilic trapping after 1 hour afforded 
alcohols (1S,2S)-29 and (1R,2S)-30 (66% overall yield) in 90:10 er and 91:9 
respectively (Entry 2). This result showed that the organolithium was configurationally 
stable for 1 hour, although the 66% isolated yield suggested partial chemical instability 
of the lithiated intermediate at 40 °C. 
 
Scheme 2.27 
Table 2.5: Asymmetric Lithiation-Trapping of N-Boc Pyrrolidine 1 at 40 °C with (+)-
Sparteine Surrogate 
Entry Time 
Yield of 
(1S,2S)-29 (%)
a 
er
b
 
Yield of 
(1R,2S)-30 (%)
a
 
er
b
 
Total 
yield (%) 
1 2 min 65 90:10 30 92:8 95 
2 1 h 46 90:10 20 91:9 66 
a
Yield after purification by chromatography. 
b
er determined by CSP-HPLC. 
 
Although the kinetic selectivity was not assessed using the 1 second lithiation-trapping 
sequence, it is reasonable to assume a level comparable to the 2 minute reaction (based 
on the results with ()-sparteine in Table 2.1 and 2.2). Considering the er values 
obtained with the (+)-sparteine surrogate (~90:10 er) and those with ()-sparteine 
(~92:8 er, in the opposite sense), it was evident that high and synthetically useful er 
could also be achieved with the (+)-sparteine surrogate. 
 
Therefore, higher reaction temperatures of 30 °C and 20 °C were investigated 
(Scheme 2.28 and Table 2.6). Alcohols (1S,2S)-29 and (1R,2S)-30 were obtained in 
94% overall yield and 90:10 er with the 2 minute lithiation-trapping at 30 °C (Entry 1), 
while a 64% total yield was achieved in the 1 hour reaction at the same temperature, 
where (1S,2S)-29 and (1R,2S)-30 were isolated in 89:11 er and 90:10 er respectively 
(Entry 2). When the reaction temperature was raised to 20 °C, trapping after 2 minutes 
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gave alcohols (1S,2S)-29 (89:11 er) and (1R,2S)-30 (91:9 er) in 73% overall yield (Entry 
3), while in the 1 hour lithiation, the alcohols were obtained in 60% total yield and 
83:17 er and 85:15 er respectively (Entry 4).  
 
Scheme 2.28 
Table 2.6: Asymmetric Lithiation-Trapping of N-Boc Pyrrolidine 1 at 30 °C and 20 
°C with (+)-Sparteine Surrogate 
Entry 
Temp 
(ᵒC) 
Time 
Yield of 
(1S,2S)-29 
(%)
a 
er
b
 
Yield of 
(1R,2S)-30 
(%)
a
 
er
b
 
Total 
yield (%) 
1 30 2 min 67 90:10 27 90:10 94 
2 30 1 h 41 89:11 23 90:10 64 
3 20 2 min 50 89:11 23 91:9 73 
4 20 1 h 40 83:17 20 85:15 60 
a
Yield after purification by chromatography. 
b
er determined by CSP-HPLC. 
 
Amazingly, high er were achieved in all of the conditions. The results in Entries 1 and 3 
showed that the kinetic selectivity at 30 °C and 20 °C using s-BuLi/(+)-sparteine 
surrogate was ~90:10 er. This value was higher than the one at 20 °C using ()-
sparteine (~85:15 er). Furthermore, the 90:10 er achieved with the 1 hour reaction was 
higher than with ()-sparteine (~85:15 er), indicating a better configurational stability of 
the lithiated N-Boc pyrrolidine with the (+)-sparteine surrogate at 30 °C. On the other 
hand, at 20 °C the 83:17 er showed some configurational instability over 1 hour. 
Finally, the 64% and 60% overall yields obtained from the 1 hour reactions was 
additional evidence for the chemical instability of the lithiated species as a function of 
the time at high temperatures. 
 
We briefly explored two other solvents for the reaction. Thus, the asymmetric lithiation-
trapping of N-Boc pyrrolidine 1 was performed in THF and TBME as solvent, applying 
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the conditions which gave the best results in Et2O, namely 30 °C for 2 minutes and 
trapping with PhCHO. In THF, alcohols (1S,2S)-29 (38% yield) and (1R,2S)-30 (21% 
yield) were isolated in 86:14 er (Scheme 2.29, Table 2.7, Entry 2). Better 
enantioselectivities, but slightly lower yields were obtained performing the lithiation in 
TBME. In this case, alcohols (1S,2S)-29 and (1R,2S)-30 were isolated in an overall 43% 
yield and 89:11 er (Entry 3). These results showed synthetically useful 
enantioselectivities with both THF and TBME. The use of THF gave higher total yields 
(59%) than TBME (43%), which was more efficient in the enantioselective outcome 
(89:11 er). 
 
Scheme 2.29 
Table 2.7: High Temperature Asymmetric Lithiation-Trapping of N-Boc Pyrrolidine 1 
in THF and TBME 
Entry Solvent 
Yield of 
(1S,2S)-29 (%)
a 
er
b 
Yield of 
(1R,2S)-30 (%)
a 
er
b 
Total 
yield (%) 
1 Et2O 67 90:10 27 90:10 94 
2 THF 38 86:14 21 86:14 59 
3 TBME 31 89:11 12 89:11 43 
a
Yield after purification by chromatography. 
b
er determined by CSP-HPLC. 
 
These data confirmed that the (+)-sparteine surrogate could complex s-BuLi in THF at 
30 °C. The loss of er observed in THF (86:14 er) compared to that obtained in Et2O 
(90:10 er) could be due to a higher coordination ability of THF, which could displace 
some of the (+)-sparteine surrogate in the complex with s-BuLi. TBME was as good as 
Et2O in terms of enantioselectivity, but the yield was not satisfactory. 
 
The use of n-BuLi was also investigated, since this organolithium reagent is generally 
preferred to s-BuLi by process chemists for process-scale reactions. Hence, N-Boc 
pyrrolidine 1 was lithiated with n-BuLi in the presence of (+)-sparteine surrogate at 30 
°C for 1 hour. Trapping with PhCHO gave alcohols (1S,2S)-29 (13% yield) and 
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(1R,2S)-30 (7% yield) in 86:14 er an 88:12 er respectively; 35% of recovered starting 1 
was also obtained after flash column chromatography (Scheme 2.30). 
 
Scheme 2.30 
 
The 20% overall yield represents a very important result since Beak had reported that n-
BuLi/()-sparteine was unreactive towards the lithiation of N-Boc pyrrolidine 1 even at 
40 °C.11 However, we have to consider that the 20% total yield plus the 35% yield of 
recovered 1 are only accountable for about half of the reaction mass. Therefore, it 
appears that competing reactions are occurring, reducing the amount of 1 available for 
lithiation, or reducing the quantity of the n-BuLi, or both. It is possible that n-BuLi 
could act as a nucleophile and attack the C=O of the Boc group forming amide 63, 
which could further react with another n-BuLi to ultimately give ketone 67, or enamine 
66 upon acidic quenching (Scheme 2.31). Unfortunately, in the case of our lithiation of 
N-Boc pyrrolidine 1 with n-BuLi we were not able to isolate any of the suggested by-
products, probably due to their volatility. 
 
Scheme 2.31 
 
In the optimisation of the high temperature asymmetric α-lithiation-trapping of N-Boc 
pyrrolidine 1, the aim was to find the highest temperature which would give the best 
yield of the products with the highest enantioselectivity. Such requirements were met 
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using a 2 minute lithiation with s-BuLi/(+)-sparteine surrogate in Et2O (94% overall 
yield and 90:10 er). Hence, using these optimised conditions, the trapping with other 
electrophiles was explored focussing on C-C bond-forming reactions: benzophenone, 
Me2SO4, PhNCO, allyl bromide and bromobenzene were chosen. The results using 
benzophenone, Me2SO4 and PhNCO are shown in Scheme 2.32. Trapping with 
benzophenone gave alcohol (S)-62 in 56% yield and 86:14 er, the use of Me2SO4 
afforded methylated pyrrolidine (R)-68 (55% yield) in a high 92:8 er, while (S)-69 was 
obtained in 58% yield and 89:11 er with PhNCO. 
 
 
Scheme 2.32 
 
The allylation of N-Boc pyrrolidine 1 was performed following the conditions reported 
by Dieter.
39
 Thus, the lithiated intermediate was first transmetallated to a N-Boc 
organocuprate using the CuCN·2LiCl complex. The organocuprate was then reacted 
with allyl bromide to give allyl pyrrolidine (S)-23 (73% yield) in 84:16 er (Scheme 
2.33). The lower er observed in this reaction was not surprising since lithium-copper 
transmetallation and allylation usually give slightly reduced er.
13,39
 
 
Scheme 2.33 
 
Finally, the arylation of N-Boc pyrrolidine 1 was achieved using the Campos 
procedure.
29,30,56
 Lithium-zinc transmetallation with ZnCl2 in THF was followed by a 
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Negishi coupling reaction with bromobenzene using t-Bu3PHBF4 and Pd(OAc)2 as 
catalyst (details of this transformation will be given in section 4.2.1). As shown in 
Scheme 2.34, phenyl pyrrolidine (S)-70 (58% yield) was obtained in a high 92:8 er. 
 
Scheme 2.34 
 
Moderate yields (55-58%) were observed with these electrophiles, except for the 
allylation which gave a good 73% yield. In addition, high enantioselectivities were 
observed with PhNCO (89:11 er), Me2SO4 (92:8 er) and bromobenzene via the 
lithiation-Negishi coupling reaction (92:8 er) and were of the same level as those 
achieved with PhCHO. Noticeably, with benzophenone and allyl bromide the 
enantioselectivity was lower. This may be due to a competing radical-mediated trapping 
from a radical intermediate. A single electron transfer (SET) mechanism has been 
reported by Gawley when benzophenone was used as electrophile,
57
 or the lithiated 
intermediate was transmetallated to form an organocuprate.
58
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2.3 High Temperature Asymmetric Lithiation-Trapping of N-Boc 
Piperidine 34 and N-Boc Piperazine 35 
 
2.3.1 High Temperature Asymmetric Lithiation-Trapping of N-Boc Piperidine 34 
 
N-Boc piperidine 34 can be successfully lithiated using s-BuLi/TMEDA in a racemic 
protocol.
4,6,7
 However, the asymmetric lithiation-trapping of 34 was shown to be 
problematic using several chiral ligands, including ()-sparteine.59,60 Recently, our 
group reported that the asymmetric lithiation-trapping of N-Boc piperidine 34 with s-
BuLi and (+)-sparteine surrogate at 78 °C gave products in high yield and 
enantioselectivity (Scheme 2.35 and Table 2.8).
61
 When the lithiation of 34 was 
performed for 6 hours, trapping with methyl chloroformate gave ester (S)-71 in 78% 
yield and 88:12 er (Entry 1). A 3 hour lithiation afforded (S)-71 in a similar yield and er 
(83%, 87:13 er, Entry 2), whereas 1 hour was not enough to complete the lithiation of 
71 and (S)-71 was isolated in a low 24% yield (Entry 3). 
 
Scheme 2.35 
Table 2.8: Optimisation of the Asymmetric Lithiation-Trapping of N-Boc Piperidine 34 
at 78 °C 
Entry Time (h) Yield of (S)-71 (%) er 
1 6 78 88:12 
2 3 83 87:13 
3 1 24 86:14 
 
The enantioselectivity obtained with N-Boc piperidine 34, ~88:12 er, was lower than 
with N-Boc pyrrolidine 1 (95:5 er). In addition, at least a 3 hour lithiation time was 
needed at 78 °C to lithiate 34. The configurational stability of the lithiated 
intermediate was also investigated by incubating the lithiated complex at 40 °C for 2 
hours before trapping with MeO2CCl at 78 °C. In this case, (S)-71 was isolated in 83% 
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yield and 79:21 er, showing a partial configurational instability of the lithiated 
intermediate at 40 °C. Moreover, the lithiated intermediate was configurationally 
unstable at 20 °C over 2 hours: ester (S)-71 was obtained in 59:41 er. 
 
The result obtained by incubating the lithiated complex at 40 °C for 2 hours was 
interesting and we wondered whether the lithiation of N-Boc piperidine 34 could be 
performed directly at higher temperatures. Thus, we began our study by carrying out the 
lithiation of 34 with s-BuLi and the (+)-sparteine surrogate at 50 °C, 40 °C and 30 
°C (Scheme 2.36 and Table 2.9). At 50 °C, a 30 minute lithiation and trapping with 
methyl chloroformate gave ester (S)-71 in 46% yield and 79:21 er (Entry 1). A higher 
64% yield (80:20 er) was obtained at 40 °C for 20 minutes (Entry 2), while at 30 °C, 
(S)-71 was isolated (47% yield) in 77:23 er (Entry 3). At each temperature, unreacted 
starting material was also recovered, as indicated in Table 2.9 (Entries 1-3). 
 
Scheme 2.36 
Table 2.9: Asymmetric Lithiation-Trapping of N-Boc Piperidine 34 at Temperature ≥ 
50 °C 
Entry Temp (ᵒC) 
Time 
(min) 
Yield of (S)-71 (%)
a 
er
b 
Yield of rec. 
SM 34 (%)
a 
1 50 30 46 79:21 21 
2 40 20 64 80:20 15 
3 30 5 47 77:23 26 
a
Yield after purification by chromatography. 
b
er determined by CSP-HPLC. 
 
Although the best yield (64%) was achieved at 40 °C, good yields were obtained at 
50 °C and at 30 °C. These results also showed a similar level of enantioselectivity at 
each temperature (77:23-80:20 er). As expected, these values were lower than that 
observed at 78 °C (~88:12 er). Unfortunately, we were unable to establish if the lower 
enantioselectivity was due to a lower kinetic selectivity of the s-BuLi/(+)-sparteine 
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surrogate complex with N-Boc piperidine 34, or to configurational stability of the 
lithiated intermediate. In addition, the recovery of 34 was probably due to incomplete 
lithiation of the substrate. 
 
2.3.2 High Temperature Asymmetric Lithiation-Trapping of N-Boc Piperazine 35 
 
The high temperature asymmetric lithiation-trapping of N-Boc piperazine 35 was also 
briefly investigated. McDermott reported the only published asymmetric lithiation-
trapping of a N-Boc piperazine with s-BuLi and ()-sparteine. However, extensive 
research on the asymmetric lithiation-trapping of N-Boc piperazines has recently been 
carried out in our group. Among those results, it was discovered that lithiation of 35 
with s-BuLi and the (+)-sparteine surrogate at 78 °C for 1 hour and reaction with 
methyl chloroformate afforded ester (S)-72 in 91% yield and 89:11 er (Scheme 2.37).
62
 
  
Scheme 2.37 
 
Our results on the “high” temperature lithiation of N-Boc piperazine 35 are shown in 
Scheme 2.38 and Table 2.10. First, 35 was lithiated with s-BuLi and the (+)-sparteine 
surrogate at 50 °C for 3 minutes and trapped with methyl chloroformate to give (S)-72 
in 71% yield and 82:18 er (Entry 1). Then, the lithiation-trapping was performed at 30 
°C for 2 minutes and (S)-72 was isolated in 88% yield and 78:22 er (Entry 2). Not 
surprisingly, the use of temperatures ≥ 50 °C resulted in a decreased enantioselectivity 
compared to the result at 78 °C. However, good yields were achieved even though 
short lithiation times were employed. 
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Scheme 2.38 
Table 2.10: Asymmetric Lithiation-Trapping of N-Boc Piperazine 35 at 50 °C and 30 
°C 
Entry Temp (ᵒC) Time (min) Yield of (S)-72 (%)a erb 
1 50 3 71 82:18 
2 30 2 88 78:22 
a
Yield after purification by chromatography. 
b
er determined by CSP-HPLC. 
 
In conclusion, the “high” temperature asymmetric lithiation-trapping of six-membered 
heterocycles such as N-Boc piperidine 34 and N-Boc piperazine 35, resulted in a 
reduction of the enantioselectivity. The values of er observed with both substrates were 
~80:20 er in each of the conditions explored. Thus, we concluded that 80:20 er is the 
highest value which can be reached with the lithiation at “high” temperature of these 
two six-membered N-Boc heterocycles. 
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2.4 High Temperature Asymmetric Lithiation-Trapping of N-Boc 
Imidazolidine 36 
 
Next, we decided to investigate a different five-membered ring substrate for the high 
temperature lithiation-trapping, namely N-Boc imidazolidine 36. The asymmetric 
lithiation and electrophilic trapping of N-Boc imidazolidine 36 has a major limitation: 
yields above 50% cannot be obtained at 78 °C.43,44 The reason is the low rate of 
interconversion of the two N-Boc rotamers 36a and 36b (Scheme 2.39) and the 
observation that the deprotonation does not occur on the aminal carbon. Therefore, since 
the lithiation is directed by the C=O of the Boc group, only pre-lithiation complex 73b, 
generated from rotamer 36b, could be α-lithiated, whereas pre-lithiation complex 73a 
will be unreactive as the carbonyl is pointing towards the aminal carbon. The low rate of 
interconversion of 36a and 36b was proven by variable temperature (VT) 
13
C NMR 
spectroscopy studies carried out in DMSO-d6 by Coldham.
43
 The half-life (t1/2) for 
rotation about the C-N bond at 78 °C was calculated to be t1/2 >100 hours; in contrast, 
t1/2 is ~10 minutes at 40 °C. 
 
Scheme 2.39 
 
Coldham’s experimental results at 78 °C were in accordance with these calculations. 
Lithiation of 36 with s-BuLi and ()-sparteine in Et2O at 78 °C for 1 hour followed by 
trapping with benzophenone gave alcohol (S)-74 in 50% yield and 92:8 er (Scheme 
2.40). Trapping with other electrophiles such as Bu3SnCl, Me3SiCl, and MeI gave 
products in 40-50% yield and high enantioselectivity (>92:8 er). The absolute 
configuration of the products was confirmed by X-ray crystallography of alcohol (R)-
74. 
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Scheme 2.40 
 
In 2010, our group reported the racemic lithiation-trapping of N-Boc imidazolidine 36 at 
30 °C, using a diamine-free methodology.5 Lithiation of 36 with s-BuLi in THF at 30 
°C for 10 minutes and then trapping gave products in 50-74% yield. For example, 
trapping with PhNCO afforded amide rac-75 in 74% yield (Scheme 2.41). These results 
showed that it was possible to obtain good yields in the lithiation-trapping of N-Boc 
imidazolidine 36 if a reaction temperature of 30 °C was used. Therefore, these results 
were evidence that at 30 °C the rotamers 36a and 36b could interconvert. In addition, 
at this temperature the lithiated intermediate was chemically stable for at least 10 
minutes. 
 
Scheme 2.41 
 
2.4.1 Investigating the Rotational Barrier for Interconversion of N-Boc Rotamers 
of N-Boc Imidazolidine 36 
 
Before investigating the “high” temperature asymmetric lithiation-trapping of N-Boc 
imidazolidine 36, we carried out our own VT NMR spectroscopic studies. We decided 
that THF-d8 was a suitable solvent for these experiments and this is important since 
THF could also be a potential solvent for the lithiation methodology as has been shown 
for N-Boc pyrrolidine 1. The equilibrium between 36a and 36b shown in Scheme 2.39, 
is related to rate constant, k, which can be calculated using the Eyring equation (1). 
k = (kB·T/h)·e
(ΔG‡/RT)
     (1) 
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where kB is Boltzmann’s constant, h is Planck’s constant, R is the gas constant and ΔG
‡
 
is the Gibbs free energy of activation. It is known that, when the exchange rate between 
36a and 36b is slow, two different sets of signals are observed in the NMR spectrum, 
one for each rotamer. In contrast, with a fast rate of interconversion, only the average 
signal is present. Between these two limits a broad and flat peak should appear. The 
temperature when this happens is called the coalescence temperature, Tc. At Tc, the rate 
constant k is given by equation (2). 
k = (π·Δν0)/√      (2) 
In this equation, Δν0 is the separation in Hertz between the peaks of 36a and 36b at a 
slow rate of interconversion. At this point, ΔG‡ can be calculated using equation (3). 
ΔG‡ = RT[ln(kB·T/h)  lnk]     (3) 
Knowing ΔG‡, it possible to calculate the rate constant k at different temperatures using 
the Eyring equation (1), assuming that the change in entropy is zero on changing the 
temperature. Finally, the half-life for rotation is given by equation (4). 
t1/2 = ln2/k     (4) 
Thus, we started our 
1
H NMR spectroscopy experiments with a sample of N-Boc 
imidazolidine 36 in THF-d8. The methylene signals at δH 3.87 and δH 3.86 were selected 
and at 20 °C we measured Δν0 = 6.11 Hz (Figure 2.1, a). This value gives a rate 
constant k = 13.6 s
1
 and a half-life t1/2 = 0.05 s at the Tc. The two signals coalesced at 
about 38 °C (311 K) (Figure 2.1, e) and therefore, the barrier for rotation, ΔG‡, was 
calculated to be 69.5 kJ mol
1
. Then, the use of these data in the Eyring equation gives a 
half-life t1/2 ~200 hours at 78 °C (195 K). At 40 °C (233 K), the value is t1/2 ~10 
minutes, while at 30 °C the half-life (t1/2) is ~2 minutes. These results in THF-d8 were 
fully comparable with those obtained by Coldham in DMSO-d6. 
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Figure 2.1: VT 
1
H NMR spectra of N-Boc imidazolidine 36 in THF-d8 
 
In order to have a deeper insight into the lithiation process of N-Boc imidazolidine 36, 
we decided to use in situ infra-red (ReactIR™) spectroscopy which is a useful method 
to monitor the course of the lithiation, as recently demonstrated by our group.
61,63
 These 
studies monitor the decrease in absorbance of the C=O peak of the Boc group after the 
addition of s-BuLi. The lithiated intermediate that forms has a C=O peak at a different 
frequency. In Scheme 2.42, the results of the lithiation of N-Boc imidazolidine 36 in the 
presence of s-BuLi and the (+)-sparteine surrogate in Et2O at 40 °C are presented. The 
reaction progress can be evaluated by the disappearance and appearance of new signals 
in the 3-D plot (a), or by a 2-D plot of the peak intensity of specific peaks (1710 cm
1
 
and 1645 cm
1
 in this case) as a function of time (b). In this example, the addition of s-
BuLi caused a decrease in the νC=O of N-Boc imidazolidine 36 (1710 cm
1
) and an 
increase in the 1645 cm
1
 peak, corresponding to the νC=O of the lithiated intermediate 
(S)-77∙L*. 
a.  
b.   a  a 
c.   a  a 
d. 
  a  a 
e.   a  a 
f. 
  a  a 
20 °C 
0 °C 
25 °C 
35 °C 
38 °C 
50 °C 
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(a) 
 
(b) 
Scheme 2.42 
 
Interestingly, these plots showed a fast initial lithiation of a part of N-Boc imidazolidine 
36 in about 2 minutes. However, the lithiation was incomplete and no further change in 
the concentration of the lithiated species and N-Boc imidazolidine 36 was observed over 
1 hour. This could be explained by a slow rate of interconversion of the two rotamers 
even at 40 °C. The peak at 1684 cm1 was also noteworthy. After an initial formation, 
the intensity of the peak remained constant over 1 hour and we believe that this peak 
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(1684 cm
1
) could be assigned to the pre-lithiation complex of the unreactive rotamer 
73a. This may represent additional evidence for the non-interconversion of the 
rotamers. On the other hand, the ReactIR™ data did not fit with the calculation of the 
half-life for rotation obtained by VT 
1
H NMR spectroscopy studies (t1/2 ~10 minutes).  
 
A reason for the difference between the ReactIR™ data and VT 1H NMR spectroscopy 
results could be due to the formation of the pre-lithiation complexes, between the 
substrate and (+)-sparteine surrogate, 73a and 73b which are equally formed under the 
lithiation conditions (Scheme 2.43). It might be possible that the rotation of the rotamers 
is blocked by the increased steric hindrance, once 73a and 73b are formed. 
 
Scheme 2.43 
 
Therefore, in order to allow the rotamers to interconvert, it is necessary that the 
formation of 73a and 73b is reversible. With Et2O as lithiation solvent, the formation of 
the pre-lithiation complexes 73a and 73b could be an irreversible process (Scheme 
2.44). This may be due to the incapacity of the Et2O to displace the chiral ligand from 
the pre-lithiation complex. Thus, only pre-lithiation complex 73b would be lithiated. 
This would lead to a highest theoretical yield of 50%. For clarity, s-butyl group of s-
BuLi is omitted in Schemes 2.44 and 2.45. 
 
Scheme 2.44 
 
In contrast, we reasoned that THF, which is a good coordinating solvent, could displace 
the chiral ligand on 73a and coordinate to the organolithium to form 79a (Scheme 2.45). 
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At this point, the rotamers could eventually interconvert due to reduced steric hindrance. 
Finally, the chiral ligand should form the reactive pre-lithiation complex 73b and lead 
to the lithiation of 36. 
 
Scheme 2.45 
 
In addition to these considerations, previous work in our group had shown that THF 
could give high enantioselectivity in the asymmetric lithiation-trapping protocol, as long 
as the (+)-sparteine surrogate was used as the chiral ligand (see Scheme 2.9). Therefore, 
we decided to study the effect of THF with N-Boc imidazolidine 36. First, the progress 
of the lithiation of N-Boc imidazolidine 36 with s-BuLi and the (+)-sparteine surrogate 
in THF at 40 °C was monitored using ReactIR™ spectroscopy (Scheme 2.46). 
 
Surprisingly, complete disappearance of the 1705 cm
1
 peak corresponding to the νC=O 
of 36 was observed in ~10 minutes, with a parallel formation of the lithiated 
intermediate (S)-77∙L* peak (at 1646 cm1). The traces obtained in THF were 
substantially different from those with Et2O (see Scheme 2.42). In particular, from the 
2-D plot (b), the formation of the lithiated intermediate appeared to proceed more in 
THF than in Et2O. In addition, the 2-D plot (b) showed an initial fast lithiation in ~1 
minute, followed by a slower lithiation. This was presumably due to the interconversion 
of unreactive rotamer 73a to rotamer 73b, which was then lithiated. 
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(a) 
 
(b) 
Scheme 2.46 
 
Thus, the ReactIR™ results suggested that higher yields of trapped products should be 
obtained in THF than in Et2O. Therefore, a range of synthetic experiments were carried 
out to providing supporting results. 
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2.4.2 Asymmetric Lithiation-Trapping of N-Boc Imidazolidine 36 
 
We decided to investigate the solvent effect by comparing the lithiation-trapping of 36 
in Et2O and in THF. First, 36 was lithiated with s-BuLi and (+)-sparteine surrogate at 
40 °C and trapped with benzophenone (Scheme 2.47 and Table 2.11). The use of 
benzophenone presented a complication due to the formation of both the desired alcohol 
(S)-74 and cyclised (S)-76, which was not always isolated. Lithiation for 1 hour in Et2O 
gave (S)-74 (40% yield) in 93:7 er (Entry 1) and 17% of recovered starting material. 
Despite the low isolated yield of (S)-74, the 
1
H NMR spectrum of the crude product 
showed 74% conversion of 36 into the products. 
 
The lithiation of N-Boc imidazolidine 36 was performed in Et2O for 30 minutes. 
Alcohol (S)-74 and cyclised (S)-76 were obtained in 36% yield (92:8 er) and 10% yield 
(77:23 er) respectively (Entry 2); starting 36 was recovered in 26% yield. It is clear that 
the er of alcohol (S)-74 and cyclised (S)-76 were considerably different. Specifically, 
the er of (S)-74 derived from direct trapping by benzophenone, whereas the er of 
oxazolidinone (S)-76 originated from a kinetic cyclisation of one lithium alkoxide over 
the other. We can assume that the (+)-sparteine surrogate would be coordinated to the 
lithium alkoxide generating a diastereomeric lithiated species, where one 
diastereoisomer would cyclise faster than the other. Using the er and yields of (S)-74 
and (S)-76, it is possible to calculate the er of the combined products. For Entry 2 this 
value was 89:11 er. Next, lithiation for 30 minutes in THF gave (S)-74 (90:10 er) in 
52% yield together with cyclised (S)-76 in 24% yield (70:30 er) (Entry 3); starting 36 
(20% yield) was also recovered. The combined er was 86:14 er in this case. The total 
isolated yield of the lithiation in Et2O (46%) was lower than the one in THF (76%), but 
the er was slightly higher for the reaction in Et2O (89:11 er versus 84:16 er). 
Interestingly, the 
1
H NMR spectra of the crude product from both Entries 2 and 3 
showed similar amounts of products:starting material and thus, a yield higher than 46% 
was expected from the reaction in Et2O (Entry 2). 
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Scheme 2.47 
Table 2.11: Asymmetric Lithiation-Trapping of N-Boc Imidazolidine 36 at 40 °C with 
Ph2CO in Et2O and THF 
Entry Solvent 
Time 
(min) 
Yield 
(%), er of 
(S)-74
a 
Yield 
(%), er of 
(S)-76
a 
Yield of 
rec. SM 
36 (%)
a
 
Total 
yield 
(%)
b 
P : SM 36
c 
1 Et2O 60 40, 93:7 - 17 40 74:26 
2 Et2O 30 36, 92:8 10, 77:23 26 46 73:27 
3 THF 30 52, 90:10 24, 70:30 20 76 78:22 
4 Et2O 20 43, 91:9 6, 75:25 34 49 64:36 
5 THF 20 50, 93:7 20, 71:29 26 70 69:31 
6 THF 10 45, 91:9 - 21 45 74:26 
a
Yield after purification by chromatography; er determined by CSP-HPLC. 
b
Total yield 
of (S)-74 + (S)-76. 
c
P : SM 36 is the ratio of (S)-74 + (S)-76 : 36, which determined by 
1
H NMR spectroscopy of the crude product. 
 
A 20 minute lithiation time was also investigated. In Et2O, (S)-74 was isolated in 43% 
yield (91:9 er) and (S)-76 in 6% yield (75:25 er) (Entry 4), from which an 89:11 er was 
calculated; there was also recovered starting 36 (34% yield). In THF, the lithiation-
trapping of N-Boc imidazolidine 36 afforded (S)-74 in 50% yield (93:7 er) and cyclised 
(S)-76 in 20% yield (71:29 er) (Entry 5), with an 87:13 er of combined products; 
starting 36 (26% yield) was also recovered. As was observed with the 30 minute 
lithiations, ~65-70% conversion of 36 for the lithiation in THF and Et2O was noticed. In 
addition, the higher value of recovered starting material 36 (~30-35%) is consistent with 
the shorter lithiation time compared to the 30 minute lithiations. The reaction in THF 
gave a better total yield (70%), but a slightly lower er (87:13 er) (Entry 5) than the one 
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in Et2O (49% overall yield and 89:11 er, Entry 4). Finally, a 10 minute lithiation in THF 
gave (S)-74 in 45% yield and 91:9 er and recovered starting 36 (21% yield, Entry 6).  
 
Analysing the products:starting material ratios obtained from the 
1
H NMR spectra of the 
crude reaction mixture, it was clear that conversions of ≥64% were achieved both in 
Et2O and THF. These values appeared to be in contrast with the ReactIR™ observations 
and did not provide any evidence for a solvent effect. 
 
Hence, other electrophiles such as phenyl isocyanate and methyl iodide were explored. 
The results with phenyl isocyanate are shown in Scheme 2.48 and Table 2.12. 
Lithiation-trapping of N-Boc imidazolidine 36 at 40 °C for 30 minutes in THF or Et2O 
gave (S)-75 in 58% (85:15 er) and 48% yield (88:12 er) respectively (Entries 1 and 2). 
Starting 36 was recovered in 18% yield in THF and 26% yield in Et2O. When the 
lithiation was performed for 20 minutes, (S)-75 was isolated in 71% yield and 85:15 er 
in THF (Entry 3) and in 30% yield (89:11 er) in Et2O (Entry 4). 36 was recovered in 
25% and 11% yield respectively. 
 
Scheme 2.48 
Table 2.12: Asymmetric Lithiation-Trapping of N-Boc Imidazolidine 36 at 40 °C with 
PhNCO in Et2O and THF 
Entry Solvent 
Time 
(min) 
Yield of
 
(S)-75 
(%)
a 
er
b 
Yield of rec. 
SM 36 (%)
a
 
1 THF 30 58 85:15 18 
2 Et2O 30 48 88:12 26 
3 THF 20 71 85:15 25 
4 Et2O 20 30 89:11 11 
a
Yield after purification by chromatography. 
b
er determined by CSP-HPLC. 
 
Finally, the electrophilic trapping was carried out with methyl iodide (Scheme 2.49 and 
Table 2.13). Methylated product (R)-80 was obtained in 56% yield (THF) and 39% 
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yield (Et2O) from the 30 minute lithiations (Entries 1 and 2), whereas the 20 minute 
reactions gave (R)-80 in 52% yield (THF) and 37% yield (Et2O) (Entries 3 and 4). As 
for the other electrophiles, recovered 36 was also isolated (19-32% yield). 
Unfortunately, with methylated (R)-80 it was not possible to develop a CSP-HPLC or 
GC method to determine the er. In addition, we assumed that the use of chiral shift 
NMR spectroscopy experiments would be ineffective due to the presence of N-Boc 
rotamers. Hence, chiral shift NMR spectroscopy studies were not attempted. 
 
Scheme 2.49 
Table 2.13: Asymmetric Lithiation-Trapping of N-Boc Imidazolidine 36 at 40 °C with 
MeI in Et2O and THF 
Entry Solvent Time (min) 
Yield of
 
(R)-80 (%)
a 
Yield of rec. 
SM 36 (%)
a
 
1 THF 30 56 19 
2 Et2O 30 39 22 
3 THF 20 52 38 
4 Et2O 20 37 32 
a
Yield after purification by chromatography. 
 
With phenyl isocyanate and methyl iodide it was not possible to determine the 
conversion of 36 due to the complexity of the 
1
H NMR spectra of the crude products. 
However, the isolated yields in THF were both >50%, whereas 49% yield was the 
highest yield achieved in Et2O. Therefore, the observation based on the isolated yields 
would suggest a solvent effect. Nevertheless, the low starting material recovery showed 
that more than 50% of 36 was probably lithiated both in Et2O and THF. Hence, these 
results could not represent a conclusive evidence for the solvent effect observed in the 
ReactIR™ spectroscopy experiments. 
 
Considering the enantioselectivities, it was noticed that in THF ~85:15 er were obtained 
with both benzophenone and phenyl isocyanate, whereas in Et2O these electrophiles 
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gave ~89:11 er. Hence, the enantioselectivity of the asymmetric lithiation-trapping of N-
Boc imidazolidine 36 in THF is lower than in Et2O, as already observed with N-Boc 
pyrrolidine 1 (see Scheme 2.29, Table 2.7). 
 
To conclude this section, we were unable to prove the solvent effect apparently 
observed in the ReactIR™ spectroscopy studies using synthetic experiments. However, 
we were very pleased to be able to achieve yields of >50% in the asymmetric lithiation-
trapping of N-Boc imidazolidine 36. 
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2.5 Conclusions and Future Work 
 
In this chapter, it was demonstrated that the asymmetric lithiation and electrophilic 
trapping of N-Boc heterocycles with s-BuLi and chiral diamines could be successfully 
performed at temperatures between 50 and 20 °C, giving good yields (47-95%) and 
synthetically useful enantioselectivities (77:23-93:7 er). It was also shown that at these 
temperatures high yields could be achieved even using very short reaction times (2-20 
min) (Scheme 2.50). Clearly, the application of this high temperature methodology to 
process-scale lithiations would potentially reduce the energy cost in using this 
chemistry. 
 
Scheme 2.50 
 
It was also illustrated that the reduction of er observed at high temperatures compared to 
the results at 78 °C was due to a lower kinetic selectivity and not due to the 
configurational instability of the lithiated intermediate. However, at temperatures > 20 
°C, the lithiated intermediate was considerably configurationally unstable and the loss 
of er was larger. 
 
Ultimately, we studied the lithiation and electrophilic trapping of N-Boc imidazolidine 
36. A solvent effect was highlighted with ReactIR™ spectroscopy studies. 
Unfortunately, synthetic results were not sufficient to support this observation. 
However, with the use of THF, we showed that high yields could be obtained (52-76%). 
For example, lithiation in THF and trapping with phenyl isocyanate gave amide (S)-75 
(85:15 er) in 71% yield (Scheme 2.51). 
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Scheme 2.51 
 
Having developed the asymmetric lithiation-trapping methodology with these N-Boc 
heterocycles, our future plan would be to apply this chemistry in the total synthesis of 
natural products and pharmaceutically active compounds. Suitable targets could include 
eletriptan (Relpax
®
), marketed by Pfizer for the acute treatment of migraine,
2
 and ()-
kainic acid as suitable targets (Figure 2.2). 
 
Figure 2.2 
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Chapter Three: Studies Towards the Synthesis of 
Stable α-Amino Sulfoxides 
 
One of the main areas of research in our group for the past few years has been the 
exploration of the synthesis of enantiopure N-Boc α-amino sulfoxides such as 82. These 
substrates could be used as stable and storable precursors to enantiopure α-substituted 
N-Boc heterocycles. It was hoped that the use of enantiopure N-Boc α-amino sulfoxides 
would address the major limitations related to asymmetric lithiation chemistry: the 
requirement for low temperatures (78 °C), long reaction times (1-6 hours) for the 
lithiations and a typical highest er of the products of ~95:5 er. 
 
The approach proposed in our group to achieve the synthesis of α-amino sulfoxide 82 in 
≥99:1 er and ≥99:1 dr was by asymmetric lithiation of N-Boc pyrrolidine 1 and trapping 
with Andersen’s sulfinate (SS)-81.
64,65
 This would be followed by sulfoxide-magnesium 
exchange to give Grignard intermediate 83 in ≥99:1 er.65-67 Finally, electrophilic 
trapping of the organomagnesium 83 should allow access to α-substituted pyrrolidines 
55 in ≥99:1 er (Scheme 3.1). 
 
Scheme 3.1 
 
This chapter describes our attempts at synthesising N-Boc α-amino sulfoxides such as 
82, including an overview of previous work in the group.  
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3.1 Overview of Synthetic Approaches to α-Amino Sulfoxides 
 
Although our interest was to access N-Boc α-amino sulfoxides such as pyrrolidine 
sulfoxides 86 and piperidine sulfoxides 87 via asymmetric lithiation-trapping of N-Boc 
heterocycles 45 (Scheme 3.2), the lack of literature reporting such a transformation 
urged us to consider the different methods which have been used to synthesise α-amino 
sulfoxides. 
 
Scheme 3.2 
 
The principal synthetic strategy to α-amino sulfoxides was oxidation of lactam-
containing α-amino sulfides. For example, Thomas in 1989, used oxidation of sulfides 
88 with m-CPBA to prepare a diastereomeric mixture of sulfoxides 89 in 90% yield 
(Scheme 3.3).
68
 
 
Scheme 3.3 
 
Similarly, a diastereomeric mixture of sulfoxide azetidones 91 was synthesised from 
sulfide 90 in a high 93% yield using sodium periodate as the oxidising agent (Scheme 
3.4).
69
 An analogous stable azetidone sulfoxide was used as a precursor for the synthesis 
of β-lactam antibiotics.70   
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Scheme 3.4 
 
More recently, research in our group was focused on the synthesis of α-amino N-Boc 
sulfoxides 82.
71
 The use of lithiation-trapping methodology
5
 would arguably be the 
most step efficient route for the synthesis of sulfoxides 82. Hence, N-Boc pyrrolidine 1 
was lithiated with s-BuLi in THF at 78 °C for 1 hour and then trapped with sulfinate 
92. Under these conditions, instead of the desired sulfoxides 82, the only product 
isolated was vinyl sulfoxide 93 (31% yield) (Scheme 3.5). Attempts to synthesise α-
amino N-Boc sulfoxides 82 via oxidation of the corresponding sulfide were also 
unsuccessful. It is also worth mentioning that the same elimination process was reported 
for the analogous lithiation-trapping of N-Boc piperidine and the corresponding vinyl 
sulfoxide was the only product isolated. 
 
Scheme 3.5 
 
In order to explain these disappointing results, two possible mechanisms which could 
lead to the formation of the undesired vinyl sulfoxide 93 were proposed: both 
mechanisms arise from the elimination of the α-sulfoxide group from 82.71 First, it was 
envisaged that an elimination mechanism triggered by the nitrogen lone pair could 
occur. According to this, the elimination of α-sulfoxide would form iminium ion 94, 
which could be subsequently deprotonated by removal of the β-proton to give 
dihydropyrrole 95. Finally, 95 could be subjected to vinylic lithiation, as reported by 
Beak in related systems,
7
 and trapped with sulfinate 92 to give vinyl sulfoxide 93 
(Scheme 3.6). Notably, the formation of dihydropyrrole 95 was previously reported 
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from an α-sulfonyl pyrrolidine in the presence of a Lewis acid under ultrasonication 
conditions.
72
 
 
Scheme 3.6 
 
The second mechanism which was hypothesised follows a pericyclic pathway. In this 
case, sulfoxide 82 would undergo a reverse cycloaddition to give dihydropyrrole 95, 
which would be lithiated
7
 and trapped with sulfinate 92 to afford vinyl sulfoxide 93 
(Scheme 3.7). This mechanism was based on the well-known elimination of 
sulfoxides.
73
 As has been reported, aryl sulfoxides can undergo β-elimination at room 
temperature, although higher temperatures are usually needed to facilitate the process.
74-
76
  
 
Scheme 3.7 
 
Hence, to understand which elimination mechanism was prevailing, a range of N-amido 
and N-thioamido heterocycles were used as substrates in the lithiation-trapping 
methodology.
77,78
 It was suggested that the increased electron withdrawing effect of 
amide and thioamide groups could make the nitrogen lone pair less available for the α-
elimination. However, the lithiation-trapping of N-thiopivaloyl pyrrolidine 96 with s-
BuLi/TMEDA in THF at 78 °C for 3 hours and trapping with sulfinate 92 gave traces 
of eliminated sulfoxide 98 and no α-amino sulfoxide 97 was formed (Scheme 3.8). 
Amides were also used, but the lithiation-trapping of these substrates was unsuccessful. 
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Scheme 3.8 
 
Slightly better results were achieved when N-thiopivaloyl azetidine 99 was lithiated. In 
this case, sulfoxides 100 were isolated in 9% yield (Scheme 3.9). It was suggested that 
the four-membered ring strain could disfavour both the reverse cycloaddition and the α-
elimination. Unfortunately, the use of s-BuLi/()-sparteine in Et2O with 99 gave only 
recovered starting material. 
 
Scheme 3.9 
 
Due to the problems encountered caused by the presumed instability of α-amino 
sulfoxides, the synthesis of acyclic α-amino sulfoxide was also explored. It was hoped 
that the absence of β-protons would provide some evidence for which elimination 
pathway was occurring. Interestingly, the oxidation of benzamide 101 and 
thiobenzamide 102 with m-CPBA gave stable sulfoxides 103 and 104 in high yields, 
84% and 77% yield respectively (Scheme 3.10). 
 
Scheme 3.10 
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As an acyclic N-Boc example, N-Boc dimethylamine 105 was lithiated and trapped with 
sulfinate 92 to give sulfoxide 106 in 71% yield (Scheme 3.11). The stability of acyclic 
sulfoxides such as 103, 104 and 106 seemed to support the hypothesis of a reverse 
cycloaddition pathway. However, the partial instability of 106 on silica (presumably due 
to α-elimination) prevented our group from having absolute certainty on the elimination 
process which was occurring.  
 
Scheme 3.11 
 
Finally, the problem of the sulfoxide stability was elegantly bypassed using 
azabicyclo[3.1.0]hexanes.
31
 In these substrates, the elimination of the sulfoxide is not 
allowed by Bredt’s rule.79,80 Azabicyclo[3.1.0]hexanes were synthesised from 4-chloro 
piperidine 107, as previously reported by Beak.
81,82
 Thus, treatment of 4-chloro N-Boc 
piperidine 107 with s-BuLi and TMEDA at 78 °C for 1 hour and subsequent trapping 
with sulfinate 92 gave diastereoisomers rac-anti-37 and rac-syn-37 in 51% and 25% 
yields respectively (Scheme 3.12). 
 
Scheme 3.12 
 
Remarkably, the asymmetric version of the lithiation-trapping of 4-chloro N-Boc 
piperidine 107 performed with s-BuLi/diamine (R,R)-4 and Andersen’s sulfinate (SS)-81 
led to sulfoxides anti-(R,R,SS)-37 (51% yield) in high 99:1 er and syn-(S,S,SS)-37 (25% 
yield) in 87:13 er (Scheme 3.13). The low er observed for syn-(S,S,SS)-37 was ascribed 
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to a competitive sulfoxide-lithium exchange process which could cause an inversion of 
configuration at the sulfur. Several chiral ligands were explored in order to obtain syn-
(S,S,SS)-37 in ≥99:1 er, but without any success. 
 
Scheme 3.13 
 
To summarise, from the background knowledge on α-amino sulfoxides in the literature 
and in our group, we could place the sulfoxides in two principal categories: stable α-
amino sulfoxides and unstable α-amino sulfoxides. Stable sulfoxides were both cyclic, 
such as lactams 89 and 91, N-thiopivaloyl azetidine 100 and N-Boc 
azabicyclo[3.1.0]hexanes 37, and acyclic such as amide 103, thioamide 104 and N-Boc 
dimethylamine 106 (Figure 3.1). 
 
Figure 3.1 
 
In contrast, sulfoxides of amide 96, N-Boc pyrrolidine 82 and N-Boc piperidine 108 
were unstable and only the corresponding vinyl sulfoxides were isolated from their 
attempted synthesis via lithiation-trapping (Figure 3.2). It can also be concluded that 
both stable and unstable sulfoxides presented chemical features which made the 
understanding of the elimination mechanism unclear.   
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Figure 3.2 
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3.2 Project Outline 
 
Considering α-amino sulfoxides in Figures 3.1 and 3.2 in relation to the proposed 
elimination mechanisms, it is possible to notice that the stability could be equally due to 
a lack of β-protons, or to a delocalisation of the nitrogen lone pair. Therefore, these 
compounds had not provided a conclusive explanation on the potential pathway for the 
elimination of the α-sulfoxide group. For this reason, we decided to explore different 
strategies which could hopefully clarify the elimination process and open the way to the 
synthesis of stable α-amino sulfoxides. 
 
We envisaged three main areas that could help in understanding the elimination 
mechanism. First, the presence of β-hydrogens that could favour the reverse 
cycloaddition mechanism would be investigated. For example, comparison of N-Boc p-
anisidine sulfoxide 40, which has no β-hydrogens, and 2-phenyl 2-sulfoxide N-Boc 
pyrrolidine 41, having β-hydrogens, could give an insight into the reverse cycloaddition 
mechanism (Figure 3.3).  
 
Figure 3.3 
 
The second strategy would be to make the nitrogen lone pair less available, so that it 
would not promote the α-elimination of the sulfoxide. For this, due to the more electron-
withdrawing character of amides, N-acyl pyrrolidine sulfoxides 109-111 were chosen as 
potential targets to be synthesised (Figure 3.4). 
 
Figure 3.4 
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Finally, we developed a conformational hypothesis. In the two previous series (N-Boc 
or N-acyl), the nitrogen is sp
2
 hybridised and thus it is planar. In those molecules, A1,3 
strain will force the α-sulfoxide substituent to occupy a pseudo-axial position.18 This is 
suitably aligned with the nitrogen lone pair and thus the elimination would be favoured 
(Figure 3.5, A). In contrast, a pyrrolidine ring with a pyramidal sp
3
 nitrogen would 
prefer to place the substituent in a pseudo-equatorial position, which would hopefully 
make the α-elimination less favourable (B). This could be achieved with a N-sulfonyl or 
N-alkyl group. 
 
Figure 3.5 
 
However, the possibility for the pyrrolidine ring with sp
3
 hybridised nitrogen (B) to 
ring-flip and generate the conformation which leads to α-elimination, could result in 
unstable and non-isolable α-amino sulfoxides. For this reason, we proposed the 
exploration of more conformationally locked substrates such as 4-substituted 
piperidines rac-syn-112 and rac-syn-113 (Figure 3.6). Our efforts in exploring these 
three approaches are described in the following sections. 
 
Figure 3.6 
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3.3 Attempted Synthesis of Acyclic and Cyclic α-Amino Sulfoxides 
 
3.3.1 Attempted Synthesis of Acyclic N-Boc α-Amino Sulfoxides 
 
We decided to start the exploration by comparing substrates with and without β-protons. 
Previous results in our group had shown that sulfoxide 106 was stable and could be 
easily synthesised via α-lithiation-trapping of N-Boc dimethylamine 105. Thus, 
treatment of 105 with s-BuLi/TMEDA in Et2O and trapping with sulfinate 92 gave 106 
in 71% yield. Further substitution of 106 was considered via deprotonation and 
trapping. First, the lithiation of sulfoxide 106 was attempted using LDA in THF at 78 
°C. A 10 minute reaction time followed by electrophilic trapping with Me2SO4 showed 
only unreacted starting material 106 by 
1
H NMR spectroscopy of the crude product. 
Thus, the lithiation time was increased to 1 hour. Unfortunately, under these conditions 
the product obtained was not the expected sulfoxide 114. Instead, N-Boc methylamine 
115 was the only product isolated after flash column chromatography in 59% yield 
(Scheme 3.14). 
 
Scheme 3.14 
 
Analysing the 
1
H NMR spectrum of the crude product, it was not possible to identify 
any trace of N-Boc methylamine 115. Therefore, we hypothesised that 115 was formed 
during purification on silica. A probable mechanism proceeds via the formation of the 
desired sulfoxide 114, which can then eliminate the sulfoxide to give iminium ion 116 
and its hydrolysis can then give N-Boc methylamine 115 (Scheme 3.15). It is worth 
noticing that, in sulfoxide 114, elimination via β deprotonation could also be occurring. 
Trapping with Me3SiCl was also attempted, but the 
1
H NMR spectrum of the crude 
product showed only decomposition of the starting sulfoxide 106. 
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Scheme 3.15 
 
Despite the simple structure of sulfoxide 106, its α-lithiation-trapping was more difficult 
than expected and the inability to isolate the desired sulfoxide 114 discouraged us from 
using 106 as a substrate for further exploration. 
 
Our interest was then attracted by the stability of sulfoxide amide 103 and thioamide 
104 (see Scheme 3.10). We wondered whether the N-Boc p-anisidine analogue 117 
could give stable sulfoxides upon lithiation-trapping. The racemic benzylic lithiation of 
117 was reported by Beak in 1997.
83
 In 2008, Clayden used n-BuLi and TMEDA to 
lithiate 117 at 78 °C in toluene for 2 hours. After quenching with MeOD, deuterated 
118 was formed in 99% yield (Scheme 3.16).
84,85
 In addition, our experience on the 
benzylic lithiation-trapping of 2-phenyl pyrrolidine (vide infra) suggested that a 
lithiation time of 2 hours was not required if s-BuLi/TMEDA was used and we 
proposed a 30 minute reaction time in Et2O at 78 °C.  
 
Scheme 3.16 
 
Thus, N-Boc N-benzyl p-anisidine 117 was synthesised from p-anisidine 119 in 89% 
yield over two steps, according to the procedure reported by Beak et al.
86,87
 N-Boc p-
anisidine 117 was then lithiated using s-BuLi and TMEDA in Et2O at 78 °C for 30 
minutes. To our initial delight, the trapping with sulfinate 92 gave two diastereomeric 
sulfoxides 40a and 40b in 30% and 20% yield respectively, which were isolated after 
flash column chromatography (Scheme 3.17). 
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Scheme 3.17 
 
Unluckily, it was noticed that sulfoxides 40a and 40b decomposed on standing. 
Subsequent attempts to repeat the lithiation-trapping reaction in Scheme 3.17 were 
unsuccessful and none of the products were isolated. Instead, N-Boc p-anisidine 120 
was isolated in quantitative yield. In contrast to sulfoxide 114, in sulfoxides 40a and 
40b, the mechanism for the elimination of the sulfoxide must be due to the nitrogen 
lone pair as there are no β-protons in the molecule. We believe that the stabilised 
iminium ion 121 is formed and then hydrolysed to give 120 (Scheme 3.18). 
 
Scheme 3.18 
 
From the above reactions, the only clear result was that both N-Boc dimethylamine 
sulfoxide 114 and N-Boc p-anisidine sulfoxide 40 were unstable. As shown in Scheme 
3.15 and Scheme 3.18, the mechanisms proposed for their instability could proceed via 
the nitrogen lone pair elimination. Indeed, with 40 this is the only mechanism which 
could happen, although with 114 both the reverse cycloaddition and the α-elimination 
pathways are possible. Therefore, these results are not conclusive and add only partial 
support for the mechanism triggered by the nitrogen lone pair. Finally, due to the lack of 
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success with these substrates, we decided not to explore other acyclic substrates and our 
interest shifted to cyclic compounds. 
 
3.3.2 Attempted Synthesis of 2-Phenyl 2-Sulfoxide N-Boc Pyrrolidine 41 
 
To start the investigation on cyclic substrates, we considered N-Boc 2-phenyl 
pyrrolidine 70 which has been proven to be a versatile substrate for benzylic lithiation-
trapping methodology, as discussed in section 4.2.2 (vide infra). We hypothesised that a 
bulky substituent like a phenyl group could force the sulfoxide substituent into a 
conformation that would reduce the chances of elimination. Thus, following the 
reported procedure, N-Boc 2-phenyl pyrrolidine 70 was lithiated and trapped with 
sulfinate 92. Purification by flash column chromatography gave only 2-phenyl 
dihydropyrrole 122 in 72% yield. This compound was found to be unstable and, on 
standing, 122 was completely hydrolysed to amino butyrophenone 123 (Scheme 3.19). 
The same instability of compound 122 was also observed by Tomooka.
88
 
 
Scheme 3.19 
 
The formation of 122 presumably proceeds via the desired phenyl sulfoxides 41, which 
then α-eliminates the sulfoxide following pathway a or b to give 122. The lack of an α 
proton in 122 does not allow vinylic lithiation as in the previous substrates (see Scheme 
3.6) and thus, dihydropyrrole 122 was isolated (Scheme 3.20). 
 
Scheme 3.20 
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Although the outcome of the lithiation reaction was completely unexpected, this result 
provides an interesting route to synthesise dihydropyrrole 122, which could be used for 
further transformations. In addition, there is only one report on this compound in the 
literature.
88
 However, the results obtained with N-Boc p-anisidine 117 and N-Boc 2-
phenyl pyrrolidine 70 provided inconclusive evidence on the elimination mechanism. 
 
3.3.3 Attempted Synthesis of Cyclic N-Amido and N-Sulfonamido Pyrrolidine 
Sulfoxides via Tin-Lithium Exchange 
 
Some of the stable, isolated sulfoxides had an amide or a thioamide group, such as 103 
and 104 (see Figure 3.1), and it was believed that the higher electron-withdrawing 
property of the amide group could improve the stability of these sulfoxides. In an amide 
group, the nitrogen lone pair can be easily delocalised through the amidic bond and thus 
it will be less available to trigger the α-elimination of the sulfoxide. Therefore, the idea 
was to attempt the synthesis of amide sulfoxides. Previous attempts in our group 
showed that the α-lithiation of pyrrolidine amides 125 and 126 (Figure 3.7) was not 
successful, due to nucleophilic addition of the organolithium base to the amide carbonyl 
group.
71
 
 
Figure 3.7 
 
Therefore, a different synthetic pathway which could lead to the desired N-amido α-
sulfoxides 128 was planned. As shown in scheme 3.21, the designed route requires 
initial formation of N-Boc tributyltin pyrrolidines 47 which would then be Boc-
deprotected and acylated to form amides 127 as key intermediates. Tin-lithium 
exchange
89
 of 127, followed by trapping with aryl sulfinate 92 could eventually give the 
desired N-amido α-sulfoxides 128. Tributyltin amides 129-131 (Figure 3.8) were 
selected as candidates for the tin-lithium exchange in our exploration. 
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Scheme 3.21 
 
 
Figure 3.8 
 
The lithiation of N-Boc pyrrolidine 1 (10 mmol) was performed with s-BuLi and 
TMEDA in Et2O at 78 °C for 15 minutes. Trapping with Bu3SnCl gave N-Boc 2-
stannyl pyrrolidine 47 in 79% yield (Scheme 3.22). Unfortunately, subsequent Boc 
deprotection using TFA resulted in decomposition when isolation of the amine was 
attempted. 
 
Scheme 3.22 
 
However, treatment of the crude stannyl amine with benzoyl chloride afforded the 
desired N-acylated pyrrolidine. First, Boc deprotection was carried out with TFA in 
CH2Cl2 and then the crude product was reacted with benzoyl chloride in a NaOH(aq) and 
CH2Cl2 system to give N-benzyl pyrrolidine 129 in a low 7% yield. Luckily, performing 
the deprotection with Me3SiI as reported by Gawley,
90
 and then reacting with benzoyl 
chloride, Et3N and DMAP in CH2Cl2 gave 129 in 70% yield (Scheme 3.23). 
Chapter Three: Studies Towards the Synthesis of Stable α-Amino Sulfoxides 
83 
 
Scheme 3.23 
 
The next step was the tin-lithium exchange of 129. Thus, N-benzoyl pyrrolidine 129 
was treated with n-BuLi in THF at 78 °C for 5 minutes followed by the addition of the 
electrophile (Scheme 3.24 and Table 3.1). Interestingly, when MeOH or sulfinate 92 
were used, ketone 132 was the only product isolated in 48% yield (Entry 1) and 62% 
yield (Entry 2) respectively. Trapping with PhCHO resulted in a complex mixture of 
products which was not purified (Entry 3). 
 
Scheme 3.24 
Table 3.1: Tin-lithium Exchange of N-Benzoyl Pyrrolidine 129 
Entry Electrophile Yield of 132 (%)
a 
1 MeOH 48 
2 Sulfinate 92 62 
3 PhCHO - 
a
Yield after purification by chromatography. 
 
A proposed mechanism for the formation of ketone 132 is shown in Scheme 3.25. First, 
tin-lithium transmetallation of N-benzoyl pyrrolidine 129 would form lithiated 
intermediate 133, which could subsequently act as a nucleophile on the amide C=O of 
another molecule of 129 or 133. Aqueous work-up would then cause hemi-aminal 134 
to collapse to ketone 132. 
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Scheme 3.25 
 
We envisaged that the formation of ketone 132 could be due to the ability of the 
nucleophile to approach the C=O group. Thus, we thought that by increasing the steric 
hindrance of the substituents on the amide moiety the nucleophilic attack on the C=O 
group could be prevented. For this purpose, pivaloyl pyrrolidine 130 and triphenylacetyl 
pyrrolidine 131 (see Figure 3.8) were synthesised from N-Boc stannyl pyrrolidine 47 
using Me3SiI deprotection followed by amide formation as shown in Scheme 3.26. For 
131, triphenylacetic acid was activated with oxalyl chloride and DMF before use in the 
acylation step. 
 
Scheme 3.26 
 
Tin-lithium exchange of amide 130 and 131 was attempted using the procedure 
employed for N-benzoyl pyrrolidine 129: n-BuLi, THF at 78 °C for 5 minutes 
(Scheme 3.27). To probe whether the transmetallation was occurring, MeOH was used 
as the electrophile. With pivaloyl amide 130, the tin-lithium exchange and MeOH 
trapping did not work and gave an unidentified mixture of products, where the desired 
amide 125 was not present. Using 131 as the substrate, transmetallation followed by 
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electrophilic trapping afforded 126 (MeOH) and 135 (Me2SO4) in 79% and 87% yields 
respectively; in contrast, trapping with diphenyl disulfide was unsuccessful. 
 
 
Scheme 3.27 
 
Encouraged by the result obtained with triphenylacetyl amide 131, we decided to 
attempt the trapping with sulfinate 92. Unfortunately, in this case, the only product 
isolated after flash column chromatography was dihydropyrrole sulfoxide 137 in low 
21% yield (Scheme 3.28), resulting from the elimination of the sulfoxide group. 
 
Scheme 3.28 
 
To our disappointment, the tin-lithium transmetallation and electrophilic trapping of 
amides 129, 130 and 131 was unsuccessful either because the substrate was not stable to 
the reaction conditions (129 and 130), or because the sulfoxide group was eliminated as 
had happened with N-Boc protected amines. 
 
We therefore decided to try an sp
3
 hybridised nitrogen and it has been reported that the 
nitrogen in N-tosyl pyrrolidine 141 is pyramidalised in the crystalline state.
91
 Therefore, 
if N-tosyl sulfoxide 138 was formed, then it would prefer a conformation with all the 
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substituents in pseudo-equatorial positions as in 138b (Scheme 3.29). This 
conformation should disfavour the α-elimination of the sulfoxide because the nitrogen 
lone pair is not suitably aligned with the leaving group. 
 
Scheme 3.29 
 
Hence, N-tosyl stannyl pyrrolidine 139 and N-2,4,6-tri-i-Pr-phenyl sulfonyl stannyl 
pyrrolidine 140 were prepared from N-Boc stannyl pyrrolidine 47. Deprotection with 
Me3SiI followed by treatment with tosyl chloride or 2,4,6-tri-i-Pr-aryl sulfonyl chloride 
afforded 139 (57% yield) and 140 (50% yield) respectively (Scheme 3.30). 
 
Scheme 3.30 
 
The tin-lithium transmetallation was initially attempted on tosyl pyrrolidine 139. 
Electrophilic trapping with MeOH gave only recovered starting 139 in 32% yield. With 
addition of sulfinate 92, the desired sulfoxide was not formed and, after purification, 
starting material 139 was isolated in 21% yield (Scheme 3.31). Due to the low yields of 
recovered 139 in both reactions, we can assume that the tin-lithium exchange process 
could happen, but this could be followed by further reactivity of the intermediate. 
Unfortunately, we were unable to isolate any other products to validate this theory. 
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Scheme 3.31 
 
No better results were obtained with the tin-lithium exchange of 2,4,6-tri-i-Pr-aryl 
sulfonyl pyrrolidine 140. A complex mixture of products was observed in the 
1
H NMR 
spectra of the crude products when MeOH or sulfinate 92 were used as electrophiles, 
whereas starting material 140 was the sole product after attempted trapping with 
Me2SO4 (Scheme 3.32). Frustratingly, despite our efforts, we were not able to isolate 
stable amino sulfoxides via tin-lithium exchange of pyrrolidine amides and 
sulfonamides. 
 
Scheme 3.32 
 
Chapter Three: Studies Towards the Synthesis of Stable α-Amino Sulfoxides 
88 
The use of N-amido and N-sulfonamido pyrrolidines in the lithiation chemistry 
presented reactivity issues other than the stability of the α-amino sulfoxides, which were 
never detected anyway. This represented a major problem with these substrates and did 
not allow any development of understanding the elimination mechanism. For these 
reasons, we decided to abandon the line of research with pyrrolidine substrates. 
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3.4 Attempted Synthesis of 4-Phenyl Piperidine Sulfoxides 
 
Irrespective of the results with the pyrrolidines series, we moved our interest to the 
exploration of six-membered ring substrates such as 4-phenyl N-ethyl piperidine 
sulfoxide rac-syn-112 and 4-phenyl N-sulfonamido piperidine sulfoxide rac-syn-113 
(Figure 3.9).  
 
Figure 3.9 
 
At first, we assumed that, by analogy with N-tosyl pyrrolidines 141, rac-syn-112 and 
rac-syn-113 have the nitrogen with sp
3
 hybridisation. In addition, it is known that the 
lithiation of 4-phenyl N-Boc piperidines tend to give syn diastereoisomers as the sole 
products.
4,92
 Combining these two factors, it possible to predict that between the two 
possible conformations which can be adopted, the favoured one is that with the 
substituents in the equatorial position 146b (Scheme 3.33). As shown for 138b, in this 
conformation the α-elimination of sulfoxide should be disfavoured. 
 
Scheme 3.33 
 
3.4.1 Lithiation-Trapping of 4-Phenyl N-Boc Piperidine 147 
 
The racemic lithiation-trapping of 4-phenyl N-Boc piperidine 147 was first reported by 
Beak and Lee in 1989.
4
 Lithiation of 147 with s-BuLi and TMEDA in Et2O at 78 °C 
for 3.5 hours, followed by trapping with methyl iodide gave methyl piperidine rac-syn-
148 in 83% yield (Scheme 3.34). Subsequently, it was demonstrated that the 
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stereochemical outcome of these reactions follows the removal of an equatorial α-proton 
from a chair-like conformation with the 4-substituent also in the equatorial position. 
Then, the electrophilic trapping proceeds with retention of configuration to give 2,4-syn 
disubstituted products.
6,7
  
 
 
Scheme 3.34 
 
It is worth noticing that this procedure, s-BuLi and TMEDA in Et2O at 78 °C for 3.5 
hours, was also applied to 4-methyl piperidine which was trapped with methyl iodide to 
give 41% yield of the methylated product.
4
 
 
More recently, Knochel reported the Negishi cross-coupling of 4-aryl N-Boc 
piperidines.
92
 Lithiation of 147 with s-BuLi and TMEDA in Et2O at 78 °C was 
followed by transmetallation with ZnCl2. Then, the organozinc was reacted with a 
mixture of aryl iodide, Pd(dba)2 and RuPhos to give α-arylated products rac-syn-149-
151 in good yields (64-79% yield) and high diastereoselectivities (97:3 to >99:1 dr) 
(Scheme 3.35). Full details of the lithiation-Negishi coupling reaction will be discussed 
in section 4.2.1. 
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Scheme 3.35 
 
The zincated intermediate 153 was stabilised by the C=O oxygen in the equatorial 
position (Scheme 3.36), as shown by DFT calculations. The relative stereochemistry 
was then maintained in the organopalladium intermediate 154 and then was imparted to 
the cross-coupling step to give the high diastereoselectivities observed. 
 
Scheme 3.36 
 
This methodology was also used to synthesise 4-substitued piperidines with substituents 
at C-4 other than the phenyl group. Products were obtained in 64-84% yield and >95:5 
dr. As examples, 4-methyl rac-syn-155 (78%, >99:1 dr) and 4-triisopropyl silyloxy 
piperidine rac-syn-156 (84%, 97:3 dr) were prepared (Figure 3.10). 
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Figure 3.10 
 
In another report, the asymmetric lithiation-trapping of 4-phenyl N-Boc piperidine 147 
was described by our group in collaboration with Coldham’s group.59 Lithiation of 147 
with s-BuLi and diamine (R,R)-4
34,35
 in Et2O 78 °C for 6 hours and then trapping with 
Me3SiCl gave silyl product (2S,4S)-157 in 48% yield and 87:13 er (Scheme 3.37). The 
absolute configuration was not proven, but assigned by analogy to the asymmetric 
deprotonation of N-Boc piperidine using s-BuLi/()-sparteine.60 Other chiral diamine 
ligands were screened, but gave lower levels of enantioselectivity (<58:42 er) and 
variable yields (24-68%). 
 
Scheme 3.37 
 
3.4.2 Exploration of the Lithiation-Trapping of 4-Phenyl N-Boc Piperidine 147 
 
Before investigating the attempted synthesis of α-amino sulfoxides rac-syn-112 and 
rac-syn-113, a short exploration of the lithiation-trapping of 4-phenyl N-Boc piperidine 
147 was carried out. We started our study with racemic methodology. Thus, lithiation of 
147 was explored using s-BuLi in the presence of TMEDA in Et2O at 78 °C or in THF 
without ligand at 78 °C or at 30 °C (Scheme 3.38 and Table 3.2). When the lithiation 
was performed with s-BuLi/TMEDA in Et2O at 78 °C, trapping with Me2SO4 gave α-
methylated piperidine rac-syn-148 in 67% yield after a 1 hour lithiation (Entry 1) and 
60% yield after 3 hours lithiation time (Entry 2). In THF without ligand, the lithiation at 
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78 °C for 3 hours afforded rac-syn-148 in 38% yield (Entry 3), whereas at 30 °C for 
10 minutes rac-syn-148 was isolated in 20% yield (Entry 4). 
 
Scheme 3.38 
Table 3.2: Optimisation of the Lithiation-Trapping of 4-Phenyl N-Boc Piperidine 147 
Entry Ligand Solvent Temp. (°C) Time (h) Yield of 148 (%)
a 
1 TMEDA Et2O 78 1 67 
2 TMEDA Et2O 78 3 60 
3 - THF 78 3 38 
4 - THF 30 10 min 20 
a
Yield after purification by chromatography. 
 
In each case, only one diastereoisomer was obtained (based on the 
1
H NMR spectra of 
the crude product) and the relative stereochemistry was assigned by analogy with 
previous examples.
4,92
 The result obtained using THF without TMEDA were rather 
surprising. Although the isolated yields were moderate at 78 °C and 30 °C, 38% and 
20% yield respectively, these were important results since it was previously reported 
that s-BuLi in THF at 30 °C did not lithiate N-Boc piperidine 34.5 Possibly, the 
presence of the phenyl group could increase the reactivity of 4-phenyl N-Boc piperidine 
147. 
 
Using the lithiation conditions which gave the highest yield, s-BuLi, TMEDA in Et2O at 
78 °C for 1 hour, the trapping was explored with other electrophiles. Trapped products 
rac-syn-157-161 were isolated in 23-90% yields (Scheme 3.39). 
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Scheme 3.39 
 
As was observed for the methylated product rac-syn-148, in all these examples, only 
one diastereoisomer of the product was isolated. The relative stereochemistry of the 
products was assumed to be syn based on the 
1
H NMR spectroscopic data of rac-syn-
158 and rac-syn-161. Key spectroscopic data, which allowed the syn diequatorial 
configuration to be identified, include the signal corresponding to the benzylic proton of 
rac-syn-158 and rac-syn-161 (δH 2.77 ppm and 2.87 ppm respectively) (Figure 3.11). 
This signal is a dddd with J values of 12.0, 12.0, 3.0, 3.0 Hz (rac-syn-158) and 11.5, 4.0 
Hz (rac-syn-161). These values indicate an axial-axial and axial-equatorial relationship. 
Hence, the 4-phenyl substituent should occupy an equatorial orientation. The other key 
spectroscopic data are the signals for the proton α to nitrogen. In oxazolidinone rac-syn-
158 (δH 4.45 ppm) and in ketone rac-syn-161 (δH 4.80 ppm), this signal is a double 
doublet with J values of 12.0, 3.5 Hz and 11.0, 4.5 Hz respectively, indicating the axial 
position of this proton. The syn configuration of rac-syn-157, rac-syn-159-160 was 
assigned by analogy with rac-syn-158 and rac-syn-161. 
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Figure 3.11 
 
Next, the asymmetric lithiation and electrophilic trapping of 4-phenyl N-Boc piperidine 
147 was explored. Our group has reported that better enantioselectivities were obtained 
using diamine (R,R)-4 as ligand and a lithiation time of 6 hours (see Scheme 3.34). We 
thought that such a long reaction time was not necessary and thus, the deprotonation 
with s-BuLi and (S,S)-4 was carried out for 1 hour. Electrophilic trapping with Me2SO4, 
PhNCO and PhMe2SiCl gave trapped products in low yields (22-31%) and >89:11 er 
(Scheme 3.40). 
 
 
Scheme 3.40 
 
These results showed that high enantioselectivity could be achieved with the 
asymmetric lithiation-trapping of 4-phenyl N-Boc piperidine 147. However, the yields 
were very unsatisfactory. In all these cases, starting material 147 was also recovered 
after flash column chromatography in 49-51% yield. This could probably indicate an 
incomplete lithiation of the substrate under the reaction conditions (s-BuLi/Alexakis 
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diamine (S,S)-4, 1 hour). Thus, a longer lithiation time (3 hours) was used (Scheme 3.42 
and Table 3.3). Trapping with PhMe2SiCl gave (2R,4R)-160 (92:8 er) in a higher 43% 
yield (Entry 2). Although this was an improved result, we were interested in yields 
≥60%. Therefore, the role of the temperature was also investigated and 147 was 
lithiated at 40 °C for 1 hour. In this case, (2R,4R)-160 was isolated in only 9% yield 
and with a lower enantioselectivity (80:20 er); starting 147 was also recovered in 64% 
yield (Entry 3).  
 
Scheme 3.41 
Table 3.3: Optimisation of the Asymmetric Lithiation-Trapping of 4-Phenyl N-Boc 
piperidine 147 
Entry Temp. (°C) Time (h) Yield of 160 (%)
a
 er
b 
Yield of rec. SM 
147 (%)
a 
1 78 1 31 90:10 51 
2 78 3 43 92:8 - 
3 40 1 9 80:20 64 
a
Yield after purification by chromatography. 
b
er determined by CSP-HPLC. 
 
The low yields observed were possibly due to a slow rate of lithiation even at 40 °C. In 
addition, the 9% yield at 40 °C could indicate chemical instability of the lithiated 
intermediate. Moreover, a decrease in the kinetic selectivity of the deprotonation was 
observed with the increase of the temperature. Due to the lack of success in the 
asymmetric lithiation-trapping of 4-phenyl N-Boc piperidine 147, no further asymmetric 
reactions were explored.  
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3.4.3 Attempted Synthesis of N-Ethyl and N-Sulfonamido Piperidine Sulfoxides via 
Tin-Lithium Exchange 
 
Next, our attention was directed to the synthesis of α-amino sulfoxides and the planned 
route was via tin-lithium exchange. Hence, 4-phenyl stannyl piperidine rac-syn-162 was 
synthesised in 70% yield from 4-phenyl piperidine 147 using s-BuLi and TMEDA in 
Et2O at 30 °C for 15 minutes followed by trapping with Bu3SnCl. Then, rac-syn-162 
was deprotected with Me3SiI and the crude amine was acylated with acetyl chloride in 
the presence of Et3N and DMAP to afford 4-phenyl acetyl piperidine rac-syn-163 (32% 
yield). Subsequently, rac-syn-163 was reduced with LiAlH4 to give the desired 4-phenyl 
N-ethyl piperidine rac-syn-164 in 74% yield (Scheme 3.42). 
 
 
Scheme 3.42 
 
Tin-lithium exchange is known on N-ethyl stannyl pyrrolidine,
50
 and we assumed that 
N-ethyl piperidine rac-syn-164 could undergo the same process. Therefore, tin-lithium 
exchange was attempted with rac-syn-164 using n-BuLi in THF at 78 °C for 5 
minutes. Unfortunately, electrophilic trapping with sulfinate 92 resulted in a mixture of 
unidentified products by 
1
H NMR spectroscopy of the crude product (Scheme 3.43). For 
this reason, further exploration on this substrate was not carried out. 
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Scheme 3.43 
 
Next, 4-phenyl N-sulfonyl piperidine rac-syn-165 was considered. Starting from 4-
phenyl stannyl piperidine rac-syn-162, rac-syn-165 (42% yield) was prepared following 
the Me3SiI deprotection and sulfonylation procedure used for the other substrates 
(Scheme 3.44). 
 
Scheme 3.44 
 
The tin-lithium exchange protocol using rac-syn-165 as substrate was not known and so 
we decided to perform a test reaction first. Thus, rac-syn-165 was treated with n-BuLi 
in THF at 78 °C for 5 minutes and then MeOH was added. The sole product isolated 
after flash column chromatography was recovered rac-syn-165 in 52% yield (Scheme 
3.45). Unfortunately, we were not able to isolate any other compound to further 
understand what happened in the reaction. Due to this unsatisfactory result, we decided 
not to carry on with the exploration using different electrophiles. 
 
Scheme 3.45 
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The disappointing results obtained with the 4-substituted piperidines led us to stop the 
study of the tin-lithium exchange on these substrates. 
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3.5 Conclusions and Future Work 
 
To our disappointment and frustration, the synthetic strategies planned to understand the 
elimination mechanism at the basis of the instability of α-amino sulfoxides were 
unsuccessful. Consequently, we could not confirm the mechanistic pathway for 
elimination of the sulfoxide group. However, the instability observed during the 
exploration of acyclic α-amino sulfoxides without β-protons could indicate that the 
elimination is triggered by the nitrogen lone pair. Unfortunately, tin-lithium exchange 
experiments with cyclic substrates presented reactivity issues which could not give 
further evidence. Alongside these negative results, we were successful in developing a 
racemic and an asymmetric lithiation-trapping methodology of 4-phenyl piperidine 147. 
Hence, future work could involve extension of the asymmetric methodology to 4-
substituted piperidines such as 4-methyl piperidine 167 and 4-triisopropyl silyloxy 
piperidine 168 (Scheme 3.46). 
 
Scheme 3.46 
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Chapter Four: Synthesis of Tetra-Substituted 
Pyrrolidines 
Our attention was attracted by the molecular complexity of tetra-substituted pyrrolidines 
and the synthesis of such tetra-substituted pyrrolidines would allow the potential 
exploration of new chemical space. Interestingly, some tetra-substituted pyrrolidines 
such as 171 have been synthesised and studied as potential hepatitis C virus (HCV) 
polymerase inhibitors (Figure 4.1).
93,94
  
 
Figure 4.1 
 
In particular, we were intrigued by the possibility of substituting each of the four 
protons next to the nitrogen atom using α-lithiation-trapping chemistry. The proposed 
synthetic route which could give tetra-substituted pyrrolidines 44 is shown in Scheme 
4.1. It was envisaged that tetra-substituted pyrrolidines could be achieved starting from 
N-Boc pyrrolidine 1 via two consecutive “high” temperature asymmetric lithiation-
Negishi coupling reactions and benzylic lithiation-trapping steps. 
 
Scheme 4.1 
 
Chapter Four: Synthesis of Tetra-Substituted Pyrrolidines 
102 
In this sequence, the use of the aryl groups is strategic for the introduction of a second 
substituent on the same carbon, because of the increased acidity of the benzylic protons 
in 172 and 174. In addition, it was envisaged that the stereochemistry of the lithiation-
Negishi coupling step could be controlled by using different chiral ligands, such as ()-
sparteine and the (+)-sparteine surrogate. For the lithiation-trapping of unsymmetrical 
N-Boc pyrrolidines 172, 173 and 174, the orientation of the C=O of the Boc group in 
the two rotamers and the ease of rotamer interconversion are key factors to be 
considered. Furthermore, electrophiles introduced in the benzylic lithiation-trapping 
step to give 173 have to be compatible with the subsequent lithiation conditions, 
narrowing the selection down to alkyl groups mainly. Our efforts at implementing this 
novel strategy to tetra-substituted pyrrolidines 44 are described in this chapter. 
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4.1 Previous Syntheses of Tetra-Substituted Pyrrolidines 
Our interest was mainly directed at pyrrolidines having α,α'-aryl substitution. 
Surprisingly, there are not many syntheses of tetra-substituted pyrrolidines with such a 
substitution pattern reported in the literature. The general strategy for the synthesis of 
2,5-tetra-substituted pyrrolidines utilises a protocol developed by Keana and co-
workers, namely the addition of Grignard reagents to nitrones.
95,96
 In a recent example 
of Keana’s approach, the Einhorn group reported the synthesis of tetra-substituted 
pyrrolidine (2S,5S)-179 (Scheme 4.2).
97
 The synthetic pathway started with 
enantioenriched dimethyl N-benzyl pyrrolidine (2R,5R)-175 (98:2 er), which was 
deprotected via hydrogenolysis and then oxidised with MeReO3 and urea-hydrogen 
peroxide
98
 to give nitrone (R)-176 (51% yield). Nucleophilic addition of PhMgBr to 
nitrone (R)-176 afforded tri-substituted pyrrolidine (2S,5R)-177, which was oxidised to 
nitrone (S)-178 using oxygen and copper(II) acetate. Then, (S)-178 was converted into 
nitroxide (2S,5S)-179 (24% yield, 96.5:3.5 er) via a second Grignard addition and 
oxidation sequence. 
 
Scheme 4.2 
 
Finally, as shown in Scheme 4.3, nitroxide (2S,5S)-179 was first recrystallized to 
enantiopurity (>99:1 er) and then quantitatively reduced with zinc in aqueous HCl to 
afford tetra-substituted amine (2S,5S)-180 (>99:1 er). 
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Scheme 4.3 
 
The diastereoselectivity of this sequence of reactions is entirely controlled in the 
Grignard addition to the nitrones. The nucleophile approached the nitrone from the least 
hindered face and therefore generated a trans relationship with the substituent on the 
stereogenic centre. This effectively created an inversion of configuration of the starting 
(2R,5R)-175 stereocentres. 
Kündig showed that amine (2S,5S)-180 could be used as precursor to a chiral lithium 
amide base in the asymmetric ortho-lithiation-trapping of tricarbonylchromium-arene 
181.
99
 In this procedure, (2S,5S)-180 was treated with n-BuLi to form the lithium amide 
and subsequent addition of Me3SiCl and substrate 181 gave ortho-disubstituted arene 
182 in 72% yield and 86.5:13.5 er (Scheme 4.4). 
 
Scheme 4.4 
 
In 2004, the methodology reported by Einhorn was used by the Tamura group to 
synthesise 2,5-alkoxyphenyl nitroxides such as (2S,5S)-183 (Figure 4.2).
100
 Such tetra-
substituted pyrrolidine nitroxides were used in the development of new liquid crystals. 
 
Figure 4.2 
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Tetra-substituted pyrrolidines could also be obtained via a cyclisation methodology as 
shown by Knight.
101
 In this synthetic route, pyrrolidine 185 was achieved in a high 97% 
yield by treatment of homoallylic sulfonamide 184 with triflic acid via a 5-endo-trig 
cyclisation (Scheme 4.5).  
 
Scheme 4.5 
 
A different approach for the synthesis of tetra-substituted pyrrolidines was reported by 
the Bubnov group in 2008.
102
 Pyrrolidinone 186 was reacted with tri-allylborane and 
then NaOH in MeOH to afford 2,2-diallyl-5,5-dimethyl pyrrolidine 187 in 91% yield 
(Scheme 4.6).  
 
Scheme 4.6 
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4.2 Overview of Methodology for the Synthesis of 2-Aryl and 2,2-Di-
Substituted Pyrrolidines 
 
As part of the overall strategy towards tetra-substituted pyrrolidines, the synthesis of 2-
aryl and 2-di-substituted pyrrolidines was required. The interest in such compounds can 
be attributed to the fact that α-arylated pyrrolidines represent a common motif in both 
natural products, such as (S)-nicotine and (R)-harmicine, and pharmaceuticals, such as 
the anti-cancer drug Veliparib
®
 (ABT-888) (Figure 4.3).
103
 Some synthetic routes to 
enantioenriched 2-aryl and 2,2-di-substituted pyrrolidines are summarised in this 
section. 
 
Figure 4.3 
 
4.2.1 Previous Asymmetric Syntheses of 2-Aryl Pyrrolidines  
 
In 1992, Meyers reported the synthesis of 2-phenyl pyrrolidine (S)-190.
104
 This protocol 
used (R)-phenylglycinol as a chiral auxiliary, which was converted into lactam 
(3R,7aR)-188 with high diastereoselectivity in one step. Reduction of (3R,7aR)-188 with 
LiAlH4 and AlCl3 afforded amino alcohol (R,S)-189 (95% yield), which was 
deprotected in two steps using diphenyl disulfide and lithium di-tert-butylbiphenylide to 
give enantiopure 2-phenyl pyrrolidine (S)-190 in 51% yield (Scheme 4.7).  
 
Scheme 4.7 
 
A similar approach was used two years later by Higashiayama and co-workers for the 
synthesis of three different 2-aryl pyrrolidines 193.
105
 In that methodology, enantiopure 
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phenylglycinol was converted with moderate yields in three steps into 1,3-oxazolidines 
191 claimed to have high diastereomeric ratio. Reduction and deprotection of 191 
afforded 2-aryl pyrrolidines 193 in low to moderate yields (13-62%) as shown in 
Scheme 4.8. 
 
Scheme 4.8 
 
Reductive amination of the iminium ion, formed by reacting (S)-valine methyl ester 194 
with keto-aldehyde 195, is an alternative method. This route showed a slightly lower 
enantioselectivity as reported by the Savoia group (Scheme 4.9).
106
 
 
Scheme 4.9 
 
In 2005, Ellman reported the addition of Grignard reagents to N-sulfinyl imines as an 
efficient method for the synthesis of 2-phenyl pyrrolidine (R)-190.
107
 As shown in 
Scheme 4.10, N-sulfinyl imine (RS)-18 was reacted with Grignard 197 to afford 
sulfinamide (R,RS)-198 in good yield (95% yield) and 90:10 dr. Acetal deprotection, 
cyclisation and reduction of the iminium ion, followed by removal of the N-sulfinyl 
group gave (R)-190 in 92% yield. 
 
Scheme 4.10 
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The scope of the aryl group was investigated by the Reddy group.
108
 Addition of a range 
of Grignard reagents to the N-sulfinyl imine (SS)-199 and subsequent cyclisation with 
LiHMDS afforded aryl pyrrolidines (S,SS)-200 in 83-91% yield and >94:6 dr. Simple 
deprotection of the N-sulfinyl group using HCl gave 2-aryl pyrrolidines (S)-193 in 98-
99% yields (Scheme 4.11). 
 
Scheme 4.11 
 
Subsequently, the same research group showed that the diastereoselectivity of the 
products could be controlled by switching the reducing agent.
109
 The two diastereomeric 
series were accessed utilising the same starting N-sulfinyl ketimines (SS)-201. 
Treatment with DIBAL-H gave pyrrolidines (S,SS)-200 (87-98% yield, 99:1 dr), 
whereas reaction with LiBHEt3 afforded pyrrolidines (R,SS)-202 (90-98% yield, 99:1 dr, 
Scheme 4.12). A similar methodology was also reported by De Kimpe, but 
diastereoselectivities were lower.
110
 
 
Scheme 4.12 
 
More recently, Guijarro reported that (R,RS)-202 could also be accessed from N-sulfinyl 
ketimines (RS)-201 via a hydrogenation approach with a ruthenium catalyst and i-
PrOH.
111
 In this case, 2-aryl pyrrolidines (R,RS)-202 were obtained in 84-92% yield and 
>98:2 er. 
 
A synthetic protocol based on the Heck coupling reaction was published in 1992 by 
Ozawa.
112
 The preparation of 2-arylated pyrrolidines was accomplished using a 
coupling reaction between N-carbamate pyrrolines and aryl triflates in 45-81% yields 
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and 82:18-87:13 er. An example is shown in Scheme 4.13. The use of pyrroline 203 and 
phenyl triflate in the presence of Pd(OAc)2 and (R)-BINAP as ligand gave (R)-204 
(81% yield, 82:18 er). Hydrogenation of the alkene afforded 2-phenyl pyrrolidine (R)-
205. 
 
Scheme 4.13 
 
In an alternative strategy, a lithiation-cyclisation protocol was reported by Beak and co-
workers in 1996.
113
 N-Boc chloroamine 206 was lithiated in toluene at ‒78 °C using s-
BuLi and (‒)-sparteine as chiral ligand. This formed a lithiated intermediate, which 
cyclised to afford 2-phenyl N-Boc pyrrolidine (S)-70 in good yield (72%) and a high 
98:2 er (Scheme 4.14). The synthesis of other 2-arylated N-Boc pyrrolidines in 
moderate to good yields and enantioselectivities >92:8 er was also reported using this 
approach. 
 
Scheme 4.14 
 
A more convergent synthetic route to 2-aryl pyrrolidines has been reported recently by 
Campos et al.
56
 According to the protocol, a broad range of 2-arylated pyrrolidines 
could be synthesised in one step from N-Boc pyrrolidine 1. Treatment of 1 with s-
BuLi/(‒)-sparteine generated chiral lithiated intermediate (S)-2, which was 
transmetallated with ZnCl2 to give organozinc (S)-208. Then, Pd-catalysed Negishi 
reaction
114
 of (S)-208 with aryl bromides gave 2-phenyl pyrrolidines (R)-172 (Scheme 
4.15).  
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Scheme 4.15 
 
In the optimised procedure, N-Boc pyrrolidine 1 was lithiated using s-BuLi and (‒)-
sparteine in TBME for 3 hours at ‒74 °C, then transmetallated with ZnCl2 and finally 
coupled with bromobenzene in a Negishi reaction using Pd(OAc)2 and t-Bu3PHBF4
115
 
as catalyst. 2-Phenyl pyrrolidine (R)-70 was obtained in 82% yield and 96:4 er (Scheme 
4.16). 
 
Scheme 4.16 
 
Interestingly, our group in collaboration with the Campos group studied the whole 
process by in situ ReactIR™ spectroscopy.30 Monitoring the change in absorbance of 
the carbonyl peak of the Boc group showed that the lithiation of N-Boc pyrrolidine 1 
with s-BuLi and (‒)-sparteine was accomplished within 1 hour. Additionally, it was 
shown that room temperature was needed for the lithium-zinc transmetallation step to 
occur. Using this methodology, the synthesis of 2-heteroaryl pyrrolidines (R)-209-212 
was achieved in good yields (70-76% yield) and enantioselectivities >94:6 er (Figure 
4.4). 
 
Figure 4.4 
 
In summary, many of the routes to 2-aryl pyrrolidines generated the products with 
excellent enantioselectivities. In contrast, high yields were often difficult to achieve 
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mainly due to the length of the synthetic pathways. It appears that the Campos Pd-
catalysed arylation arguably represents the most advantageous and efficient process to 
2-aryl pyrrolidines as it combines high yield and good enantioselectivity. 
 
4.2.2 Previous Asymmetric Syntheses of 2,2-Di-Substituted Pyrrolidines 
 
The introduction of a quaternary stereogenic centre with a phenyl substituent in the 
pyrrolidine ring represents a synthetic challenge which has been tackled using several 
chemical strategies by different research groups. For example, the possibility of 
synthesising proline-based non-natural amino acids has attracted some attention. 
 
In 1997, Van Betsbrugge and Tourwe reported the synthesis of 2-phenyl proline ethyl 
ester (R)-216.
116
 The high level of enantioselectivity arose from enzymatic resolution of 
allyl-phenyl glycinate 213 using pig liver esterase (PLE). (R)-214 was obtained in 65% 
yield and 98:2 er. Then, Boc protection and hydroboration afforded amino alcohol (R)-
215 (60% yield), which was cyclised using a Mitsunobu reaction with PPh3 and DEAD 
to give (R)-216 in 55% yield (Scheme 4.17).   
 
Scheme 4.17 
 
A different cyclisation approach was used by Maruoka (Scheme 4.18).
117
 Alkylation of 
α-phenyl imino acid derivative 217 with iodo-chloropropane in the presence of a chiral 
phase-transfer catalyst, (S)-218, and CsOH·H2O, followed by hydrolysis with HCl gave 
the chiral alkylated intermediate (S)-219. Cyclisation of (S)-219 was performed with 
Na2CO3 and 2-phenyl prolinate (R)-220 was obtained in 88% yield and 82:18 er. The 
moderate enantioselectivity observed was probably due to the steric hindrance of the 
phenyl group as higher enantioselectivities (>99:1 er) were obtained with smaller 
substituents such as methyl or allyl groups. 
Chapter Four: Synthesis of Tetra-Substituted Pyrrolidines 
112 
 
Scheme 4.18 
 
An access to 2-aryl proline-derived amino acids was proposed by Tagliabue and Penso 
in 2010.
118
 Treatment of sulfonamide (S)-221 with NaNH2 at 0 °C initiated a 
rearrangement of the aryl moiety, with retention of configuration at the stereogenic 
centre (Scheme 4.19). The process generated di-substituted pyrrolidine (R)-222 in high 
yield and high enantioselectivity (90%, 97:3 er). Other substituents on the benzene ring 
led to a reduction in the yields. 
 
Scheme 4.19 
 
In related work, ammonium salt (1S,2S)-223 was shown to give 2-aryl proline (R)-224 
following a Sommelet-Hauser rearrangement.
119
 Deprotonation of (1S,2S)-223 with t-
BuOK at ‒40 °C triggered the [2,3]-sigmatropic shift which formed enantiopure ester 
(R)-224 in 96% yield (Scheme 4.20). 
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Scheme 4.20 
 
An example of the synthesis of 2,2-di-substituted pyrrolidines with an aryl-alkyl 
substitution was reported by Yeung via the bromo-aminocyclisation of sulfonamides.
120
 
In the optimised procedure, sulfonamide 225 was treated with NBS in CHCl3 at ‒62 °C 
for 60 hours in the presence of a cinchonidine-derived catalyst 227 (Scheme 4.21). (R)-
226 was obtained in an excellent 98% yield and high enantioselectivity (97.5:2.5 er). In 
this case, similar results were obtained using a range of substituents on the aryl group. 
 
Scheme 4.21 
 
Similarly, Wirth showed that 2,2-di-substituted pyrrolidines could be accessed via an 
asymmetric oxyamination of alkenes catalysed by chiral hypervalent iodine reagents.
121
 
Reaction of 228 with hypervalent iodine reagent 229 in the presence of Me3SiOTf and  
TsNH2 in CH2Cl2/Et2O at ‒78 °C for 4 hours gave isourea (S)-230 in 71% yield and 
98:2 er (Scheme 4.22). Subsequent two-step hydrolysis afforded di-substituted 
pyrrolidine (S)-231 (29% yield, 98:2 er).  
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Scheme 4.22 
 
One of the most convergent synthetic pathways to access 2,2-di-substituted pyrrolidines 
was presented by Xiao and co-workers in 2005.
122
 This approach used the increased 
acidity of the benzylic proton of 2-aryl pyrrolidines. Thus, treatment of 2-phenyl N-Boc 
pyrrolidine rac-70 with n-BuLi in the presence of TMEDA in THF at ‒78 °C, followed 
by trapping with methyl iodide afforded pyrrolidine rac-232 in 44% yield (Scheme 
4.23). 
 
Scheme 4.23 
 
Interestingly, under these conditions, the 2,5-di-substituted pyrrolidine was not 
obtained, indicating that lithiation using n-BuLi as a base proceeded solely towards the 
benzylic position. 
 
The benzylic lithiation of 2-phenyl N-Boc pyrrolidine rac-70 has recently been fully 
investigated by the O’Brien group in collaboration with the Coldham group.123 To start 
with, the lithiation event was monitored using in situ ReactIR™ spectroscopy studies. 
When rac-70 was treated with n-BuLi in THF at ‒78 °C, an initial rapid lithiation was 
observed, but full conversion to the lithiated intermediate was never achieved. The n-
BuLi/THF-mediated lithiation of rac-70 was also conducted at 0 °C and under these 
conditions, complete lithiation took place in 2 minutes or less. It was suggested that the 
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reason for the difference between the results at ‒78 °C and 0 °C was due to the rate of 
interconversion of the Boc rotamers 70a and 70b of the substrate (Scheme 4.24).  
 
Scheme 4.24 
 
It was proposed that at ‒78 °C rotation of the Boc group about the C-N was 
significantly slower than the rate of lithiation. In contrast, at 0 °C the interconversion of 
the rotamers could happen rapidly, leading to full formation of the lithiated species. As 
expected, n-BuLi in THF at ‒78 °C was not a strong enough base to deprotonate 
rotamer 70a. To confirm those observations, variable temperature (VT) 
1
H NMR 
spectroscopy studies of rac-70 were performed in THF-d8. The half-life (t1/2) for 
rotation of the Boc group was calculated and t1/2 was ~10 hours at 78 °C, while at 0°C 
t1/2 was ~0.3 seconds. 
 
Additional evidence was shown with synthetic experiments at ‒78 °C and 0 °C. 
Lithiation at ‒78 °C with n-BuLi for 3 hours and trapping with methyl chloroformate 
gave rac-235 in 39% yield with 52% yield of recovered starting material. In contrast, at 
0 °C, lithiation with n-BuLi in THF for 5 minutes followed by electrophilic quench 
afforded trapped products in excellent yields. As examples, the trapping with Me2SO4 
and methyl chloroformate gave rac-232 and rac-235 in 98% and 77% yields 
respectively (Scheme 4.25). 
 
Scheme 4.25 
 
These results showed that the yields were highly affected by interconversion of the N-
Boc rotamers. Moreover, the use of in situ ReactIR™ spectroscopy and VT 1H NMR 
spectroscopy studies was essential to establish the optimal reaction conditions. 
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Ultimately, in non-symmetrical substrates, such as rac-70, understanding the half-life 
(t1/2) for rotation of the Boc group is a fundamental parameter for the success of the 
lithiation. 
 
The lithiation-trapping of enantioenriched 2-phenyl N-Boc pyrrolidine (R)-70 (97:3 er) 
was also reported. n-BuLi was used to lithiate (R)-70 in THF at ‒50 °C and subsequent 
electrophilic trapping with Me2SO4 afforded 2,2-di-substituted pyrrolidine (R)-232 in 
87% yield and 93:7 er (Scheme 4.26). 
 
Scheme 4.26 
 
The slight reduction of er suggested a partial configurational instability of the lithiated 
intermediate. This observation was supported by the data obtained using MeO2CCl as 
electrophile at different temperatures (Scheme 4.27 and Table 4.1). Lithiation of 2-
phenyl N-Boc pyrrolidine (R)-70 (97:3 er) with n-BuLi in THF at ‒78 °C gave (R)-235 
(31% yield) in high 97:3 er (Entry 1). Increasing the temperature to ‒50 °C resulted in a 
lower 90:10 er of (R)-235 (74% yield) with a 10 minute reaction (Entry 2), whereas 5 
minute lithiation afforded (R)-235 in 94:6 er (Entry 3). At higher temperatures, the 
enantioselectivity was progressively reduced (Entries 4 and 5). 
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Scheme 4.27 
Table 4.1: Optimisation of the Benzylic Lithiation-Trapping of 2-Phenyl N-Boc 
Pyrrolidine (R)-70 in THF 
Entry Temp (°C) Time (min) Yield of 235 (%) er 
1 ‒78 60 31 97:3 
2 ‒50 10 74 90:10 
3 ‒50 5 78 94:6 
4 ‒30 5 79 65:35 
5 0 5 82 50:50 
 
These results showed that the configurational stability of the lithiated intermediate was 
dependent on the temperature and on the lithiation time. Increasing the reaction 
temperature was detrimental for the configurational stability of the lithiated 
intermediate. In addition, the results at ‒50 °C revealed a dependency on the reaction 
time, as the 10 minute lithiation gave lower er than the 5 minute reaction.  
 
Recently, Gawley reported a protocol for the benzylic lithiation-trapping under similar 
conditions.
124
 Thus, enantioenriched (R)-70 (96:4 er) was lithiated at ‒60 °C with n-
BuLi in Et2O in the presence of TMEDA. Trapping with Me2SO4 gave (R)-232 (86% 
yield) in 96:4 er (Scheme 4.28). The dynamics of racemisation of the lithiated 
intermediate were investigated in different solvents and calculations showed that the 
rate of racemisation was faster in THF than in Et2O. Crucially, the data obtained by 
Gawley indicated that the lithiated intermediate was configurationally stable in 
Et2O/TMEDA and so the er was transferred from the starting material to the product. 
This result was in agreement with the results obtained by O’Brien and Coldham (see 
Scheme 4.27). 
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Scheme 4.28 
 
In summary, 2,2-di-substituted pyrrolidines could be accessed in good enantioselectivity 
via several approaches. However, it is clear that the benzylic lithiation-trapping 
methodology reported by O’Brien, Coldham and Gawley is the shortest route which 
could afford high yields and er in two synthetic steps from N-Boc pyrrolidine 1. 
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4.3 Development of Methodology for the Synthesis of Tri-Substituted 
Pyrrolidines 
 
4.3.1 Syntheses of 2,2-Di-Substituted N-Boc Pyrrolidines 
 
To start our work on the synthesis of tetra-substituted pyrrolidines, the synthesis of 
racemic 2-phenyl N-Boc pyrrolidine rac-70 was explored. Although this substrate could 
be prepared following the lithiation-Negishi reaction protocol as reported by our group,
5
 
on a scale of >1 g low yields of rac-70 were generally obtained. For this reason the 
synthesis of rac-70 was accomplished using a more scalable literature procedure.
125
 
Hence, 5 g of 2-pyrrolidinone 236 was treated with Me3SiCl and PhMgCl to afford 237 
(18% yield), which was reduced using NaBH4 to give rac-190. Then, the formation of 
rac-70 was achieved by Boc protection (Scheme 4.29).  
 
Scheme 4.29 
 
Despite the low yielding arylation of 236, this synthetic pathway allowed the 
preparation of 1.6 g of rac-70. Thus, this substrate was used for the racemic synthesis of 
rac-232 according to our group’s procedure.123 Benzylic lithiation of rac-70 with n-
BuLi in THF at 0 °C for 5 minutes and Me2SO4 trapping gave rac-232 in an excellent 
99% yield (Scheme 4.30). 
 
Scheme 4.30 
 
Next, we focussed on the synthesis of enantioenriched 70. Therefore, as shown in 
Scheme 4.31, 2-phenyl N-Boc pyrrolidine (S)-70 was synthesised using Campos’s 
procedure,
56
 but reducing the lithiation time to 30 minutes. Asymmetric lithiation of 1 
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with s-BuLi and the (+)-sparteine surrogate in Et2O at ‒78 °C, transmetallation (ZnCl2) 
and Negishi reaction afforded (S)-70 in 57% yield and 94:6 er (by CSP-HPLC). 
 
Scheme 4.31 
 
To pursue the idea of synthesising tetra-substituted pyrrolidines using four consecutive 
steps at temperatures above ‒78 °C, 2-phenyl N-Boc pyrrolidine (S)-70 was also 
prepared using the high temperature asymmetric lithiation protocol described in Chapter 
3. Under those conditions, (S)-70 (50% yield) was isolated in 90:10 er after lithiation 
using s-BuLi/(+)-sparteine surrogate in Et2O at ‒30 °C for 2 minutes (Scheme 4.32). 
 
Scheme 4.32 
 
The next aim was the synthesis of enantioenriched di-substituted N-Boc pyrrolidine (S)-
232. At this point, understanding the configurational stability of the lithiated 
intermediate and optimisation of the yield were key aspects for the success of our 
strategy. According to Gawley, the use of TMEDA in Et2O at ‒60 °C should give 
trapped products with good yields and high er.
124
 However, our interest in high 
temperature lithiations pushed us to investigate temperatures above ‒60 °C. The results 
of the lithiation of (S)-70 with n-BuLi and TMEDA at different temperatures and 
reaction times using Me2SO4 as electrophile are summarised in Scheme 4.33 and Table 
4.2. At ‒50 °C in Et2O, the reaction was incomplete after 5 minutes, but a near-
quantitative yield of (S)-232 was achieved with a 30 minute lithiation time (Entries 1 
and 2). In both cases, the er of the starting material (94:6 er) was maintained in the 
product. When the temperature was raised to ‒30 °C, excellent yields were obtained 
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after 30 and 60 minutes lithiation time and (S)-232 was isolated in 94% and 96% yields 
respectively (Entries 3 and 4). At this temperature, the er of (S)-232 (~91:9 er) was 
slightly lower than at ‒50 °C. Finally, THF was used as solvent and lithiation at ‒50 °C 
for 30 minutes gave (S)-232 in 23% yield and 58:42 er (Entry 5). In this case, starting 
(S)-70 was also recovered in 53% yield. 
 
Scheme 4.33 
Table 4.2: Exploration of the Configurational Stability of the Lithiated Intermediate in 
the Benzylic Lithiation-Trapping of N-Boc Pyrrolidine (S)-70 at Temperatures ≥ ‒50 °C 
Entry Solvent Temp (°C) Time (min) Yield of (S)-232 (%)
a 
er
b 
1 Et2O ‒50 5 23 93:7 
2 Et2O ‒50 30 97 94:6 
3 Et2O ‒30 30 94 91:9 
4 Et2O ‒30 60 96 92:8 
5 THF ‒50 30 23 58:42 
a
Yield after purification by chromatography. 
b
er determined by CSP-HPLC. 
 
Two main conclusions could be inferred from these data. First, the same level of er of 
the starting material and product at ‒50 °C (~94:6 er) indicated that the configuration of 
the stereogenic centre was preserved in the lithiated intermediate and then transferred to 
the product. At ‒30 °C, however, partial configurational instability of the organolithium 
was found. The use of TMEDA with THF gave a configurationally labile 
organolithium, possibly due to a competition between the ligand and the solvent for the 
coordination to the lithium. These results were in agreement with Gawley’s study.124 
 
For comparison, the benzylic lithiation of 2-phenyl pyrrolidine (S)-70 was also 
investigated using the O’Brien group conditions.123 Thus, (S)-70 was treated with n-
BuLi in THF at ‒50 °C for 5 minutes and then trapped with Me2SO4 to give (S)-232 in 
74% yield and 80:20 er (Scheme 4.34). In the absence of TMEDA the reduction in er 
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was larger, even at ‒50 °C. Hence, Gawley’s conditions (n-BuLi, TMEDA, Et2O, ‒50 
°C, 30 min) were preferred for the preparation of (S)-232. 
 
Scheme 4.34 
 
One of the limitations of the benzylic lithiation route to (S)-232 was the difficulty in 
preparing >1 g of product, mainly caused by the low yield of the lithiation-Negishi 
coupling reaction upon scale-up. In order to have sufficient amounts of di-substituted 
pyrrolidines for exploration of the synthesis of tetra-substituted pyrrolidines, we decided 
to synthesise both (R)-232 and (S)-232 using a lithiation-cyclisation method previously 
published by our group.
123
 Scheme 4.35 shows the route to (R)-232, which utilised 
enantioenriched α-methylbenzylamine (R)-238 (98:2 er) as starting material. (R)-238 
was alkylated with 3-chloro propanol and then protected using Boc2O to afford amino 
alcohol (R)-240. Subsequent activation of the hydroxyl group with 2,4,6-tri-i-Pr-
benzenesulfonyl chloride gave N-Boc amino sulfonate (R)-241 (74% yield). Since the 
last step would use s-BuLi, the bulky i-propyl groups on the benzenesulfonyl moiety 
were essential to block ortholithiation, which has been observed previously.
126
 
 
Scheme 4.35 
 
In the final step, 8.0 mmol of (R)-241 was treated with s-BuLi and TMEDA in Et2O at 
78 °C for 2 hours to give 1.81 g of 2,2-di-substituted N-Boc pyrrolidine (R)-232 in 
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87% yield and 98:2 er (Scheme 4.36). The proposed mechanism proceeds via the 
formation of lithiated intermediate 242 which then cyclises with inversion of 
configuration
84
 at the carbon-lithium centre. 
 
Scheme 4.36 
 
This methodology allowed the synthesis of multi-gram quantities of (R)-232 without 
reduction of er (98:2 er) and the use of a large-scale lithiation (8.0 mmol) showed the 
robustness of this approach. In addition, the 5 hour reaction time reported by O’Brien 
and Coldham was shown to be unnecessary as the 2 hour lithiation gave a very good 
yield. 
 
N-Boc pyrrolidine (S)-232 was synthesised in 98:2 er and 57% overall yield starting 
from α-methylbenzylamine (S)-238 of 98:2 er and following the same route described 
above (Scheme 4.37).  
 
Scheme 4.37 
 
4.3.2 Attempted Synthesis of Heteroaryl N-Boc Pyrrolidines 
 
At this point, we also investigated the possibility of replacing the phenyl group with a 
heteroaromatic ring. This strategy could potentially diversify the range of substituents α 
to the nitrogen atom and, for example, give access to more interesting products from a 
pharmaceutical point of view. For this purpose, the pyridine ring would be a suitable 
substitution and the introduction into N-Boc pyrrolidine 1 has already been described by 
Campos.
30
 The lithiation-transmetallation-Negishi protocol with s-BuLi and (‒)-
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sparteine at ‒78 °C and 2-bromo pyridine was described to give (R)-211 in 71% yield 
and high enantioselectivity (94:6 er) (Scheme 4.38).   
 
Scheme 4.38 
 
Unfortunately, repeating the reaction several times in our laboratory gave low yields 
(<25% yield). Therefore, a different synthetic pathway, inspired by the lithiation-
cyclisation protocol published by Beak in 1996 (see Scheme 4.14) was explored.
113
 For 
this route, pyridylmethyl-3-chloropropyl N-Boc amine 245 was synthesised in two steps 
from 3-chloropropyl amine hydrochloride 244. Thus, as shown in Scheme 4.39, 
reductive amination of amine 244 and aldehyde 243 with NaBH(OAc)3 was followed by 
Boc protection to give N-Boc protected amine 245 in 32% yield. 
 
Scheme 4.39 
 
With 245 in hand, the asymmetric lithiation-cyclisation was carried out according to 
Beak’s procedure: s-BuLi and (‒)-sparteine in toluene at ‒78 °C for 3 hours. Cyclised 
product (S)-211 was obtained in 82% yield (Scheme 4.40, Table 4.3, Entry 1). Although 
the yield was very good, (S)-211 was formed in 51:49 er, which was much unexpected 
considering the high er reported in the literature with the phenyl substituent. Next, the 
same reaction conditions were tried using Et2O as solvent. However, in this case (S)-211 
was obtained in 56% yield and 50:50 er, with 42% of unreacted starting material 
recovered (Entry 2). 
Chapter Four: Synthesis of Tetra-Substituted Pyrrolidines 
125 
 
Scheme 4.40 
Table 4.3: Exploration of the Asymmetric Lithiation-Cyclisation of 245 
Entry Chiral ligand Solvent 
Yield of 211 
(%)
a 
er
b 
Yield of rec. SM 
245 (%)
a 
1 (‒)-sparteine Toluene 82 51:49 - 
2 (‒)-sparteine Et2O 56 50:50 42 
3 
(+)-sparteine 
surrogate 
Toluene 58 60:40 42 
4 
(+)-sparteine 
surrogate 
Et2O 58 62:38 42 
a
Yield after purification by chromatography. 
b
er determined by CSP-HPLC. 
 
The lithiation-cyclisation reaction of 245 was also performed with the (+)-sparteine 
surrogate as chiral ligand (Entries 3 and 4). The use of toluene or Et2O as solvent gave 
(R)-211 in 58% yield and 60:40 er or 62:38 er respectively. In both the reactions, 
unreacted starting material was recovered in 42% yield. A slightly higher level of 
enantioselectivity was observed with the (+)-sparteine surrogate compared to (‒)-
sparteine, although very unsatisfying. In addition, the yields were significantly lower. 
 
The low enantioselectivity observed might be due to the formation of an azaenolate 
intermediate with a similar mechanism to the one shown in Scheme 4.76 (vide infra). If 
the possible delocalisation of the lithiated intermediate was the problem for the low er 
obtained with 245, then using a pyridine such as 246 could give the cyclised product 
with a better enantioselectivity. Thus, pyridylmethyl-3-chloropropyl N-Boc amine 246 
Chapter Four: Synthesis of Tetra-Substituted Pyrrolidines 
126 
was synthesised from 3-chloropropyl amine hydrochloride 244 and 3-
pyridinecarboxaldehyde via the same route shown in Scheme 4.39. Lithiation of 246 
with s-BuLi and (‒)-sparteine in toluene at ‒78 °C for 3 hours afforded (S)-247 in 36% 
yield and 53:47 er and recovered 246 in 40% yield (Scheme 4.41, Table 4.4, Entry 1). 
The use of Et2O as solvent gave a 70% yield of (S)-247 in 51:49 er; unreacted starting 
material was also isolated in 23% yield (Entry 2). 
 
Scheme 4.41 
Table 4.4: Exploration of the Asymmetric Lithiation-Cyclisation of 246 
Entry Chiral ligand Solvent 
Yield of 247 
(%)
a 
er
b 
Yield of rec. SM 
246 (%)
a 
1 (‒)-sparteine Toluene 36 53:47 40 
2 (‒)-sparteine Et2O 70 51:49 23 
3 
(+)-sparteine 
surrogate 
Toluene 30 66:34 54 
4 
(+)-sparteine 
surrogate 
Et2O 50 64:36 23 
a
Yield after purification by chromatography. 
b
er determined by CSP-HPLC. 
 
The use of the (+)-sparteine surrogate was then explored. Lithiation-cyclisation of 246 
with s-BuLi and the (+)-sparteine surrogate at ‒78 °C for 3 hours in toluene gave (R)-
247 (30% yield) in 66:34 er and recovered starting material in 54% yield (Entry 3). 
With Et2O, (R)-247 was obtained in 50% yield and 64:36 er (Entry 4). 
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The low enantioselectivities obtained with the lithiation of 245 and 246 showed that the 
proposed delocalisation of the electrons on the pyridine nitrogen is not the only 
mechanism affecting the er of the products. It is possible that the pyridine nitrogen 
could coordinate to the lithium of the lithiated intermediate, disturbing the formation of 
the chiral ligand/lithiated intermediate complex, and thus leading to lower 
enantioselectivity. 
 
Discouraged by the poor quality of these results the exploration of this route to 
pyridinyl pyrrolidines was abandoned. 
 
4.3.3 Synthesis of α,α’-Tri-Substituted N-Boc Pyrrolidines 
 
With di-substituted pyrrolidines rac-232, (S)-232 and (R)-232 in hand, the next 
challenge was the synthesis of tri-substituted N-Boc pyrrolidines. For the success of this 
phase, it was important to understand the rate of interconversion of the N-Boc rotamers 
(S)-232a and (S)-232b (Scheme 4.42) at the low temperatures used for lithiation 
reactions. In fact, since the lithiation is directed by the carbonyl of the Boc group, only 
rotamer 232b could be α-lithiated; rotamer 232a will be unreactive as the carbonyl is 
pointing towards the fully substituted quaternary centre. 
 
Scheme 4.42 
 
Hence, to obtain information on the rate of interconversion of the N-Boc rotamers 232a 
and 232b, VT 
1
H NMR spectroscopy studies were performed with (R)-232 in toluene-
d8. In the 
1
H NMR spectrum of (R)-232 at 25 °C (298 K) the signals for the methyl 
group were separated, at δH 1.60 (2.1H) and δH 1.85 (0.9H), and showed a ~70:30 
mixture of rotamers. The separation of those signals was ~124 Hz (Figure 4.5 a). As 
expected, the methyl signals became broader and closer together on raising the 
temperature to 45 °C and 60 °C (b, c). 
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Figure 4.5 
 
Although overlap with other signals made identification difficult, we estimated that the 
coalescence temperature was ~65 °C (338 K) (d). Therefore, the rate of interconversion 
at the coalescence temperature would be k = 275.3 s
1
 and the half-life for rotation, t1/2 = 
2.5 · 103 s. These values corresponded to a free energy of activation, ΔG‡, of 67.3 kJ 
mol
1
 at 65 °C. Assuming that the change in entropy is approximately zero, similar 
values for ΔG‡ could be expected at lower temperatures.127 Therefore, the half-life for 
rotation at 78 °C (195 K) was calculated to be >2 days. In contrast, at 40 °C (233 K), 
t1/2 would be ~3 minutes. 
 
These data clearly revealed that only a partial lithiation of 232 could be achieved at 78 
°C, since the rotation of the N-Boc rotamers would be very slow compared to the usual 
lithiation timescale. In contrast, a reaction temperature of 40 °C should allow a fast 
enough interconversion of the unreactive rotamer 232a to the reactive rotamer 232b, 
and this should give full lithiation of the substrate. Assuming that the lithiated 
intermediate is chemically and configurationally stable at 40 °C, as was observed with 
lithiated N-Boc pyrrolidine 1 (see Scheme 2.23 and Table 2.1), then a 30 minute 
lithiation time should give high yields and good diastereoselectivities. 
 
In order to further understand the lithiation of 2,2-di-substituted N-Boc pyrrolidine 232 
at different temperatures, we decided to monitor the progress of the lithiation using in 
situ ReactIR™ spectroscopy studies. In Scheme 4.43, the results of the addition of s-
a.  
b.   a  a 
c.   a  a 
d. 
  a  a 
e.   a  a 
25 °C 
45 °C 
60 °C 
65 °C 
70 °C 
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BuLi to a solution of (S)-232 and (+)-sparteine surrogate in Et2O at 78 °C are 
presented. Surprisingly, two different peaks for νC=O, at 1711 cm
1 
and 1694 cm
1
, were 
observed in the starting material region. Upon addition of s-BuLi, a rapid loss (<2 min) 
of the 1694 cm
1
 peak and parallel formation of the lithiated intermediate (2S,5S)-
248∙L* (νC=O 1627 cm
1
) were observed. In contrast, the absorbance of the peak at 1711 
cm
1
 did not change over the 1 hour period. 
 
Scheme 4.43 
 
We suspected that the 1711 cm
1 
and 1694 cm
1
 peaks were associated with rotamers 
(S)-232a and (S)-232b respectively. The different νC=O values for the two rotamers 
could arise from a different planarity of the NC=O unit. To confirm this hypothesis, an 
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in situ ReactIR™ spectroscopy experiment was carried out at 40 °C. At this 
temperature the interconversion of (S)-232a into (S)-232b should affect the 1711 cm
1 
peak. Thus, the progress of the lithiation of di-substituted N-Boc pyrrolidine (S)-232 
with s-BuLi and (+)-sparteine surrogate in Et2O at 40 °C was followed (Scheme 4.44). 
 
Scheme 4.44 
 
Analysing these traces separately after the addition of s-BuLi, we noticed that the 1695 
cm
1
 peak decreased rapidly. Simultaneously, a reduction in intensity of the peak at 
1711 cm
1
 was observed. The 1627 cm
1
 peak of the lithiated intermediate (2S,5S)-
248∙L* formed fast and then was constant. The comparison of the traces at 1711 cm1 
and 1695 cm
1
 allowed the assignment of these absorbances to rotamers (S)-232a and 
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(S)-232b respectively. Presumably, the slow decrease of the 1711 cm
1
 peak represented 
the interconversion of (S)-232a into (S)-232b and its subsequent lithiation. 
 
Some conclusions can be drawn from the ReactIR™ spectroscopy studies. At 78 °C 
rotamer (S)-232b was lithiated within 2 minutes after the addition of s-BuLi, while 
rotamer (S)-232a was left untouched (see Scheme 4.43). This was due to the slow rate 
of interconversion of the N-Boc rotamers at 78 °C. Therefore, complete lithiation of 
(S)-232 could not be achieved at 78 °C. On the other hand, at 40 °C, rotamer (S)-
232a could interconvert into rotamer (S)-232b, which was then fully lithiated within 30 
minutes. In addition, lithiated intermediate (2S,5S)-248∙L* appeared chemically stable 
at both temperatures for at least 1 hour. Finally, these data were consistent with the 
results obtained from the VT 
1
H NMR spectroscopy experiments. 
 
The racemic lithiation-Me2SO4 trapping of rac-232 was then explored. With the data 
obtained from the VT 
1
H NMR spectroscopy and in situ ReactIR™ spectroscopy, ‒40 
°C was chosen as the reaction temperature. Lithiation of rac-232 was performed using 
s-BuLi for 30 minutes and trapping with Me2SO4. The lithiation in THF alone gave an 
inseparable mixture of diastereoisomers (2R*,5R*)-249 and (2R*,5S*)-250 in 81% yield 
(Scheme 4.45, Table 4.5, Entry 1). With the addition of TMEDA in THF, (2R*,5R*)-
249 and (2R*,5S*)-250 were isolated in 93% yield (Entry 2) and switching solvent to 
Et2O with TMEDA resulted in a similar yield of the two diastereoisomers (90% yield, 
Entry 3). The use of TMEDA clearly improved the yields. Importantly, these data 
represent the first example of a lithiation-trapping procedure with 2,2-di-substituted N-
Boc pyrrolidines. 
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Scheme 4.45 
Table 4.5: Racemic Lithiation-Me2SO4 Trapping of rac-232 
Entry Solvent Ligand Yield of (2R*,5R*)-249 + (2R*,5S*)-250 (%)
a,b 
1 THF - 81 
2 THF TMEDA 93 
3 Et2O TMEDA 90 
a
Yield after purification by chromatography. 
b
dr not determined. 
 
The main issue with (2R*,5R*)-249 and (2R*,5S*)-250 was that the two 
diastereoisomers were not separable using flash chromatography or with CSP-HPLC. 
Moreover, the presence N-Boc rotamers made measurement of the diastereomeric ratio 
impossible by 
1
H NMR spectroscopy. The problem was solved by removing the Boc 
group. Treating diastereoisomers (2R*,5R*)-249 and (2R*,5S*)-250 (from the reaction 
in Entry 3) with TFA for 1 hour, followed by basic work-up with aqueous NaOH gave 
deprotected (2R*,5R*)-249 and (2R*,5S*)-250 in 92% yield and 55:45 dr (Scheme 
4.46). The dr was measured using the signals for the NCH protons in the 
1
H NMR 
spectrum of the crude product. This value indicated little diastereoselectivity in the 
lithiation-trapping of rac-232 probably due to the similar steric size of the phenyl and 
the methyl groups. 
 
Scheme 4.46 
 
The high yields obtained for the lithiation of rac-232 were encouraging for the planned 
synthesis of tetra-substituted pyrrolidines. The next step was the instalment of an aryl 
group using the lithiation-Negishi protocol. Lithiation of rac-232  was performed with 
s-BuLi in THF at ‒40 °C for 30 minutes. Subsequent transmetallation with ZnCl2 and 
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Negishi coupling with bromobenzene gave substituted pyrrolidines (2R*,5R*)-253 and 
(2R*,5S*)-254 in 42% yield (Scheme 4.47). Luckily, the two diastereoisomers were 
resolved on CSP-HPLC, which showed a 64:36 mixture of (2R*,5R*)-253 and 
(2R*,5S*)-254. The major product was assigned as (2R*,5R*)-253 based on the 
reactions of (S)-232 and (R)-232 in the presence of chiral ligands, which are described 
later. The same ratio was also measured by 
1
H NMR spectroscopy of the deprotected 
amines, using the signals for the NCH protons. 
 
Scheme 4.47 
 
The yield obtained from the lithiation-Negishi reaction was not as high as the trapping 
with Me2SO4 (~90% yield), but yields of 50-70% are typical in our group for these type 
of Negishi reactions. 
 
The development of the synthesis of tri-substituted pyrrolidines moved to the 
investigation of the lithiation-trapping of enantioenriched 2,2-di-substituted N-Boc 
pyrrolidine (R)-232. Me2SO4 was initially chosen as the electrophile for this exploration 
and 78 °C was used with the hope of a higher diastereoselectivity in the formation of 
the lithiated intermediate. Thus, (R)-232 (98:2 er) was lithiated with s-BuLi and 
TMEDA in Et2O at 78 °C for 30 minutes and then trapped with Me2SO4 to give an 
inseparable 60:40 mixture of (2R,5S)-250 and (2R,5R)-249 (51% yield) (Scheme 4.48). 
Starting material (R)-232 was also recovered in 42% yield. The diastereomeric ratio was 
measured by 
1
H NMR spectroscopy of the deprotected amine (2R,5S)-252 and (2R,5R)-
251 (83% crude yield, 60:40 dr). The 51% yield was consistent with the calculated half-
life for rotation of the N-Boc rotamers at 78 °C (t1/2 >2 days). 
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Scheme 4.48 
 
Considering the results obtained with (R)-232 and rac-232, it is reasonable to assume 
that there is an intrinsic substrate control on the stereochemistry of the lithiation-
trapping reaction. The ~60:40 dr observed suggests that there is a preference for 
substitution trans to the phenyl group of the stereogenic centre. 
 
With the desire of improving the diastereoselectivity, chiral ligands were explored 
starting with the (+)-sparteine surrogate. In Scheme 4.49 and Table 4.6 are shown the 
results of the lithiation of (R)-232 (98:2 er) with s-BuLi and (+)-sparteine surrogate in 
Et2O followed by reaction with Me2SO4. Lithiation at 78 °C for 1 hour gave (2R,5R)-
249 and (2R,5S)-250 as an 87:13 mixture in 45% yield (Entry 1). Starting (R)-232 was 
recovered (43% yield). The lithiation at 40 °C for 30 minutes gave an 81:19 mixture of 
(2R,5R)-249 and (2R,5S)-250 in an improved 82% yield (Entry 2). 
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Scheme 4.49 
Table 4.6: Asymmetric Lithiation-Me2SO4 Trapping of (R)-232 
Entry 
Chiral 
ligand 
Temp 
(°C) 
Time 
(min) 
Yield of (2R,5R)-
249 + (2R,5S)-250 
(%)
a 
(2R,5R) : (2R,5S)
b 
1 
(+)-sparteine 
surrogate 
78 60 45 87:13 
2 
(+)-sparteine 
surrogate 
40 30 82 81:19 
3 ()-sparteine 78 60 45 2:98 
4 ()-sparteine 40 30 96 9:91 
a
Yield after purification by chromatography. 
b
dr determined by 
1
H NMR spectroscopy 
of the deprotected amines. 
 
Next, the lithiation-trapping of (R)-232 was performed using (‒)-sparteine as the chiral 
ligand. In theory, ()-sparteine should have the opposite sense of induction and give 
(2R,5S)-250 as the major diastereoisomer. This should help in the assignment of the 
relative stereochemistry of the products. Hence, (R)-232 (98:2 er) was lithiated with s-
BuLi and (‒)-sparteine in Et2O. Lithiation at 78 °C for 1 hour and trapping with 
Me2SO4 gave a 98:2 mixture of (2R,5S)-250 and (2R,5R)-249 (45% yield) and 
unreacted (R)-232 (53% yield) (Entry 3). A 30 minute lithiation at 40 °C afforded a 
91:9 mixture of (2R,5S)-250 and (2R,5R)-249 in 96% yield (Entry 4). 
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The results obtained were consistent with the calculated half-life for interconversion of 
the N-Boc rotamers at 78 °C (t1/2 >2 days) and 40 °C (t1/2 ~3 minutes). In fact, at 78 
°C, incomplete lithiation was expected and recovered starting material (43% and 53% 
yields) was obtained. These values indicated that the low yields (45% for both) were not 
due to chemical instability of the lithiated intermediate. The 82% and 96% yields at 40 
°C indicated that the rotamers were interconverting. Despite the improvement of the 
diastereoselectivity from 60:40 dr (see Scheme 4.48) to 87:13 dr, the stereochemical 
induction with the (+)-sparteine surrogate at 78 °C was considerably lower with (R)-
232 than it was with N-Boc pyrrolidine 1, as described in section 2.2.1. In addition, the 
81:19 dr at 40 °C was probably due to a lower kinetic selectivity, as we believe that 
the lithiated intermediate would be configurationally stable at 40 °C. 
 
The relative stereochemistry of the major diastereoisomer from these reactions was 
assigned based on the established sense of induction obtained with the (+)-sparteine 
surrogate and (‒)-sparteine in s-BuLi-mediated reactions with N-Boc pyrrolidine 1. The 
relative stereochemistry was supported by X-ray crystallographic analysis of another tri-
substituted pyrrolidine (see Figure 4.6), the synthesis of which is described later. 
 
Arguably, the amazing 98:2 dr obtained at 78 °C was the most impressive result from 
these reactions. At 40 °C, an excellent 96% yield was achieved with a slightly reduced 
91:9 dr. The reaction at 78 °C with s-BuLi/(‒)-sparteine gave the same yield (45%) as 
that with the (+)-sparteine surrogate (45%). Recalling the 
1
H NMR spectrum of (R)-232 
where a ~70:30 population of the two rotamers was observed (see Figure 4.5) and 
considering that at 78 °C the t1/2 was >2 days, it can be assumed that the major rotamer 
in (R)-232 has the carbonyl pointing towards the unsubstituted α-carbon. (i.e. rotamer 
232b in Scheme 4.42). 
 
From the results obtained with the two chiral ligands, it was clear that using (R)-232 as 
starting material, s-BuLi/(‒)-sparteine had a higher diasteroinduction, in the opposite 
sense, compared to s-BuLi/(+)-sparteine surrogate. Considering that the lithiation will 
occur on the pseudo-equatorial proton, a match/mismatch mechanism is proposed to 
explain this phenomenon. 
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First, we have to consider that the substrate, (R)-232, has an intrinsic, albeit minor, 
substrate control for a substitution trans to the phenyl group of the stereogenic centre. 
Hence, lithiation of the pseudo-equatorial proton in conformation Y, which leads to the 
formation of the lithiated intermediate trans to the phenyl, would be favoured (Scheme 
4.50). Second, it is known, from studies on other N-Boc heterocycles, that s-BuLi/()-
sparteine is selective towards the deprotonation of the pseudo-equatorial proton in 
conformation Y. Hence, it is reasonable to assume that conformers X and Y would form 
the respective lithiated intermediates at different rates (k2 and k3). In particular, the 
reaction of s-BuLi/()-sparteine with conformation Y will represent the matched case 
and will have a faster rate (k3) than the reaction of s-BuLi/()-sparteine with the 
mismatched conformer X, i.e. k3 > k2. The combination of substrate control and 
substrate/ligand matching generates the high diastereoselectivity observed. 
 
Scheme 4.50 
 
On the other hand, with s-BuLi/(+)-sparteine surrogate, the matched situation is 
lithiation of the pseudo-equatorial proton in conformer X. This is in opposition to the 
substrate control and results in lower dr obtained with (R)-232 and s-BuLi/(+)-sparteine 
surrogate. 
 
Scheme 4.51 
 
With these considerations, the (+)-sparteine surrogate should be the matching ligand for 
the opposite enantiomer of the di-substituted pyrrolidine, (S)-232. Thus, the lithiation of 
(S)-232 was explored with s-BuLi and the (+)-sparteine surrogate and Me2SO4 as 
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electrophile (Scheme 4.52, Table 4.7). At 78 °C, a 1 hour lithiation afforded a 92:8 
mixture of (2S,5R)-250 and (2S,5S)-249 in 51% yield, and unreacted (S)-232 in 40% 
yield (Entry 1). At 40 °C for 30 minutes, (2S,5R)-250 and (2S,5S)-249 were isolated as 
a 94:6 mixture in a high 85% yield (Entry 2).  
 
Scheme 4.52 
Table 4.7: Asymmetric Lithiation-Me2SO4 Trapping of (S)-232 
Entry 
Temp 
(°C) 
Time 
(min) 
Yield of (2S,5R)-
250 + (2S,5S)-249 
(%)
a 
(2S,5R) : (2S,5S)
b 
Yield of 
rec. (S)-232 
(%)
a
 
1 78 60 51 92:8 40 
2 40 30 85 94:6 - 
a
Yield after purification by chromatography. 
b
dr determined by 
1
H NMR spectroscopy 
of the deprotected amines. 
 
The use of s-BuLi/(+)-sparteine surrogate in combination with (S)-232 gave excellent 
diastereoselectivity and this observation was consistent with the proposed matched 
chiral ligand theory. The high 94:6 dr obtained from the reaction at 40 °C was the 
highest value achieved using the high temperature asymmetric lithiation-trapping of di-
substituted pyrrolidines. 
 
At this point we decided to use methylated tri-substituted pyrrolidines (2R*,5R*)-249 
and (2R*,5S*)-250 to pursue the synthesis of tetra-substituted pyrrolidines, using them 
as substrates for lithiation-trapping. In order to obtain information on the lithiation-
trapping of this tri-substituted pyrrolidine, we started with racemic methodology and 
thus, (2R*,5R*)-249 and (2R*,5S*)-250 were used as substrates. Tri-substituted 
pyrrolidines (2R*,5R*)-249 and (2R*,5S*)-250 were lithiated using s-BuLi and 
TMEDA in THF at 30 °C for 1 hour and then trapped with Me2SO4 or benzophenone 
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(Scheme 4.53). In both cases, the reactions were unsuccessful and the 
1
H NMR 
spectrum of the crude product showed only unreacted starting mixture. We found the 
lithiation of (2R*,5R*)-249 and (2R*,5S*)-250 harder than expected. Therefore, no 
further exploration was carried out with this substrate, although lithiation-trapping at 0 
°C could be considered in the future. 
 
Scheme 4.53 
 
Therefore, we switched our attention to the introduction of aryl groups, which should 
favour the fourth lithiation by increasing the acidity of the proton α to nitrogen. The 
knowledge of the ligand effect on the diastereoselectivity, gained with the methylation 
of 232, was fundamental for planning the next synthetic step towards tetra-substituted 
pyrrolidines. A 30 minute lithiation time and 40 °C were selected as the reaction 
conditions. Thus, lithiation of (S)-232 was performed with s-BuLi and the (+)-sparteine 
surrogate, followed by transmetallation with ZnCl2 and reaction with Pd(OAc)2, 
t
Bu3PHBF4 and bromobenzene (Scheme 4.54, Table 4.8). The two diastereoisomers, 
(2S,5S)-253 and (2S,5R)-254, were isolated as an inseparable mixture with (2S,5S)-253 
as the major product. A 56% yield of a 96:4 mixture of (2S,5S)-253 and (2S,5R)-253 
was obtained with (S)-232 of 98:2 er (Entry 1). CSP-HPLC showed >99:1 er for the 
major diastereoisomer and 98:2 er for the minor diastereoisomer. Unreacted (S)-232 
(42% yield) was also recovered. 
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Scheme 4.54 
Table 4.8: Asymmetric Lithiation-Negishi Coupling Reaction of (S)-232 
Entry 
er of 
SM 
Yield of (2S,5S)-253 
+ (2S,5R)-254 (%)
a
 
(2S,5S)-253: 
(2S,5R)-254 
b
 
er of 
(2S,5S)-
253
c 
er of 
(2S,5R)-
254 
c 
1 98:2 56 96:4 >99:1 98:2 
2 94:6 38 94:6 >99:1 76:24 
3 80:20 58 86:14 98:2 18:82 
a
Yield after purification by chromatography. 
b
dr determined by CSP-HPLC. 
c
er 
determined by CSP-HPLC. 
 
As outlined at the beginning of this chapter, the plan for this part of the project was to 
synthesise tetra-substituted pyrrolidines starting from N-Boc pyrrolidine 1. For this 
purpose, the lithiation-Negishi protocol was performed with (S)-232 of 94:6 er 
(previously obtained by a Negishi reaction of N-Boc pyrrolidine 1, see Scheme 4.33, 
Table 4.2). A 94:6 mixture of (2S,5S)-253 (>99:1 er) and (2S,5R)-254 (76:24 er) was 
obtained in 38% yield (Entry 2). Next, (S)-232 of 80:20 er was used, which was 
synthesised from N-Boc pyrrolidine 1 via high temperature asymmetric lithiation-
Negishi coupling followed by benzylic lithiation-trapping. In this case, a 84:16 mixture 
of (2S,5S)-253 and (2R,5S)-254 in 58% yield, with 98:2 er for the major diastereoisomer 
and 82:18 er for the minor diastereoisomer was obtained (Entry 3). 
 
Using (S)-232 of 98:2 er and 94:6 er gave the major product, (2S,5S)-253, in >99:1 er. 
Interestingly, the enantioselectivity (76:24 er) of the minor diastereoisomer in Entry 2 
was considerably lower than those observed in the previous examples. On the other 
hand, the major diastereoisomer was obtained in an excellent >99:1 er. Unfortunately, in 
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this case, the products were isolated in a mediocre 38% yield. Unexpectedly, with (S)-
232 of 80:20 er, an extremely high 98:2 er for the major diastereoisomer was achieved. 
In addition, it was noticed that the major enantiomer of the minor diastereoisomer was 
(2R,5S)-254, which is the opposite sense to those obtained from the higher er substrates, 
(2S,5R)-254. Moreover, a good diastereoselectivity of 86:14 dr was also observed. 
 
With (R)-232 (98:2 er), the lithiation was accomplished with the use of s-BuLi and (‒)-
sparteine at 40 °C for 30 minutes. The lithiated intermediate was then transmetallated 
with ZnCl2 and subsequent Negishi coupling with bromobenzene gave a 95:5 mixture of 
(2R,5R)-253 and (2R,5S)-254 in 60% yield, with >99:1 er for (2R,5R)-253 and 99:1 er 
for (2R,5S)-254. Starting material (R)-232 was also recovered in 32% yield (Scheme 
4.55). 
 
Scheme 4.55 
 
The good diastereoselectivities of ≥95:5 dr achieved with both (S)-232 and (R)-232 
were further evidence for the match/mismatch ligand effect. In addition, excellent 
enantioselectivities of the major diastereoisomers (>99:1 er) and of the minor 
diastereoisomers (>98:2 er) were observed. Although the yields of these reactions were 
not as high as the yields using Me2SO4 as electrophile (85-96% yield), a range of 50-
70% yields is typical for the transmetallation-Negishi coupling. 
 
Next, the lithiation-Negishi coupling method was tested using the mismatching ligand 
on (S)-232. The reaction conditions were maintained as in the previous examples, s-
BuLi at 40 °C for 30 minutes, but (‒)-sparteine was used as the chiral ligand. 
Transmetallation and Negishi reaction with bromobenzene afforded an 81:19 mixture of 
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(2S,5R)-254 and (2S,5S)-253 in 56% yield (Scheme 4.56). A >99:1 er for the major 
diastereoisomer and 94:6 er for the minor diastereoisomer were showed by CSP-HPLC. 
 
Scheme 4.56 
 
As expected from the use of the mismatching ligand, the diastereoselectivity was lower 
and of the same level observed in the lithiation of (R)-232 (98:2 er) with s-BuLi/(+)-
sparteine surrogate at 40 °C and the electrophilic trapping with Me2SO4 (81:19 dr) (see 
Scheme 4.49, Table 4.6, Entry 2). The enantioselectivity of the major diastereoisomer 
(>99:1 er) was comparable to those measured in the reactions with the matching chiral 
ligands (see Scheme 4.54 and Scheme 4.8), while the minor diastereoisomer was 
obtained in a slightly lower 94:6 er. 
 
Analysing the data obtained from all of the lithiation-Negishi coupling reactions, it can 
be noticed that the er of the major diastereoisomer (>99:1 er) was always higher than 
those of the starting substrates (98:2 er). In the example with (S)-232 of 80:20 er, this 
was even more evident as it gave a 98:2 er of the major diastereoisomer. These results 
can be rationalised with a chiral amplification mechanism and an example is shown in 
Scheme 4.57, using the results obtained from (S)-232 of 80:20 er. In the substrate, (S)-
232 was the major enantiomer (80%) and because the (+)-sparteine surrogate was used, 
the reaction gave the desired (2S,5S)-253 as the major product in a high 
diastereoselectivity (~97:3 dr). The minor enantiomer (R)-232 also reacted, but with the 
mismatched ligand, (+)-sparteine surrogate, and therefore the diastereoselectivity was 
lower (~85:15 dr). The minor diastereoisomer obtained from the minor starting material 
(R)-232 was (2R,5R)-253. In other words, the opposite enantiomer of the desired 
product and this can explain the high enantioselectivity observed for (2S,5S)-253 (98:2 
er). This reaction also showed that (2R,5S)-254 was the major enantiomer of the minor 
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diastereoisomer in contrast to the result obtained using (S)-232 (98:2 er) (see Scheme 
4.54). This was due to the larger amount of the minor enantiomer (R)-232 (20%) in the 
reacting substrate. 
 
Scheme 4.57 
 
The same principle can be extended to the enantioenriched substrates (S)-232 and (R)-
232, explaining the excellent >99:1 er of the major diastereoisomers. Furthermore, with 
(S)-232 (96:4 er) the minor diastereoisomer (2S,5R)-254 was obtained in 76:24 er (see 
Scheme 4.54, Table 4.8). This is consistent with an increased amount of (2R,5S)-254 
from the 4% of the minor enantiomer, (R)-232, in the starting substrate. 
 
With this exploration, it was shown that the insertion of an aryl group was attainable 
using the lithiation-Negishi coupling protocol on 2,2-di-substituted pyrrolidines. 
Amazingly, it was possible to amplify the er of the substrate from 80:20 er to 98:2 er as 
well as from 98:2 er to >99:1 er. Finally, the chiral amplification mechanism helped to 
explain the different ers of the minor diastereoisomers. In all this discussion, we could 
conclude that a lithiation temperature of 40 °C is needed for high yields, as it allows 
the interconversion of the N-Boc rotamers. 
 
Next, we investigated the lithiation-transmetallation-Negishi coupling reaction using 
other aryl bromides in order to expand the scope of the methodology. Thus, (R)-232 was 
lithiated with s-BuLi and the matching chiral ligand, (‒)-sparteine, at 40 °C for 30 
minutes and then transmetallated with ZnCl2. The subsequent Negishi coupling was 
performed under the standard conditions (Pd(OAc)2, 
t
Bu3PHBF4 and the aryl bromide) 
Chapter Four: Synthesis of Tetra-Substituted Pyrrolidines 
144 
at room temperature. Aryl bromides, which were reported to give above 70% yields in 
the arylation of N-Boc pyrrolidine 1,
30
 were selected for this exploration and the results 
are shown in Scheme 4.58. Use of 3-bromo-2-fluoro-5-methylpyridine, 2-bromo-
pyridine, 3-bromo-thiophene, N-tri-i-Pr-silyl 3-bromo-pyrrole and 2-bromo-anisole 
gave arylated products (2R,5R)-257-261 in 45-76% yields and 94:6-97:3 dr. In all these 
reactions, the diastereoisomers of each of the products were not separable by flash 
column chromatography. The diastereoselectivities were measured using 
1
H NMR 
spectroscopy of the crude N-Boc deprotected amines as described later. 
 
Scheme 4.58 
 
Luckily, tri-substituted pyrrolidine (2R,5R)-258 was a crystalline solid and X-ray 
crystallography analysis was used to determine its relative stereochemistry (Figure 4.6). 
This analysis showed that the aryl groups were in a trans relationship and thus, the 
lithiation-transmetallation-Negishi coupling reaction proceeded with the 
stereochemistry expected using of s-BuLi/(‒)-sparteine. The relative stereochemistry of 
the other tri-substituted pyrrolidines was assumed to be (2R,5R) by analogy. 
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Figure 4.6 
 
As previously mentioned, the dr of N-Boc tri-substituted pyrrolidines (2R,5R)-257-261 
was determined using 
1
H NMR spectroscopy of the amines. Hence, (2R,5R)-257-261 
were deprotected using TFA in CH2Cl2, followed by basic work-up with aqueous 
NaOH, to give the crude amines (2R,5R)-262-265, which were obtained in almost 
quantitative yields (89-99% yields, Scheme 4.59). They were analysed by 
1
H NMR 
spectroscopy without further purification. 
 
Scheme 4.59 
 
With (2R,5R)-261, addition of TFA caused instantaneous decomposition of the 
substrate. A mechanism which could explain the instability of this substrate in acid is 
shown in Scheme 4.60. Thus, the N-TIPS protected pyrrole 267 could be protonated to 
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give iminium ion 268, which could be attacked by another pyrrole ring to form adduct 
269, which would react again to potentially give polypyrroles. 
 
Scheme 4.60 
 
To determine the diastereoselectivity of (2R,5R)-261, the opposite diastereoisomer was 
deliberately synthesised. Using (R)-232 as substrate, the lithiation was performed at 40 
°C for 30 minutes with s-BuLi and the mismatching chiral ligand, the (+)-sparteine 
surrogate. Transmetallation and Negishi coupling with N-tri-i-Pr-silyl 3-bromo-pyrrole 
afforded pyrrolidine (2R,5S)-270 in 56% yield and 74:26 dr (Scheme 4.61). 
 
Scheme 4.61 
 
Comparing the 
1
H NMR spectra of crude products obtained from the lithiation of (R)-
232 with (‒)-sparteine and the (+)-sparteine surrogate, we were able to confidently 
determine the dr for both reactions. In the example with the mismatching ligand, a 
74:26 dr was observed, a value which was slightly lower than the 81:19 dr obtained 
when the Negishi coupling was carried out with bromobenzene (see Scheme 4.56). 
 
In summary, a range of tri-substituted N-Boc pyrrolidines has been successfully 
synthesised via lithiation-trapping of 2,2-di-substituted pyrrolidines. With the 
investigation of tri-substituted pyrrolidines it was shown that in situ ReactIR™ 
spectroscopy and VT 
1
H NMR spectroscopy were extremely important for monitoring 
the rotamer interconversion process. Hence, the synthesis of tri-substituted pyrrolidines 
was accomplished in excellent yields (82-96% yield) with the lithiation at ‒40 °C using 
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Me2SO4 as electrophile. Moreover, the application of the substrate-chiral ligand 
match/mismatch mechanism allowed the achievement of very high diastereoselectivities 
(>91:9 dr). Finally, the amazing >99:1 er of the major diastereoisomers was rationalised 
using the proposed chiral amplification mechanism. 
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4.4 Development of Methodology for the Synthesis of Tetra-Substituted 
Pyrrolidines 
 
At this point of our synthetic route towards tetra-substituted N-Boc pyrrolidines, we 
were enthusiastic to be a single synthetic step away from our goal. From the lithiation-
trapping of di-substituted and tri-substituted N-Boc pyrrolidines, we understood the 
importance of the rotamer interconversion and the configurational stability of the 
lithiated intermediate for achieving trapped products in high yields and ers. These 
parameters needed to be considered for the success of this final step. 
 
4.4.1 Investigation of a Tri-Substituted Pyrrolidine by VT NMR Spectroscopy and 
in situ ReactIR™ Spectroscopy 
 
Considering that tri-substituted N-Boc pyrrolidine (2S,5S)-253 exists as a mixture of 
rotamers (2S,5S)-253a and (2S,5S)-253b (Scheme 4.62) (from 
1
H NMR spectroscopy of 
the pure product), it was clear that we had to investigate in detail (2S,5S)-253 in order to 
successfully perform the final benzylic lithiation.  
 
Scheme 4.62 
 
Therefore, VT 
1
H NMR spectroscopy studies of tri-substituted (2S,5S)-253 were first 
undertaken to calculate the rate of interconversion of the N-Boc rotamers. Thus, 
(2S,5S)-253 was dissolved in deuterated DMSO-d6 and 
1
H NMR spectra were recorded 
at different temperatures starting from 25 °C. Indeed, at 25 °C (298 K), the signals for 
the benzylic proton of (2S,5S)-253a and (2S,5S)-253b were well separated, at δH 5.22 
(dd, 0.5H) and δH 5.12 (dd, 0.5H), also showing a ~50:50 mixture of rotamers. The 
separation of those signals was ~49 Hz (Figure 4.7, a). As predicted, on increasing the 
temperature, the benzylic proton signals became broader and closer together, 65 °C and 
72 °C (Figure 4.7, b and c), and then completely coalesced at 105 °C (e). Although the 
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1
H NMR spectrum at the exact coalescence temperature was not recorded, it was fair to 
assume that this temperature was between 72 °C and 75 °C. 
 
Figure 4.7: VT 
1
H NMR spectra of (2S,5S)-253 in DMSO-d6. 
 
Using a coalescence temperature of 74 °C (347 K), the free energy of activation (ΔG‡) 
was calculated to be ~71.9 kJ mol
1. Similar values for ΔG‡ could be assumed at lower 
temperatures, if the change in entropy is assumed to be zero.
127
 Hence, at 78 °C (195 
K) a half-life for rotation of ~36 days was calculated, whereas at 30 °C (243 K) the t1/2 
was ~6.5 minutes. 
 
Figure 4.8 shows the half-life for rotation of the N-Boc rotamers of substrates (S)-70, 
(S)-232 and (2S,5S)-253. These data show that upon increasing the steric hindrance 
around the Boc group, the t1/2 at 78 °C progressively increases. As a result, higher 
temperatures are needed to allow N-Boc rotation to occur on a timescale that would be 
compatible with the lithiation methodology. 
 
a.  
b.   a  a 
c.   a  a 
d. 
  a  a 
e.   a  a 
25 °C 
65 °C 
72 °C 
75 °C 
105 °C 
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Figure 4.8 
 
The VT 
1
H NMR data showed that high temperatures should be used to achieve high 
yields from the lithiation-trapping of (2S,5S)-253. As was observed for other 
unsymmetrical substrates, the use of high temperatures should allow the unreactive 
rotamer (2S,5S)-253a to interconvert into the reactive rotamer (2S,5S)-253b. It could be 
predicted that for (2S,5S)-253, a 1 hour lithiation time at 30 °C should give >99% 
lithiation of the substrate. 
 
Next, lithiation of tri-substituted pyrrolidine (2S,5S)-253 was examined using in situ 
ReactIR™ spectroscopy. First, (2S,5S)-253 was treated at ‒78 °C with n-BuLi in the 
presence of TMEDA in Et2O (Scheme 4.63). A major peak for the νC=O of N-Boc group 
of the substrate was observed at 1701 cm
‒1
 with a shoulder at 1695 cm
‒1
. These were 
interpreted as being due to the two rotamers. Addition of n-BuLi caused fast 
disappearance of the 1695 cm
‒1
 peak with formation of a new peak at 1631 cm
‒1
 signal, 
corresponding to the νC=O of the lithiated intermediate (2S,5S)-271∙L. These signals 
remained stable for the entire process. The peak at 1701 cm
‒1
 was unaffected by the 
addition of n-BuLi and could thus be associated with the νC=O of the unreactive rotamer 
(2S,5S)-253a. 
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Scheme 4.63 
 
Then, the lithiation of (2S,5S)-253 using n-BuLi/TMEDA in Et2O was monitored at ‒30 
°C, a temperature which should allow the rotamers to interconvert. Two different peaks 
for the νC=O of (2S,5S)-253 were identified, at 1709 cm
‒1 
and 1699 cm
‒1
 (Scheme 4.64). 
When n-BuLi was added, a rapid (~1 minute) decrease of the 1699 cm
‒1
 peak was 
observed. At the same time, the lithiated intermediate peak (1627 cm
‒1
) appeared and 
the intensity gradually increased during the whole period of observation. The 1709 cm
‒1
 
peak slowly decreased and this could be easily seen from the two-dimensional plot (b).  
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(a) 
 
(b) 
Scheme 4.64 
 
From the data observed with the in situ ReactIR™ spectroscopy at ‒78 °C and ‒30 °C, 
it was possible to assign the 1709 cm
‒1 
and 1699 cm
‒1
 peaks to rotamers (2S,5S)-253a 
and (2S,5S)-253b respectively. At ‒78 °C only rotamer (2S,5S)-253b reacted. The slow 
decrease of the 1709 cm
‒1 peak at ‒30 °C could be explained by the slow 
interconversion of rotamer (2S,5S)-253a into rotamer (2S,5S)-253b, which was then 
lithiated. These results were consistent with the rotamer interconversion half-life 
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calculated from the VT 
1
H NMR spectroscopy studies. In addition, the almost 
instantaneous disappearance of the reactive rotamer (2S,5S)-253b peak (1695 cm
‒1
 or 
1699 cm
‒1
) showed that the lithiation of (2S,5S)-253b was extremely fast even at ‒78 
°C. Finally, it was clear that a reaction temperature of ‒30 °C for at least 10 minutes 
was needed to achieve high yields with the lithiation-trapping of (2S,5S)-253. 
 
4.4.2 Investigation of the Configurational Stability of Lithiated Tri-Substituted N-
Boc Pyrrolidine 271: Synthesis of Tetra-Substituted Pyrrolidines 
 
The requirement of high temperatures and long reaction times for the final benzylic 
lithiation reaction raised an important question about the configurational stability of the 
lithiated intermediate. This was explored in a series of experiments. To start with, 
lithiation of a 64:36 mixture of (2R*,5R*)-253 and (2R*,5S*)-254 using n-BuLi in THF 
at 0 °C for 5 minutes and then trapping with Me2SO4 was carried out. This gave a 55:45 
mixture (by 
1
H NMR spectroscopy of the crude product) of (2R*,5R*)-272 and meso-
273 in 29% yield (Scheme 4.65). The diastereoselectivity obtained from the reaction at 
0 °C (55:45 dr) showed that at such a high temperature the configuration of the lithiated 
intermediate was not maintained, but a trans substitution to the phenyl group was 
favoured. In addition, the low yield obtained was possibly due to decomposition of the 
lithiated intermediate, as there was no starting material recovered after purification. 
 
Scheme 4.65 
 
Next, we explored the benzylic lithiation of (2S,5S)-253 at 78 °C and 50 °C in order 
to study the configurational stability of the lithiated intermediate. This specific 
exploration was carried out using an 86:14 mixture of (2S,5S)-253 and (2R,5S)-254. Our 
interest was to observe whether n-BuLi in THF with no ligand (e.g. TMEDA) could 
maintain the dr of the substrate. Hence, the mixture was lithiated with n-BuLi in THF 
and then trapped with Me2SO4 (Scheme 4.66 and Table 4.9). At 78 °C, lithiation for 1 
hour followed by reaction with Me2SO4 gave a 78:22 mixture of (2S,5S)-272 and meso-
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273. The diastereoisomers were separated by flash chromatography to give (2S,5S)-272 
(35% yield) in 97:3 er (by CSP-HPLC) and an 8% yield of meso-273 (Entry 1). When 
the reaction was carried out at 50 °C for 3 minutes, Me2SO4 trapping afforded a 70:30 
mixture of (2S,5S)-272 in 34% yield and 97:3 er and meso-273 (10% yield) (Entry 2). 
Unreacted starting material was recovered in 56% yield from both of the reactions.  
 
Scheme 4.66 
Table 4.9: Exploration of the Benzylic Lithiation-Trapping of (2S,5S)-253 and (2R,5S)-
254 at 78 °C and 50 °C 
Entry 
Temp 
(°C) 
Time 
(min) 
Yield of 
(2S,5S)-272 
(%)
a 
er
b 
Yield of 
meso-273 
(%)
a 
(2S,5S)-272 : meso-273
c 
1 78 60 35 97:3 8 78:22 
2 50 3 34 97:3 10 70:30 
a
Yield after purification by chromatography. 
b
er determined by CSP-HPLC. 
c
ratio 
determined by 
1
H NMR spectroscopy of the crude product. 
 
The overall yield of ~45% for (2S,5S)-272 and meso-273 isolated in these reactions was 
not surprising, as the half-life for the rotamer interconversion was ~3 hours at 50 °C 
and >35 days at 78 °C. The high recovered yield for unreacted (2S,5S)-253 and 
(2S,5S)-254 (56% yield) proved the slow rate of rotamer interconversion and indicated 
that the lithiated intermediate was chemically stable under these conditions. The 
decrease of the 86:14 dr of the starting material to 78:22 dr (78 °C) and to 70:30 dr 
(50 °C) was significant. It clearly revealed that the lithiated intermediate was partially 
configurationally unstable even at 78 °C. Therefore, n-BuLi in THF was not suitable 
for good yields and high diastereoselectivities. 
 
Since (2S,5S)-272 was a solid and suitable crystals could be grown, X-ray 
crystallography was used to establish the relative stereochemistry of this tetra-
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substituted pyrrolidine (Figure 4.9). The trans geometry of the phenyl groups showed 
that the benzylic lithiation process occurred predominantly with retention of 
configuration of the stereogenic centre. 
                                                                                       
                                                                                 
 
Figure 4.9 
 
The VT 
1
H NMR spectroscopy and in situ IR studies with (2S,5S)-253 showed that at 
30 °C the rotamers should interconvert and high yields could be expected. In addition, 
from the studies carried out with (S)-70 (see Scheme 4.33 and Table 4.2), it was known 
that the use of n-BuLi in the presence of TMEDA increased the configurational stability 
of the lithiated intermediate. Thus, the benzylic lithiation of a 96:4 mixture of (2S,5S)-
253 and (2S,5R)-254 was performed using n-BuLi and TMEDA in Et2O at 30 °C, 
followed by trapping with Me2SO4 (Scheme 4.67, Table 4.10). A 30 minute lithiation 
gave a 91:9 mixture of (2S,5S)-272 and meso-273, which after separation were isolated 
in 85% yield (99:1 er) and 2% yield respectively (Entry 1). In the 60 minute lithiation 
experiment, flash column chromatography of the crude mixture of (2S,5S)-272 and 
meso-273 (90:10 dr) afforded (2S,5S)-272 in 87% yield (99:1 er) and meso-273 in 3% 
yield (Entry 2). 
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Scheme 4.67 
Table 4.10: Benzylic Lithiation-Trapping of (2S,5S)-253 and (2S,5R)-254 at 30 °C 
Entry 
Time 
(min) 
Yield of 
(2S,5S)-272 
(%)
a 
er
b 
Yield of 
meso-273 
(%)
a 
(2S,5S)-272 : meso-273
c 
1 30 85 99:1 2 91:9 
2 60 87 99:1 3 90:10 
a
Yield after purification by chromatography. 
b
er determined by CSP-HPLC. 
c
ratio 
determined by 
1
H NMR spectroscopy of the crude product. 
 
First, excellent isolated yields were achieved under both conditions (≥85%), proving 
that the rotamers were able to interconvert at 30 °C. Furthermore, the 91:9 dr showed a 
lower value of diastereoselectivity compared to the 96:4 dr of the starting material. The 
reduction of dr was probably due to a partial configurational instability of the lithiated 
intermediate. However, the similar dr observed in the 30 minute and 60 minute 
experiments suggested that there was no further loss of dr over 1 hour. 
 
In order to complete the synthesis of a tetra-substituted pyrrolidine via four lithiation-
trapping steps starting from N-Boc pyrrolidine 1, the benzylic lithiation (n-BuLi, 
TMEDA, 30 °C in Et2O for 1 hour) was performed using the 94:6 mixture of (2S,5S)-
253 and (2S,5R)-254 (see Scheme 4.54, Table 4.8, Entry 2). From this, an 89:11 mixture 
of (2S,5S)-272 (88% yield and 99:1 er) and meso-273 was obtained (Scheme 4.68). 
 
Scheme 4.68 
Chapter Four: Synthesis of Tetra-Substituted Pyrrolidines 
157 
The 88% yield of this reaction represented the highest yield achieved in the exploration 
of the benzylic lithiation-trapping of tri-substituted pyrrolidines. Moreover, the 
diastereoselectivity level (89:11 dr) was comparable with those observed in Scheme 
4.67 and Table 4.10 (~90:10 dr). 
 
At this point, we wanted to explore the configurational stability at even higher 
temperatures. For that reason, a 95:5 mixture of (2R,5R)-253 and (2R,5S)-254 was 
treated at 0 °C for 1 minute with n-BuLi and TMEDA in Et2O. Subsequent trapping 
with Me2SO4 produced an 89:11 mixture of (2R,5R)-272 and meso-273. After flash 
column chromatography, (2R,5R)-272 was isolated in 85% yield and 99:1 er, while 
meso-273 was not recovered (Scheme 4.69). Amazingly, a very high 89:11 dr was 
observed even at 0 °C with a 1 minute reaction. This value was of the same level with 
those achieved at 30 °C, showing a diastereoselectivity and configurational stability of 
the lithiated intermediate at such a high temperature for a lithiation reaction. 
 
Scheme 4.69 
 
Finally, the optimised protocol was applied to the 81:19 mixture of (2S,5R)-254 and 
(2S,5S)-253. Lithiation with n-BuLi, TMEDA in Et2O at 30 °C for 1 hour and Me2SO4 
trapping gave an 81:19 mixture of meso-273 and (2S,5S)-272, which were isolated in 
40% yield and 8% yield respectively after flash column chromatography (Scheme 4.70). 
This result demonstrated that compounds with a cis relative stereochemistry between 
the aryl groups were attainable via this route. Interestingly, no reduction in dr was 
observed with this substrate, showing a high configurational stability of the lithiated 
intermediate. 
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Scheme 4.70 
 
In this last section, the accomplishment of our original aim for this project, the synthesis 
of tetra-substituted pyrrolidines via four sequential lithiation reactions starting from N-
Boc pyrrolidine 1 has been realised. The synthetic pathway which led to the isolation of 
(2S,5S)-272 in an excellent 99:1 er is shown in Scheme 4.71. It can be seen that reaction 
temperatures of 50 °C, 40 °C and 30 °C were needed in order to have high yields of 
the products. In fact, the appropriate temperature had to be selected to obtain high yields 
in each step. 
 
Scheme 4.71 
 
We have also developed a synthetic route which used reaction temperatures which were 
all above ‒50 °C. In this case, it was also possible to obtain tetra-substituted pyrrolidine 
(2S,5S)-272, but the yields and the stereoselectivities of each reaction were considerably 
lower (Scheme 4.72). In addition, the benzylic lithiations were performed without 
TMEDA as ligand, causing a larger reduction in dr in the second and in the last steps. 
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Scheme 4.72 
 
4.4.3 Synthesis of α,α’-Tetra-Substituted N-Boc Pyrrolidines 
 
As a final demonstration of our methodology, we wanted to introduce a different 
electrophile in the final benzylic lithiation. Hence, the electrophilic trapping was 
performed with methyl chloroformate. Using the 94:6 mixture of (2S,5S)-253 and 
(2S,5R)-254 under the optimised benzylic lithiation conditions, ester (2S,5S)-274 was 
obtained in a high 88% yield and 91:9 dr (Scheme 4.73). This result showed that a good 
yield could be obtained with methyl chloroformate as electrophile. The 
diastereoselectivity was comparable to those observed earlier. 
 
Scheme 4.73 
 
Similarly, an 81:19 mixture of (2S,5R)-254 and (2S,5S)-253 was treated with n-
BuLi/TMEDA in Et2O at ‒30 °C for 1 hour and then trapped with methyl chloroformate 
(Scheme 4.74). The product with the phenyl groups in a cis relative stereochemistry, 
(2R,5S)-275, was isolated in 57% yield and 86:14 dr. In this case, only moderate yields 
could be achieved and the diastereoselectivity observed (86:14 dr) was slightly higher 
than the starting material (81:19 dr).  
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Scheme 4.74 
 
Next, the final benzylic lithiation was carried out on some of the tri-substituted 
pyrrolidines with a non-phenyl aromatic ring, the syntheses of which were described 
earlier (see Scheme 4.58). To increase the variation of the substituents α to the nitrogen 
and to prepare tetra-substituted pyrrolidines with four different substituents, methyl 
chloroformate was chosen as the electrophile. Pyrrolidines (2R,5R)-258, 259, 261 were 
lithiated with n-BuLi and TMEDA in Et2O at ‒30 °C for 1 hour and then trapped using 
methyl chloroformate (Scheme 4.75). (2R,5R)-276-278 were obtained in 35-52% yield 
and 75:25-98:2 dr. Unreacted starting materials were also isolated after flash column 
chromatography in 45%, 53% and 38% yields respectively. The diastereoselectivities 
for (2R,5R)-277 and (2R,5R)-278 were measured using 
1
H NMR spectroscopy of the 
crude products.  
 
 
Scheme 4.75 
 
The yields obtained with these substrates (35-52%) were considerably lower than 
expected and could be due to a reduced rate of interconversion of the N-Boc rotamers. 
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This might be due to an increased steric hindrance of the aryl groups, which could 
interfere with the rotation of the Boc group. The recovery of unreacted starting materials 
could be evidence of the slow rotamer interconversion. Thus, to achieve high yields 
with these substrates, longer reaction times or higher temperatures might be needed. 
Unfortunately, we could not investigate this in detail as only small amounts of material 
were available. 
 
Furthermore, the results showed that the dr of the products differed from the dr of the 
starting material. This was particularly evident with (2R,5R)-277, the 75:25 dr obtained 
represented a large reduction from the 97:3 dr of the starting material. This observation 
could be explained with the mechanism proposed in Scheme 4.76. In the lithiated 
intermediate (2R,5R)-279∙L, the C-Li bond could be labile via delocalisation onto the 
nitrogen atom of the pyridine, forming azaenolate 280. The negative charge on the 
nitrogen of azaenolate 280 could be stabilised by coordination to the lithium atom, 
which could coordinate with the carbonyl oxygen, increasing the stability of this 
intermediate.
128
 The just-formed double bond represents loss of stereochemistry at that 
carbon. Next, it could be possible that azaenolate 280 would attack the electrophile from 
the least hindered face, which should be opposite to the phenyl substituent. This would 
explain the large drop in diastereomeric ratio observed in the benzylic lithiation-
trapping of (2R,5R)-259.   
 
Scheme 4.76 
 
Importantly, these results showed that we accomplished the aim of this part of the 
project and a range of tetra-substituted N-Boc pyrrolidines could be achieved in good 
yields (57-88%) and high dr (75:25-98:2 dr) with the benzylic lithiation-trapping of tri-
substituted pyrrolidines. These results would not have been possible without a 
preliminary investigation of the rotamer interconversion and lithiated intermediate 
configurational stability. 
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4.5 Conclusions and Future Work 
 
The synthesis of tri- and tetra-substituted pyrrolidines, which were previously unknown 
in the literature, has been reported in this chapter. VT 
1
H NMR spectroscopy allowed 
the calculation of the half-life for rotation of the N-Boc group of the di-substituted 
pyrrolidine 232 and tri-substituted pyrrolidine 253. With 232 at 40 °C, t1/2 ≈ 3 minutes 
and the lithiation-trapping gave high yields both in the racemic protocol (81-90% 
yields) and in the asymmetric procedure (82-96% yields). Furthermore, with this 
substrate an interesting match/mismatch mechanism was discovered to be at the basis of 
the high diastereoselectivities observed in the asymmetric protocol. In fact, di-
substituted pyrrolidine (R)-232 (98:2 er) and s-BuLi/()-sparteine at 78 °C gave a 98:2 
dr when trapped with Me2SO4. Using (S)-232 and the matching (+)-sparteine surrogate, 
the highest diastereoselectivity was 96:4 dr, in the opposite sense, when the reaction 
was performed at 40 °C. 
 
A lithiation-transmetallation-Negishi reaction protocol was also reported with 232 as 
substrate. Good dr and excellent ers of the major diastereoisomers (>98:2 er) were 
observed. This was explained using a chiral amplification mechanism. This effect meant 
that (2S,5S)-253 was obtained in an excellent 98:2 er, starting from an 80:20 er of 
substrate (S)-232. The lithiation-Negishi protocol was then used with (R)-232 to 
synthesise five different tri-substituted pyrrolidines in good yields (45-76% yield) and 
high drs (>94:6 dr). 
 
Furthermore, the synthesis of α,α’-tetra-substituted pyrrolidines was reported. It was 
shown that the use of TMEDA as a ligand in the benzylic lithiation of 253 increased the 
configurational stability of the lithiated intermediate and tetra-substituted pyrrolidines 
were obtained in ~90:10 dr. Moreover, the first synthesis of (2S,5S)-272 starting from 
N-Boc pyrrolidine 1 via four sequential lithiation-trapping steps was presented. When 
the lithiation-transmetallation-Negishi reaction of 1 was performed at ‒78 °C and 
TMEDA was used in the benzylic lithiation step, (2S,5S)-272 was obtained in 99:1 er 
and 89:11 dr. In contrast, the use of high temperature (‒30 °C) in the first lithiation 
reaction and no ligand in the benzylic step afforded (2S,5S)-272 in 97:3 er and 70:30 dr. 
Finally, the first synthesis of tetra-substituted pyrrolidines with four different 
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substituents α to the nitrogen was reported. Products were obtained in moderate to good 
yields (35-88% yield). 
 
Unfortunately, the introduction of aryl substituents other than a phenyl group into N-
Boc pyrrolidine 1 was unsatisfactory with low yields and modest ers. This represented 
the major limitation of the developed protocol. 
 
As future work, we identified that the installation of heterocycles α to the nitrogen in N-
Boc pyrrolidine 1 should be the main aim for the subsequent development in the tetra-
substituted pyrrolidines part of the project. This approach would lead to the synthesis of 
novel tri- and tetra-substituted pyrrolidines. We also propose the use of electrophiles 
other than Me2SO4 and methyl chloroformate, although compatibility with the lithiation 
conditions must be taken into account. One of our objectives remains the introduction of 
a pyridine ring as the first heterocycle and thus, new synthetic strategies aimed to solve 
this issue should be explored. We propose to start this exploration with the reductive 
cyclisation of N-sulfinyl ketimine (SS)-282 following Reddy’s procedure.
109
 With this 
synthetic pathway, both enantiomeric series of 2-pyridyl pyrrolidine would be accessed 
by selecting the appropriate reducing agent (Scheme 4.77).  
 
Scheme 4.77 
 
In addition, we propose to differentiate the aryl groups by using nitrogen heteroaromatic 
rings such as pyrroles, pyridines, pyrimidines and thiazoles. Examples of designed tetra-
substituted pyrrolidines are shown in Figure 4.10. 
 
Figure 4.10 
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Moreover, the methodology for the synthesis of α,α'-tetra substituted N-Boc 
pyrrolidines could be extended to other heterocycles. Hence, we propose to apply the 
two sequential asymmetric lithiation-Negishi coupling reactions and benzylic lithiation 
steps to N-Boc piperidine 34 and N-thiopivaloyl azetidine 99
78
 (Scheme 4.78). 
 
Scheme 4.78 
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Chapter Five: Experimental 
 
5.1 General Methods 
 
All-non aqueous reactions were carried out under oxygen free Ar using flame-dried 
glassware. Et2O and THF were freshly distilled from sodium and benzophenone 
respectively. Alkyllithiums were titrated against N-benzylbenzamide before use.
129
 All 
diamines used in lithiations were distilled over CaH2 before use. Petrol refers to the 
fraction of petroleum ether boiling in the range 40-60 °C and was purchased in 
Winchester quantities. Brine refers to a saturated solution. Water is distilled water. 
 
Flash column chromatography was carried out using Fluka Chemie GmbH silica (220-
440 mesh). Thin layer chromatography was carried out using commercially available 
Merck F254 aluminium backed silica plates. Proton (400 MHz) and carbon (100.6 MHz) 
NMR spectra were recorded on a Jeol ECX-400 instrument using an internal deuterium 
lock. For samples recorded in CHCl3, chemical shifts are quoted in parts per million 
relative to CHCl3 (δH 7.27) and CDCl3 (δC 77.0, central line of triplet). Carbon NMR 
spectra were recorded with broad band proton decoupling and assigned using DEPT 
experiments. Coupling constants (J) are quoted in Hertz. Melting points were carried 
out on a Gallenkamp melting point apparatus. Boiling points give for compounds 
purified by Kügelrohr distillation correspond to the oven temperature during distillation. 
Infrared spectra were recorded on an ATI Mattson Genesis FT-IR spectrometer. 
Electrospray high and low resonance mass spectra were recorded at room temperature 
on a Bruker Daltronics microOTOF spectrometer. In situ ReactIR™ infra-red 
spectroscopic monitoring was performed on a Mettler-Toledo ReactIR™ iC10 
spectrometer equipped with a silicon-tipped (SiComp) probe. 
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5.2 General Procedures 
 
General Procedure A: Asymmetric Lithiation-trapping of N-Boc Pyrrolidine 1 and 
N-Boc piperidine 34 using s-BuLi/Chiral Ligand at temperatures above −78 °C 
s-BuLi (1.3 M solution in hexanes, 1.3 eq.) was added dropwise to a stirred solution of 
N-Boc heterocycles (N-Boc Pyrrolidine 1 or N-Boc piperidine 34) (1.0 eq.) and diamine 
(1.3 eq.) in solvent (Et2O, THF, TBME) (3.5-7 mL) at the specified temperature (−50 - 
0 °C) under Ar.  The resulting solution was stirred at the specified temperature for the 
specified time (1 s - 1 h).   Then, the electrophile (PhCHO, Me2SO4, phenyl isocyanate, 
methyl chloroformate or benzophenone in Et2O (1 mL)) (2.0 eq.) was added. The 
resulting solution was stirred at the specified temperature for 10 min and then allowed 
to warm to rt over 1 h. Then, saturated NH4Cl(aq) (10 mL) was added and the two layers 
were separated.  The aqueous layer was extracted with Et2O (3 × 10 mL).  The 
combined organic layers were dried (Na2SO4) and evaporated under reduced pressure to 
give the crude product. 
 
General Procedure B: High Temperature Lithiation-trapping of N-Boc 
Imidazolidine 36 
s-BuLi (1.3 eq.) was added dropwise to a stirred solution of N-Boc-N-i-Pr 
imidazolidine 36 (1.0 eq.) and (+)-sparteine surrogate (1.3 eq.) in solvent (Et2O, THF) 
(3.5 - 7 mL) at 40 °C or 30 °C under Ar. The resulting solution was stirred at the 
specified temperature for the specified time (5 min - 1 h). Then, the electrophile (phenyl 
isocyanate, methyl iodide, or benzophenone in solvent (Et2O, THF) (1 mL)) (2.0 eq.) 
was added. The resulting solution was stirred at the specified temperature for 10 min 
and then allowed to warm to rt over 1 h. Then, saturated NaHCO3(aq) (5 mL) and Et2O 
(5 mL) were added and the two layers were separated. The aqueous layer was extracted 
with Et2O (3 × 5 mL) and the combined organic layers were dried (Na2SO4) and 
evaporated under reduced pressure to give the crude product. 
 
General Procedure C: Lithiation-trapping of 4-phenyl N-Boc piperidine 147 
s-BuLi (1.15 mL of a 1.3 M solution in hexanes, 1.5 mmol, 1.3 eq.) was added dropwise 
to a stirred solution of 4-phenyl N-Boc piperidine 147 (300 mg, 1.15 mmol, 1.0 eq.) and 
diamine (1.3 eq.) in Et2O (3.8 mL) at 78 °C or 40 °C under Ar. The resulting solution 
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was stirred at the specified temperature for 1 h or 3 h. Then, electrophile (Me2SO4, 
Me3SiCl, PhMe2SiCl, phenyl isocyanate, PhCONMe2 or benzophenone in Et2O (1 mL)) 
(2.3 mmol, 2.0 eq.) was added. The resulting solution was stirred at rt for 16 h. Then, 
saturated NH4Cl(aq) (5 mL) and Et2O (20 mL) were added and the two layers were 
separated. The aqueous layer was extracted with Et2O (3 × 5 mL) and the combined 
organic layers were dried (Na2SO4) and evaporated under reduced pressure to give the 
crude product. 
 
General Procedure D: Methylation of 2-phenyl N-Boc Pyrrolidine (S)-70 
n-BuLi (1.1 eq.) was added dropwise to a stirred solution of phenyl pyrrolidine (S)-70 
(1.0 eq., 94:6 er) and TMEDA (1.1 eq.) in specified solvent (Et2O, THF) at the specified 
temperature (50, 30 °C) under Ar. The resulting solution was stirred at the specified 
temperature for the specified time (5 min - 1 h). Then, Me2SO4 (1.5 eq.) was added. The 
resulting solution was stirred at the specified temperature for 10 min and then allowed 
to warm to rt over 1 h. Then, saturated NH4Cl(aq) (2 - 10 mL) and Et2O (2 - 10 mL) were 
added and the two layers were separated. The aqueous layer was extracted with Et2O (3 
× 5 - 10 mL) and the combined organic layers were dried (Na2SO4) and evaporated 
under reduced pressure to give the crude product. 
 
General Procedure E: Alkylation of α-methylbenzylamine 238 
3-Chloro-1-propanol (2.3 g, 2.0 mL, 23.9 mmol, 1.0 eq.) was added dropwise to a 
stirred mixture of α-methylbenzylamine ((R)-238 or (S)-238) (5.8 g, 6.1 mL, 47.9 mmol, 
2.0 eq.) and water (0.7 mL) at rt. The resulting solution was stirred and heated at reflux 
for 16 h. After being allowed to cool to rt, 20% NaOH(aq) (30 mL) was added and the 
aqueous layer was extracted with CH2Cl2 (3 × 30 mL). The combined organic layers 
were dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
 
General Procedure F: Boc protection of Amino Alcohol 239 
A solution of di-tert-butyl dicarbonate (1.0 eq.) in CH2Cl2 (11, 14 mL) was added 
dropwise to a stirred solution of amino alcohol ((R)-239 or (S)-239) (1.0 eq.) in CH2Cl2 
(45, 57 mL) at rt under Ar. The resulting solution was stirred at rt for 16 h. Then, water 
(50 mL) was added and the two layers were separated. The aqueous layer was extracted 
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with CH2Cl2 (2 × 25 mL). The combined organic layers were dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. 
 
General Procedure G: Sulfonylation of N-Boc Amino Alcohol 240 
2,4,6-Tri-i-propyl-benzenesulfonyl chloride (1.05 eq.) was added to a stirred solution of 
the N-Boc amino alcohol ((R)-240 or (S)-240) (1.0 eq.), Et3N (1.2 eq.) and DMAP (0.1 
eq.) in CH2Cl2 (50 mL) at 0 °C under Ar. The resulting solution was allowed to warm to 
rt and stirred at rt for 16 h. Water (50 mL) was added and the two layers were separated. 
The aqueous layer was extracted with CH2Cl2 (3 × 50 mL). The combined organic 
layers were dried (MgSO4) and evaporated under reduced pressure to give the crude 
product. 
 
General Procedure H: Lithiation-Cyclisation of N-Boc Amino Sulfonate 241 
s-BuLi (8.0 mL of a 1.3 M solution in hexanes, 10.4 mmol, 1.3 eq.) was added dropwise 
to a stirred solution of N-Boc amino sulfonate ((R)-241 or (S)-241) (4.36 g, 8.0 mmol, 
1.0 eq.) and TMEDA (1.2 g, 1.56 mL, 10.4 mmol, 1.3 eq.) in Et2O (56 mL) at –78 °C 
under Ar. The resulting solution was stirred at –78 °C for 2 h. Then, MeOH (1 mL) was 
added and the resulting solution was allowed to warm to rt over 1 h. Et2O (30 mL) and 1 
M HCl(aq) (20 mL) were added and the two layers were separated. The aqueous layer 
was extracted with Et2O (3 × 20 mL). The combined organic layers were dried (MgSO4) 
and evaporated under reduced pressure to give the crude product. 
 
General Procedure I: Synthesis of N-Boc Chloro-Propylamine 245 and 246 
NaBH(OAc)3 (5.9 g, 28 mmol, 1.4 eq.) was added to a stirred solution of 3-
chloropropylamine hydrochloride (2.6 g, 20 mmol, 1.0 eq.) and aldehyde (2-
pyridinecarboxaldehyde or 3-pyridinecarboxaldehyde) (2.14 g, 1.9 mL, 20 mmol, 1.eq.) 
in 1,2-dichloroethane (80 mL) at rt for 3 h. Saturated NaHCO3(aq) (50 mL) was added 
and the two layers were separated. The aqueous layer was extracted with CH2Cl2 (3 × 
30 mL) and the combined organic layers were dried (MgSO4) and evaporated under 
reduced pressure to give the crude amine. The amine was dissolved in CH2Cl2 (10 mL) 
and added to a stirred solution of di-tert-butylcarbonate (4.36 g, 20 mmol, 1.0 eq.) in 
CH2Cl2 (30 mL) at 0 °C. The resulting mixture was stirred at rt for 16 h. Saturated 
NH4Cl(aq) (30 mL) was added and the two layers were separated. The aqueous layer was 
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extracted with CH2Cl2 (3 × 10 mL). The combined organic layers were dried (MgSO4) 
and evaporated under reduced pressure to give the crude product. 
 
General Procedure J: Lithiation-cyclisation of N-Boc Chloro-Propylamine 245 and 
246 
s-BuLi (0.2 mL of a 1.3 M solution in hexanes, 0.26 mmol, 1.3 eq.) was added dropwise 
to a stirred solution of N-Boc chloro-propylamine (245 or 246) (57 mg, 0.2 mmol, 1.0 
eq.) and diamine (1.3 eq.) in the specified solvent (toluene, Et2O) (2 mL) at –78 °C 
under Ar. The resulting solution was stirred at –78 °C for 3 h. Then, MeOH (1 mL) was 
added and the resulting solution was allowed to warm to rt over 1 h. Et2O (5 mL) and 
saturated NH4Cl(aq) (5 mL) were added and the two layers were separated. The aqueous 
layer was extracted with Et2O (3 × 5 mL). The combined organic layers were dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. 
 
General Procedure K: Lithiation-Methylation of Di-substituted Pyrrolidine 232 
s-BuLi (1.3 eq.) was added dropwise to a stirred solution of pyrrolidine ((R)-232 of 
98:2, (S)-232 of 98:2 er or rac-232) (1.0 eq.) and diamine ((+)-sparteine surrogate, ()-
sparteine, TMEDA) (1.3 eq.) in the specified solvent (Et2O, THF) (1.4, 2.6, 2.8, 3.5 mL) 
at the specified temperature (78, 40 °C) under Ar. The resulting solution was stirred 
at the specified temperature for the specified time (30, 60 min). Then, Me2SO4 (2.0 eq.) 
was added. The resulting solution was stirred at the specified temperature for 10 min 
and then allowed to warm to rt over 1 h. Then, saturated NH4Cl(aq) (2, 4, 5 mL) and 
Et2O (2, 4, 5 mL) were added and the two layers were separated. The aqueous layer was 
extracted with Et2O (3 × 2, 4, 5 mL) and the combined organic layers were dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. 
 
General Procedure L: TFA Deprotection 
TFA (10.0 eq.) was added to a stirred solution of a mixture of pyrrolidines ((2R,5R) and 
(2R,5S) or (2S,5R) and (2S,5S)) (1.0 eq.) in CH2Cl2 (0.3 - 1 mL). The resulting mixture 
was stirred at rt for 1 h. Then, 1 M NaOH(aq) (1 mL) was added and the two layers were 
separated. The organic layer was washed with 1 M NaOH(aq) (2 × 1 mL), dried (MgSO4) 
and evaporated under reduced pressure to give the crude product. 
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General Procedure M: Lithiation-Negishi Coupling of Di-substituted Pyrrolidine 
232 
s-BuLi (1.1, 1.2, 1.3 eq.) was added dropwise to a stirred solution of pyrrolidine ((S)-
232 or (R)-232) (1.0 eq.) and diamine ((+)-sparteine surrogate, ()-sparteine) (1.1, 1.2, 
1.3 eq.) in Et2O (1 - 7 mL) at 40 °C under Ar. The resulting solution was stirred at 40 
°C for 30 min. Then, ZnCl2 (0.6 eq.) was added and the resulting mixture was stirred at 
40 °C for 30 min. The reaction mixture was allowed to warm to rt over 30 min. Then, 
aryl-bromide (bromobenzene, 3-bromo-2-fluoro-5-methylpyridine, 3-bromo-N-
triisopropylsilyl-pyrrole, 2-bromo-anisole, 2-bromo-pyridine, 2-bromo-thiophene) 
(0.83, 1.2, 1.3 eq.) and a mixture of t-Bu3PHBF4 (0.05 eq.) and Pd(OAc)2 (0.04 eq.) 
were added. The resulting mixture was stirred at rt for 16 h. NH4OH(aq) (0.1 mL) and 
Et2O (5 mL) were added and mixture stirred for 1 h. The solids were removed by 
filtration through a pad of Celite

 and washed with Et2O (5 mL). The filtrate was 
washed with 1 M HCl(aq) (5 mL) and water (2 × 5 mL), dried (MgSO4) and evaporated 
under reduced pressure to give the crude product. 
 
General Procedure N: Benzylic Lithiation-Methylation of Tri-substituted 
Pyrrolidines in THF without TMEDA 
n-BuLi (1.3 eq.) was added dropwise to a stirred solution of a known mixture phenyl 
pyrrolidines ((2S,5S)-253 (98:2 er) and (2S,5R)-254 (82:18 er) or (2R*,5R*)-253 and 
(2R*,5S*)-254) (1.0 eq.) in THF (3, 4, 4.5 mL) at the specified temperature (78, 50, 0 
°C) under Ar. The resulting solution was stirred at the specified temperature for the 
specified time (3, 5, 60 min). Then, Me2SO4 (2.0 eq.) was added. The resulting solution 
was stirred at the specified temperature for 10 min and then allowed to warm to rt over 
1 h. Then, saturated NH4Cl(aq) (5 mL) and Et2O (5 mL) were added and the two layers 
were separated. The aqueous layer was extracted with Et2O (3 × 5 mL) and the 
combined organic layers were dried (MgSO4) and evaporated under reduced pressure to 
give the crude product. 
 
General Procedure O: Benzylic Lithiation-Trapping of Tri-substituted 
Pyrrolidines in Et2O with TMEDA 
n-BuLi (1.1 eq.) was added dropwise to a stirred solution of a known mixture of phenyl 
pyrrolidines ((2S,5S)-253 (>99:1 er) and (2S,5R)-254 (92:8 er) or (2S,5S)-253 (>99:1 er) 
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and (2S,5R)-254 (76:24 er) or (2R,5R)-253 (>99:1 er) and (2R,5S)-254 (99:1 er) or 
(2S,5R)-254 (>99:1 er) and (2S,5S)-253 (94:6 er)) (1.0 eq.) and TMEDA (1.1 eq.) in 
Et2O (1, 1.6, 2 mL) at the specified temperature (0, 30 °C under Ar. The resulting 
solution was stirred at the specified temperature for the specified time (1, 30, 60 min). 
Then, electrophile (Me2SO4, methyl chloroformate) (1.5 eq.) was added. The resulting 
solution was stirred at the specified temperature for 10 min and then allowed to warm to 
rt over 1 h. Then, saturated NH4Cl(aq) (2 mL) and Et2O (2 mL) were added and the two 
layers were separated. The aqueous layer was extracted with Et2O (3 × 2 mL) and the 
combined organic layers were dried (MgSO4) and evaporated under reduced pressure to 
give the crude product. 
 
General Procedure P: Benzylic Lithiation-Trapping of Tri-substituted Heteroaryl 
Pyrrolidines 
n-BuLi (1.1 eq.) was added dropwise to a stirred solution of a known mixture of 
heteroaryl pyrrolidines (2R,5R)-258 and (2R,5S)-296 or (2R,5R)-259 and (2R,5S)-297 or 
(2R,5R)-261 and (2R,5S)-270 (1.0 eq.) and TMEDA (1.1 eq.) in Et2O (1, 1.5 mL) at 30 
°C under Ar. The resulting solution was stirred at 30 °C for 1 h. Then, methyl 
chloroformate (1.5 eq.) was added. The resulting solution was stirred at 30 °C for 10 
min and then allowed to warm to rt over 1 h. Then, saturated NH4Cl(aq) (2 mL) and Et2O 
(2 mL) were added and the two layers were separated. The aqueous layer was extracted 
with Et2O (3 × 2 mL) and the combined organic layers were dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. 
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5.3 Experimental for Chapter Two 
 
Pyrrolidine-1-carboxylic acid tert-butyl ester 1 
 
A solution of di-tert-butyl dicarbonate (27.5 g, 125.8 mmol, 1.05 eq.) in CH2Cl2 (77 
mL) was added dropwise to a solution of pyrrolidine (8.5 g, 119.8 mmol, 1.0 eq.) in 
CH2Cl2 (130 mL) at 0 °C under Ar. The resulting solution was allowed to warm to rt 
and stirred for 3 h. Then, 10% NaHCO3(aq) (120 mL) and CH2Cl2 (200 mL) were added. 
The aqueous layer was extracted with CH2Cl2 (3 × 50 mL) and the combined organic 
layers were dried (Na2SO4) and evaporated under reduced pressure to give the crude 
product. Purification by Kügelrohr short path distillation gave N-Boc pyrrolidine 1 (20 
g, 98%) as a colourless oil, bp 86-92 °C/2.0 mmHg (lit.,
130
 70-75 °C/0.5 mmHg); 
1
H 
NMR (400 MHz, CDCl3) δ 3.42-3.19 (m, 4H, NCH2), 1.89-1.76 (m, 4H, NCH2CH2), 
1.45 (s, 9H, CMe3). Spectroscopic data consistent with those reported in the 
literature.
130 
Lab Book Reference: GG2/39/1 
 
2-(Hydroxyphenylmethyl)pyrrolidine-1-carboxylic acid tert-butyl ester (1R,2R)-29 
and (1S,2R)-30 
 
(Table 2.1, Entry 1) 
Using general procedure A: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (171 mg, 1.0 mmol, 1.0 eq.) and ()-sparteine (304 mg, 
299 μL, 1.3 mmol, 1.3 eq.) in Et2O (7 mL) at 40 °C under Ar for 1 sec. Then, PhCHO 
(212 mg, 203 μL, 2.0 mmol, 2.0 eq.) gave the crude product. Purification by flash 
column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave hydroxy 
pyrrolidine (1R,2R)-29 (18 mg, 6%, 92:8 er by CSP-HPLC) as a colourless oil, RF (98:2 
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CH2Cl2-acetone) 0.4; 
1
H NMR (400 MHz, CDCl3) δ 7.40-7.26 (m, 5H, Ph), 5.87 (br s, 
1H, OH), 4.52 (br d, J = 8.0 Hz, 1H, CHO), 4.09 (td, J = 8.0, 3.5 Hz, 1H, NCH), 3.51-
3.42 (m, 1H, NCH), 3.41-3.31 (m, 1H, NCH), 1.85-1.65 (m, 2H, 2 × CH), 1.64-1.40 (m, 
2H, 2 × CH), 1.52 (s, 9H, CMe3); CSP-HPLC: Chiralcel OD (98:2 hexane-i-PrOH, 0.5 
mL min
1
) (1R,2R)-29 24.2 min, (1S,2S)-29 28.5 min and hydroxy pyrrolidine (1S,2R)-
30 (10 mg, 4%, 91:9 er by CSP-HPLC) as an off-white solid, RF (98:2 CH2Cl2-acetone) 
0.3; 
1
H NMR (400 MHz, CDCl3) (65:35 mixture of rotamers) δ 7.41-7.21 (m, 5H, Ph), 
5.48 (br s, 0.65H, OH), 5.17 (br s, 0.35H, OH), 4.87 (br s, 0.65H, CHO), 4.32 (br s, 
0.65H, NCH), 4.01 (br s, 0.35H, CHO), 3.57 (br s, 0.35H, NCH), 3.29 (br s, 1H, NCH), 
2.82 (br s, 0.65H, NCH), 2.30 (br s, 0.35H, NCH), 2.02-1.85 (m, 1H, CH), 1.84-1.70 
(m, 1H, CH), 1.57 (s, 3.15H, CMe3), 1.55-1.41 (m, 1H, CH), 1.52 (s, 5.85H, CMe3), 
1.23-1.07 (m, 1H, CH); CSP-HPLC: Chiralcel AD-H (98:2 hexane-i-PrOH, 1.0 mL 
min
1
) (1S,2R)-30 13.5 min, (1R,2S)-30 18.0 min. Spectroscopic data consistent with 
those reported in the literature.
28
 
Lab Book Reference: GG2/29 
 
(Table 2.1, Entry 2) 
Using general procedure A: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (171 mg, 1.0 mmol, 1.0 eq.) and ()-sparteine (304 mg, 
299 μL, 1.3 mmol, 1.3 eq.) in Et2O (7 mL) at 40 °C under Ar for 2 min. Then, PhCHO 
(212 mg, 203 μL, 2.0 mmol, 2.0 eq.) gave the crude product. Purification by flash 
column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave hydroxy 
pyrrolidine (1R,2R)-29 (160 mg, 58%, 93:7 er by CSP-HPLC) as a colourless oil, CSP-
HPLC: Chiralcel OD (98:2 hexane-i-PrOH, 0.5 mL min
1
) (1R,2R)-29 23.5 min, 
(1S,2S)-29 28.5 min and hydroxy pyrrolidine (1S,2R)-30 (72 mg, 26%, 91:9 er by CSP-
HPLC) as an off-white solid, CSP-HPLC: Chiralcel AD-H (98:2 hexane-i-PrOH, 1.0 
mL min
1
) (1S,2R)-30 13.6 min, (1R,2S)-30 17.9 min. 
Lab Book Reference: GG2/44 
 
(Table 2.1, Entry 3) 
Using general procedure A: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (171 mg, 1.0 mmol, 1.0 eq.) and ()-sparteine (304 mg, 
299 μL, 1.3 mmol, 1.3 eq.) in Et2O (7 mL) at 40 °C under Ar for 20 min. Then, 
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PhCHO (212 mg, 203 μL, 2.0 mmol, 2.0 eq.) gave the crude product. Purification by 
flash column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave 
hydroxy pyrrolidine (1R,2R)-29 (160 mg, 58%, 92:8 er by CSP-HPLC) as a colourless 
oil, CSP-HPLC: Chiralcel OD (98:2 hexane-i-PrOH, 0.5 mL min
1
) (1R,2R)-29 23.5 
min, (1S,2S)-29 28.8 min and hydroxy pyrrolidine (1S,2R)-30 (80 mg, 29%, 92:8 er by 
CSP-HPLC) as an off-white solid, CSP-HPLC: Chiralcel AD-H (98:2 hexane-i-PrOH, 
1.0 mL min
1
) (1S,2R)-30 13.9 min, (1R,2S)-30 18.0 min. 
Lab Book Reference: GG2/51 
 
(Table 2.1, Entry 4) 
Using general procedure A: s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (85 mg, 0.5 mmol, 1.0 eq.) and ()-sparteine (152 mg, 150 
μL, 0.65 mmol, 1.3 eq.) in Et2O (3.5 mL) at 40 °C under Ar for 1 h. Then, PhCHO 
(106 mg, 100 μL, 1.0 mmol, 2.0 eq.) gave the crude product. Purification by flash 
column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave hydroxy 
pyrrolidine (1R,2R)-29 (72 mg, 52%, 92:8 er by CSP-HPLC) as a colourless oil, CSP-
HPLC: Chiralcel OD (98:2 hexane-i-PrOH, 0.5 mL min
1
) (1R,2R)-29 23.5 min, 
(1S,2S)-29 28.8 min and hydroxy pyrrolidine (1S,2R)-30 (38 mg, 27%, 90:10 er by 
CSP-HPLC) as an off-white solid, CSP-HPLC: Chiralcel AD-H (98:2 hexane-i-PrOH, 
1.0 mL min
1
) (1S,2R)-30 15.5 min, (1R,2S)-30 19.6 min. 
Lab Book Reference: GG5/21 
 
(Table 2.2, Entry 1) 
Using general procedure A: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (171 mg, 1.0 mmol, 1.0 eq.) and ()-sparteine (304 mg, 
299 μL, 1.3 mmol, 1.3 eq.) in Et2O (7 mL) at 30 °C under Ar for 1 sec. Then, PhCHO 
(212 mg, 203 μL, 2.0 mmol, 2.0 eq.) gave the crude product. Purification by flash 
column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave hydroxy 
pyrrolidine (1R,2R)-29 (34 mg, 12%, 89:11 er by CSP-HPLC) as a colourless oil, CSP-
HPLC: Chiralcel OD (98:2 hexane-i-PrOH, 0.5 mL min
1
) (1R,2R)-29 24.0 min, 
(1S,2S)-29 28.5 min and hydroxy pyrrolidine (1S,2R)-30 (20 mg, 7%, 89:11 er by CSP-
HPLC) as an off-white solid, CSP-HPLC: Chiralcel AD-H (98:2 hexane-i-PrOH, 1.0 
mL min
1
) (1S,2R)-30 13.4 min, (1R,2S)-30 17.9 min. 
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Lab Book Reference: GG2/30 
(Table 2.2, Entry 2) 
Using general procedure A: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (171 mg, 1.0 mmol, 1.0 eq.) and ()-sparteine (304 mg, 
299 μL, 1.3 mmol, 1.3 eq.) in Et2O (7 mL) at 30 °C under Ar for 2 min. Then, PhCHO 
(212 mg, 203 μL, 2.0 mmol, 2.0 eq.) gave the crude product. Purification by flash 
column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave hydroxy 
pyrrolidine (1R,2R)-29 (161 mg, 58%, 90:10 er by CSP-HPLC) as a colourless oil, CSP-
HPLC: Chiralcel OD (98:2 hexane-i-PrOH, 0.5 mL min
1
) (1R,2R)-29 25.7 min, 
(1S,2S)-29 29.9 min and hydroxy pyrrolidine (1S,2R)-30 (94 mg, 34%, 89:11 er by 
CSP-HPLC) as an off-white solid, CSP-HPLC: Chiralcel AD-H (98:2 hexane-i-PrOH, 
1.0 mL min
1
) (1S,2R)-30 13.7 min, (1R,2S)-30 18.2 min. 
Lab Book Reference: GG2/4 
 
(Table 2.2, Entry 3) 
Using general procedure A: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (171 mg, 1.0 mmol, 1.0 eq.) and ()-sparteine (304 mg, 
299 μL, 1.3 mmol, 1.3 eq.) in Et2O (7 mL) at 30 °C under Ar for 20 min. Then, 
PhCHO (212 mg, 203 μL, 2.0 mmol, 2.0 eq.) gave the crude product. Purification by 
flash column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave 
hydroxy pyrrolidine (1R,2R)-29 (135 mg, 49%, 88:12 er by CSP-HPLC) as a colourless 
oil, CSP-HPLC: Chiralcel OD (98:2 hexane-i-PrOH, 0.5 mL min
1
) (1R,2R)-29 23.4 
min, (1S,2S)-29 28.5 min and hydroxy pyrrolidine (1S,2R)-30 (77 mg, 28%, 87:13 er by 
CSP-HPLC) as an off-white solid, CSP-HPLC: Chiralcel AD-H (98:2 hexane-i-PrOH, 
1.0 mL min
1
) (1S,2R)-30 13.7 min, (1R,2S)-30 18.0 min. 
Lab Book Reference: GG2/50 
 
(Table 2.2, Entry 4) 
Using general procedure A: s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (85 mg, 0.5 mmol, 1.0 eq.) and ()-sparteine (152 mg, 150 
μL, 0.65 mmol, 1.3 eq.) in Et2O (3.5 mL) at 30 °C under Ar for 1 h. Then, PhCHO 
(106 mg, 100 μL, 1.0 mmol, 2.0 eq.) gave the crude product. Purification by flash 
column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave hydroxy 
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pyrrolidine (1R,2R)-29 (59 mg, 42%, 87:13 er by CSP-HPLC) as a colourless oil, CSP-
HPLC: Chiralcel OD (98:2 hexane-i-PrOH, 0.5 mL min
1
) (1R,2R)-29 23.7 min, 
(1S,2S)-29 29.1 min and hydroxy pyrrolidine (1S,2R)-30 (42 mg, 30%, 84:16 er by 
CSP-HPLC) as an off-white solid, CSP-HPLC: Chiralcel AD-H (98:2 hexane-i-PrOH, 
1.0 mL min
1
) (1S,2R)-30 14.7 min, (1R,2S)-30 18.9 min. 
Lab Book Reference: GG5/22 
 
(Table 2.3, Entry 1) 
Using general procedure A: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (171 mg, 1.0 mmol, 1.0 eq.) and ()-sparteine (304 mg, 
299 μL, 1.3 mmol, 1.3 eq.) in Et2O (7 mL) at 20 °C under Ar for 1 min. Then, PhCHO 
(212 mg, 203 μL, 2.0 mmol, 2.0 eq.) gave the crude product. Purification by flash 
column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave hydroxy 
pyrrolidine (1R,2R)-29 (147 mg, 53%, 86:14 er by CSP-HPLC) as a colourless oil, CSP-
HPLC: Chiralcel OD (98:2 hexane-i-PrOH, 0.5 mL min
1
) (1R,2R)-29 24.8 min, 
(1S,2S)-29 29.1 min and hydroxy pyrrolidine (1S,2R)-30 (91 mg, 33%, 85:15 er by 
CSP-HPLC) as an off-white solid, CSP-HPLC: Chiralcel AD-H (98:2 hexane-i-PrOH, 
1.0 mL min
1
) (1S,2R)-30 13.5 min, (1R,2S)-30 17.9 min. 
Lab Book Reference: GG2/7 
 
(Table 2.3, Entry 2) 
Using general procedure A: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (171 mg, 1.0 mmol, 1.0 eq.) and ()-sparteine (304 mg, 
299 μL, 1.3 mmol, 1.3 eq.) in Et2O (7 mL) at 20 °C under Ar for 2 min. Then, PhCHO 
(212 mg, 203 μL, 2.0 mmol, 2.0 eq.) gave the crude product. Purification by flash 
column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave hydroxy 
pyrrolidine (1R,2R)-29 (141 mg, 51%, 87:13 er by CSP-HPLC) as a colourless oil, CSP-
HPLC: Chiralcel OD (98:2 hexane-i-PrOH, 0.5 mL min
1
) (1R,2R)-29 25.5 min, 
(1S,2S)-29 29.7 min and hydroxy pyrrolidine (1S,2R)-30 (86 mg, 31%, 85:15 er by 
CSP-HPLC) as an off-white solid, CSP-HPLC: Chiralcel AD-H (98:2 hexane-i-PrOH, 
1.0 mL min
1
) (1S,2R)-30 13.8 min, (1R,2S)-30 18.2 min. 
Lab Book Reference: GG2/5 
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(Table 2.3, Entry 3) 
Using general procedure A: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (171 mg, 1.0 mmol, 1.0 eq.) and ()-sparteine (304 mg, 
299 μL, 1.3 mmol, 1.3 eq.) in Et2O (7 mL) at 10 °C under Ar for 30 sec. Then, PhCHO 
(212 mg, 203 μL, 2.0 mmol, 2.0 eq.) gave the crude product. Purification by flash 
column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave hydroxy 
pyrrolidine (1R,2R)-29 (120 mg, 43%, 80:20 er by CSP-HPLC) as a colourless oil, CSP-
HPLC: Chiralcel OD (98:2 hexane-i-PrOH, 0.5 mL min
1
) (1R,2R)-29 24.6 min, 
(1S,2S)-29 29.1 min and hydroxy pyrrolidine (1S,2R)-30 (80 mg, 29%, 80:20 er by 
CSP-HPLC) as an off-white solid, CSP-HPLC: Chiralcel AD-H (98:2 hexane-i-PrOH, 
1.0 mL min
1
) (1S,2R)-30 13.9 min, (1R,2S)-30 18.4 min. 
Lab Book Reference: GG2/13 
 
 
(Table 2.3, Entry 4) 
Using general procedure A: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (171 mg, 1.0 mmol, 1.0 eq.) and ()-sparteine (304 mg, 
299 μL, 1.3 mmol, 1.3 eq.) in Et2O (7 mL) at 0 °C under Ar for 10 sec. Then, PhCHO 
(212 mg, 203 μL, 2.0 mmol, 2.0 eq.) gave the crude product. Purification by flash 
column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave hydroxy 
pyrrolidine (1R,2R)-29 (110 mg, 40%, 75:25 er by CSP-HPLC) as a colourless oil, CSP-
HPLC: Chiralcel OD (98:2 hexane-i-PrOH, 0.5 mL min
1
) (1R,2R)-29 24.4 min, 
(1S,2S)-29 29.0 min and hydroxy pyrrolidine (1S,2R)-30 (75 mg, 27%, 75:25 er by 
CSP-HPLC) as an off-white solid, CSP-HPLC: Chiralcel AD-H (98:2 hexane-i-PrOH, 
1.0 mL min
1
) (1S,2R)-30 13.5 min, (1R,2S)-30 17.8 min. 
Lab Book Reference: GG2/8 
 
(Table 2.3, Entry 5) 
Using general procedure A: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (171 mg, 1.0 mmol, 1.0 eq.) and ()-sparteine (304 mg, 
299 μL, 1.3 mmol, 1.3 eq.) in Et2O (7 mL) at 0 °C under Ar for 1 min. Then, PhCHO 
(212 mg, 203 μL, 2.0 mmol, 2.0 eq.) gave the crude product. Purification by flash 
column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave hydroxy 
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pyrrolidine (1R,2R)-29 (97 mg, 35%, 65:35 er by CSP-HPLC) as a colourless oil, CSP-
HPLC: Chiralcel OD (98:2 hexane-i-PrOH, 0.5 mL min
1
) (1R,2R)-29 24.8 min, 
(1S,2S)-29 28.6 min and hydroxy pyrrolidine (1S,2R)-30 (69 mg, 25%, 62:38 er by 
CSP-HPLC) as an off-white solid, CSP-HPLC: Chiralcel AD-H (98:2 hexane-i-PrOH, 
1.0 mL min
1
) (1S,2R)-30 13.8 min, (1R,2S)-30 18.2 min. 
Lab Book Reference: GG2/6 
 
2-(Hydroxydiphenylmethyl)pyrrolidine-1-carboxylic acid tert-butyl ester (S)-62 
 
(Table 2.4, Entry 1) 
s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 eq.) was added dropwise 
to a stirred solution of N-Boc pyrrolidine 1 (171 mg, 1.0 mmol, 1.0 eq.) and diamine 
(S,S)-4 (403 mg, 1.3 mmol, 1.3 eq.) in Et2O (7 mL) at 78 °C under Ar. The resulting 
solution was stirred at 78 °C for 1 h. Then, a solution of benzophenone (364 mg, 2.0 
mmol, 2.0 eq.) in Et2O (1 mL) was added. The resulting solution was stirred at 78 °C 
for 10 min and then allowed to warm to rt over 1 h. Then, saturated NH4Cl(aq) (10 mL) 
and Et2O (5 mL) were added and the two layers were separated. The aqueous layer was 
extracted with Et2O (3 × 5 mL) and the combined organic layers were dried (Na2SO4) 
and evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica with 99.5:0.5 CH2Cl2-acetone as eluent gave hydroxy 
pyrrolidine (S)-62 (290 mg, 82%, 95:5 er by CSP-HPLC) as a white solid, mp 146-148 
°C (lit.,
11
 147-149 °C); [α]D 127.4 (c 1.0 in CHCl3) (lit.,
11
 [α]D +132.1 (c 1.97 in 
CHCl3) for (R)-3 of 90:10 er); 
1
H NMR (400 MHz, CDCl3) δ 7.43-7.36 (m, 4H, Ph), 
7.35-7.24 (m, 6H, Ph), 6.48 (br s, 1H, OH), 4.90 (dd, J = 9.0, 4.0 Hz, 1H, NCH), 3.35 
(br m, 1H, NCH), 2.86 (br s, 1H, NCH), 2.09 (dddd, J = 13.0, 9.0, 9.0, 9.0 Hz, 1H, CH), 
1.96-1.87 (m, 1H, CH), 1.53-1.35 (m, 1H, CH), 1.43 (s, 9H, CMe3), 0.76 (br s, 1H, CH); 
CSP-HPLC: Chiralcel OD (99:1 hexane-i-PrOH, 1.0 mL min
1
) (R)-62 13.3 min, (S)-62 
15.2 min. Spectroscopic data consistent with those reported in the literature.
11
 
Lab Book Reference: GG2/19/1 
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(Table 2.4, Entry 2) 
Using general procedure A: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (171 mg, 1.0 mmol, 1.0 eq.) and diamine (S,S)-4 (403 mg, 
1.3 mmol, 1.3 eq.) at 40 °C for 1 sec. Then, benzophenone (364 mg, 2.0 mmol, 2.0 
eq.) gave the crude product. Purification by flash column chromatography on silica with 
99.5:0.5 CH2Cl2-acetone as eluent gave hydroxy pyrrolidine (S)-62 (53 mg, 15%, 86:14 
er by CSP-HPLC) as a white solid, CSP-HPLC: Chiralcel OD (99:1 hexane-i-PrOH, 1.0 
mL min
1
) (R)-62 13.1 min, (S)-62 15.2 min and starting material 1 (87 mg, 50%). 
Lab Book Reference: GG2/22/1 
 
(Table 2.4, Entry 3) 
Using general procedure A: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (171 mg, 1.0 mmol, 1.0 eq.) and diamine (S,S)-4 (403 mg, 
1.3 mmol, 1.3 eq.) at 40 °C for 2 min. Then, benzophenone (364 mg, 2.0 mmol, 2.0 
eq.) gave the crude product. Purification by flash column chromatography on silica with 
99.5:0.5 CH2Cl2-acetone as eluent gave hydroxy pyrrolidine (S)-62 (173 mg, 49%, 
86:14 er by CSP-HPLC) as a white solid, CSP-HPLC: Chiralcel OD (99:1 hexane-i-
PrOH, 1.0 mL min
1
) (R)-62 13.2 min, (S)-62 15.5 min. 
Lab Book Reference: GG2/20/1 
 
(Table 2.4, Entry 4) 
Using general procedure A: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (171 mg, 1.0 mmol, 1.0 eq.) and diamine (S,S)-4 (403 mg, 
1.3 mmol, 1.3 eq.) at 30 °C for 1 sec. Then, benzophenone (364 mg, 2.0 mmol, 2.0 
eq.) gave the crude product. Purification by flash column chromatography on silica with 
99.5:0.5 CH2Cl2-acetone as eluent gave hydroxy pyrrolidine (S)-62 (50 mg, 14%, 80:20 
er by CSP-HPLC) as a white solid, CSP-HPLC: Chiralcel OD (99:1 hexane-i-PrOH, 1.0 
mL min
1
) (R)-62 12.8 min, (S)-62 14.6 min and starting material 1 (94 mg, 55%). 
Lab Book Reference: GG2/23/1 
 
(Table 2.4, Entry 5) 
Using general procedure A: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (171 mg, 1.0 mmol, 1.0 eq.) and diamine (S,S)-4 (403 mg, 
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1.3 mmol, 1.3 eq.) at 30 °C for 2 min. Then, benzophenone (364 mg, 2.0 mmol, 2.0 
eq.) gave the crude product. Purification by flash column chromatography on silica with 
99.5:0.5 CH2Cl2-acetone as eluent gave hydroxy pyrrolidine (S)-62 (159 mg, 45%, 
81:19 er by CSP-HPLC) as a white solid, CSP-HPLC: Chiralcel OD (99:1 hexane-i-
PrOH, 1.0 mL min
1
) (R)-62 12.9 min, (S)-62 14.7 min and starting material 1 (26 mg, 
15%). 
Lab Book Reference: GG2/21/1 
 
2-(Hydroxyphenylmethyl)pyrrolidine-1-carboxylic acid tert-butyl ester (1S,2S)-29 
and (1R,2S)-30 
 
(Table 2.5, Entry 1) 
Using general procedure A: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (171 mg, 1.0 mmol, 1.0 eq.) and (+)-sparteine surrogate 
(252 mg, 1.3 mmol, 1.3 eq.) in Et2O (7 mL) at 40 °C under Ar for 2 min. Then, 
PhCHO (212 mg, 203 μL, 2.0 mmol, 2.0 eq.) gave the crude product. Purification by 
flash column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave 
hydroxy pyrrolidine (1S,2S)-29 (181 mg, 65%, 90:10 er by CSP-HPLC) as a colourless 
oil, CSP-HPLC: Chiralcel OD (98:2 hexane-i-PrOH, 0.5 mL min
1
) (1R,2R)-29 24.4 
min, (1S,2S)-29 28.5 min and hydroxy pyrrolidine (1R,2S)-30 (83 mg, 30%, 92:8 er by 
CSP-HPLC) as an off-white solid, CSP-HPLC: Chiralcel AD-H (98:2 hexane-i-PrOH, 
1.0 mL min
1
) (1S,2R)-30 13.8 min, (1R,2S)-30 17.7 min. 
Lab Book Reference: GG2/40 
 
(Table 2.5, Entry 2) 
Using general procedure A: s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (85 mg, 0.5 mmol, 1.0 eq.) and (+)-sparteine surrogate 
(126 mg, 0.65 mmol, 1.3 eq.) in Et2O at 40 °C under Ar for 1 h. Then, PhCHO (106 
mg, 100 μL, 1.0 mmol, 1.0 eq.) gave the crude product. Purification by flash column 
chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave and hydroxy 
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pyrrolidine (1S,2S)-29 (63 mg, 46%, 90:10 er by CSP-HPLC) as a colourless oil, CSP-
HPLC: Chiralcel OD (98:2 hexane-i-PrOH, 0.5 mL min
1
) (1R,2R)-29 24.0 min, 
(1S,2S)-29 29.0 min and hydroxy pyrrolidine (1R,2S)-30 (27 mg, 20%, 91:9 er by CSP-
HPLC) as an off-white solid, CSP-HPLC: Chiralcel AD-H (98:2 hexane-i-PrOH, 1.0 
mL min
1
) (1S,2R)-30 14.8 min, (1R,2S)-30 18.5 min. 
Lab Book Reference: GG3/37 
 
(Table 2.6, Entry 1) 
Using general procedure A: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (171 mg, 1.0 mmol, 1.0 eq.) and (+)-sparteine surrogate 
(252 mg, 1.3 mmol, 1.3 eq.) in Et2O (7 mL) at 30 °C under Ar for 2 min. Then, 
PhCHO (212 mg, 203 μL, 2.0 mmol, 2.0 eq.) gave the crude product. Purification by 
flash column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave 
hydroxy pyrrolidine (1S,2S)-29 (187 mg, 67%, 90:10 er by CSP-HPLC) as a colourless 
oil, CSP-HPLC: Chiralcel OD (98:2 hexane-i-PrOH, 0.5 mL min
1
) (1R,2R)-29 24.0 
min, (1S,2S)-29 28.6 min and hydroxy pyrrolidine (1R,2S)-30 (75 mg, 27%, 90:10 er by 
CSP-HPLC) as an off-white solid, CSP-HPLC: Chiralcel AD-H (98:2 hexane-i-PrOH, 
1.0 mL min
1
) (1S,2R)-30 13.8 min, (1R,2S)-30 17.7 min. 
Lab Book Reference: GG2/41 
 
(Table 2.6, Entry 2) 
Using general procedure A: s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (85 mg, 0.5 mmol, 1.0 eq.) and (+)-sparteine surrogate 
(126 mg, 0.65 mmol, 1.3 eq.) in Et2O at 30 °C under Ar for 1 h. Then, PhCHO (106 
mg, 100 μL, 1.0 mmol, 1.0 eq.) gave the crude product. Purification by flash column 
chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave and hydroxy 
pyrrolidine (1S,2S)-29 (56 mg, 41%, 89:11 er by CSP-HPLC) as a colourless oil, CSP-
HPLC: Chiralcel OD (98:2 hexane-i-PrOH, 0.5 mL min
1
) (1R,2R)-29 23.7 min, 
(1S,2S)-29 28.7 min and hydroxy pyrrolidine (1R,2S)-30 (31 mg, 23%, 90:10 er by 
CSP-HPLC) as an off-white solid, CSP-HPLC: Chiralcel AD-H (98:2 hexane-i-PrOH, 
1.0 mL min
1
) (1S,2R)-30 14.9 min, (1R,2S)-30 18.6 min. 
Lab Book Reference: GG3/38 
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(Table 2.6, Entry 3) 
Using general procedure A: s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (85 mg, 0.5 mmol, 1.0 eq.) and (+)-sparteine surrogate 
(126 mg, 0.65 mmol, 1.3 eq.) in Et2O at 20 °C under Ar for 2 min. Then, PhCHO (106 
mg, 100 μL, 1.0 mmol, 1.0 eq.) gave the crude product. Purification by flash column 
chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave and hydroxy 
pyrrolidine (1S,2S)-29 (69 mg, 50%, 89:11 er by CSP-HPLC) as a colourless oil, CSP-
HPLC: Chiralcel OD (98:2 hexane-i-PrOH, 0.5 mL min
1
) (1R,2R)-29 23.6 min, 
(1S,2S)-29 28.9 min and hydroxy pyrrolidine (1R,2S)-30 (32 mg, 23%, 91:9 er by CSP-
HPLC) as an off-white solid, CSP-HPLC: Chiralcel AD-H (98:2 hexane-i-PrOH, 1.0 
mL min
1
) (1S,2R)-30 15.3 min, (1R,2S)-30 19.6 min. 
Lab Book Reference: GG5/26 
 
(Table 2.6, Entry 4) 
Using general procedure A: s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (85 mg, 0.5 mmol, 1.0 eq.) and (+)-sparteine surrogate 
(126 mg, 0.65 mmol, 1.3 eq.) in Et2O at 20 °C under Ar for 1 h. Then, PhCHO (106 
mg, 100 μL, 1.0 mmol, 1.0 eq.) gave the crude product. Purification by flash column 
chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave and hydroxy 
pyrrolidine (1S,2S)-29 (55 mg, 40%, 83:17 er by CSP-HPLC) as a colourless oil, CSP-
HPLC: Chiralcel OD (98:2 hexane-i-PrOH, 0.5 mL min
1
) (1R,2R)-29 23.6 min, 
(1S,2S)-29 28.6 min and hydroxy pyrrolidine (1R,2S)-30 (28 mg, 20%, 85:15 er by 
CSP-HPLC) as an off-white solid, CSP-HPLC: Chiralcel AD-H (98:2 hexane-i-PrOH, 
1.0 mL min
1
) (1S,2R)-x30 15.2 min, (1R,2S)-30 19.4 min. 
Lab Book Reference: GG5/27 
 
(Table 2.7, Entry 2) 
Using general procedure A: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (171 mg, 1.0 mmol, 1.0 eq.) and (+)-sparteine surrogate 
(252 mg, 1.3 mmol, 1.3 eq.) in THF (7 mL) at 30 °C under Ar for 2 min. Then, 
PhCHO (212 mg, 203 μL, 2.0 mmol, 2.0 eq.) gave the crude product. Purification by 
flash column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave 
starting material 1 (34 mg, 38%) and hydroxy pyrrolidine (1S,2S)-29 (105 mg, 38%, 
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86:14 er by CSP-HPLC) as a colourless oil, CSP-HPLC: Chiralcel OD (98:2 hexane-i-
PrOH, 0.5 mL min
1
) (1R,2R)-29 23.8 min, (1S,2S)-29 28.4 and hydroxy pyrrolidine 
(1R,2S)-30 (58 mg, 21%, 86:14 er by CSP-HPLC) as an off-white solid, CSP-HPLC: 
Chiralcel AD-H (98:2 hexane-i-PrOH, 1.0 mL min
1
) (1S,2R)-30 13.8 min, (1R,2S)-30 
17.0 min. 
Lab Book Reference: GG2/80 
 
(Table 2.7, Entry 3) 
Using general procedure A: s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (85 mg, 0.5 mmol, 1.0 eq.) and (+)-sparteine surrogate 
(126 mg, 0.65 mmol, 1.3 eq.) in TBME (3.5 mL) at 30 °C under Ar for 2 min. Then, 
PhCHO (106 mg, 100 μL, 1.0 mmol, 1.0 eq.) gave the crude product. Purification by 
flash column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave 
hydroxy pyrrolidine (1S,2S)-29 (43 mg, 31%, 89:11 er by CSP-HPLC) as a colourless 
oil, CSP-HPLC: Chiralcel OD (98:2 hexane-i-PrOH, 0.5 mL min
1
) (1R,2R)-29 24.0 
min, (1S,2S)-29 29.0 and hydroxy pyrrolidine (1R,2S)-30 (16 mg, 12%, 89:11 er by 
CSP-HPLC) as an off-white solid, CSP-HPLC: Chiralcel AD-H (98:2 hexane-i-PrOH, 
1.0 mL min
1
) (1S,2R)-30 14.6 min, (1R,2S)-30 18.6 min. 
Lab Book Reference: GG3/39 
 
(Scheme 2.30) 
n-BuLi (0.26 mL of a 2.5 M solution in hexanes, 0.65 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of N-Boc pyrrolidine 1 (85 mg, 0.5 mmol, 1.0 eq.) and 
(+)-sparteine surrogate (126 mg, 0.65 mmol, 1.3 eq.) in Et2O (3.5 mL) at 30 °C under 
Ar. The resulting solution was stirred at 30 °C for 1 h. Then, a solution of PhCHO 
(106 mg, 100 μL, 1.0 mmol, 1.0 eq.) was added. The resulting solution was stirred at 
30 °C for 10 min and then allowed to warm to rt over 1 h. Then, saturated NH4Cl(aq) (5 
mL) and Et2O (5 mL) were added and the two layers were separated. The aqueous layer 
was extracted with Et2O (3 × 5 mL) and the combined organic layers were dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. Purification 
by flash column chromatography on silica with 98:2 CH2Cl2-acetone as eluent gave 
recovered starting material 1 (30 mg, 35%) and hydroxy pyrrolidine (1S,2S)-29 (18 mg, 
13%, 86:14 er by CSP-HPLC) as a colourless oil, CSP-HPLC: Chiralcel OD (98:2 
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hexane-i-PrOH, 0.5 mL min
1
) (1R,2R)-29 24.0 min, (1S,2S)-29 29.0 and hydroxy 
pyrrolidine (1R,2S)-30 (10 mg, 7%, 88:12 er by CSP-HPLC) as an off-white solid, CSP-
HPLC: Chiralcel AD-H (98:2 hexane-i-PrOH, 1.0 mL min
1
) (1S,2R)-30 14.6 min, 
(1R,2S)-30 18.6 min. 
Lab Book Reference: GG6/87 
 
2-(Hydroxydiphenylmethyl)pyrrolidine-1-carboxylic acid tert-butyl ester (S)-62 
 
(Scheme 2.32) 
Using general procedure A: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (171 mg, 1.0 mmol, 1.0 eq.) and (+)-sparteine surrogate 
(256 mg, 1.3 mmol, 1.3 eq.) in Et2O (7 mL) at 30 °C under Ar for 2 min. Then, a 
solution of benzophenone (364 mg, 2.0 mmol, 2.0 eq.) gave the crude product. 
Purification by flash column chromatography on silica with 99.5:0.5 CH2Cl2-acetone as 
eluent gave hydroxy pyrrolidine (S)-62 (198 mg, 56%, 86:14 er by CSP-HPLC) as a 
white solid, [α]D 114.7 (c 1.0 in CHCl3) (lit.,
11
 [α]D +132.1 (c 1.97 in CHCl3) for (R)-
62 of 90:10 er);
 
CSP-HPLC: Chiralcel OD (99:1 hexane-i-PrOH, 1.0 mL min
1
) (R)-62 
12.2 min, (S)-62 13.7 min. 
Lab Book Reference: GG2/67/1 
 
2-Methylpyrrolidine-1-carboxylic acid tert-butyl ester (R)-68 
 
(Scheme 2.32) 
Using general procedure A: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (171 mg, 1.0 mmol, 1.0 eq.) and (+)-sparteine surrogate 
(252 mg, 1.3 mmol, 1.3 eq.) in Et2O (7 mL) at 30 °C under Ar for 2 min. Then, 
Me2SO4 (252 mg, 190 μL, 2.0 mmol, 2.0 eq.) gave the crude product. Purification by 
flash column chromatography on silica with 96:4 petrol-EtOAc as eluent gave methyl 
Chapter Five: Experimental 
185 
pyrrolidine (R)-68 (102 mg, 55%, 92:8 er by CSP-GC) as a colourless oil, [α]D 22.6 (c 
1.0 in CHCl3) (lit.,
11
 [α]D +31.2 (c 2.76 in CHCl3) for (S)-68 of 97.5:2.5 er); RF (96:4 
petrol-EtOAc) 0.3; 
1
H NMR (400 MHz, CDCl3) δ 3.86 (br s, 1H, NCH), 3.35 (br s, 2H, 
2 × CH), 2.05-1.91 (m, 1H, CH), 1.91-1.82 (m, 1H, CH), 1.91-1.71 (m, 1H, CH), 1.58-
1.49 (m, 1H, CH), 1.46 (s, 9H, CMe3), 1.15 (br d, J = 6.0 Hz, 3H, Me); CSP-GC: (S)-68 
4.2 min, (R)-68 4.7 min. Spectroscopic data consistent with those reported in the 
literature.
11
 
Lab Book Reference: GG2/45/1 
 
2-(Phenylcarbamoyl)pyrrolidine-1-carboxylic acid tert-butyl ester (S)-69 
 
(Scheme 2.32) 
Using general procedure A: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), N-Boc pyrrolidine 1 (171 mg, 1.0 mmol, 1.0 eq.) and (+)-sparteine surrogate 
(252 mg, 1.3 mmol, 1.3 eq.) in Et2O (7 mL) at 30 °C under Ar for 2 min. Then, phenyl 
isocyanate (238 mg, 220 μL, 2.0 mmol, 2.0 eq.) gave the crude product. Purification by 
flash column chromatography on silica with 80:20 petrol- EtOAc as eluent gave 
pyrrolidine (S)-69 (168 mg, 58%, 89:11 er by CSP-HPLC) as a white solid, mp 160-162 
°C (lit.,
131
 185-188 °C); [α]D 106.1 (c 1.0 in CHCl3) (lit.,
131
 [α]D 138.3 (c 0.24 in 
CHCl3) for (S)-69 of 90:10 er); RF (80:20 petrol-EtOAc) 0.1; 
1
H NMR (400 MHz, 
CDCl3) δ 9.50 (br s, 1H, NH), 7.52 (dd, J = 8.5, 1.0 Hz, 2H, Ph), 7.38-7.23 (m, 2H, Ph), 
7.07 (br s, 1H, Ph), 4.60-4.20 (m, 1H, NCH), 3.70-3.21 (m, 2H, NCH), 2.62-1.75 (m, 
4H, CH), 1.49 (s, 9H, CMe3); CSP-HPLC: Chiralcel OD (90:10 hexane-i-PrOH, 1.0 mL 
min
1
) (R)-69 5.8 min, (S)-69 6.7 min. Spectroscopic data consistent with those reported 
in the literature.
131
 
Lab Book Reference: GG2/68/1 
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2-Allylpyrrolidine-1-carboxylic acid tert-butyl ester (S)-23 
 
(Scheme 2.33) 
s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 1.3 eq.) was added dropwise 
to a stirred solution of N-Boc pyrrolidine 1 (85 mg, 0.5 mmol, 1.0 eq.) and (+)-sparteine 
surrogate (126 mg, 0.65 mmol, 1.3 eq.) in Et2O (3.5 mL) at 30 °C under Ar. The 
resulting solution was stirred at 30 °C for 2 min. Then, CuCN·2LiCl (420 μL of a 0.6 
M solution in THF, 0.25 mmol, 0.5 eq. of CuCN) was added dropwise. The resulting 
solution was allowed to warm to 0 °C over 15 min and then re-cooled to 30 °C. Then, 
allyl bromide (121 mg, 86 μL, 1.0 mmol, 2.0 eq.) was added and the reaction mixture 
was stirred at rt for 16 h. NH4OH(aq) (10 mL) and Et2O (5 mL) were added and mixture 
was stirred for 20 min. The solids were removed by filtration through a pad of Celite

 
and washed with Et2O (5 mL). The two layers of the filtrate were separated. The 
aqueous layer was extracted with Et2O (3 × 5 mL) and the combined organic layers 
were dried (Na2SO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with 9:1 petrol-EtOAc as eluent 
gave allyl pyrrolidine (S)-23 (77 mg, 73%, 86:14 er by CSP-GC) as a colourless oil, 
[α]D 31.4 (c 1.0 in CHCl3) (lit.,
132
 [α]D 45.4 (c 1.26 in CHCl3) for (S)-23 of 96:4 er); 
RF (9:1 petrol-EtOAc) 0.3; 
1
H NMR (400 MHz, CDCl3) δ 5.75 (dddd, J = 17.5, 10.0, 
7.0, 7.0 Hz, 1H, =CH), 5.09-5.04 (m, 1H, =CHAHB), 5.03-5.01 (m, 1H, =CHAHB), 3.93-
3.69 (br m, 1H, NCH), 3.42-3.23 (br m, 2H, 2 × NCH), 2.64-2.32 (br m, 1H, 
CHAHBCH=CH2), 2.17-2.06 (m, 1H, CHAHBCH=CH2), 1.95-1.65 (m, 4H, 2 × CH2), 
1.47 (s, 9H, CMe3); CSP-GC: (R)-23 8.7 min, (S)-23 9.0 min. Spectroscopic data 
consistent with those reported in the literature.
13
 
Lab Book Reference: GG5/23/1 
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2-Phenylpyrrolidine-1-carboxylic acid tert-butyl ester (S)-70 
 
(Scheme 2.34) 
s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 eq.) was added dropwise 
to a stirred solution of N-Boc pyrrolidine 1 (171 mg, 1.0 mmol, 1.0 eq.) and (+)-
sparteine surrogate (252 mg, 1.3 mmol, 1.3 eq.) in Et2O (7 mL) at 30 °C under Ar. The 
resulting solution was stirred at 30 °C for 2 min. Then, ZnCl2 (0.6 mL of a 1.0 M 
solution in Et2O, 0.6 mmol, 0.6 eq.) was added and the resulting mixture was stirred at 
30 °C for 30 min. The reaction mixture was allowed to warm to rt over 30 min. Then, 
bromobenzene (204 mg, 140 μL, 1.3 mmol, 1.3 eq.) and a mixture of tBu3PHBF4 (11 
mg, 0.0625 mmol, 0.0625 eq.) and Pd(OAc)2 (11 mg, 0.05 mmol, 0.05 eq.) were added. 
The resulting mixture was stirred at rt for 16 h. NH4OH(aq) (0.3 mL) and Et2O (5 mL) 
were added and mixture stirred for 1 h. The solids were removed by filtration through a 
pad of Celite

 and washed with Et2O (5 mL). The organic layer was extracted with 1 M 
HCl(aq) (5 mL) and water (2 × 5 mL), dried (Na2SO4) and evaporated under reduced 
pressure to give the crude product. Purification by flash column chromatography on 
silica with 99:1 CH2Cl2-Et2O as eluent gave phenyl pyrrolidine (S)-70 (142 mg, 58%, 
92:8 er by CSP-HPLC) as a white solid, mp 57-58 °C (lit.,
56
 61.9-62.7 °C); [α]D 81.5 
(c 1.0 in acetone) (lit.,
13
 [α]D +83.2 (c 0.7 in acetone) for (R)-70 of 95:5 er); RF (99:1 
CH2Cl2-Et2O) 0.3; 
1
H NMR (400 MHz, CDCl3) (67:33 mixture of rotamers) δ 7.33-7.26 
(m, 2H, Ph), 7.25-7.13 (m, 3H, Ph), 4.96 (br s, 0.33H, NCH), 4.77 (br s, 0.67H, NCH), 
3.74-3.41 (m, 2H, 2 × NCH), 2.40-2.19 (br m, 1H, CH), 1.98-1.75 (m, 3H, 3 × CH), 
1.46 (s, 3H, CMe3), 1.18 (s, 6H, CMe3); CSP-HPLC: Chiralcel AD-H (99:1 hexane-i-
PrOH, 0.5 mL min
1
) (R)-70 11.5 min, (S)-70 12.5 min. Spectroscopic data consistent 
with those reported in the literature.
56
 
Lab Book Reference: GG2/47/1 
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1-tert-Butyl 2-methyl piperidine-1,2-dicarboxylate (S)-71 
 
(Table 2.9, Entry 1) 
Using general procedure A: s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq.), N-Boc piperidine 34 (93 mg, 0.5 mmol, 1.0 eq.) and (+)-sparteine surrogate 
(126 mg, 0.65 mmol, 1.3 eq.) in Et2O (3.5 mL) at 50 °C under Ar for 30 min. Then, 
methyl chloroformate (94 mg, 77 μL, 1.0 mmol, 2.0 eq.) gave the crude product. 
Purification by flash column chromatography on silica with 95:5 petrol-EtOAc as eluent 
gave starting material 34 (19 mg, 21%) as a colourless oil and ester (S)-71 (56 mg, 46%, 
80:20 er by CSP-HPLC) as a colourless oil, [α]D 26.0 (c 1.5 in CHCl3) (lit.,
61
 [α]D 
31.7 (c 1.0 in CHCl3) for (S)-71 of 88:12 er); RF (95:5 petrol-EtOAc) 0.2; 
1
H NMR 
(400 MHz, CDCl3) (50:50 mixture of rotamers) δ 4.90 (br s, 0.5H, NCH), 4.73 (br s, 
0.5H, NCH), 4.09-3.86 (br m, 1H, NCH), 3.73 (s, 3H, OMe), 3.05-2.76 (br m, 1H, 
NCH), 2.27-2.13 (br m, 1H, CH), 1.71-1.33 (m, 5H, CH), 1.49-1.40 (br m, 9H, CMe3); 
CSP-HPLC: Chiralcel OD (99.7:0.3 hexane-i-PrOH, 0.4 mL min
1
) (R)-71 34.5 min, 
(S)-71 40.1 min. Spectroscopic data consistent with those reported in the literature.
61
 
Lab Book Reference: GG4/22/1 
 
(Table 2.9, Entry 2) 
Using general procedure A: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), N-Boc piperidine 34 (185 mg, 1.0 mmol, 1.0 eq.) and (+)-sparteine surrogate 
(252 mg, 1.3 mmol, 1.3 eq.) in Et2O (7 mL) at 40 °C under Ar for 20 min. Then, 
methyl chloroformate (189 mg, 150 μL, 2.0 mmol, 2.0 eq.) gave the crude product. 
Purification by flash column chromatography on silica with 95:5 petrol-EtOAc as eluent 
gave starting material 34 (28 mg, 15%) as a colourless oil and ester (S)-71 (155 mg, 
64%, 79:21 er by CSP-HPLC) as a colourless oil, [α]D 30.4 (c 1.0 in CHCl3) (lit.,
61
 
[α]D 31.7 (c 1.0 in CHCl3) for (S)-71 of 88:12 er); CSP-HPLC: Chiralcel OD (99.7:0.3 
hexane-i-PrOH, 0.4 mL min
1
) (R)-71 33.2 min, (S)-71 38.4 min. 
Lab Book Reference: GG2/55/1 
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(Table 2.9, Entry 3) 
Using general procedure A: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), N-Boc piperidine 34 (185 mg, 1.0 mmol, 1.0 eq.) and (+)-sparteine surrogate 
(252 mg, 1.3 mmol, 1.3 eq.) in Et2O (7 mL) at 30 °C under Ar for 5 min. Then, methyl 
chloroformate (189 mg, 150 μL, 2.0 mmol, 2.0 eq.) gave the crude product. Purification 
by flash column chromatography on silica with 95:5 petrol-EtOAc as eluent gave 
starting material 34 (48 mg, 26%) as a colourless oil and ester (S)-71 (115 mg, 47%, 
77:23 er by CSP-HPLC) as a colourless oil, CSP-HPLC: Chiralcel OD (99.7:0.3 
hexane-i-PrOH, 0.4 mL min
1
) (R)-71 33.6 min, (S)-71 38.5 min. 
Lab Book Reference: GG2/54/1 
 
1-tert-Butyl 2-methyl 4-tert-butylpiperazine-1,2-dicarboxylate (S)-72 
 
(Table 2.10, Entry 1) 
s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 1.3 eq.) was added dropwise 
to a stirred solution of N-Boc-N’-tert-butyl piperazine 35 (121 mg, 0.5 mmol, 1.0 eq.) 
and (+)-sparteine surrogate (126 mg, 0.65 mmol, 1.3 eq.) in Et2O (3.5 mL) at 50 °C 
under Ar. The resulting solution was stirred at 50 °C for 3 min. Then, methyl 
chloroformate (94 mg, 76 μL, 1.0 mmol, 2.0 eq.) was added. The resulting solution was 
stirred at 50 °C for 10 min and then allowed to warm to rt over 1 h. Then, saturated 
NH4Cl(aq) (1 mL) and NaHCO3(aq) (10 mL) were added and the two layers were 
separated. The aqueous layer was extracted with Et2O (3 × 5 mL) and the combined 
organic layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with 80:20 petrol-
EtOAc as eluent gave N-Boc piperazine (S)-72 (106 mg, 71%, 82:18 er by CSP-HPLC) 
as a colourless oil, RF (80:20 petrol-EtOAc) 0.3; 
1
H NMR (400 MHz, CDCl3) (50:50 
mixture of rotamers) δ 4.71 (br s, 0.5H, NCH), 4.54 (br s, 0.5H, NCH), 3.84 (br d, J = 
12.5 Hz, 0.5H, NCH), 3.79-3.70 (m, 3.5H, NCH + OMe), 3.49 (br dd, J = 14.0, 14.0 Hz, 
1H, NCH), 3.14 (br dd, J = 12.5, 12.5 Hz, 0.5H, NCH), 3.04 (br dd, J = 12.5, 12.5 Hz, 
0.5H, NCH), 2.92 (br d, J = 11.0 Hz, 0.5H, NCH), 2.85 (br d, J = 11.0 Hz, 0.5H, NCH), 
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2.32-2.21 (m, 1H, NCH), 2.11 (ddd, J = 11.0, 11.0, 3.5 Hz, 1H, NCH), 1.47 (s, 4.5H, 
OCMe3), 1.42 (s, 4.5H, OCMe3), 1.00 (s, 9H, NCMe3); 
13
C NMR (100.6 MHz, CDCl3) 
(mixture of rotamers) δ 171.5 (CO2Me), 171.2 (CO2Me), 155.8 (NC=O), 155.4 
(NC=O), 80.1 (CMe3), 56.2 (NCH), 55.0 (NCH), 53.6 (NCMe3), 52.0 (OMe), 47.5 
(NCH2), 45.2 (NCH2), 42.8 (NCH2), 41.9 (NCH2), 28.3 (Me3), 25.8 (Me3); MS (ESI) 
m/z 301 (M + H)
+
; HRMS (ESI) m/z calcd for C15H28N2O4 (M + H)
+
 301.2122, found 
301.2111 (+3.4 ppm error); CSP-HPLC: Chiralcel AD (99:1 hexane-i-PrOH, 1.0 mL 
min
1
) (R)-72 12.1 min, (S)-72 25.6 min. 
Lab Book Reference: GG3/64/1 
 
(Table 2.10, Entry 2) 
s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 eq.) was added dropwise 
to a stirred solution of N-Boc-N’-tert-butyl piperazine 35 (242 mg, 1.0 mmol, 1.0 eq.) 
and (+)-sparteine surrogate (252 mg, 1.3 mmol, 1.3 eq.) in Et2O (7 mL) at 30 °C under 
Ar. The resulting solution was stirred at 30 °C for 2 min. Then, methyl chloroformate 
(189 mg, 150 μL, 2.0 mmol, 2.0 eq.) was added. The resulting solution was stirred at 
30 °C for 10 min and then allowed to warm to rt over 1 h. Then, saturated NH4Cl(aq) (1 
mL) and NaHCO3(aq) (10 mL) were added and the two layers were separated. The 
aqueous layer was extracted with Et2O (3 × 5 mL) and the combined organic layers 
were dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with 80:20 petrol-EtOAc as 
eluent gave N-Boc piperazine (S)-72 (265 mg, 88%, 78:22 er by CSP-HPLC) as a 
colourless oil, CSP-HPLC: Chiralcel AD (99:1 hexane-i-PrOH, 1.0 mL min
1
) (R)-72 
14.7 min, (S)-72 18.1 min. 
Lab Book Reference: GG2/81/1 
 
3-Isopropylimidazolidine-1-carboxylic acid tert-butyl ester 36 
 
N-i-Pr-ethylene diamine (4.1 g, 40.1 mmol, 1.0 eq.) was added dropwise to a stirred 
solution of paraformaldehyde (1.2 g, 40.1 mmol, 1.0 eq.), K2CO3 (18.7 g, 135.2 mmol, 
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3.9 eq.) and MgSO4 (18.65 g, 155.0 mmol, 3.9 eq.) in CHCl3 (135 mL) at rt. The 
resulting solution was stirred at rt for 16 h. Then, di-tert-butyl dicarbonate (8.8 g, 40.1 
mmol, 1.0 eq.) was added and the resulting solution was stirred at rt for 24 h. The solids 
were removed by filtration through Celite
®
 and washed with CHCl3 (150 mL). The 
filtrate was evaporated under reduced pressure and the residue was partitioned between 
saturated brine (50 mL) and CH2Cl2 (50 mL). The two layers were separated and the 
aqueous layer was extracted with CH2Cl2 (2 × 50 mL). The combined organic layers 
were dried (Na2SO4) and evaporated under reduced pressure to give the crude product. 
Purification by Kügelrohr short path distillation gave N-Boc-N-i-Pr imidazolidine 36 
(8.2 g, 95%) as a colourless oil, bp 97-102 °C/3.0 mmHg (lit.,
5
 165-167 °C/12.0 
mmHg); 
1
H NMR (400 MHz, CDCl3) (50:50 mixture of rotamers) δ 4.04 (s, 1H, 
NCH2N), 3.96 (s, 1H, NCH2N), 3.48 (t, J = 6.5 Hz, 1H, BocNCH2), 3.43 (t, J = 6.5 Hz, 
1H, BocNCH2), 2.83 (t, J = 6.5 Hz, 1H, NCH2), 2.82 (t, J = 6.5 Hz, 1H, NCH2), 2.44 
(septet, J = 6.5 Hz, 0.5 H, NCH), 2.43 (septet, J = 6.5 Hz, 0.5 H, NCH), 1.46 (s, 9H, 
CMe3), 1.12 (br d, J = 6.5 Hz, 6H, NCHMe2). Spectroscopic data consistent with those 
reported in the literature.
5 
Lab Book Reference: GG2/16/1 
 
3-i-Propyl-5-hydroxydiphenylmethylimidazolidine-1-carboxylic acid tert-butyl 
ester (S)-74 and 6-i-propyl-1,1-diphenyltetrahydroimidazo[1,5-c]oxazol-3-one (S)-
76 
 
(Table 2.11, Entry 2) 
Using general procedure B: s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq.), N-Boc-N-i-Pr imidazolidine 36 (107 mg, 0.5 mmol, 1.0 eq.) and (+)-sparteine 
surrogate (126 mg, 0.65 mmol, 1.3 eq.) in THF (3.5 mL) at 40 °C under Ar for 30 min. 
Then, a solution of benzophenone (182 mg, 1.0 mmol, 2.0 eq.) in THF (1 mL) gave the 
crude product which contained (by 
1
H NMR spectroscopy) a 55:23:22 mixture of (S)-
74, (S)-76 and 36. Purification by flash column chromatography on silica with 85:15 
petrol-EtOAc as eluent gave substituted imidazolidine (S)-74 (103 mg, 52%, 90:10 er 
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by CSP-HPLC) as a yellow solid, [α]D +103.0 (c 1.5 in CHCl3) (lit.,
44
 [α]D 129.7 (c 
4.58 in CHCl3) for (R)-74 of 92:8 er); RF (85:15 petrol-EtOAc) 0.1; 
1
H NMR (400 MHz, 
CDCl3) δ 7.60 (d, J = 7.5 Hz, 2H, o-Ph), 7.49-7.12 (m, 8H, Ph), 5.02-4.69 (br m, 1H, 
NCH), 4.65-4.24 (br m, 1H, NCHN), 3.99-3.62 (br m, 1H, NCHN), 3.11 (d, J = 8.5 Hz, 
1H, NCH), 2.67 (dd, J = 8.5, 6.0 Hz, 1H, NCH), 2.56 (br s, 1H, NCHMe), 1.38-0.96 (br 
m, 9H, CMe3), 1.11 (d, J = 6.5 Hz, 3H, NCHMe), 1.03 (d, J = 6.5 Hz, 3H, NCHMe); 
13
C 
NMR (100.6 MHz, CDCl3) δ 154.2 (C=O), 146.3 (ipso-Ph), 145.4 (ipso-Ph), 129.3 (Ph), 
127.7 (Ph), 127.2 (Ph), 127.1 (Ph), 126.7 (Ph), 80.6 (CMe3), 80.1 (Ph2CO), 67.0 
(NCH2N), 62.8 (NCH), 53.2 (NCH2), 52.2 (NCH), 27.5 (CMe3), 20.8 (Me), 20.6 (Me); 
CSP-HPLC: Chiralcel AD (95:5 hexane-i-PrOH, 1.0 mL min
1
) (R)-74 6.7 min, (S)-74 
16.7 min, cyclic carbamate (S)-76 (39 mg, 24%, 70:30 er by CSP-HPLC) as a white 
solid, mp 119-121 °C (lit.,
44
 117-120 °C); RF (80:20 petrol-EtOAc) 0.1; 
1
H NMR (400 
MHz, CDCl3) δ 7.53-7.48 (m, 2H, Ph), 7.41-7.26 (m, 8H, Ph), 4.81 (dd, J = 9.0, 6.0 Hz, 
1H, NCH), 4.29 (d, J = 7.0 Hz, 1H, NCHN), 4.09 (d, J = 7.0 Hz, 1H, NCHN), 2.79 (dd, 
J = 9.0, 6.0 Hz, 1H, NCH), 2.59 (septet, J = 6.5 Hz, 1H, NCHMe), 2.06 (dd, J = 9.0, 9.0 
Hz, NCH), 1.01 (d, J = 6.5 Hz, 3H, NCHMe), 1.00 (d, J = 6.5 Hz, 3H, NCHMe);
 13
C 
NMR (100.6 MHz, CDCl3) δ 160.8 (C=O), 142.6 (ipso-Ph), 139.6 (ipso-Ph), 128.6 (Ph), 
128.5 (Ph), 128.4 (Ph), 127.9 (Ph), 125.8 (Ph), 125.1 (Ph), 86.0 (Ph2CO), 67.6 
(NCH2N), 67.3 (NCH), 52.8 (NCH), 51.9 (NCH2), 21.5 (Me), 21.1 (Me); CSP-HPLC: 
Chiralcel AD-H (95:5 hexane-i-PrOH, 1.0 mL min
1
) (S)-76 12.3 min, (R)-76 18.0 min, 
and recovered N-Boc-N-i-Pr imidazolidine 36 (22 mg, 20%). Spectroscopic data 
consistent with those reported in the literature.
44
 
Lab Book Reference: GG5/4 
 
(Table 2.11, Entry 1) 
Using general procedure B: s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq.), N-Boc-N-i-Pr imidazolidine 36 (107 mg, 0.5 mmol, 1.0 eq.) and (+)-sparteine 
surrogate (126 mg, 0.65 mmol, 1.3 eq.) in Et2O (3.5 mL) at 40 °C under Ar for 1 h. 
Then, a solution of benzophenone (182 mg, 1.0 mmol, 2.0 eq.) in Et2O (1 mL) gave the 
crude product which contained (by 
1
H NMR spectroscopy) a 56:18:26 mixture of (S)-
74, (S)-76 and 36. Purification by flash column chromatography on silica with 85:15 
petrol-EtOAc as eluent gave substituted imidazolidine (S)-74 (81 mg, 40%, 93:7 er by 
CSP-HPLC) as a yellow solid, CSP-HPLC: Chiralcel AD (95:5 hexane-i-PrOH, 1.0 mL 
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min
1
) (R)-74 6.6 min, (S)-74 15.3 min and recovered N-Boc-N-i-Pr imidazolidine 36 
(18 mg, 17%). 
Lab Book Reference: GG3/45/1 
 
(Table 2.11, Entry 3) 
Using general procedure B: s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq.), N-Boc-N-i-Pr imidazolidine 36 (107 mg, 0.5 mmol, 1.0 eq.) and (+)-sparteine 
surrogate (126 mg, 0.65 mmol, 1.3 eq.) in Et2O (3.5 mL) at 40 °C under Ar for 30 min. 
Then, a solution of benzophenone (182 mg, 1.0 mmol, 2.0 eq.) in Et2O (1 mL) gave the 
crude product which contained (by 
1
H NMR spectroscopy) a 56:17:27 mixture of (S)-
74, (S)-76 and 36. Purification by flash column chromatography on silica with 85:15 
petrol-EtOAc as eluent gave substituted imidazolidine (S)-74 (72 mg, 36%, 92:8 er by 
CSP-HPLC) as a yellow solid, CSP-HPLC: Chiralcel AD (95:5 hexane-i-PrOH, 1.0 mL 
min
1
) (R)-74 6.7 min, (S)-74 16.7 min, cyclic carbamate (S)-76 (16 mg, 10%, 77:23 er 
by CSP-HPLC) as a white solid, CSP-HPLC: Chiralcel AD-H (95:5 hexane-i-PrOH, 1.0 
mL min
1
) (S)-76 12.2 min, (R)-76 17.9 min, and recovered N-Boc-N-i-Pr 
imidazolidine 36 (28 mg, 26%). 
Lab Book Reference: GG5/11 
 
(Table 2.11, Entry 4) 
Using general procedure X B: s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 
mmol, 1.3 eq.), N-Boc-N-i-Pr imidazolidine 36 (107 mg, 0.5 mmol, 1.0 eq.) and (+)-
sparteine surrogate (126 mg, 0.65 mmol, 1.3 eq.) in THF (3.5 mL) at 40 °C under Ar 
for 20 min. Then, a solution of benzophenone (182 mg, 1.0 mmol, 2.0 eq.) in THF (1 
mL) gave the crude product which contained (by 
1
H NMR spectroscopy) a 45:24:31 
mixture of (S)-74, (S)-76 and 36. Purification by flash column chromatography on silica 
with 85:15 petrol-EtOAc as eluent gave substituted imidazolidine (S)-74 (98 mg, 50%, 
93:7 er by CSP-HPLC) as a yellow solid, CSP-HPLC: Chiralcel AD (95:5 hexane-i-
PrOH, 1.0 mL min
1
) (R)-74 6.7 min, (S)-74 16.7 min, cyclic carbamate (S)-76 (33 mg, 
20%, 71:29 er by CSP-HPLC) as a white solid, CSP-HPLC: Chiralcel AD-H (95:5 
hexane-i-PrOH, 1.0 mL min
1
) (S)-76 12.1 min, (R)-76 17.7 min, and recovered N-Boc-
N-i-Pr imidazolidine 36 (28 mg, 26%). 
Lab Book Reference: GG5/8 
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(Table 2.11, Entry 5) 
Using general procedure B: s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq.), N-Boc-N-i-Pr imidazolidine 36 (107 mg, 0.5 mmol, 1.0 eq.) and (+)-sparteine 
surrogate (126 mg, 0.65 mmol, 1.3 eq.) in Et2O (3.5 mL) in Et2O (1 mL) at 40 °C 
under Ar for 20 min. Then, a solution of benzophenone (182 mg, 1.0 mmol, 2.0 eq.) 
gave the crude product which contained (by 
1
H NMR spectroscopy) a 54:10:36 mixture 
of (S)-74, (S)-76 and 36. Purification by flash column chromatography on silica with 
85:15 petrol-EtOAc as eluent gave substituted imidazolidine (S)-74 (86 mg, 43%, 91:9 
er by CSP-HPLC) as a yellow solid, CSP-HPLC: Chiralcel AD (95:5 hexane-i-PrOH, 
1.0 mL min
1
) (R)-74 6.6 min, (S)-74 16.4 min, cyclic carbamate (S)-76 (10 mg, 6%, 
75:25 er by CSP-HPLC) as a white solid, CSP-HPLC: Chiralcel AD-H (95:5 hexane-i-
PrOH, 1.0 mL min
1
) (S)-76 12.2 min, (R)-76 17.9 min, and recovered N-Boc-N-i-Pr 
imidazolidine 36 (36 mg, 34%). 
Lab Book Reference: GG5/17 
 
(Table 2.11, Entry 6) 
Using general procedure B: s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq.), N-Boc-N-i-Pr imidazolidine 36 (107 mg, 0.5 mmol, 1.0 eq.) and (+)-sparteine 
surrogate (126 mg, 0.65 mmol, 1.3 eq.) in THF (3.5 mL) at 40 °C under Ar for 10. 
Then, a solution of benzophenone (182 mg, 1.0 mmol, 2.0 eq.) in THF (1 mL) gave the 
crude product which contained (by 
1
H NMR spectroscopy) a 48:26:26 mixture of (S)-
74, (S)-76 and 36. Purification by flash column chromatography on silica with 85:15 
petrol-EtOAc as eluent gave substituted imidazolidine (S)-74 (90 mg, 45%, 91:9 er by 
CSP-HPLC) as a yellow solid, CSP-HPLC: Chiralcel AD (95:5 hexane-i-PrOH, 1.0 mL 
min
1
) (R)-74 6.8 min, (S)-74 16.5 min, and recovered N-Boc-N-i-Pr imidazolidine 36 
(23 mg, 21%). 
Lab Book Reference: GG3/70/1 
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3-Isopropyl-5-phenylcarbamoylimidazolidine-1-carboxylic acid tert-butyl ester (S)-
75 
 
(Table 2.12, Entry 1) 
Using general procedure B: s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq.), N-Boc-N-i-Pr imidazolidine 36 (107 mg, 0.5 mmol, 1.0 eq.) and (+)-sparteine 
surrogate (126 mg, 0.65 mmol, 1.3 eq.) in THF (3.5 mL) at 40 °C under Ar for 30 min. 
Then, phenyl isocyanate (119 mg, 110 μL, 1.0 mmol, 2.0 eq.) gave the crude product. 
Purification by flash column chromatography on silica with 95:5 petrol-EtOAc as eluent 
gave recovered N-Boc-N-i-Pr imidazolidine 36 (19 mg, 18%) and substituted 
imidazolidine (S)-75 (97 mg, 58%, 85:15 er by CSP-HPLC) as a colourless oil, RF 
(80:20 petrol-EtOAc) 0.1; 
1
H NMR (400 MHz, CDCl3) (50:50 mixture of rotamers) δ 
9.27 (br s, 0.5H, NH), 8.29 (br s, 0.5H, NH), 7.57-7.49 (m, 2H, Ph), 7.38-7.29 (m, 2H, 
Ph), 7.17-7.05 (m, 1H, Ph), 4.65-4.47 (m, 0.5H, NCH), 4.47-4.26 (m, 1H, NCH2N), 
4.25-3.93 (m, 1.5H, NCH + NCH2N), 3.64-3.43 (m, 0.5H, NCH), 3.34-3.16 (m, 0.5H, 
NCH), 3.15-2.88 (m, 1H, NCH), 2.70-2.47 (m, 1H, NCHMe), 1.62-1.38 (m, 9H, CMe3), 
1.25-1.06 (m, 6H, NCHMe);
 13
C NMR (100.6 MHz, CDCl3) (mixture of rotamers) δ 
169.6 (C=O), 168.7 (C=O), 155.1 (C=O), 153.4 (C=O), 137.8 (ipso-Ph), 137.5 (ipso-
Ph), 128.8 (Ph), 124.0 (Ph), 119.6 (Ph), 81.4 (CMe3), 67.3 (NCH2N), 66.9 (NCH2N), 
61.1 (NCH), 59.7 (NCH), 55.0 (NCH2), 52.5 (NCH), 28.2 (CMe3), 21.3 (Me); CSP-
HPLC: Chiralcel AD-H (95:5 hexane-i-PrOH, 1.0 mL min
1
) (R)-75 11.3 min, (S)-75 
17.5 min. Spectroscopic data consistent with those reported in the literature.
44
 
Lab Book Reference: GG5/10 
 
(Table 2.12, Entry 2) 
Using general procedure B: s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq.), N-Boc-N-i-Pr imidazolidine 36 (107 mg, 0.5 mmol, 1.0 eq.) and (+)-sparteine 
surrogate (126 mg, 0.65 mmol, 1.3 eq.) in Et2O (3.5 mL) at 40 °C under Ar for 30 min. 
Then, phenyl isocyanate (119 mg, 110 μL, 1.0 mmol, 2.0 eq.) gave the crude product. 
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Purification by flash column chromatography on silica with 95:5 petrol-EtOAc as eluent 
gave recovered N-Boc-N-i-Pr imidazolidine 36 (28 mg, 26%) and substituted 
imidazolidine (S)-75 (81 mg, 48%, 88:12 er by CSP-HPLC) as a colourless oil, CSP-
HPLC: Chiralcel AD-H (95:5 hexane-i-PrOH, 1.0 mL min
1
) (R)-75 11.0 min, (S)-75 
17.1 min. 
Lab Book Reference: GG5/13 
 
(Table 2.12, Entry 3) 
Using general procedure B:  s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq.), N-Boc-N-i-Pr imidazolidine 36 (107 mg, 0.5 mmol, 1.0 eq.) and (+)-sparteine 
surrogate (126 mg, 0.65 mmol, 1.3 eq.) in THF (3.5 mL) at 40 °C under Ar for 20 min. 
Then, phenyl isocyanate (119 mg, 110 μL, 1.0 mmol, 2.0 eq.) gave the crude product. 
Purification by flash column chromatography on silica with 95:5 petrol-EtOAc as eluent 
gave recovered N-Boc-N-i-Pr imidazolidine 36 (27 mg, 25%) and substituted 
imidazolidine (S)-75 (118 mg, 71%, 85:15 er by CSP-HPLC) as a colourless oil, CSP-
HPLC: Chiralcel AD-H (95:5 hexane-i-PrOH, 1.0 mL min
1
) (R)-75 10.9 min, (S)-75 
17.0 min. 
Lab Book Reference: GG5/16 
 
(Table 2.12, Entry 4) 
Using general procedure B: s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq.), N-Boc-N-i-Pr imidazolidine 36 (107 mg, 0.5 mmol, 1.0 eq.) and (+)-sparteine 
surrogate (126 mg, 0.65 mmol, 1.3 eq.) in Et2O (3.5 mL) at 40 °C under Ar for 20 min. 
Then, phenyl isocyanate (119 mg, 110 μL, 1.0 mmol, 2.0 eq.) gave the crude product. 
Purification by flash column chromatography on silica with 95:5 petrol-EtOAc as eluent 
gave recovered N-Boc-N-i-Pr imidazolidine 36 (12 mg, 11%) and substituted 
imidazolidine (S)-75 (51 mg, 30%, 89:11 er by CSP-HPLC) as a colourless oil, CSP-
HPLC: Chiralcel AD-H (95:5 hexane-i-PrOH, 1.0 mL min
1
) (R)-75 10.9 min, (S)-75 
16.9 min. 
Lab Book Reference: GG5/19 
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3-Isopropyl-5-methylimidazolidine-1-carboxylic acid tert-butyl ester (R)-80 
 
(Table 2.13, Entry 1) 
Using general procedure B: s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq.), N-Boc-N-i-Pr imidazolidine 36 (107 mg, 0.5 mmol, 1.0 eq.) and (+)-sparteine 
surrogate (126 mg, 0.65 mmol, 1.3 eq.) in THF (3.5 mL) at 40 °C under Ar for 30 min. 
Then, methyl iodide (142 mg, 60 μL, 1.0 mmol, 2.0 eq.) gave the crude product. 
Purification by flash column chromatography on silica with 70:30 petrol-EtOAc as 
eluent gave substituted imidazolidine (R)-80 (64 mg, 56%) as a colourless oil, RF (70:30 
petrol-EtOAc) 0.2; 
1
H NMR (400 MHz, CDCl3) (60:40 mixture of rotamers) δ 4.37-
4.26 (m, 0.6H, NCH2N), 4.18-4.08 (m, 0.4H, NCH2N), 4.02-3.88 (m, 2H, NCH + 
NCH2N), 3.19-3.02 (m, 1H, NCH), 2.47-2.34 (m, 2H, NCH + NCHMe), 1.46 (s, 9H, 
CMe3), 1.14-1.09 (m, 6H, NCHMe);
 13
C NMR (100.6 MHz, CDCl3) (mixture of 
rotamers) δ 153.9 (C=O), 79.7 (CMe3), 67.0 (NCH2N), 59.5 (NCH2) 58.6 (NCH2), 53.6 
(NCH), 52.3 (NCH), 28.3 (CMe3), 21.1 (Me), 19.4 (Me), 18.7 (Me) and recovered N-
Boc-N-i-Pr imidazolidine 36 (20 mg, 19%). Spectroscopic data consistent with those 
reported in the literature.
44
 
Lab Book Reference: GG5/9 
 
(Table 2.13, Entry 2) 
Using general procedure B: s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq.), N-Boc-N-i-Pr imidazolidine 36 (107 mg, 0.5 mmol, 1.0 eq.) and (+)-sparteine 
surrogate (126 mg, 0.65 mmol, 1.3 eq.) in Et2O (3.5 mL) at 40 °C under Ar for 30 min. 
Then, methyl iodide (142 mg, 60 μL, 1.0 mmol, 2.0 eq.) gave the crude product. 
Purification by flash column chromatography on silica with 70:30 petrol-EtOAc as 
eluent gave substituted imidazolidine (R)-80 (44 mg, 39%) as a colourless oil and 
recovered N-Boc-N-i-Pr imidazolidine 36 (24 mg, 22%). 
Lab Book Reference: GG5/12 
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(Table 2.13, Entry 3) 
Using general procedure B: s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq.), N-Boc-N-i-Pr imidazolidine 36 (107 mg, 0.5 mmol, 1.0 eq.) and (+)-sparteine 
surrogate (126 mg, 0.65 mmol, 1.3 eq.) in THF (3.5 mL) at 40 °C under Ar for 20 min. 
Then, methyl iodide (142 mg, 60 μL, 1.0 mmol, 2.0 eq.) gave the crude product. 
Purification by flash column chromatography on silica with 70:30 petrol-EtOAc as 
eluent gave substituted imidazolidine (R)-80 (60 mg, 52%) as a colourless oil and 
recovered N-Boc-N-i-Pr imidazolidine 36 (41 mg, 38%). 
Lab Book Reference: GG5/15 
 
(Table 2.13, Entry 4) 
Using general procedure B: s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq.), N-Boc-N-i-Pr imidazolidine 36 (107 mg, 0.5 mmol, 1.0 eq.) and (+)-sparteine 
surrogate (126 mg, 0.65 mmol, 1.3 eq.) in Et2O (3.5 mL) at 40 °C under Ar for 20 min. 
Then, methyl iodide (142 mg, 60 μL, 1.0 mmol, 2.0 eq.) gave the crude product. 
Purification by flash column chromatography on silica with 70:30 petrol-EtOAc as 
eluent gave substituted imidazolidine (R)-80 (42 mg, 37%) as a colourless oil and 
recovered N-Boc-N-i-Pr imidazolidine 36 (34 mg, 32%). 
Lab Book Reference: GG5/18 
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ReactIR™ monitoring of the lithiation of N-Boc-N-i-Pr imidazolidine 36 in Et2O 
 
Et2O (10 mL) was added to a flask equipped with a stirred bar and ReactIR™ probe at rt 
under Ar. After cooling to 40 °C, a solution of (+)-sparteine surrogate (252 mg, 1.3 
mmol, 1.3 eq.) in Et2O (2 mL) was added followed by a solution of N-Boc 
imidazolidine 36 (214 mg, 1.0 mmol, 1.0 eq.) in Et2O (2 mL). The solution was stirred 
for 5 min (to verify the stability of the readout on ReactIR™). Then, s-BuLi (1.0 mL of 
a 1.3 M solution in hexanes, 1.3 mmol, 1.3 eq.) was added dropwise. The solution was 
stirred at 40 °C for 64 min. For N-Boc imidazolidine 36, a peak at 1710 cm1 was 
observed and assigned to νC=O. After addition of s-BuLi, a new peak at 1684 cm
1
 was 
observed which was assigned to νC=O in the pre-lithiation complex. A new peak at 1645 
cm
1
 was observed which was assigned to νC=O in the lithiated intermediate. After a 
lithiation time of 1 min, approximately half of N-Boc imidazolidine 36 had been 
lithiated to give the lithiated intermediate. 
Lab Book Reference: JDF6_559 
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ReactIR™ monitoring of the lithiation of N-Boc-N-i-Pr imidazolidine 36 in THF 
 
THF (10 mL) was added to a flask equipped with a stirred bar and ReactIR™ probe at rt 
under Ar. After cooling to 40 °C, a solution of (+)-sparteine surrogate (252 mg, 1.3 
mmol, 1.3 eq.) in THF (2 mL) was added followed by a solution of N-Boc 
imidazolidine 36 (214 mg, 1.0 mmol, 1.0 eq.) in THF (2 mL). The solution was stirred 
for 5 min (to verify the stability of the readout on ReactIR™). Then, s-BuLi (1.0 mL of 
a 1.3 M solution in hexanes, 1.3 mmol, 1.3 eq.) was added dropwise. The solution was 
stirred at 40 °C for 13 min. For N-Boc imidazolidine 36, a peak at 1705 cm1 was 
observed and assigned to νC=O. After addition of s-BuLi, a new peak at 1646 cm
1
 was 
observed which was assigned to νC=O in the lithiated intermediate. After a lithiation time 
of 9 min, complete lithiation of N-Boc imidazolidine 36 to give the lithiated 
intermediate was observed. 
Lab Book Reference: PJR 6/448 
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5.4 Experimental for Chapter Three 
 
Methyl p-toluenesulfinate 92 
 
Bromine (4.86 g, 1.56 mL, 30.4 mmol, 3.0 eq.) was added to stirred suspension of 
Na2CO3 (5.37 g, 50.7 mmol, 5.0 eq.) and p-tolyl disulfide (2.5 g, 10.1 mmol, 1.0 eq.) in 
MeOH (215 mL) at rt. The resulting yellow suspension was stirred at rt for 3 h during 
which time the suspension became colourless. Then, the solvent was evaporated under 
reduced pressure. CH2Cl2 (100 mL) and water (100 mL) were added to the residue and 
the two layers were separated. The aqueous layer was extracted with CH2Cl2 (2 × 50 
mL). The combined organic layers were washed with saturated NH4Cl(aq) (50 mL) and 
brine (50 mL), dried (MgSO4) and evaporated under reduced pressure to give the crude 
product as a colourless oil. Purification by Kügelrohr short path distillation gave 
sulfinate 92 (3.2 g, 92% yield) as a colourless oil, bp 91-94 °C/2.0 mmHg (lit.,
133
 129-
130 °C/16.0 mmHg); 
1
H NMR (400 MHz, CDCl3) δ 7.60 (d, J = 8.0 Hz, 2H, m-
C6H4Me), 7.35 (d, J = 8.0 Hz, 2H, o-C6H4Me), 3.47 (s, 3H, OMe), 2.43 (s, 3H, Me). 
Spectroscopic data consistent with those reported in the literature.
134
 
 
N-Methyl N-p-tolylsulfinylmethyl carbamic acid tert-butyl ester 106 
 
s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 eq.) was added dropwise 
to a stirred solution of N-Boc dimethylamine 105 (145 mg, 1.0 mmol, 1.0 eq.) and 
TMEDA (151 mg, 194 μL, 1.3 mmol, 1.3 eq.) in Et2O (2 mL) at 78 °C under Ar. The 
resulting solution was stirred at 78 °C for 2 h. Then, p-tolylsulfinate 92 (340 mg, 2.0 
mmol, 2.0 eq.) was added. The resulting solution was allowed to warm to rt over 16 h. 
Then, MeOH (1 mL), saturated NH4Cl(aq) (2 mL) and Et2O (10 mL) were added and the 
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two layers were separated. The aqueous layer was extracted with Et2O (3 × 5 mL) and 
the combined organic layers were dried (MgSO4) and evaporated under reduced 
pressure to give the crude product. Purification by flash column chromatography on 
silica with 98:2 CH2Cl2-acetone with 1% Et3N as eluent gave sulfoxide 106 (203 mg, 
71%) as a colourless oil, RF (98:2 CH2Cl2-acetone with 1% Et3N) 0.3; 
1
H NMR (400 
MHz, CDCl3) (50:50 mixture of rotamers) δ 7.56 (d, J = 8.0 Hz, 1H, m-C6H4Me), 7.52 
(d, J = 8.0 Hz, 1H, m-C6H4Me), 7.38-7.31 (m, 2H, o-C6H4Me), 4.59 (d, J = 13.0 Hz, 
0.5H, NCH), 4.38 (d, J = 13.0 Hz, 0.5H, NCH), 4.30 (d, J = 13.0 Hz, 0.5H, NCH), 4.10 
(d, J = 13.0 Hz, 0.5H, NCH), 3.07 (s, 1.5H, NMe), 2.94 (s, 1.5H, NMe), 2.42 (s, 1.5H, 
C6H4Me), 2.41 (s, 1.5H, C6H4Me), 1.45 (s, 4.5H, CMe3), 1.38 (s, 4.5H, CMe3). 
Spectroscopic data consistent with those reported previously in the group.
71
  
Lab Book Reference: GG2/96/1 
 
Attempted synthesis of tert-butyl methyl(1-(p-tolylsulfinyl)ethyl)carbamate 114 
 
n-BuLi (170 μL of a 2.5 M solution in hexanes, 0.49 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of isopropylamine (42 mg, 58 μL, 0.42 mmol, 1.3 eq.) in 
THF (1.7 mL) at 78 °C under Ar. The resulting solution was warmed to 0 °C and 
stirred for 15 min and then re-cooled to 78 °C. Then, a solution of sulfoxide 106 (100 
mg, 0.35 mmol, 1.0 eq.) in THF (3.4 mL) was added dropwise over 10 min. The 
resulting mixture was stirred at 78 °C for 10 min. Then, Me2SO4 (62 mg, 46 μL, 0.52 
mmol, 1.5 eq.) was added and the mixture was allowed to warm to rt over 2 h. Then, 
saturated NH4Cl(aq) (4 mL) and Et2O (5 mL) were added and the two layers were 
separated. The aqueous layer was extracted with Et2O (3 × 5 mL) and the combined 
organic layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. The 
1
H NMR spectrum of the crude product showed only starting 
sulfoxide 106 and therefore purification was not attempted. 
Lab Book Reference: GG3/6 
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Attempted synthesis of tert-butyl methyl(p-tolylsulfinyl(trimethylsilyl)methyl) 
carbamate 290 
 
n-BuLi (170 μL of a 2.5 M solution in hexanes, 0.49 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of isopropylamine (42 mg, 58 μL, 0.42 mmol, 1.3 eq.) in 
THF (1.7 mL) at 78 °C under Ar. The resulting solution was warmed to 0 °C and 
stirred for 15 min and then re-cooled to 78 °C. Then, a solution of sulfoxide 106 (100 
mg, 0.35 mmol, 1.0 eq.) in THF (3.4 mL) was added dropwise over 10 min. The 
resulting mixture was stirred at 78 °C for 10 min. Then, Me3SiCl (56 mg, 66 μL, 0.52 
mmol, 1.5 eq.) was added and the mixture was allowed to warm to rt over 2 h. Then, 
saturated NH4Cl(aq) (4 mL) and Et2O (5 mL) were added and the two layers were 
separated. The aqueous layer was extracted with Et2O (3 × 5 mL) and the combined 
organic layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. The 
1
H NMR spectrum of the crude product showed no identifiable 
products and therefore purification was not attempted. 
Lab Book Reference: GG3/16 
 
N-Boc methylamine 115 
 
n-BuLi (100 μL of a 2.5 M solution in hexanes, 0.26 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of isopropylamine (26 mg, 36 μL, 0.26 mmol, 1.3 eq.) in 
THF (1 mL) at 78 °C under Ar. The resulting solution was warmed to 0 °C and stirred 
for 15 min and then re-cooled to 78 °C. Then, a solution of sulfoxide 106 (67 mg, 0.22 
mmol, 1.0 eq.) in THF (2 mL) was added dropwise over 10 min. The resulting mixture 
was stirred at 78 °C for 1 h. Then, Me2SO4 (42 mg, 31 μL, 0.49 mmol, 1.5 eq.) was 
added and the mixture was allowed to warm to rt over 2 h. Then, saturated NH4Cl(aq) (4 
mL) and Et2O (5 mL) were added and the two layers were separated. The aqueous layer 
Chapter Five: Experimental 
204 
was extracted with Et2O (3 × 5 mL) and the combined organic layers were dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. Purification 
by flash column chromatography on silica with 96:4 CH2Cl2-acetone with 1% Et3N as 
eluent gave N-Boc methylamine 115 (17 mg, 59%) as a colourless oil, RF (96:4 CH2Cl2-
acetone with 1% Et3N) 0.2; 
1
H NMR (400 MHz, CDCl3) δ 4.80 (br s, 1H, NH), 2.83 (br 
s, 3H, NMe), 1.46 (s, 9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) (mixture of rotamers) 
δ 156.2 (C=O), 155.9 (C=O), 80.1 (CMe3), 79.8 (CMe3), 32.7 (Me), 32.5 (Me), 28.3 
(CMe3). Spectroscopic data consistent with those reported in the literature.
135
 
Lab Book Reference: GG3/7 
 
tert-Butyl 4-methoxyphenylcarbamate 120 
 
A solution of di-tert-butyl dicarbonate (13.63 g, 62.4 mmol, 1.0 eq.) in THF (40 mL) 
was added dropwise to a stirred solution of p-anisidine (10.0 g, 81.2 mmol, 1.3 eq.) in 
THF (40 mL) at 0 °C under Ar. The resulting solution was stirred at rt for 16 h. Then, 
water (100 mL) and CH2Cl2 (100 mL) were added. The aqueous layer was extracted 
with CH2Cl2 (2 × 50 mL) and the combined organic layers were dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica with 70:30 petrol-EtOAc as eluent gave N-Boc p-
anisidine 120 (13.8 g, 99%) as a white solid, mp 84-87 °C (lit.,
87
 92-94 °C), RF (70:30 
petrol-EtOAc) 0.5; 
1
H NMR (400 MHz, CDCl3) δ 7.27 (br d, J = 9.0 Hz, 2H, Ar), 6.84 
(d, J = 9.0 Hz, 2H, Ar), 6.36 (br s, 1H, NH), 3.78 (s, 3H, OMe), 1.51 (s, 9H, CMe3). 
Spectroscopic data consistent with those reported in the literature.
87
  
Lab Book Reference: GG2/97/1 
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tert-Butyl benzyl(4-methoxyphenyl)carbamate 117 
 
A solution of N-Boc p-anisidine 120 (4.0 g, 18.0 mmol, 1.0 eq.) in THF (47 mL) was 
added to a stirred suspension of NaH (792 mg of a 60% wt dispersion in mineral oil, 
19.8 mmol, 1.1 eq.) and benzyl bromide (3.4 g, 2.35 mL, 19.8 mmol, 1.1 eq.) in THF 
(31 mL) at 0 °C under Ar. The resulting mixture was stirred at rt for 16 h. Then, water 
(50 mL) and Et2O (50 mL) were added and the two layers were separated. The aqueous 
layer was extracted with Et2O (2 × 50 mL) and the combined organic layers were dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. Purification 
by flash column chromatography on silica with 95:5 to 80:20 petrol-Et2O as eluent gave 
N-Boc N-benzyl p-anisidine 117 (5.1 g, 90%) as a white solid, mp 44-46 °C (lit.,
86
 42-
43 °C), RF (80:20 petrol- Et2O) 0.3; 
1
H NMR (400 MHz, CDCl3) δ 7.33-7.27 (m, 2H, 
Ar), 7.27-7.21 (m, 3H, Ar), 7.11-6.92 (m, 2H, Ar), 6.79 (br d, J = 8.5 Hz, 2H, Ar), 4.78 
(s, 2H, NCH2), 3.78 (s, 3H, OMe), 1.43 (s, 9H, CMe3). Spectroscopic data consistent 
with those reported in the literature.
86
 
Lab Book Reference: GG3/17/1 
 
tert-Butyl 4-methoxyphenyl(phenyl(p-tolylsulfinyl)methyl)carbamate 40a and 40b 
 
s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 eq.) was added dropwise 
to a stirred solution of N-Boc N-benzyl p-anisidine 117 (313 mg, 1.0 mmol, 1.0 eq.) and 
TMEDA (151 mg, 194 μL, 1.3 mmol, 1.3 eq.) in Et2O (2 mL) at 78 °C under Ar. The 
resulting solution was stirred at 78 °C for 30 min. Then, p-tolylsulfinate 92 (255 mg, 
1.5 mmol, 1.5 eq.) was added. The resulting solution was stirred at 30 °C for 10 min 
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and then allowed to warm to rt over 1 h. Then, MeOH (1 mL), saturated NH4Cl(aq) (2 
mL) and Et2O (5 mL) were added and the two layers were separated. The aqueous layer 
was extracted with Et2O (3 × 5 mL) and the combined organic layers were dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. Purification 
by flash column chromatography on silica with 98:2 CH2Cl2-acetone with 0.5% Et3N as 
eluent gave sulfoxide 40a (135 mg, 30%) as a yellow solid, mp 65-68 °C, RF (98:2 
CH2Cl2-acetone with 0.5% Et3N) 0.2; IR (CHCl3) 2963, 1691 (C=O), 1494, 1347, 1224, 
1142, 1018, 817 cm
1
; 
1
H NMR (400 MHz, CDCl3) δ 7.61 (d, J = 8.0 Hz, 2H, Ar), 7.33-
7.22 (m, 7H, Ar), 6.68 (d, J =9.0 Hz, 2H, Ar), 6.56 (br d, J = 8.0 Hz, 2H, Ar), 5.57 (s, 
1H, NCH), 3.77 (s, 3H, OMe), 2.43 (s, 3H, C6H4Me), 1.34 (s, 9H, CMe3); 
13
C NMR 
(100.6 MHz, CDCl3) (mixture of rotamers) δ 158.3 (C=O), 155.6 (ipso-Ar), 153.1 (ipso-
Ar), 142.1 (ipso-Ar), 140.9 (ipso-Ar), 140.7 (ipso-Ar), 137.9 (ipso-Ar), 136.4 (ipso-Ar), 
135.4 (Ar), 134.4 (Ar), 131.1 (Ar), 130.1 (Ar), 129.7 (Ar), 129.6 (Ar), 129.0 (Ar), 128.0 
(Ar), 127.8 (Ar), 126.7 (Ar), 124.3 (Ar), 114.3 (Ar), 113.3 (Ar), 80.1 (CMe3), 55.4 
(OMe or NCH), 55.2 (OMe or NCH), 28.3 (CMe3), 28.1 (CMe3), 21.3 (Me), 21.2 (Me); 
MS (ESI) m/z 474 [(M + Na)
+
, 2], 452 [(M + H)
+
, 1], 393 (20), 352 (50), 312 (100), 256 
(20); HRMS (ESI) m/z calcd for C26H29NO4S (M + H)
+
 452.1890, found 452.1919 (+5.5 
ppm error) and sulfoxide 40b (92 mg, 20%) as a yellow solid, mp 68-70 °C, RF (98:2 
CH2Cl2-acetone with 0.5% Et3N) 0.1; IR (CHCl3) 2964, 1691 (C=O), 1494, 1224, 1143, 
1042, 817 cm
1
; 
1
H NMR (400 MHz, CDCl3) δ 7.27-7.17 (m, 3H, Ar), 7.17-7.03 (m, 
6H, Ar), 6.88-6.76 (m, 4H, Ar), 6.33-5.93 (m, 1H, NCH), 3.84 (s, 3H, OMe), 2.31 (s, 
3H, C6H4Me), 1.74-1.27 (m, 9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) (mixture of 
rotamers) δ 158.3 (C=O), 155.6 (ipso-Ar), 153.1 (ipso-Ar), 142.0 (ipso-Ar), 141.0 (ipso-
Ar), 140.7 (ipso-Ar), 137.9 (ipso-Ar), 136.7 (ipso-Ar), 135.4 (Ar), 134.4 (Ar), 131.4 
(Ar), 131.0 (Ar), 130.0 (Ar), 129.7 (Ar), 129.6 (Ar), 129.0 (Ar), 128.0 (Ar), 127.8 (Ar), 
126.8 (Ar), 124.3 (Ar), 114.1 (Ar), 113.3 (Ar), 80.1 (CMe3), 55.5 (OMe or NCH), 55.2 
(OMe or NCH), 28.3 (CMe3), 28.1 (CMe3), 21.5 (Me), 21.2 (Me); MS (ESI) m/z 474 
[(M + Na)
+
, 10], 452 [(M + H)
+
, 5], 393 (40), 352 (60), 312 (100), 256 (20); HRMS 
(ESI) m/z calcd for C26H29NO4S (M + H)
+
 452.1890, found 452.1902 (+4.1 ppm error). 
Subsequent attempts to repeat this lithiation-trapping reaction were unsuccessful and 
sulfoxide 40a and 40b were not isolated probably due to their instability. 
Lab Book Reference: GG3/26 
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tert-Butyl 5-phenyl-2,3-dihydro-1H-pyrrole-1-carboxylate 122 and tert-butyl 4-oxo-
4-phenylbutylcarbamate 123 
 
n-BuLi (520 μL of a 2.5 M solution in hexanes, 1.3 mmol, 1.3 eq.) was added to a 
stirred solution of N-Boc 2-Ph-pyrrolidine 70 (247 mg, 1.0 mmol, 1.0 eq.) in THF (10 
mL) at 0 °C under Ar. The resulting mixture was stirred at 0 °C for 5 min. Then, p-
tolylsulfinate 92 (340 mg, 2.0 mmol, 2.0 eq.) was added. The reaction was stirred at 0 
°C for 10 min and then allowed to warm to rt over 30 min. Then, MeOH (0.6 mL), 
saturated NH4Cl(aq) (5 mL) and Et2O (5 mL) were added and the two layers were 
separated. The aqueous layer was extracted with Et2O (3 × 5 mL) and the combined 
organic layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with 90:10 petrol-
Et2O with 0.5% Et3N as eluent gave dihydropyrrole 122 (178 mg, 72%) as a yellow oil, 
RF (90:10 petrol-Et2O) 0.2; 
1
H NMR (400 MHz, CDCl3) δ 7.33-7.22 (m, 5H, Ph), 5.23 
(t, J = 3.0 Hz, 1H, C=CH), 4.05 (t, J = 9.0 Hz, 2H, NCH2), 2.62 (td, J = 9.0, 3.0 Hz, 2H, 
CH2), 1.19 (s, 9H, CMe3). On standing, this compound was unstable and converted into 
N-Boc aminophenone 123 (158 mg, 60%) as an off-white solid, 
1
H NMR (400 MHz, 
CDCl3) δ 7.95 (d, J = 7.5 Hz, 2H, o-Ph), 7.55 (t, J = 7.5 Hz, 1H, p-Ph), 7.45 (t, J = 7.5 
Hz, 2H, m-Ph), 4.75 (br s, 1H, NH), 3.22 (q, J = 7.0 Hz, 2H, NCH2), 3.02 (t, J = 7.0 Hz, 
2H, CH2CO), 1.93 (quin, J = 7.0 Hz, 2H, CH2), 1.41 (s, 9H, CMe3). Spectroscopic data 
of 123 consistent with those reported in the literature.
88
  
Lab Book Reference: GG3/56 
 
2-(Tributylstannyl)pyrrolidine-1-carboxylic acid tert-butyl ester 47 
 
s-BuLi (10.0 mL of a 1.3 M solution in hexanes, 13.0 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of N-Boc pyrrolidine 1 (1.71 g, 10.0 mmol, 1.0 eq.) and 
TMEDA (1.51 g, 1.94 mL, 13.0 mmol, 1.3 eq.) in Et2O (56 mL) at 78 °C under Ar. 
Chapter Five: Experimental 
208 
The resulting solution was stirred at 78 °C for 15 min. Then, Bu3SnCl (4.0 mL, 15.0 
mmol, 1.5 eq.) was added. The resulting solution was stirred at 78 °C for 10 min and 
then allowed to warm to rt over 16 h. Then, saturated NH4Cl(aq) (40 mL) and Et2O (100 
mL) were added and the two layers were separated. The aqueous layer was extracted 
with Et2O (3 × 40 mL) and the combined organic layers were dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica with 98:2 petrol-EtOAc as eluent gave stannyl 
pyrrolidine 47 (3.64 g, 79%) as a colourless oil, RF (98:2 petrol-EtOAc) 0.3; 
1
H NMR 
(400 MHz, CDCl3) (75:25 mixture of rotamers) δ 3.69 (dd, J = 8.5, 2.0 Hz, 0.25H, 
NCH), 3.45-3.23 (m, 2H, NCH), 3.22-3.12 (m, 0.75H, NCH), 2.27-2.03 (m, 1H, CH), 
1.97-1.75 (m, 2H, CH), 1.56-1.40 (m, 6H, CH), 1.48 (s, 2.25H, CMe3), 1.43 (s, 6.75H, 
CMe3), 1.35-1.23 (m, 6H, CH), 0.95-0.81 (m, 15H, CH). Spectroscopic data consistent 
with those reported in the literature.
11
 
Lab Book Reference: GG3/63/1 
 
Phenyl(2-(tributylstannyl)pyrrolidin-1-yl)methanone 129 
 
Me3SiI (0.71 mL, 5.0 mmol, 1.3 eq.) was added to a stirred solution of stannyl 
pyrrolidine 47 (1.78 g, 3.9 mmol, 1.0 eq.) in CH2Cl2 (30 mL) at rt under Ar. The 
resulting solution was stirred at rt for 30 min. Then, water (6 mL) and CH2Cl2 (100 mL) 
were added and the two layers were separated. The organic layer was washed with 
water (2 × 30 mL) and brine (30 mL), dried (MgSO4) and evaporated under reduced 
pressure. The residue was dissolved in CH2Cl2 (50 mL) and then DMAP (47 mg, 0.39 
mmol, 0.1 eq.), benzoyl chloride (0.49 mL, 4.3 mmol, 1.1 eq.) and Et3N (0.81 mL, 5.8 
mmol, 1.5 eq.) were added. The resulting mixture was stirred at rt for 20 h. Then, 
NaHCO3(aq) (50 mL) and  CH2Cl2 (50 mL) were added and the two layers were 
separated. The organic layer was washed with NH4Cl(aq) (2 × 50 mL) and brine (50 mL), 
dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with 80:20 petrol-Et2O as eluent 
gave pyrrolidine 129 (1.27 g, 70%) as a colourless oil, RF (98:2 petrol-EtOAc) 0.3; IR 
(CHCl3) 2911, 2881, 1653 (C=O), 1526, 1427, 1380, 1342, 707, 623 cm
1
;
 1
H NMR 
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(400 MHz, CDCl3) δ 7.50-7.45 (m, 2H, Ph), 7.41-7.36 (m, 3H, Ph), 3.57 (dd, J = 8.5, 
8.5 Hz, 1H, NCH), 3.50 (ddd, J = 11.0, 7.0, 4.5 Hz, 1H, NCH), 3.39 (ddd, J = 11.0, 7.0, 
7.0 Hz, 1H, NCH), 2.26 (ddddd, J = 12.5, 7.0, 7.0, 7.0, 7.0 Hz, 1H, CH), 2.05-1.93 (m, 
1H, CH), 1.93-1.77 (m, 2H, CH), 1.68-1.42 (m, 6H, CH2), 1.32 (sextet, J = 7.5 Hz, 6H, 
CH2Me), 0.97-0.91 (m, 6H, CH2), 0.89 (t, J = 7.5 Hz, 9H, CH2Me); 
13
C NMR (100.6 
MHz, CDCl3) δ 167.8 (C=O), 137.3 (ipso-Ph), 129.5 (Ph), 128.2 (Ph), 127.1 (Ph), 50.1 
(NCH2), 47.7 (NCH), 29.6 (CH2), 29.2 (CH2), 27.8 (CH2), 27.6 (CH2), 13.8 (Me), 10.2 
(CH2); MS (ESI) m/z 466 [(M + H)
+
, 100], 408 (70); HRMS (ESI) m/z calcd for 
C23H39NOSn (M + H)
+
 466.2130, found 466.2122 (+1.1 ppm error). 
Lab Book Reference: GG3/20/1 
 
TFA (0.75 mL, 9.8 mmol, 20.0 eq.) was added to a stirred solution of stannyl 
pyrrolidine 47 (230 mg, 0.5 mmol, 1.0 eq.) in CH2Cl2 (4 mL) at 0 °C under Ar. After 
stirring for 1 h at rt, the solvent was evaporated under reduced pressure to give a yellow 
oil. The residue was dissolved in CH2Cl2 (0.4 mL) and benzoyl chloride (84 mg, 70 μL, 
1.2 eq.) and NaOH(aq) (1.0 M, 3.2 mL) were added. The biphasic system was vigorously 
stirred at rt for 16 h. The two layers were separated and the aqueous layer was extracted 
with CH2Cl2 (3 × 5 mL). The combined organic layers were dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica with 70:30 petrol-Et2O as eluent gave pyrrolidine 129 
(17 mg, 7%) as a colourless oil. 
Lab Book Reference: GG2/82/2 
 
Pyrrolidine-1,2-diylbis(phenylmethanone) 132 
 
(Table 3.1, Entry 2) 
n-BuLi (210 μL of a 2.5 M solution in hexanes, 0.5 mmol, 1.0 eq.) was added dropwise 
to a stirred solution of stannyl pyrrolidine 129 (232 mg, 0.5 mmol, 1.0 eq.) in THF (2 
mL) at 78 °C under Ar. The resulting solution was stirred at 78 °C for 5 min. Then, 
p-tolylsulfinate 92 (340 mg, 2.0 mmol, 2.0 eq.) was added. The resulting solution was 
stirred at 78 °C for 10 min and then allowed to warm to rt over 1 h. Then, MeOH (1 
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mL), saturated NH4Cl(aq) (2 mL) and Et2O (5 mL) were added and the two layers were 
separated. The aqueous layer was extracted with Et2O (3 × 5 mL) and the combined 
organic layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with 50:50 petrol-
EtOAc with 1% Et3N as eluent gave pyrrolidine 132 (44 mg, 62%) as a white solid, mp 
93-95 °C; RF (50:50 petrol-EtOAc) 0.2; IR (CHCl3) 2962, 2835, 1667 (C=O, ketone), 
1598 (C=O, amide), 1553, 1400, 1208, 690 cm
1
; 
1
H NMR (400 MHz, CDCl3) δ 8.10-
8.06 (m, 2H, Ph), 7.65-7.57 (m, 3H, Ph), 7.54-7.48 (m, 2H, Ph), 7.45-7.39 (m, 3H, Ph), 
5.72 (dd, J = 8.5, 5.0 Hz, 1H, NCH), 3.75 (ddd, J = 10.5, 7.0, 7.0 Hz, 1H, NCH), 3.63 
(ddd, J = 10.5, 6.5, 6.5 Hz, 1H, NCH), 2.45-2.36 (m, 1H, CH), 2.09-1.90 (m, 3H, CH); 
13
C NMR (100.6 MHz, CDCl3) δ 198.3 (C=O), 169.7 (C=O), 136.6 (ipso-Ph), 135.6 
(ipso-Ph), 133.5 (Ph), 130.3 (Ph), 128.9 (Ph), 128.8 (Ph), 128.4 (Ph), 127.5 (Ph), 61.2 
(NCH), 49.9 (NCH2), 29.2 (CH2), 25.1 (CH2); MS (ESI) m/z 302 [(M + Na)
+
, 40], 280 
[(M + H)
+
, 100]; HRMS (ESI) m/z calcd for C18H17NO2 (M + H)
+
 280.1332, found 
280.1329 (+1.2 ppm error). 
Lab Book Reference: GG3/23/1 
 
(Table 3.1, Entry 1) 
n-BuLi (260 μL of a 2.5 M solution in hexanes, 0.65 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of stannyl pyrrolidine 129 (232 mg, 0.5 mmol, 1.0 eq.) in 
THF (2 mL) at 78 °C under Ar. The resulting solution was stirred at 78 °C for 5 min. 
Then, MeOH (32 mg, 40 μL, 2.0 mmol, 2.0 eq.) was added. The resulting solution was 
stirred at 78 °C for 10 min and then allowed to warm to rt over 1 h. Then, saturated 
NH4Cl(aq) (2 mL) and Et2O (5 mL) were added and the two layers were separated. The 
aqueous layer was extracted with Et2O (3 × 5 mL) and the combined organic layers 
were dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with 50:50 petrol-EtOAc as 
eluent gave pyrrolidine 132 (35 mg, 48%) as a colourless oil. 
Lab Book Reference: GG3/25/1 
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Attempted synthesis of 2-(hydroxyphenylmethyl)pyrrolidin-1-yl)(phenyl) 
methanone 291 
 
n-BuLi (210 μL of a 2.5 M solution in hexanes, 0.5 mmol, 1.0 eq.) was added dropwise 
to a stirred solution of stannyl pyrrolidine 129 (232 mg, 0.5 mmol, 1.0 eq.) in THF (2 
mL) at 78 °C under Ar. The resulting solution was stirred at 78 °C for 5 min. Then, 
PhCHO (80 mg, 75 μL, 1.5 mmol, 1.5 eq.) was added. The resulting solution was stirred 
at 78 °C for 10 min and then allowed to warm to rt over 1 h. Then, saturated NH4Cl(aq) 
(2 mL) and Et2O (5 mL) were added and the two layers were separated. The aqueous 
layer was extracted with Et2O (3 × 5 mL) and the combined organic layers were dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. The 
1
H 
NMR spectrum of the crude product showed no identifiable products and therefore 
purification was not attempted. 
Lab Book Reference: GG3/24 
 
2-(Tributylstannyl)pyrrolidine 292 
 
Me3SiI (790 μL, 5.5 mmol, 1.3 eq.) was added to a stirred solution of stannyl 
pyrrolidine 47 (1.97 g, 4.3 mmol, 1.0 eq.) in CH2Cl2 (32 mL) at rt under Ar. The 
resulting solution was stirred at rt for 30 min. Then, water (6 mL) and CH2Cl2 (75 mL) 
were added and the two layers were separated. The organic layer was washed with 
water (2 × 30 mL) and brine (30 mL), dried (MgSO4) and evaporated under reduced 
pressure to give the crude stannyl pyrrolidine 292, which was sufficiently pure (by 
1
H 
NMR spectroscopy) for use in the next step. 
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2,2-Dimethyl-1-(2-(tributylstannyl)pyrrolidin-1-yl)propan-1-one 130 
 
Pivaloyl chloride (133 mg, 136 μL, 1.5 mmol, 1.5 eq.) was added to a stirred solution of 
stannyl pyrrolidine 292 (360 mg, 1.0 mmol, 1.0 eq.) and DMAP (12 mg, 0.1 mmol, 0.1 
eq.) in CH2Cl2 (11 mL) at rt under Ar. Then, Et3N (152 mg, 210 μL, 1.5 mmol, 1.5 eq.) 
was added and the reaction mixture was stirred at rt for 60 h. Then, saturated 
NaHCO3(aq) (15 mL) and  CH2Cl2 (15 mL) were added and the two layers were 
separated. The organic layer was washed with saturated NH4Cl(aq) (15 mL) and brine 
(15 mL), dried (MgSO4) and evaporated under reduced pressure to give the crude 
product. Purification by flash column chromatography on silica with 95:5 petrol-Et2O as 
eluent gave stannyl pyrrolidine 130 (330 mg, 74%) as a yellow oil, RF (80:20 petrol-
Et2O) 0.4; 
1
H NMR (400 MHz, CDCl3) δ 3.70 (ddd, J = 10.5, 6.0, 6.0 Hz, 1H, NCH), 
3.53-3.44 (m, 2H, NCH), 2.14-2.04 (m, 1H, CH), 1.97-1.89 (m, 2H, CH), 1.89-1.79 (m, 
1H, CH), 1.55-1.41 (m, 6H, CH2), 1.30 (sextet, J = 7.5 Hz, 6H, CH2Me), 1.25 (s, 9H, 
CMe3), 0.92-0.79 (m, 6H, CH2), 0.89 (t, J = 7.5 Hz, 9H, CH2Me); 
13
C NMR (100.6 
MHz, CDCl3) δ 174.2 (C=O), 50.1 (NCH), 48.0 (NCH2), 38.7 (CMe3), 29.2 (CH2), 28.7 
(CH2), 28.0 (CH2), 27.8 (CMe3), 27.6 (CH2), 13.8 (Me), 9.9 (CH2). Spectroscopic data 
consistent with those reported in the literature.
48
  
Lab Book Reference: GG3/35/1 
 
Attempted synthesis of 2,2-dimethyl-1-(pyrrolidin-1-yl)propan-1-one 125 
 
n-BuLi (100 μL of a 2.5 M solution in hexanes, 0.26 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of stannyl pyrrolidine 130 (126 mg, 0.2 mmol, 1.0 eq.) in 
THF (2 mL) at 78 °C under Ar. The resulting solution was stirred at 78 °C for 5 min. 
Then, MeOH (13 mg, 16 μL, 0.4 mmol, 2.0 eq.) was added. The resulting solution was 
stirred at 78 °C for 10 min and then allowed to warm to rt over 1 h. Then, saturated 
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NH4Cl(aq) (4 mL) and Et2O (5 mL) were added and the two layers were separated. The 
aqueous layer was extracted with Et2O (3 × 5 mL) and the combined organic layers 
were dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
The 
1
H NMR spectrum of the crude product showed no identifiable products and 
therefore purification was not attempted. 
Lab Book Reference: GG3/41 
 
2,2,2-Triphenyl-1-(2-(tributylstannyl)pyrrolidin-1-yl)ethanone 131 
 
Oxalyl chloride (870 mg, 580 μL, 6.8 mmol, 1.6 eq.) was added to a stirred suspension 
of   triphenylacetic acid (1.36 g, 4.7 mmol, 1.1 eq.) in CH2Cl2 (8 mL) at rt under Ar. 
Then, DMF (1 drop) was added and the reaction mixture was stirred and heated at 35 °C 
for 2 h until a brown solution was formed and effervescence ceased. Then, the solvent 
was evaporated under reduced pressure to give a light brown solid. The solid was 
dissolved in CH2Cl2 (8 mL) and added to a stirred solution of stannyl pyrrolidine 292 
(1.54 g, 4.3 mmol, 1.0 eq.) and DMAP (52 mg, 0.4 mmol, 0.1 eq.) in CH2Cl2 (50 mL) at 
rt under Ar. Then, Et3N (1.29 g, 1.79 mL, 12.8 mmol, 3.0 eq.) was added and the 
reaction mixture was stirred at rt for 60 h. Then, saturated NaHCO3(aq) (15 mL) and 
CH2Cl2 (15 mL) were added and the two layers were separated. The organic layer was 
washed with saturated NH4Cl(aq) (15 mL) and brine (15 mL), dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica with 95:5 petrol-Et2O as eluent gave stannyl 
pyrrolidine 131 (1.93 g, 71%) as a white solid, mp 121-123 °C; RF (95:5 petrol-Et2O) 
0.3; IR (CHCl3) 2971, 2912, 1585 (C=O), 1470, 1424, 1379, 1196, 763, 731, 691 cm
1
;
 
1
H NMR (400 MHz, CDCl3) δ 7.30-7.23 (m, 6H, Ph), 7.23-7.16 (m, 9H, Ph), 3.69 (dd, J 
= 8.5, 8.5 Hz, 1H, NCH),  2.79 (ddd, J = 11.0, 7.0, 4.0 Hz, 1H, NCH), 2.29 (ddd, J = 
11.0, 8.5, 6.5 Hz, 1H, NCH), 2.10-1.97 (m, 1H, CH), 1.80-1.69 (m, 1H, CH), 1.65-1.55 
(m, 1H, CH), 1.55-1.40 (m, 7H, CH + CH2), 1.31 (sextet, J = 7.5 Hz, 6H, CH2Me), 
1.00-0.82 (m, 6H, CH2), 0.89 (t, J = 7.5 Hz, 9H, CH2Me); 
13
C NMR (100.6 MHz, 
CDCl3) δ 169.0 (C=O), 143.3 (ipso-Ph), 130.5 (Ph), 127.5 (Ph), 126.3 (Ph), 67.6 
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(CPh3), 49.6 (NCH), 48.7 (NCH2), 29.3 (CH2), 28.5 (CH2), 27.7 (CH2), 27.6 (CH2), 13.8 
(Me), 10.4 (CH2); MS (ESI) m/z 654 [(M + Na)
+
, 100], 632 [(M + H)
+
, 80]; HRMS 
(ESI) m/z calcd for C36H49NOSn (M + H)
+
 632.2916, found 632.2891 (+2.9 ppm error). 
Lab Book Reference: GG3/34/1 
 
2,2,2-Triphenyl-1-(pyrrolidin-1-yl)ethanone 126 
 
n-BuLi (100 μL of a 2.5 M solution in hexanes, 0.26 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of stannyl pyrrolidine 131 (126 mg, 0.2 mmol, 1.0 eq.) in 
THF (2 mL) at 78 °C under Ar. The resulting solution was stirred at 78 °C for 5 min. 
Then, MeOH (13 mg, 16 μL, 0.4 mmol, 2.0 eq.) was added. The resulting solution was 
stirred at 78 °C for 10 min and then allowed to warm to rt over 1 h. Then, saturated 
NH4Cl(aq) (5 mL) and Et2O (5 mL) were added and the two layers were separated. The 
aqueous layer was extracted with Et2O (3 × 5 mL) and the combined organic layers 
were dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with 70:30 petrol-EtOAc gave 
pyrrolidine 126 (54 mg, 79%) as a white solid, mp 175-177 °C (lit.,
136
 188.5 °C); RF 
(70:30 petrol-EtOAc) 0.3; 
1
H NMR (400 MHz, CDCl3) δ 7.32-7.18 (m, 15H, Ph), 3.66 
(t, J = 6.5 Hz, 2H, NCH2), 2.44 (t, J = 6.5 Hz, 2H, NCH2), 1.72 (quin, J = 6.5 Hz, 2H, 
CH2), 1.57 (quin, J = 6.5 Hz, 2H, CH2). Spectroscopic data consistent with those 
reported in the literature.
136
  
Lab Book Reference: GG3/40/1 
 
1-(2-Methylpyrrolidin-1-yl)-2,2,2-triphenylethanone 135 
 
n-BuLi (260 μL of a 2.5 M solution in hexanes, 0.65 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of stannyl pyrrolidine 131 (315 mg, 0.5 mmol, 1.0 eq.) in 
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THF (5 mL) at 78 °C under Ar. The resulting solution was stirred at 78 °C for 5 min. 
Then, Me2SO4 (126 mg, 100 μL, 1.0 mmol, 2.0 eq.) was added. The resulting solution 
was stirred at 78 °C for 10 min and then allowed to warm to rt over 1 h. Then, 
saturated NH4Cl(aq) (5 mL) and Et2O (5 mL) were added and the two layers were 
separated. The aqueous layer was extracted with Et2O (3 × 5 mL) and the combined 
organic layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with 80:20 petrol-
Et2O gave pyrrolidine 135 (155 mg, 87%) as a white solid, mp 178-180 °C; RF (80:20 
petrol-Et2O) 0.3; IR (CHCl3) 2960, 2924, 2829, 1600 (C=O), 1470, 1432, 1371, 1160, 
691 cm
1
; 
1
H NMR (400 MHz, CDCl3) δ 7.32-7.26 (m, 6H, Ph), 7.26-7.20 (m, 9H, Ph), 
4.45-4.35 (m, 1H, NCH), 2.84 (ddd, J = 11.0, 7.0, 4.5 Hz, 1H, NCH), 2.16 (ddd, J = 
11.0, 8.0, 6.5 Hz, 1H, NCH), 2.05-1.95 (m, 1H, CH), 1.64-1.54 (m, 1H, CH), 1.53-1.41 
(m, 1H, CH), 1.40-1.31 (m, 1H, CH), 1.29 (d, J = 6.5 Hz, 3H, Me). 
13
C NMR (100.6 
MHz, CDCl3) δ 170.7 (C=O), 142.9 (ipso-Ph), 130.4 (Ph), 127.6 (Ph), 126.4 (Ph), 67.7 
(CPh3), 54.7 (NCH), 47.9 (NCH2), 31.7 (CH2), 24.7 (CH2), 19.2 (Me); MS (ESI) m/z 
378 [(M + Na)
+
, 100], 356 [(M + H)
+
, 80]; HRMS (ESI) m/z calcd for C25H25NO (M + 
H)
+
 356.2009, found 356.2013 (1.8 ppm error). 
Lab Book Reference: GG3/49/1 
 
Attempted synthesis of 2,2,2-triphenyl-1-(2-(phenylthio)pyrrolidin-1-yl)ethanone 
136 
 
n-BuLi (520 μL of a 2.5 M solution in hexanes, 1.3 mmol, 1.3 eq.) was added dropwise 
to a stirred solution of stannyl pyrrolidine 131 (315 mg, 1.0 mmol, 1.0 eq.) in THF (5 
mL) at 78 °C under Ar. The resulting solution was stirred at 78 °C for 5 min. Then, 
diphenyl disulfide (327 mg, 1.5 mmol, 1.5 eq.) was added. The resulting solution was 
stirred at 78 °C for 10 min and then allowed to warm to rt over 1 h. Then, saturated 
NH4Cl(aq) (5 mL) and Et2O (10 mL) were added and the two layers were separated. The 
aqueous layer was extracted with Et2O (3 × 5 mL) and the combined organic layers 
were dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
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The 
1
H NMR spectrum of the crude product showed no identifiable products and 
therefore purification was not attempted. 
Lab Book Reference: GG3/50 
 
2,2,2-Triphenyl-1-(5-(p-tolylsulfinyl)-2,3-dihydro-1H-pyrrol-1-yl)ethanone 137 
 
n-BuLi (260 μL of a 2.5 M solution in hexanes, 0.65 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of stannyl pyrrolidine 131 (315 mg, 0.5 mmol, 1.0 eq.) in 
THF (5 mL) at 78 °C under Ar. The resulting solution was stirred at 78 °C for 5 min. 
Then, p-tolylsulfinate 92 (128 mg, 0.75 mmol, 1.5 eq.) was added. The resulting 
solution was stirred at 78 °C for 10 min and then allowed to warm to rt over 1 h. Then, 
MeOH (0.5 mL), saturated NH4Cl(aq) (5 mL) and Et2O (5 mL) were added and the two 
layers were separated. The aqueous layer was extracted with Et2O (3 × 5 mL) and the 
combined organic layers were dried (MgSO4) and evaporated under reduced pressure to 
give the crude product. Purification by flash column chromatography on silica with 
90:10 to 50:50 petrol-EtOAc with 0.5% of Et3N gave pyrrolidine 126 (74 mg, 43%) as a 
white solid and sulfoxide 137 (50 mg, 21%) as a white solid, mp 160-163 °C; RF (50:50 
petrol-EtOAc with 0.5% of Et3N) 0.3; IR (CHCl3) 2962, 1612 (C=O), 1363, 1212, 1020, 
691 cm
1
;
 1
H NMR (400 MHz, CDCl3) δ 7.65 (d, J = 8.0 Hz, 2H, Ar), 7.27 (d, J = 8.0 
Hz, 2H, Ar), 7.22-7.15 (m, 9H, Ar), 6.93-6.87 (m, 6H, Ar), 6.30 (dd, J = 3.5, 2.0 Hz, 
1H, C=CH), 3.45-3.37 (m, 1H, NCH), 2.67-2.42 (m, 2H, NCH and CH), 2.47 (s, 3H, 
Me), 2.41-2.29 (m, 1H, CH); 
13
C NMR (100.6 MHz, CDCl3) δ 169.7 (C=O), 152.3 
(ipso-Ar), 142.3 (ipso-Ar), 141.7 (=C), 141.5 (ipso-Ar), 130.0 (Ar), 129.4 (Ar), 127.8 
(Ar), 127.4 (Ar), 126.7 (Ar), 116.3 (=CH), 66.7 (CPh3), 51.7 (NCH2), 29.4 (CH2), 21.5 
(Me); MS (ESI) m/z 500 [(M + Na)
+
, 100], 478 [(M + H)
+
, 50]; HRMS (ESI) m/z calcd 
for C31H27NO2S (M + H)
+
 478.1835, found 478.1855 (4.4 ppm error). 
Lab Book Reference: GG3/43/2 
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N-4-Toluenesulfonyl-2-(tributylstannyl)pyrrolidine 139 
 
Et3N (769 mg, 1.04 mL, 7.5 mmol, 3.0 eq.) was added to a stirred solution of stannyl 
pyrrolidine 292 (1.15 g, 2.5 mmol, 1.0 eq.), p-toluenesulfonyl chloride (524 mg, 2.75 
mmol, 1.1 eq.) and DMAP (30 mg, 0.25 mmol, 0.1 eq.) in CH2Cl2 (29 mL) at rt under 
Ar. Then, the reaction mixture was stirred at rt for 20 h. Then, saturated NaHCO3(aq) (30 
mL) and  CH2Cl2 (30 mL) were added and the two layers were separated. The organic 
layer was washed with saturated NH4Cl(aq) (30 mL) and brine (30 mL), dried (MgSO4) 
and evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica with 90:10 petrol-Et2O as eluent gave tosyl 
pyrrolidine 139 (737 mg, 57%) as a colourless oil, RF (90:10 petrol-Et2O) 0.2; IR 
(CHCl3) 2911, 2879, 2826, 1437, 1320, 1139, 1076, 1031, 986, 803 cm
1
;
 1
H NMR (400 
MHz, CDCl3) δ 7.69 (d, J = 8.0 Hz, 2H, o-C6H4SO2), 7.31 (d, J = 8.0 Hz, 2H, m-
C6H4SO2), 3.34-3.25 (m, 1H, NCH), 3.25-3.17 (m, 1H, NCH), 3.15-3.08 (m, 1H, NCH), 
2.43 (s, 3H, C6H4Me), 1.96-1.71 (m, 3H, CH), 1.68-1.43 (m, 7H, CH + CH2), 1.35 
(sextet, J = 7.5 Hz, 6H, CH2Me), 1.11-0.97 (m, 6H, CH2), 0.92 (t, J = 7.5 Hz, 9H, 
CH2Me); 
13
C NMR (100.6 MHz, CDCl3) δ 142.9 (ipso-Ar), 133.8 (ipso-Ar), 129.4 (Ar), 
127.6 (Ar), 49.1 (NCH), 48.9 (NCH2), 31.0 (CH2), 29.2 (CH2), 27.5 (CH2), 26.4 (CH2), 
21.5 (ArMe), 13.7 (Me), 9.8 (CH2); MS (ESI) m/z 538 [(M + Na)
+
, 25], 516 [(M + H)
+
, 
100]; HRMS (ESI) m/z calcd for C23H41NO2SSn (M + H)
+
 516.1955, found 516.1956 
(1.6 ppm error). 
Lab Book Reference: GG3/67/1 
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Attempted synthesis of N-4-toluenesulfonyl-pyrrolidine 141 
 
n-BuLi (100 μL of a 2.5 M solution in hexanes, 0.26 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of tosyl pyrrolidine 139 (103 mg, 0.2 mmol, 1.0 eq.) in 
THF (2 mL) at 78 °C under Ar. The resulting solution was stirred at 78 °C for 5 min. 
Then, MeOH (13 mg, 16 μL, 0.4 mmol, 2.0 eq.) was added. The resulting solution was 
stirred at 78 °C for 10 min and then allowed to warm to rt over 1 h. Then, saturated 
NH4Cl(aq) (4 mL) and Et2O (5 mL) were added and the two layers were separated. The 
aqueous layer was extracted with Et2O (3 × 5 mL) and the combined organic layers 
were dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with 95:5 petrol-Et2O as eluent 
gave recovered tosyl pyrrolidine 139 (33 mg, 32%) as a colourless oil. 
Lab Book Reference: GG3/71 
 
Attempted synthesis of 2-(p-tolylsulfinyl) N-4-toluenesulfonyl-pyrrolidine 142 
 
n-BuLi (260 μL of a 2.5 M solution in hexanes, 0.65 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of tosyl pyrrolidine 139 (257 mg, 0.5 mmol, 1.0 eq.) in 
THF (5 mL) at 78 °C under Ar. The resulting solution was stirred at 78 °C for 5 min. 
Then, p-tolylsulfinate 92 (128 mg, 0.75 mmol, 2.0 eq.) was added. The resulting 
solution was stirred at 78 °C for 10 min and then allowed to warm to rt over 1 h. Then, 
saturated NH4Cl(aq) (4 mL) and Et2O (5 mL) were added and the two layers were 
separated. The aqueous layer was extracted with Et2O (3 × 5 mL) and the combined 
organic layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with 95:5 petrol-
Et2O as eluent gave recovered tosyl pyrrolidine 139 (55 mg, 21%) as a colourless oil. 
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Lab Book Reference: GG3/72 
 
2-(Tributylstannyl) N-(2,4,6-triisopropylphenylsulfonyl)pyrrolidine 140 
 
Et3N (769 mg, 1.04 mL, 7.5 mmol, 3.0 eq.) was added to a stirred solution of stannyl 
pyrrolidine 292 (1.15 g, 2.5 mmol, 1.0 eq.), 2,4,6-triisopropylsulfonyl chloride (832 mg, 
2.75 mmol, 1.1 eq.) and DMAP (30 mg, 0.25 mmol, 0.1 eq.) in CH2Cl2 (29 mL) at rt 
under Ar. Then, the reaction mixture was stirred at rt for 20 h. Then, saturated 
NaHCO3(aq) (30 mL) and  CH2Cl2 (30 mL) were added and the two layers were 
separated. The organic layer was washed with saturated NH4Cl(aq) (30 mL) and brine 
(30 mL), dried (MgSO4) and evaporated under reduced pressure to give the crude 
product. Purification by flash column chromatography on silica with 98:2 petrol-Et2O as 
eluent gave sulfonyl pyrrolidine 140 (781 mg, 50%) as a colourless oil, RF (98:2 petrol-
Et2O) 0.3; IR (CHCl3) 2913, 2882, 2827, 1575, 1439, 1272, 1128, 1055, 651 cm
1
;
 1
H 
NMR (400 MHz, CDCl3) δ 7.15 (s, 2H, Ar), 4.25 (septet, J = 7.0 Hz, 2H, ArCH), 3.48 
(dd, J = 7.5, 7.5 Hz, 1H, NCH), 3.13 (ddd, J = 10.0, 7.0, 7.0 Hz, 1H, NCH), 3.03 (ddd, J 
= 10.0, 7.0, 7.0 Hz, 1H, NCH), 2.90 (septet, J = 7.0 Hz, 1H, ArCH), 2.30-2.13 (m, 1H, 
CH), 1.99-1.80 (m, 3H, CH), 1.61-1.46 (m, 6H, CH2), 1.33 (sextet, J = 7.5 Hz, 6H, 
CH2), 1.26 (d, J = 7.0 Hz, 6H, CHMe2), 1.25 (d, J = 7.0 Hz, 6H, CHMe2), 1.24 (d, J = 
7.0 Hz, 6H, CHMe2), 1.00-0.93 (m, 6H, CH2), 0.91 (t, J = 7.5 Hz, 9H, CH2Me); 
13
C 
NMR (100.6 MHz, CDCl3) δ 152.6 (ipso-Ar), 151.1 (ipso-Ar), 137.7 (ipso-Ar), 123.7 
(Ar), 48.1 (NCH2), 47.1 (NCH), 34.1 (ArCH), 31.0 (CH2), 29.4 (Me), 29.2 (CH2), 27.6 
(CH2), 26.2 (CH2), 25.0 (Me), 24.8 (Me), 23.6 (Me), 13.7 (Me), 10.0 (CH2); MS (ESI) 
m/z 650 [(M + Na)
+
, 40], 628 [(M + H)
+
, 100]; HRMS (ESI) m/z calcd for 
C31H57NO2SSn (M + H)
+
 628.3209, found 628.3206 (0.5 ppm error). 
Lab Book Reference: GG3/68/1 
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Attempted synthesis of N-(2,4,6-triisopropylphenylsulfonyl)pyrrolidine 143 
 
n-BuLi (100 μL of a 2.5 M solution in hexanes, 0.26 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of tosyl pyrrolidine 140 (103 mg, 0.2 mmol, 1.0 eq.) in 
THF (2 mL) at 78 °C under Ar. The resulting solution was stirred at 78 °C for 5 min. 
Then, MeOH (13 mg, 16 μL, 0.4 mmol, 2.0 eq.) was added. The resulting solution was 
stirred at 78 °C for 10 min and then allowed to warm to rt over 1 h. Then, saturated 
NH4Cl(aq) (4 mL) and Et2O (5 mL) were added and the two layers were separated. The 
aqueous layer was extracted with Et2O (3 × 5 mL) and the combined organic layers 
were dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
The 
1
H NMR spectrum of the crude product showed no identifiable products and 
therefore purification was not attempted. 
Lab Book Reference: GG3/73 
 
Attempted synthesis of 2-(p-tolylsulfinyl) N-(2,4,6-triisopropylphenylsulfonyl) 
pyrrolidine 145 
 
n-BuLi (260 μL of a 2.5 M solution in hexanes, 0.65 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of tosyl pyrrolidine 140 (257 mg, 0.5 mmol, 1.0 eq.) in 
THF (5 mL) at 78 °C under Ar. The resulting solution was stirred at 78 °C for 5 min. 
Then, p-tolylsulfinate 92 (128 mg, 0.75 mmol, 2.0 eq.) was added. The resulting 
solution was stirred at 78 °C for 10 min and then allowed to warm to rt over 1 h. Then, 
saturated NH4Cl(aq) (4 mL) and Et2O (5 mL) were added and the two layers were 
separated. The aqueous layer was extracted with Et2O (3 × 5 mL) and the combined 
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organic layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. The 
1
H NMR spectrum of the crude product showed no identifiable 
products and therefore purification was not attempted. 
Lab Book Reference: GG3/74 
 
Attempted synthesis of 2-methyl-1-(2,4,6-triisopropylphenylsulfonyl)pyrrolidine 
144 
 
n-BuLi (100 μL of a 2.5 M solution in hexanes, 0.25 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of stannyl pyrrolidine 140 (125 mg, 0.2 mmol, 1.0 eq.) in 
THF (2 mL) at 78 °C under Ar. The resulting solution was stirred at 78 °C for 5 min. 
Then, Me2SO4 (50 mg, 40 μL, 1.0 mmol, 2.0 eq.) was added. The resulting solution was 
stirred at 78 °C for 10 min and then allowed to warm to rt over 1 h. Then, saturated 
NH4Cl(aq) (2 mL) and Et2O (5 mL) were added and the two layers were separated. The 
aqueous layer was extracted with Et2O (3 × 5 mL) and the combined organic layers 
were dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
The 
1
H NMR spectrum of the crude product showed only starting material and therefore 
purification was not attempted. 
Lab Book Reference: GG3/85 
 
4-Phenylpiperidine-1-carboxylic acid tert-butyl ester 147 
 
A solution of di-tert-butyl dicarbonate (7.1 g, 32.5 mmol, 1.05 eq.) in CH2Cl2 (20 mL) 
was added dropwise to a solution of 4-phenylpiperidine (5.0 g, 31.0 mmol, 1.0 eq.) in 
CH2Cl2 (33 mL) at 0 °C under Ar. The resulting solution was allowed to warm to rt and 
stirred for 3 h. Then, 10% NaHCO3(aq) (30 mL) and CH2Cl2 (70 mL) were added. The 
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aqueous layer was extracted with CH2Cl2 (3 × 25 mL) and the combined organic layers 
were washed with brine (50 mL), dried (Na2SO4) and evaporated under reduced 
pressure to give the crude product. Purification by Kügelrohr short path distillation gave 
4-phenyl N-Boc piperidine 147 (8.0 g, 99%) as a colourless oil, bp 133-135 °C/0.5 
mmHg; 
1
H NMR (400 MHz, CDCl3) δ 7.35-7.28 (m, 2H, Ph), 7.25-7.19 (m, 3H, Ph), 
4.24 (br s, 2H, NCH), 2.80 (br t, J = 11.5 Hz, 2H, NCH), 2.64 (tt, J = 12.0, 3.5 Hz, 1H, 
CHPh), 1.82 (br d, J = 13.0 Hz, 2H, CH), 1.69-1.56 (m, 2H, CH), 1.48 (s, 9H, CMe3). 
Spectroscopic data consistent with those reported in the literature.
137 
Lab Book Reference: GG1/86/1 
 
2-Methyl-4-phenylpiperidine-1-carboxylic acid tert-butyl ester rac-syn-148 
 
(Table 3.2, Entry 1) 
Using general procedure C: s-BuLi (1.15 mL of a 1.3 M solution in hexanes, 1.5 mmol, 
1.3 eq.), 4-phenyl N-Boc piperidine 147 (300 mg, 1.15 mmol, 1.0 eq.) and TMEDA 
(174 mg, 220 μL, 1.5 mmol, 1.3 eq.) at 78 °C for 1 h and then Me2SO4 (290 mg, 210 
μL, 2.3 mmol, 2.0 eq.) gave the crude product. Purification by flash column 
chromatography on silica with 97:3 hexane-EtOAc as eluent gave 4-phenylpiperidine 
rac-syn-148 (212 mg, 67%) as a colourless oil, RF (95:5 hexane-EtOAc) 0.2; IR 
(CHCl3) 2973, 2932, 1692 (C=O), 1478, 1453, 1413, 1365, 1250, 1171, 1142, 759, 700 
cm
1
; 
1
H NMR (400 MHz, CDCl3) δ 7.35-7.28 (m, 2H, Ph), 7.25-7.17 (m, 3H, Ph), 
4.02-3.90 (m, 1H, NCH), 3.81 (ddd, J = 14.0, 7.5, 3.0 Hz, 1H, NCH), 3.25 (ddd, J = 
14.0, 10.0, 6.5 Hz, 1H, NCH), 2.81-2-71 (m, 1H, CHPh), 2.22-2.10 (m, 1H, CH), 1.91 
(dddd, J = 13.5, 6.5, 3.0, 1.5 Hz, 1H, CH), 1.68-1.56 (m, 2H, CH), 1.49 (s, 9H, CMe3), 
1.20 (d, J = 6.5 Hz, 3H, Me); 
13
C NMR (100.6 MHz, CDCl3) δ 155.8 (C=O), 146.4 
(ipso-Ph), 128.7 (Ph), 127.1 (Ph), 126.5 (Ph), 79.2 (CMe3), 49.9 (NCH), 37.7 (CHPh), 
37.4 (NCH2), 36.9 (CH2), 31.0 (CH2), 28.3 (CMe3), 19.5 (Me); MS (ESI) m/z 298 [(M + 
Na)
+
, 60], 276 [(M + H)
+
, 5], 220 (100), 176 (5); HRMS (ESI) m/z calcd for C17H25NO2 
(M + H)
+
 276.1958, found 276.1953 (+1.9 ppm error) and starting material 147 (45 mg, 
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14%) as a colourless oil. Spectroscopic data consistent with those reported in the 
literature.
138
 
Lab Book Reference: GG1/54/1 
 
(Table 3.2, Entry 2) 
s-BuLi (0.76 mL of a 1.3 M solution in hexanes, 1.0 mmol, 1.3 eq.) was added dropwise 
to a stirred solution of 4-phenyl N-Boc piperidine 147 (200 mg, 0.76 mmol, 1.0 eq.) and 
TMEDA (115 mg, 150 μL, 1.0 mmol, 1.3 eq.) in Et2O (2.5 mL) at 78 °C under Ar. The 
resulting solution was stirred at 78 °C for 3 h. Then, Me2SO4 (144 mg, 110 μL, 1.14 
mmol, 1.5 eq.) was added. The resulting solution was stirred at rt for 16 h. Then, 
saturated NH4Cl(aq) (5 mL) and Et2O (20 mL) were added and the two layers were 
separated. The aqueous layer was extracted with Et2O (3 × 5 mL) and the combined 
organic layers were dried (Na2SO4) and evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with 97:3 hexane-
EtOAc as eluent gave 4-phenylpiperidine rac-syn-148 (125 mg, 60%) as a colourless 
oil. 
Lab Book Reference: GG1/49/1 
 
(Table 3.2, Entry 3) 
s-BuLi (1.15 mL of a 1.3 M solution in hexanes, 1.5 mmol, 1.3 eq.) was added dropwise 
to a stirred solution of 4-phenyl N-Boc piperidine 147 (300 mg, 1.15 mmol, 1.0 eq.) in 
THF (3.8 mL) at 78 °C under Ar. The resulting solution was stirred at 78 °C for 3 h. 
Then, Me2SO4 (290 mg, 210 μL, 2.3 mmol, 2.0 eq.) was added. The resulting solution 
was stirred at rt for 16 h. Then, saturated NH4Cl(aq) (5 mL) and Et2O (20 mL) were 
added and the two layers were separated. The aqueous layer was extracted with Et2O (3 
× 5 mL) and the combined organic layers were dried (Na2SO4) and evaporated under 
reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with 97:3 hexane-EtOAc as eluent gave 4-phenylpiperidine 
rac-syn-148 (120 mg, 38%) as a colourless oil and starting material 147 (72 mg, 24%) 
as a colourless oil. 
Lab Book Reference: GG1/56/1 
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(Table 3.2, Entry 4) 
s-BuLi (1.15 mL of a 1.3 M solution in hexanes, 1.5 mmol, 1.3 eq.) was added dropwise 
to a stirred solution of 4-phenyl N-Boc piperidine 147 (300 mg, 1.15 mmol, 1.0 eq.) in 
THF (3.8 mL) at 30 °C under Ar. The resulting solution was stirred at 30 °C for 10 
min. Then, Me2SO4 (290 mg, 210 μL, 2.3 mmol, 2.0 eq.) was added. The resulting 
solution was stirred at rt for 16 h. Then, saturated NH4Cl(aq) (5 mL) and Et2O (20 mL) 
were added and the two layers were separated. The aqueous layer was extracted with 
Et2O (3 × 5 mL) and the combined organic layers were dried (Na2SO4) and evaporated 
under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with 97:3 hexane-EtOAc as eluent gave 4-phenylpiperidine 
rac-syn-148 (63 mg, 20%) as a colourless oil. 
Lab Book Reference: GG1/66/1 
 
4-Phenyl-2-trimethylsilylpiperidine-1-carboxylic acid tert-butyl ester rac-syn-157 
 
(Scheme 3.39) 
Using general procedure C: s-BuLi (1.15 mL of a 1.3 M solution in hexanes, 1.5 mmol, 
1.3 eq.), 4-phenyl N-Boc piperidine 147 (300 mg, 1.15 mmol, 1.0 eq.) and TMEDA 
(174 mg, 220 μL, 1.5 mmol, 1.3 eq.) at 78 °C for 1 h and then Me3SiCl (250 mg, 290 
μL, 2.3 mmol, 2.0 eq.) gave the crude product. Purification by flash column 
chromatography on silica with 97:3 petrol-EtOAc as eluent gave 4-phenylpiperidine 
rac-syn-157 (327 mg, 86%) as a cloudy oil, RF (97:3 petrol-EtOAc) 0.3; IR (CHCl3) 
2935, 1691 (C=O), 1424, 1244, 1169, 839, 754, 699 cm
1
; 
1
H NMR (400 MHz, CDCl3) 
δ 7.35-7.29 (m, 2H, Ph), 7.25-7.19 (m, 3H, Ph), 4.11 (br d, J = 12.5 Hz, 1H, NCH), 2.96 
(br dd, J = 11.5, 11.5 Hz, 1H, NCH), 2.71 (dddd, J = 12.0, 12.0, 4.0, 4.0 Hz, 1H, 
CHPh), 2.41 (br d, J = 11.5 Hz, 1H, NCH), 1.87-1.77 (m, 2H, CH), 1.66-1.53 (m, 2H, 
CH), 1.47 (s, 9H, CMe3), 0.07 (s, 9H, SiMe3);
 13
C NMR (100.6 MHz, CDCl3) δ 155.5 
(C=O), 146.6 (ipso-Ph), 128.7 (Ph), 127.1 (Ph), 126.5 (Ph), 79.0 (CMe3), 50.9 (NCH), 
47.8 (NCH2), 44.7 (CHPh),  34.0 (CH2), 33.3 (CH2), 28.2 (CMe3), 1.1 (SiMe3);  MS 
(ESI) m/z 356 [(M + Na)
+
, 30], 334 [(M + H)
+
, 15], 278 (80), 262 (100), 234 (5); HRMS 
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(ESI) m/z calcd for C19H31NO2Si (M + H)
+
 334.2197, found 334.2197 (0.8 ppm error). 
Spectroscopic data consistent with those reported in the literature.
59
 
Lab Book Reference: GG1/63/1 
 
1,1,7-Triphenyltetrahydro-oxazolo[3,4-α]pyridin-3-one rac-syn-158 
 
(Scheme 3.39) 
Using general procedure C: s-BuLi (1.15 mL of a 1.3 M solution in hexanes, 1.5 mmol, 
1.3 eq.), 4-phenyl N-Boc piperidine 147 (300 mg, 1.15 mmol, 1.0 eq.) and TMEDA 
(174 mg, 220 μL, 1.5 mmol, 1.3 eq.) in Et2O (3.8 mL) at 78 °C for 1 h and then 
benzophenone (420 mg, 2.3 mmol, 2.0 eq.) in Et2O (1 mL) gave the crude product. 
Purification by flash column chromatography on silica with 6:4 petrol-Et2O as eluent 
gave oxazolidinone rac-syn-158 (100 mg, 23%) as a white solid, mp 226-228 °C; RF 
(6:4 petrol-Et2O) 0.1; IR (CHCl3) 2948, 1748 (C=O), 1451, 1418, 1380, 909, 733, 650 
cm
1
; 
1
H NMR (400 MHz, CDCl3) δ 7.58-7.03 (m, 15H, Ph), 4.45 (dd, J = 12.0, 3.5 Hz, 
1H, NCH), 4.09 (ddd, J = 13.5, 5.0, 1.5 Hz, 1H, NCH), 3.05 (ddd, J = 13.5, 13.5, 3.5 
Hz, 1H, NCH), 2.77 (dddd, J = 12.0, 12.0, 3.0, 3.0 Hz, 1H, CHPh), 1.85-1.54 (m, 4H, 
CH); 
13
C NMR (100.6 MHz, CDCl3) δ 156.6 (C=O), 144.7 (ipso-Ph), 142.9 (ipso-Ph), 
139.4 (ipso-Ph), 128.9 (Ph), 128.8 (Ph), 128.6 (Ph), 128.5 (Ph), 128.1 (Ph), 127.0 (Ph), 
126.9 (Ph), 126.2 (Ph), 126.1 (Ph), 88.2 (Ph2CO), 63.2 (NCH), 41.9 (NCH2), 41.6 
(CHPh), 35.6 (CH2), 31.3 (CH2); MS (ESI) m/z 370 [(M + H)
+
, 100]; HRMS (ESI) m/z 
calcd for C25H23NO2 (M + H)
+
 370.1802, found 370.1789 (+3.8 ppm error). 
Lab Book Reference: GG1/67/1 
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4-Phenyl-2-phenylcarbamoylpiperidine-1-carboxylic acid tert-butyl ester rac-syn-
159 
 
(Scheme 3.39) 
Using general procedure C: s-BuLi (1.15 mL of a 1.3 M solution in hexanes, 1.5 mmol, 
1.3 eq.), 4-phenyl N-Boc piperidine 147 (300 mg, 1.15 mmol, 1.0 eq.) and TMEDA 
(174 mg, 220 μL, 1.3 mmol, 1.3 eq.) in Et2O (3.8 mL) at 78 °C for 1 h and then phenyl 
isocyanate (274 mg, 250 μL, 2.3 mmol, 2.0 eq.) gave the crude product. Purification by 
flash column chromatography on silica with 97:3 CH2Cl2-Et2O as eluent gave 4-
phenylpiperidine rac-syn-159 (190 mg, 50%) as a white solid, mp 222-224 °C (lit.,
7
 
225-226 °C); RF (97:3 CH2Cl2-Et2O) 0.2; IR (CHCl3) 2982, 1692 (C=O), 1600, 1524, 
1442, 1155, 905, 730, 650 cm
1
; 
1
H NMR (400 MHz, CDCl3) δ 8.17 (br s, 1H, NH), 
7.53 (dd, J = 8.5, 1.0 Hz, 2H, Ph), 7.36-7.29 (m, 4H, Ph), 7.28-7.20 (m, 3H, Ph), 7.11 
(tt, J = 7.5, 1.0 Hz, 1H, Ph),  4.38 (dd, J = 8.5, 8.5 Hz, 1H, NCH), 3.71-3.55 (m, 2H, 
NCH), 2.78 (dddd, J = 10.5, 10.5, 6.5, 6.5 Hz, 1H, CHPh), 2.31-2.19 (m, 2H, CH), 2.14 
(dddd, J = 13.5, 6.5, 6.5, 6.5 Hz, 1H, CH), 1.75 (dddd, J = 13.5, 10.5, 6.0, 6.0 Hz, 1H, 
CH), 1.47 (s, 9H, CMe3); MS (ESI) m/z 403 [(M + Na)
+
, 100], 381 [(M + H)
+
, 30], 325 
(15), 281 (50); HRMS (ESI) m/z calcd for C23H28N2O3 (M + H)
+
 381.2173, found 
381.2162 (+2.8 ppm error). Spectroscopic data consistent with those reported in the 
literature.
7
 
Lab Book Reference: GG1/55/3 
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2-Dimethylphenylsilyl-4-phenylpiperidine-1-carboxylic acid tert-butyl ester rac-
syn-160 
 
(Scheme 3.39) 
Using general procedure C: s-BuLi (1.15 mL of a 1.3 M solution in hexanes, 1.5 mmol, 
1.3 eq.), 4-phenyl N-Boc piperidine 147 (300 mg, 1.15 mmol, 1.0 eq.) and TMEDA 
(174 mg, 220 μL, 1.5 mmol, 1.3 eq.) at 78 °C for 1 h and then PhMe2SiCl (392 mg, 
386 μL, 2.3 mmol, 2.0 eq.) gave the crude product. Purification by flash column 
chromatography on silica with 96:4 petrol-EtOAc as eluent gave 4-phenylpiperidine 
rac-syn-160 (407 mg, 90%) as a white solid, mp 144-145 °C; RF (96:4 petrol-EtOAc) 
0.3; IR (CHCl3) 3020, 1685 (C=O), 1425, 1218, 929, 782, 736, 669 cm
1
; 
1
H NMR (400 
MHz, CDCl3) δ 7.63-7.56 (m, 2H, Ph), 7.38-7.28 (m, 5H, Ph), 7.25-7.16 (m, 3H, Ph), 
4.11 (br s, 1H, NCH), 3.09-2.91 (br m, 1H, NCH), 2.79-2.60 (br m, 1H, NCH), 2.67 
(dddd, J = 12.0, 12.0, 4.0, 4.0 Hz, 1H, CHPh), 1.88-1.77 (m, 2H, CH), 1.73-1.54 (m, 
2H, CH), 1.47 (s, 9H, CMe3), 0.48 (s, 3H, SiMe), 0.44 (s, 3H, SiMe); 
13
C NMR (100.6 
MHz, CDCl3) δ 155.6 (C=O), 146.4 (ipso-Ph), 142.1 (ipso-Ph), 134.3 (Ph), 128.7 (Ph), 
128.5 (Ph), 127.7 (Ph), 127.1 (Ph), 126.5 (Ph), 79.3 (CMe3), 50.1 (NCH), 47.8 (NCH2), 
44.4 (CHPh), 33.4 (CH2), 28.1 (CMe3), 2.7 (SiMe), 3.3 (SiMe); MS (ESI) m/z 418 
[(M + Na)
+
, 70], 396 [(M + H)
+
, 80], 318 (100); HRMS (ESI) m/z calcd for 
C24H33NO2Si (M + H)
+
 396.2353, found 396.2348 (+1.1 ppm error). 
Lab Book Reference: GG1/72/1 
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2-Benzoyl-4-phenylpiperidine-1-carboxylic acid tert-butyl ester rac-syn-161 
 
(Scheme 3.39) 
Using general procedure C: s-BuLi (1.15 mL of a 1.3 M solution in hexanes, 1.5 mmol, 
1.3 eq.), 4-phenyl N-Boc piperidine 147 (300 mg, 1.15 mmol, 1.0 eq.) and TMEDA 
(174 mg, 220 μL, 1.5 mmol, 1.3 eq.) at 78 °C for 1 h and then PhCONMe2 (380 mg, 
350 μL, 2.3 mmol, 2.0 eq.) gave the crude product. Purification by flash column 
chromatography on silica with 9:1 to 8:2 petrol-EtOAc as eluent gave 4-
phenylpiperidine rac-syn-161 (192 mg, 45%) as a white solid, mp 155-157 °C; RF 
(85:15 petrol-EtOAc) 0.3; IR (CHCl3) 3029, 2979, 1693 (C=O), 1450, 1408, 1250, 
1157, 1016, 761, 731, 700 cm
1
; 
1
H NMR (400 MHz, CDCl3) δ 8.02 (d, J = 7.5 Hz, 2H, 
Ph), 7.54 (t, J = 7.5 Hz, 1H, Ph), 7.45 (t, J = 7.5 Hz, 2H, Ph), 7.33-7.28 (m, 2H, Ph), 
7.24-7.18 (m, 3H, Ph), 4.80 (dd, J = 11.0, 4.5 Hz, 1H, NCH), 4.13-3.99 (m, 1H, NCH), 
3.48 (ddd, J = 13.5, 9.0, 5.0 Hz, 1H, NCH), 2.87 (dddd, J = 11.5, 11.5, 4.0, 4.0 Hz, 1H, 
CHPh), 2.24 (dddd, J = 13.5, 5.0, 4.0, 1.5 Hz, 1H, CH), 2.12-2.03 (m, 1H, CH), 1.96-
1.66 (m, 2H, CH), 1.28 (s, 9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) δ 155.9 (C=O), 
145.2 (ipso-Ph), 136.0 (ipso-Ph), 133.1 (Ph), 128.8 (Ph), 128.7 (Ph), 128.5 (Ph), 127.0 
(Ph), 126.8 (Ph), 81.1 (CMe3), 60.5 (NCH), 43.7 (NCH2), 40.0 (CHPh), 33.5 (CH2), 
31.3 (CH2), 27.7 (CMe3); MS (ESI) m/z 388 [(M + Na)
+
, 95], 366 [(M + H)
+
, 5], 310 
(40), 266 (100); HRMS (ESI) m/z calcd for C23H27NO3 (M + H)
+
 366.2064, found 
366.2062 (+0.8 ppm error). 
Lab Book Reference: GG1/64/1 
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(2R,4R)-2-Methyl-4-phenylpiperidine-1-carboxylic acid tert-butyl ester (2R,4R)-148 
 
(Scheme 3.40) 
Using general procedure C: s-BuLi (1.15 mL of a 1.3 M solution in hexanes, 1.5 mmol, 
1.3 eq.), 4-phenyl N-Boc piperidine 147 (300 mg, 1.15 mmol, 1.0 eq.) and diamine 
(S,S)-4 (465 mg, 1.5 mmol, 1.3 eq.) at 78 °C for 1 h and then  Me2SO4 (290 mg, 210 
μL, 2.3 mmol, 2.0 eq.) gave the crude product. Purification by flash column 
chromatography on silica with 97:3 hexane-EtOAc as eluent gave 4-phenylpiperidine 
(2R,4R)-148 (70 mg, 22%, 91:9 er by CSP-HPLC)) as a colourless oil, [α]D 68.8 (c 
0.55 in CHCl3) (lit.,
138
 [α]D 72.1 (c 0.6 in CHCl3) for (2R,4R)-148); CSP-HPLC: 
Chiralcel OD (99:1 hexane-i-PrOH, 0.5 mL min
1
) (2S,4S)-148 15.9 min, (2R,4R)-148 
17.3 and starting material 147 (152 mg, 50%) as a colourless oil. 
Lab Book Reference: GG1/79/1 
 
(2R,4R)-4-Phenyl-2-phenylcarbamoylpiperidine-1-carboxylic acid tert-butyl ester 
(2R,4R)-159 
 
(Scheme 3.40) 
Using general procedure C: s-BuLi (1.15 mL of a 1.3 M solution in hexanes, 1.5 mmol, 
1.3 eq.), 4-phenyl N-Boc piperidine 147 (300 mg, 1.15 mmol, 1.0 eq.) and diamine 
(S,S)-4 (465 mg, 1.5 mmol, 1.3 eq.) in Et2O (3.8 mL) at 78 °C under Ar for 1 h then, 
phenyl isocyanate (274 mg, 250 μL, 2.3 mmol, 2.0 eq.) gave the crude product. 
Purification by flash column chromatography on silica with 97:3 CH2Cl2-Et2O as eluent 
gave 4-phenylpiperidine (2R,4R)-159 (110 mg, 25%, 89:11 er by CSP-HPLC) as a 
white solid, [α]D 48.7 (c 1.0 in CHCl3); CSP-HPLC: Chiralcel OD (9:1 hexane-i-
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PrOH, 1.0 mL min
1
) (2S,4S)-159 11.7 min, (2R,4R)-159 17.0 and starting material 47 
(148 mg, 49%) as a colourless oil. 
Lab Book Reference: GG1/74/1 
 
(2R,4R)-2-Dimethylphenylsilyl-4-phenylpiperidine-1-carboxylic acid tert-butyl 
ester (2R,4R)-160 
 
(Scheme 3.40) 
Using general procedure C: s-BuLi (1.15 mL of a 1.3 M solution in hexanes, 1.5 mmol, 
1.3 eq.) 4-phenyl N-Boc piperidine 147 (300 mg, 1.15 mmol, 1.0 eq.) and diamine (S,S)-
4 (465 mg, 1.5 mmol, 1.3 eq.) at 78 °C for 1 h and then PhMe2SiCl (392 mg, 386 μL, 
2.3 mmol, 2.0 eq.) gave the crude product. Purification by flash column 
chromatography on silica with 96:4 petrol-EtOAc as eluent gave 4-phenylpiperidine 
(2R,4R)-160 (138 mg, 31%, 90:10 er by CSP-HPLC) as a white solid, CSP-HPLC: 
Chiralcel OD (99.9:0.1 hexane-i-PrOH, 0.5 mL min
1
) (2S,4S)-160 11.9 min, (2R,4R)-
160 13.2 and starting material 147 (154 mg, 51%) as a colourless oil. 
Lab Book Reference: GG1/77/1 
 
(Table 3.3, Entry 2) 
Using general procedure C: s-BuLi (1.15 mL of a 1.3 M solution in hexanes, 1.5 mmol, 
1.3 eq.), 4-phenyl N-Boc piperidine 147 (300 mg, 1.15 mmol, 1.0 eq.) and diamine 
(S,S)-4 (465 mg, 1.5 mmol, 1.3 eq.) at 78 °C for 3 h and then PhMe2SiCl (392 mg, 386 
μL, 2.3 mmol, 2.0 eq.) gave the crude product. Purification by flash column 
chromatography on silica with 96:4 petrol-EtOAc as eluent gave 4-phenylpiperidine 
(2R,4R)-160 (170 mg, 43%, 92:8 er by CSP-HPLC) as a white solid, [α]D 44.0 (c 1.0 
in CHCl3); CSP-HPLC: Chiralcel OD (99.9:0.1 hexane-i-PrOH, 0.5 mL min
1
) (2S,4S)-
160 12.0 min, (2R,4R)-160 13.2. 
Lab Book Reference: GG1/84/1 
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(Table 3.3, Entry 3) 
Using general procedure C: s-BuLi (1.15 mL of a 1.3 M solution in hexanes, 1.5 mmol, 
1.3 eq.), 4-phenyl N-Boc piperidine 147 (300 mg, 1.15 mmol, 1.0 eq.) and diamine 
(S,S)-4 (465 mg, 1.5 mmol, 1.3 eq.) at 40 °C for 1 h and then PhMe2SiCl (392 mg, 386 
μL, 2.3 mmol, 2.0 eq.) gave the crude product. Purification by flash column 
chromatography on silica with 96:4 petrol-EtOAc as eluent gave 4-phenylpiperidine 
(2R,4R)-160 (43 mg, 9%, 80:20 er by CSP-HPLC) as a white solid, CSP-HPLC: 
Chiralcel OD (99.9:0.1 hexane-i-PrOH, 0.5 mL min
1
) (2S,4S)-160 11.8 min, (2R,4R)-
160 13.0 and starting material 147 (193 mg, 64%) as a colourless oil. 
Lab Book Reference: GG1/85/1 
 
4-Phenyl-2-(tributylstannyl)piperidine-1-carboxylic acid tert-butyl ester rac-syn-
162 
 
s-BuLi (4.0 mL of a 1.3 M solution in hexanes, 5.2 mmol, 1.3 eq.) was added dropwise 
to a stirred solution of 4-phenyl N-Boc piperidine 147 (1.04 g, 4.0 mmol, 1.0 eq.) and 
TMEDA (604 mg, 0.78 mL, 5.2 mmol, 1.3 eq.) in Et2O (22 mL) at 30 °C under Ar. 
The resulting solution was stirred at 30 °C for 15 min. Then, Bu3SnCl (1.63 mL, 6.0 
mmol, 1.5 eq.) was added. The resulting solution was stirred at 30 °C for 10 min and 
then allowed to warm to rt over 16 h. Then, saturated NH4Cl(aq) (10 mL) and Et2O (10 
mL) were added and the two layers were separated. The aqueous layer was extracted 
with Et2O (3 × 15 mL) and the combined organic layers were dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica with 98:2 petrol-EtOAc as eluent gave stannyl 
piperidine rac-syn-162 (1.52 g, 70%) as a colourless oil, RF (98:2 petrol-EtOAc) 0.4; IR 
(CHCl3) 2911, 2878, 1645 (C=O), 1405, 1217, 1148, 1125, 990, 837 cm
1
; 
1
H NMR 
(400 MHz, CDCl3) δ 7.36-7.29 (m, 2H, Ph), 7.24-7.18 (m, 3H, Ph), 4.30-4.20 (m, 1H, 
NCH), 2.90 (td, J = 13.0, 2.5 Hz, 1H, NCH), 2.74-2.60 (m, 2H, NCH and CHPh), 1.93-
1.86 (m, 1H, CH), 1.85-1.74 (m, 1H, CH), 1.77-1.58 (m, 2H, CH), 1.56-1.40 (m, 6H, 
CH2), 1.45 (s, 9H, CMe3), 1.29 (sextet, J = 7.5 Hz, 6H, CH2Me), 0.88 (t, J = 7.5 Hz, 9H, 
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CH2Me), 0.85-0.70 (m, 6H, CH2); 
13
C NMR (100.6 MHz, CDCl3) δ 156.1 (C=O), 146.4 
(ipso-Ph), 128.4 (Ph), 126.6 (Ph), 126.1 (Ph), 79.3 (CMe3), 47.5 (NCH2), 46.3 (NCH), 
45.9 (CHPh), 38.4 (CH2), 33.7 (CH2), 29.2 (CH2), 28.4 (CMe3), 27.6 (CH2), 13.8 (Me), 
11.9 (CH2); MS (ESI) m/z 552 [(M + H)
+
, 100], 494 (30); HRMS (ESI) m/z calcd for 
C28H49NO2Sn (M + H)
+
 552.2863, found 552.2857 (0.3 ppm error). 
Lab Book Reference: GG3/83/1 
 
4-Phenyl-2-(tributylstannyl)piperidin-1-yl ethanone rac-syn-163 
 
Me3SiI (210 μL, 1.5 mmol, 1.3 eq.) was added to a stirred solution of stannyl piperidine 
rac-syn-162 (630 mg, 1.14 mmol, 1.0 eq.) in CH2Cl2 (8 mL) at rt under Ar. The 
resulting solution was stirred at rt for 30 min. Then, water (2 mL) and CH2Cl2 (15 mL) 
were added and the layers were separated. The organic layer was washed with water (2 
× 25 mL) and brine (25 mL), dried (MgSO4) and evaporated under reduced pressure. 
The residue was dissolved in CH2Cl2 (13 mL) and then DMAP (13 mg, 0.11 mmol, 0.1 
eq.) and acetyl chloride (98 mg, 90 μL, 1.25 mmol, 1.1 eq.) were added at 0 °C under 
Ar. Then, Et3N (346 mg, 480 μL, 3.42 mmol, 3.0 eq.) was added and the reaction 
mixture was stirred at rt for 16 h. Then, saturated NaHCO3(aq) (25 mL) and  CH2Cl2 (25 
mL) were added and the two layers were separated. The organic layer was washed with 
saturated NH4Cl(aq) (25 mL) and brine (25 mL), dried (MgSO4) and evaporated under 
reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with 90:10 petrol-EtOAc as eluent gave N-acetyl stannyl 
piperidine rac-syn-163 (182 mg, 32%) as a colourless oil, RF (90:10 petrol-EtOAc) 0.2; 
IR (CHCl3) 2911, 2878, 2827, 1593 (C=O), 1431, 888, 711 cm
1
; 
1
H NMR (400 MHz, 
CDCl3) δ 7.36-7.30 (m, 2H, Ph), 7.26-7.18 (m, 3H, Ph), 4.01 (ddd, J = 13.5, 4.0, 2.5 Hz, 
1H, NCH), 3.27 (ddd, J = 13.5, 13.5, 2.5 Hz, 1H, NCH), 2.78 (dddd, J = 12.0, 12.0, 4.0, 
4.0 Hz, 1H, CHPh), 2.53 (dd, J = 13.5, 2.0 Hz, 1H, NCH), 2.13 (s, 3H, Me), 2.01-1.90 
(m, 2H, CH), 1.81-1.63 (m, 2H, CH), 1.59-1.40 (m, 6H, CH2), 1.30 (sextet, J = 7.5 Hz, 
6H, CH2Me), 0.89 (t, J = 7.5 Hz, 9H, CH2Me), 0.86-0.77 (m, 6H, CH2); 
13
C NMR 
(100.6 MHz, CDCl3) δ 169.3 (C=O), 145.6 (ipso-Ph), 128.5 (Ph), 126.8 (Ph), 126.4 
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(Ph), 49.9 (NCH2), 45.9 (CHPh), 44.7 (NCH), 38.3 (CH2), 34.4 (CH2), 29.3 (CH2), 27.6 
(CH2), 21.5 (Me), 13.8 (Me), 12.0 (CH2); MS (ESI) m/z 494 [(M + H)
+
, 100], 436 (20); 
HRMS (ESI) m/z calcd for C25H43NOSn (M + H)
+
 492.2287, found 492.2251 (+6.5 ppm 
error). 
Lab Book Reference: GG3/91/1 
 
N-Ethyl-4-phenyl-2-(tributylstannyl)piperidine rac-syn-164 
 
A solution of N-acetyl stannyl piperidine rac-syn-163 (180 mg, 0.36 mmol, 1.0 eq.) in 
Et2O (0.25 mL) was added to a stirred suspension of LiAlH4 (29 mg, 0.77 mmol, 2.1 
eq.) in Et2O (0.9 mL) at 0 °C under Ar. The resulting mixture was stirred at 0 °C for 20 
min and then at rt for 1 h. Then, MeOH (0.5 mL) was carefully added followed by basic 
alumina and the solvent was evaporated under reduced pressure. Purification by flash 
column chromatography on basic alumina column with 98:2 petrol-EtOAc 98:2 as 
eluent gave N-ethyl stannyl piperidine rac-syn-164 (128 mg, 74%) as a colourless oil, 
IR (CHCl3) 2913, 2882, 2828, 1602, 1435, 1357, 1057, 914 cm
1
; 
1
H NMR (400 MHz, 
CDCl3) δ 7.34-7.28 (m, 2H, Ph), 7.26-7.18 (m, 3H, Ph), 3.30-3.18 (m, 1H, NCH), 2.83-
2.68 (m, 1H, CHPh), 2.60-2.50 (m, 1H, NCH), 2.48-2.35 (m, 1H, NCH), 2.34-2.20 (m, 
1H, NCH), 2.05-1.90 (m, 3H, NCH and CH), 1.89-1.81 (m, 2H, CH), 1.58-1.39 (m, 6H, 
CH2), 1.32 (sextet, J = 7.5 Hz, 6H, CH2Me), 1.09 (t, J = 7.0 Hz, 3H, NCH2Me), 0.97-
0.79 (m, 6H, CH2), 0.90 (t, J = 7.5 Hz, 9H, CH2Me); 
13
C NMR (100.6 MHz, CDCl3) δ 
146.9 (ipso-Ph), 128.4 (Ph), 126.9 (Ph), 126.0 (Ph), 58.0 (NCH), 54.0 (NCH2), 45.2 
(CHPh), 39.7 (NCH2), 33.2 (CH2), 29.2 (CH2), 27.8 (CH2), 27.5 (CH2), 13.8 (Me), 11.8 
(Me), 9.3 (CH2); MS (ESI) m/z 480 [(M + H)
+
, 100]; HRMS (ESI) m/z calcd for 
C25H45NSn (M + H)
+
 480.2651, found 480.2651 (0.2 ppm error). 
Lab Book Reference: GG3/92/1 
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Attempted synthesis of N-ethyl-4-phenyl-2-(p-tolylsulfinyl)piperidine rac-syn-112 
 
n-BuLi (100 μL of a 2.5 M solution in hexanes, 0.25 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of N-ethyl stannyl piperidine rac-syn-164 (190 mg, 0.19 
mmol, 1.0 eq.) in THF (2 mL) at 78 °C under Ar. The resulting solution was stirred at 
78 °C for 5 min. Then, p-tolylsulfinate 92 (47 mg, 0.28 mmol, 1.5 eq.) was added. The 
resulting solution was stirred at 78 °C for 10 min and then allowed to warm to rt over 
1 h. Then, MeOH (0.3 mL) and saturated NH4Cl(aq) (2 mL) and Et2O (5 mL) were added 
and the two layers were separated. The aqueous layer was extracted with Et2O (3 × 5 
mL) and the combined organic layers were dried (MgSO4) and evaporated under 
reduced pressure to give the crude product. The 
1
H NMR spectrum of the crude product 
showed no identifiable products and therefore purification was not attempted. 
Lab Book Reference: GG3/96 
 
4-Phenyl-2-(tributylstannyl)-1-(2,4,6-triisopropylphenylsulfonyl)piperidine 
rac-syn-165 
 
Me3SiI (280 μL, 1.95 mmol, 1.3 eq.) was added to a stirred solution of stannyl 
piperidine rac-syn-162 (825 mg, 1.5 mmol, 1.0 eq.) in CH2Cl2 (11 mL) at rt under Ar. 
The resulting solution was stirred at rt for 30 min. Then, water (3 mL) and CH2Cl2 (20 
mL) were added and the layers were separated. The organic layer was washed with 
water (2 × 25 mL) and brine (25 mL), dried (MgSO4) and evaporated under reduced 
pressure. The residue was dissolved in CH2Cl2 (17 mL) and then, DMAP (18 mg, 0.15 
mmol, 0.1 eq.) and 2,4,6-triisopropylsulfonyl chloride (500 mg, 1.65 mmol, 1.1 eq.) 
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were added at 0 °C under Ar. Then, Et3N (455 mg, 630 μL, 4.5 mmol, 3.0 eq.) was 
added and the reaction mixture was stirred at rt for 24 h. Then, saturated NaHCO3(aq) (25 
mL) and  CH2Cl2 (25 mL) were added and the two layers separated. The organic layer 
was washed with saturated NH4Cl(aq) (25 mL) and brine (25 mL), dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica with 98:2 petrol-EtOAc as eluent gave stannyl 
piperidine rac-syn-165 (452 mg, 42%) as a colourless oil, RF (98:2 petrol-EtOAc) 0.1; 
IR (CHCl3) 2914, 2882, 2826, 1439, 1270, 1127, 666 cm
1
; 
1
H NMR (400 MHz, 
CDCl3) δ 7.36-7.29 (m, 2H, Ph), 7.25-7.18 (m, 3H, Ph), 7.16 (s, 2H, Ar), 4.28 (septet, J 
= 7.0 Hz, 2H, ArCH), 3.37 (ddd, J = 12.0, 3.5, 3.5 Hz, 1H, NCH), 2.90 (m, 2H, ArCH 
and PhCH), 2.84 (dd, J = 13.0, 2.0 Hz, 1H, NCH), 2.68-2.57 (m, 1H, NCH), 2.15-2.06 
(m, 1H, CH), 1.93 (m, 1H, CH), 1.84-1.76 (m, 2H, CH), 1.64-1.43 (m, 6H, CH2), 1.34 
(sextet, J = 7.5 Hz, 6H, CH2Me), 1.28 (d, J = 7.0 Hz, 6H, Me), 1.26 (d, J = 7.0 Hz, 12H, 
Me), 1.01 (m, 6H, CH2), 0.91 (t, J = 7.5 Hz, 9H, CH2Me); 
13
C NMR (100.6 MHz, 
CDCl3) δ 153.2 (ipso-Ar), 151.9 (ipso-Ar), 145.8 (ipso-Ar), 129.8 (ipso-Ar), 128.5 (Ar), 
126.8 (Ar), 126.4 (Ar), 123.9 (Ar), 49.9 (NCH2), 45.7 (CHPh), 44.6 (NCH), 38.4 (CH2), 
34.1 (ArCH), 32.3 (CH2), 29.2 (CH2), 29.1 (ArCH), 27.6 (CH2), 25.0 (Me), 24.7 (Me), 
23.5 (Me), 13.8 (Me), 11.6 (CH2); MS (ESI) m/z 718 [(M + H)
+
, 100]; HRMS (ESI) m/z 
calcd for C38H63NO2SSn (M + H)
+
 718.3680, found 718.3667 (+1.5 ppm error). 
Lab Book Reference: GG3/87/1 
 
Attempted synthesis of 4-phenyl-1-(2,4,6-triisopropylphenylsulfonyl)piperidine 
rac-syn-166 
 
n-BuLi (100 μL of a 2.5 M solution in hexanes, 0.26 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of stannyl piperidine rac-syn-165 (143 mg, 0.2 mmol, 1.0 
eq.) in THF (2 mL) at 78 °C under Ar. The resulting solution was stirred at 78 °C for 
5 min. Then, MeOH (13 mg, 16 μL, 0.4 mmol, 2.0 eq.) was added. The resulting 
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solution was stirred at 78 °C for 10 min and then allowed to warm to rt over 1 h. Then, 
saturated NH4Cl(aq) (4 mL) and Et2O (5 mL) were added and the two layers were 
separated. The aqueous layer was extracted with Et2O (3 × 5 mL) and the combined 
organic layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with 98:2 petrol-
EtOAc as eluent gave stannyl piperidine rac-syn-165 (74 mg, 52%) as a colourless oil. 
Lab Book Reference: GG3/89 
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5.5 Experimental for Chapter Four 
 
2-Phenylpyrroline 237 
 
Et3N (8.5 mL, 61.7 mmol, 1.05 eq.) was added to a stirred solution of pyrrolidin-2-one 
236 (5.0 g, 58.7 mmol, 1.0 eq.) in Et2O (150 mL) at rt under Ar. The mixture was 
cooled to 0 °C and Me3SiCl (7.8 mL, 61.7 mmol, 1.05 eq.) was added dropwise. Then, 
the mixture was stirred and heated at reflux for 2 h. After being allowed to cool to rt, the 
solids were removed by filtration. Then, PhMgCl (29.3 mL of a 2.0 M THF, 58.7 mmol, 
1.05 eq.) was added to the filtrate under Ar and the resulting mixture was stirred and 
heated at reflux for 3 h. After being allowed to cool to rt, 1 M HCl(aq) (30 mL) was 
added and the two layers were separated. The aqueous layer was basified to pH 10 by 
the addition of 2 M NaOH(aq) solution and extracted with EtOAc (3 x 25 mL). The 
combined organic layers were washed with brine (15 mL), dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica with 50:50 petrol-EtOAc as eluent gave 2-
phenylpyrroline 237 (1.55 g, 18%) as a colourless oil, RF (50:50 petrol-EtOAc) 0.5; 
1
H 
NMR (400 MHz, CDCl3) δ 7.90-7.83 (m, 2H, Ph), 7.49-7.38 (m, 3H, Ph), 4.08 (tt, J = 
7.5, 2.0 Hz, 2H, NCH2), 2.97 (tt, J = 8.0, 2.0 Hz, 2H, CH2), 2.05 (tt, J = 8.0, 7.5 Hz, 2H, 
CH2); 
13
C NMR (100.6 MHz, CDCl3) δ 174.4 (C=N), 134.5 (ipso-Ph), 130.3 (Ph), 128.4 
(Ph), 127.6 (Ph), 61.4 (NCH2), 34.9 (CH2), 22.6 (CH2). Spectroscopic data consistent 
with those reported in the literature.
125
  
Lab Book Reference: GG4/1/1 
 
2-Phenylpyrrolidine rac-190 
 
NaBH4 (325 mg, 8.6 mmol, 1.1 eq.) was added to a stirred solution of 2-phenylpyrroline 
237 (1.14 g, 7.8 mmol, 1.0 eq.) in 4:1 MeOH-water (27 mL) at rt. The resulting mixture 
was stirred at rt for 16 h. Then, 2 M HCl(aq) was added until pH ~ 2 was obtained and the 
mixture was stirred for 30 min. Then, 2 M NaOH(aq) was added until pH ~ 13 was 
Chapter Five: Experimental 
238 
obtained and the aqueous mixture was extracted with CH2Cl2 (3 × 25 mL). The 
combined organic layers were dried (MgSO4) and evaporated under reduced pressure to 
give the crude product. Purification by Kügelrohr distillation gave 2-phenylpyrrolidine 
rac-190 (1.1 g, 96%) as a colourless oil, bp 110-115 °C/4.0 mmHg (lit.,
139
 101-103 
°C/0.1 mmHg); 
1
H NMR (400 MHz, CDCl3) δ 7.40-7.29 (m, 4H, Ph), 7.26-7.21 (m, 1H, 
Ph), 4.12 (dd, J = 7.5, 7.5 Hz, 1H, NCH), 3.22 (ddd, J = 10.0, 8.0, 5.5 Hz, 1H, NCH), 
3.02 (ddd, J = 10.0, 8.0, 7.0 Hz, 1H, NCH), 2.25-2.15 (m, 1H, CH), 1.99 (s, 1H, NH), 
1.98-1.81 (m, 2H, CH), 1.74-1.63 (m, 1H, CH). Spectroscopic data consistent with 
those reported in the literature.
139
 
Lab Book Reference: GG4/2/1 
 
2-Phenylpyrrolidine-1-carboxylic acid tert-butyl ester rac-70 
 
A solution of di-tert-butyl dicarbonate (1.7 g, 7.8 mmol, 1.1 eq.) in CH2Cl2 (5 mL) was 
added dropwise to a stirred solution of 2-phenylpyrrolidine rac-190 (1.05 g, 7.1 mmol, 
1.0 eq.) in CH2Cl2 (16 mL) at 0 °C under Ar. The resulting solution was allowed to 
warm to rt and stirred at rt for 16 h. Then, water (25 mL) and CH2Cl2 (12 mL) were 
added. The aqueous layer was extracted with CH2Cl2 (3 × 12 mL) and the combined 
organic layers were dried (Na2SO4) and evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with 98:2 
CH2Cl2-Et2O as eluent gave phenyl pyrrolidine rac-70 (1.6 g, 92%) as a white solid, mp 
57-58 °C (lit.,
56
 61.9-62.7 °C); RF (98:2 CH2Cl2-Et2O) 0.4. Spectroscopic data 
consistent with those reported in the literature.
56
  
Lab Book Reference: GG4/3/1 
 
2-Methyl-2-phenylpyrrolidine-1-carboxylic acid tert-butyl ester rac-232 
 
n-BuLi (2.76 mL of a 2.5 M solution in hexanes, 6.9 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of phenyl pyrrolidine rac-70 (1.3 g, 5.3 mmol, 1.0 eq.) in 
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THF (29 mL) at 0 °C under Ar. The resulting solution was stirred at 0 °C for 5 min. 
Then, Me2SO4 (1.34 g, 1.0 mL, 1.0 mmol, 2.0 eq.) was added. The resulting solution 
was stirred at 0 °C for 10 min and then allowed to warm to rt over 1 h. Then, saturated 
NH4Cl(aq) (20 mL) and Et2O (20 mL) were added and the two layers were separated. 
The aqueous layer was extracted with Et2O (3 × 15 mL) and the combined organic 
layers were dried (MgSO4) and evaporated under reduced pressure to give the crude 
product. Purification by flash column chromatography on silica with 80:20 petrol-Et2O 
as eluent gave pyrrolidine rac-232 (1.37 g, 99%) as a colourless oil, RF (80:20 petrol-
Et2O) 0.2; 
1
H NMR (400 MHz, CDCl3) (75:25 mixture of rotamers) δ 7.33-7.15 (m, 5H, 
Ph), 3.75-3.56 (m, 2H, NCH), 2.12-1.99 (m, 2H, CH), 1.94-1.79 (m, 2H, CH), 1.76 (s, 
3H, Me), 1.46 (s, 2.25H, CMe3), 1.13 (s, 6.75H, CMe3). Spectroscopic data consistent 
with those reported in the literature.
63
 
Lab Book Reference: GG4/13/1 
 
(S)-2-Phenylpyrrolidine-1-carboxylic acid tert-butyl ester (S)-70 
 
(Scheme 4.32) 
s-BuLi (4.6 mL of a 1.3 M solution in hexanes, 6.0 mmol, 1.2 eq.) was added dropwise 
to a stirred solution of N-Boc pyrrolidine 1 (856 mg, 5.0 mmol, 1.0 eq.) and (+)-
sparteine surrogate (1.17 g, 6.0 mmol, 1.2 eq.) in Et2O (12 mL) at 30 °C under Ar. The 
resulting solution was stirred at 30 °C for 2 min. Then, ZnCl2 (3.0 mL of a 1.0 M 
solution in Et2O, 3.0 mmol, 0.6 eq.) was added and the resulting mixture was stirred at 
30 °C for 30 min. The reaction mixture was allowed to warm to rt over 30 min. Then, 
bromobenzene (1.0 g, 680 μL, 6.5 mmol, 1.3 eq.) and a mixture of t-Bu3PHBF4 (94 mg, 
0.325 mmol, 0.0625 eq.) and Pd(OAc)2 (56 mg, 0.25 mmol, 0.05 eq.) were added. The 
resulting mixture was stirred at rt for 16 h. NH4OH(aq) (0.5 mL) and Et2O (10 mL) were 
added and mixture was stirred for 1 h. The solids were removed by filtration through a 
pad of Celite

 and washed with Et2O (15 mL). The filtrate was washed with 1 M HCl(aq) 
(15 mL) and water (2 × 15 mL), dried (MgSO4) and evaporated under reduced pressure 
to give the crude product. Purification by flash column chromatography on silica with 
99:1 CH2Cl2-Et2O as eluent gave phenyl pyrrolidine (S)-70 (608 mg, 50%, 90:10 er by 
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CSP-HPLC) as a white solid, mp 57-58 °C (lit.,
56
 61.9-62.7 °C); [α]D 64.6 (c 1.0 in 
CHCl3); [α]D 62.0 (c 1.0 in acetone) (lit.,
13
 [α]D +83.2 (c 0.7 in acetone) for (R)-70 of 
95:5 er); RF (99:1 CH2Cl2-Et2O) 0.3; CSP-HPLC: Chiralcel AD-H (99:1 hexane-i-
PrOH, 0.5 mL min
1
) (R)-70 11.8 min, (S)-70 12.8 min. Spectroscopic data consistent 
with those reported in the literature.
56 
Lab Book Reference: GG4/33/1 
 
(Scheme 4.31) 
s-BuLi (3.38 mL of a 1.3 M solution in hexanes, 4.4 mmol, 1.1 eq.) was added dropwise 
to a stirred solution of N-Boc pyrrolidine 1 (685 mg, 0.7 mL, 4.0 mmol, 1.0 eq.) and 
(+)-sparteine surrogate (855 mg, 4.4 mmol, 1.1 eq.) in Et2O (10 mL) at 78 °C under 
Ar. The resulting solution was stirred at 78 °C for 30 min. Then, ZnCl2 (2.4 mL of a 
1.0 M solution in Et2O, 2.4 mmol, 0.6 eq.) was added and the resulting mixture was 
stirred at 78 °C for 30 min. The reaction mixture was allowed to warm to rt over 30 
min. Then, bromobenzene (753 mg, 500 μL, 4.8 mmol, 1.2 eq.) and a mixture of t-
Bu3PHBF4 (58 mg, 0.2 mmol, 0.05 eq.) and Pd(OAc)2 (36 mg, 0.16 mmol, 0.04 eq.) 
were added. The resulting mixture was stirred at rt for 16 h. NH4OH(aq) (0.3 mL) and 
Et2O (10 mL) were added and mixture was stirred for 1 h. The solids were removed by 
filtration through a pad of Celite

 and washed with Et2O (15 mL). The filtrate was 
washed with 1 M HCl(aq) (10 mL) and water (2 × 10 mL), dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica with 99:1 CH2Cl2-Et2O as eluent gave phenyl 
pyrrolidine (S)-70 (561 mg, 57%, 94:6 er by CSP-HPLC) as a white solid, RF (99:1 
CH2Cl2-Et2O) 0.3; CSP-HPLC: Chiralcel AD-H (99:1 hexane-i-PrOH, 0.5 mL min
1
) 
(R)-70 14.1 min, (S)-70 15.6 min. 
Lab Book Reference: GG5/94/1 
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(S)-2-Methyl-2-phenylpyrrolidine-1-carboxylic acid tert-butyl ester (S)-232  
 
(Table 4.2, Entry 1) 
Using general procedure D: n-BuLi (90 μL of a 2.5 M solution in hexanes, 0.22 mmol, 
1.1 eq.), phenyl pyrrolidine (S)-70 (49 mg, 0.2 mmol, 1.0 eq., 94:6 er) and TMEDA (25 
mg, 33 μL, 0.22 mmol, 1.1 eq.) in Et2O (2 mL) at 50 °C under Ar for 5 min. Then, 
Me2SO4 (38 mg, 28 μL, 0.3 mmol, 1.5 eq.) gave the crude product. Purification by flash 
column chromatography on silica with 90:10 petrol-Et2O as eluent gave pyrrolidine (S)-
232 (12 mg, 23%, 93:7 er by CSP-HPLC) as an off-white solid, CSP-HPLC: Chiralcel 
OD (99:1 hexane-i-PrOH, 1.0 mL min
1
) (S)-232 7.0 min, (R)-232 7.9 min. 
Lab Book Reference: GG5/97/1 
 
(Table 4.2, Entry 2) 
Using general procedure D: n-BuLi (620 μL of a 2.5 M solution in hexanes, 1.56 mmol, 
1.1 eq.), phenyl pyrrolidine (S)-70 (350 mg, 1.42 mmol, 1.0 eq., 94:6 er) and TMEDA 
(181 mg, 230 μL, 1.56 mmol, 1.1 eq.) in Et2O (14 mL) at 50 °C under Ar for 30 min. 
Then, Me2SO4 (269 mg, 200 μL, 2.13 mmol, 1.5 eq.) gave the crude product. 
Purification by flash column chromatography on silica with 90:10 petrol-Et2O as eluent 
gave pyrrolidine (S)-232 (362 mg, 97%, 94:6 er by CSP-HPLC) as an off-white solid, 
CSP-HPLC: Chiralcel OD (99:1 hexane-i-PrOH, 1.0 mL min
1
) (S)-232 7.6 min, (R)-
232 8.6 min. 
Lab Book Reference: GG6/3/1 
 
(Table 4.2, Entry 3) 
Using general procedure D: n-BuLi (90 μL of a 2.5 M solution in hexanes, 0.22 mmol, 
1.1 eq.), phenyl pyrrolidine (S)-70 (49 mg, 0.2 mmol, 1.0 eq., 94:6 er) and TMEDA (25 
mg, 33 μL, 0.22 mmol, 1.1 eq.) in Et2O (2 mL) at 30 °C under Ar for 30 min. Then, 
Me2SO4 (38 mg, 28 μL, 0.3 mmol, 1.5 eq.) gave the crude product. Purification by flash 
column chromatography on silica with 90:10 petrol-Et2O as eluent gave pyrrolidine (S)-
232 (49 mg, 94%, 91:9 er by CSP-HPLC) as an off-white solid, CSP-HPLC: Chiralcel 
OD (99:1 hexane-i-PrOH, 1.0 mL min
1
) (S)-232 6.9 min, (R)-232 7.9 min. 
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Lab Book Reference: GG5/98/1 
 
(Table 4.2, Entry 4) 
Using general procedure D: n-BuLi (90 μL of a 2.5 M solution in hexanes, 0.22 mmol, 
1.1 eq.), phenyl pyrrolidine (S)-70 (49 mg, 0.2 mmol, 1.0 eq., 94:6 er) and TMEDA (25 
mg, 33 μL, 0.22 mmol, 1.1 eq.) in Et2O (2 mL) at 30 °C under Ar for 1 h. Then, 
Me2SO4 (38 mg, 28 μL, 0.3 mmol, 1.5 eq.) gave the crude product. Purification by flash 
column chromatography on silica with 90:10 petrol-Et2O as eluent gave pyrrolidine (S)-
232 (50 mg, 96%, 92:8 er by CSP-HPLC) as an off-white solid, CSP-HPLC: Chiralcel 
OD (99:1 hexane-i-PrOH, 1.0 mL min
1
) (S)-232 7.0 min, (R)-232 7.9 min. 
Lab Book Reference: GG5/99/1 
 
(Table 4.2, Entry 5) 
Using general procedure D: n-BuLi (44 μL of a 2.5 M solution in hexanes, 0.11 mmol, 
1.1 eq.), phenyl pyrrolidine (S)-70 (24 mg, 0.1 mmol, 1.0 eq., 94:6 er) and TMEDA (13 
mg, 16 μL, 0.11 mmol, 1.1 eq.) in THF (1 mL) at 50 °C under Ar for 30 min. Then, 
Me2SO4 (19 mg, 14 μL, 0.15 mmol, 1.5 eq.) gave the crude product. Purification by 
flash column chromatography on silica with 90:10 petrol-Et2O as eluent gave 
pyrrolidine (S)-232 (6 mg, 23%, 58:42 er by CSP-HPLC) as an off-white solid, CSP-
HPLC: Chiralcel OD (99:1 hexane-i-PrOH, 1.0 mL min
1
) (S)-232 6.6 min, (R)-232 7.5 
min and recovered phenyl pyrrolidine (S)-70 (13 mg, 53%). 
Lab Book Reference: GG6/67/1 
 
(Scheme 4.34) 
n-BuLi (1.16 mL of a 2.5 M solution in hexanes, 2.9 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of phenyl pyrrolidine (S)-70 (550 mg, 2.24 mmol, 1.0 eq., 
90:10 er) in THF (16 mL) at 50 °C under Ar. The resulting solution was stirred at 50 
°C for 5 min. Then, Me2SO4 (565 mg, 420 μL, 4.5 mmol, 2.0 eq.) was added. The 
resulting solution was stirred at 50 °C for 10 min and then allowed to warm to rt over 
1 h. Then, saturated NH4Cl(aq) (10 mL) and Et2O (10 mL) were added and the two layers 
were separated. The aqueous layer was extracted with Et2O (3 × 5 mL) and the 
combined organic layers were dried (MgSO4) and evaporated under reduced pressure to 
give the crude product. Purification by flash column chromatography on silica with 
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80:20 petrol-Et2O as eluent gave pyrrolidine (S)-232 (433 mg, 74%, 80:20 er by CSP-
HPLC) as an off-white solid, [α]D 49.6 (c 1.0 in CHCl3) (lit.,
63
 [α]D +54.0 (c 1.0 in 
CHCl3) for (R)-232 of 98:2 er); CSP-HPLC: Chiralcel OD (99:1 hexane-i-PrOH, 1.0 
mL min
1
) (S)-232 6.6 min, (R)-232 7.5 min. 
Lab Book Reference: GG4/37/1 
 
(R)-3-(1-Phenylethylamino)propan-1-ol (R)-239 
 
Using general procedure E: 3-Chloro-1-propanol (2.3 g, 2.0 mL, 23.9 mmol, 1.0 eq.), 
(R)-(+)-α-methylbenzylamine (R)-238 (5.8 g, 6.1 mL, 47.9 mmol, 2.0 eq.) and water 
(0.7 mL) gave the crude product. Purification by Kügelrohr distillation gave amino 
alcohol (R)-239 (4.1 g, 95%) as a colourless oil, bp 106-108 °C/0.6 mmHg; [α]D +45.6 
(c 0.65 in CHCl3) (lit.,
63
 [α]D +51.6 (c 1.2 in CHCl3); 
1
H NMR (400 MHz, CDCl3) δ 
7.38-7.23 (m, 5H, Ph), 3.80-3.72 (m, 3H, CH2OH + NCH), 2.96 (br s, 1H, NH), 2.83-
2.75 (m, 1H), 2.71-2.63 (m, 1H), 1.79-1.68 (m, 1H), 1.67-1.57 (m, 1H), 1.39 (d, J = 6.5 
Hz, 3H, Me); 
13
C NMR (100.6 MHz, CDCl3) δ 144.8 (ipso-Ph), 128.5 (Ph), 127.0 (Ph), 
126.4 (Ph), 64.1 (OCH2), 58.6 (NCH), 47.7 (NCH2), 31.2 (CH2), 24.1 (Me). 
Spectroscopic data consistent with those reported in the literature.
63
  
Lab Book Reference: GG4/26/1 
 
(S)-3-(1-Phenylethylamino)propan-1-ol (S)-239 
 
Using general procedure E: 3-chloro-1-propanol (2.3 g, 2.0 mL, 23.9 mmol, 1.0 eq.) and 
(S)-(+)-α-methylbenzylamine (S)-238 (5.8 g, 6.1 mL, 47.9 mmol, 2.0 eq.) in water (0.7 
mL) gave the crude product. Purification by Kügelrohr distillation gave the amino 
alcohol (S)-239 (3.65 g, 85%) as a colourless oil, [α]D –47.7 (c 1.0 in CHCl3) (lit.,
63
 [α]D 
+51.6 (c 1.2 in CHCl3) for (R)-239). 
Lab Book Reference: GG4/27/1 
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(R)-tert-Butyl 3-hydroxypropyl(1-phenylethyl)carbamate (R)-240 
 
Using general procedure F: a solution of di-tert-butyl dicarbonate (5.0 g, 22.9 mmol, 1.0 
eq.) in CH2Cl2 (14 mL) and amino alcohol (R)-239 (4.1 g, 22.9 mmol, 1.0 eq.) in 
CH2Cl2 (57 mL) gave the crude product. Purification by flash column chromatography 
on silica with 80:20 petrol-Et2O as eluent gave N-Boc-amino alcohol (R)-240 (5.83 g, 
91%) as a colourless oil, RF (80:20 petrol-Et2O) 0.2; [α]D +70.0 (c 1.0 in CHCl3) (lit.,
63
 
[α]D +75.8 (c 1.0 in CHCl3)); 
1
H NMR (400 MHz, CDCl3) δ 7.38-7.24 (m, 5H, Ph), 5.22 
(br s, 1H, NCH), 3.57-3.45 (m, 2H, CH2OH), 3.43-3.06 (br m, 2H), 2.62 (br s, 1H), 
1.66-1.27 (br m, 2H), 1.56 (d, J = 7.0 Hz, 3H, Me), 1.46 (s, 9H, CMe3).  
Lab Book Reference: GG4/29/1 
 
(S)-3-(1-Phenylethylamino)propan-1-ol (S)-240 
 
Using general procedure F: di-tert-butyl dicarbonate (4.45 g, 20.4 mmol, 1.0 eq.) in 
CH2Cl2 (11 mL) and amino alcohol (S)-239 (3.65 g, 20.4 mmol, 1.0 eq.) in CH2Cl2 (45 
mL) gave the crude product. Purification by flash column chromatography on silica 
with 80:20 petrol-Et2O as eluent gave N-Boc-amino alcohol (S)-240 (5.5 g, 96%) as a 
colourless oil, [α]D 72.3 (c 1.0 in CHCl3) (lit.,
63
 [α]D +75.8 (c 1.0 in CHCl3) for (R)-
240).  
Lab Book Reference: GG4/30/1 
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(R)-3-(tert-Butoxycarbonyl(1-phenylethyl)amino)propyl 2,4,6-tri-i-propyl-
benzenesulfonate (R)-241 
 
Using general procedure G: 2,4,6-Tri-i-propyl-benzenesulfonyl chloride (7.57 g, 21.9 
mmol, 1.05 eq.), N-Boc amino alcohol (R)-240 (5.83 g, 20.9 mmol, 1.0 eq.), Et3N (2.5 
g, 3.5 mL, 25.1 mmol, 1.2 eq.) and DMAP (256 mg, 2.1 mmol, 0.1 eq.) in CH2Cl2 (50 
mL) gave the crude product. Purification by flash column chromatography on silica 
with 90:10-80:20 petrol-Et2O as eluent gave N-Boc amino sulfonate (R)-241 (8.4 g, 
74%) as a colourless oil, RF (90:10 petrol-Et2O) 0.1; [α]D +44.4 (c 1.0 in CHCl3) (lit.,
63
 
[α]D +41.7 (c 1.0 in CHCl3)); 
1
H NMR (400 MHz, CDCl3) δ 7.35-7.21 (m, 5H, Ph), 7.17 
(s, 2H, Ar), 5.70-5.06 (br m, 1H, NCH), 4.08 (septet, J = 7.0 Hz, 2H, CHMe2), 4.01-
3.78 (br m, 2H), 3.03 (br s, 2H), 2.91 (septet, J = 7.0 Hz, 1H, CHMe2), 1.93-1.57 (br m, 
2H), 1.51 (d, J = 7.0 Hz, 3H, Me), 1.44 (s, 9H, CMe3), 1.29-1.17 (m, 18H, CHMe2). 
Spectroscopic data consistent with those reported in the literature.
63
 
Lab Book Reference: GG4/31/1 
 
(S)-3-(tert-Butoxycarbonyl(1-phenylethyl)amino)propyl 2,4,6-tri-i-propyl-
benzenesulfonate (S)-241 
 
Using general procedure G: 2,4,6-tri-i-propyl-benzenesulfonyl chloride (6.27 g, 20.7 
mmol, 1.05 eq.), N-Boc amino alcohol (S)-240 (5.5 g, 19.7 mmol, 1.0 eq.), Et3N (2.4 g, 
3.3 mL, 23.6 mmol, 1.2 eq.) and DMAP (240 mg, 1.97 mmol, 0.1 eq.) in CH2Cl2 (50 
mL) gave the crude product. Purification by flash column chromatography on silica 
with 90:10-80:20 petrol-Et2O as eluent gave N-Boc amino sulfonate (S)-241 (8.5 g, 
79%) as a colourless oil, [α]D 43.4 (c 1.0 in CHCl3) (lit.,
63
 [α]D +41.7 (c 1.0 in CHCl3) 
for (R)-241). 
Lab Book Reference: GG4/32/1 
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(R)-2-Methyl-2-phenylpyrrolidine-1-carboxylic acid tert-butyl ester (R)-232 
 
Using general procedure H: s-BuLi (8.0 mL of a 1.3 M solution in hexanes, 10.4 mmol, 
1.3 eq.), N-Boc amino sulfonate (R)-241 (4.36 g, 8.0 mmol, 1.0 eq.) and TMEDA (1.2 
g, 1.56 mL, 10.4 mmol, 1.3 eq.) in Et2O (56 mL) gave the crude product. Purification by 
flash column chromatography on silica with 80:20 petrol-Et2O as eluent gave 
pyrrolidine (R)-232 (1.81 g, 87%, 98:2 er by CSP-HPLC) as a white solid, [α]D +60.0 (c 
1.0 in CHCl3) (lit.,
63
 [α]D +54.0 (c 1.0 in CHCl3); CSP-HPLC: Chiralcel OD (99:1 
hexane:i-PrOH, 1.0 mL min
–1
) (S)-232 6.6 min, (R)-232 7.5 min. 
Lab Book Reference: GG4/44/1 
 
(S)-2-Methyl-2-phenylpyrrolidine-1-carboxylic acid tert-butyl ester (S)-232 
 
Using general procedure H: s-BuLi (8.0 mL of a 1.3 M solution in hexanes, 10.4 mmol, 
1.3 eq.), N-Boc amino sulfonate (S)-241 (4.36 g, 8.0 mmol, 1.0 eq.) and TMEDA (1.2 g, 
1.56 mL, 10.4 mmol, 1.3 eq.) in Et2O (56 mL) gave the crude product. Purification by 
flash column chromatography on silica with 80:20 petrol-Et2O as eluent gave 
pyrrolidine (S)-232 (1.87 g, 89%, 98:2 er by CSP-HPLC) as a white solid, [α]D –60.9 (c 
1.0 in CHCl3) (lit.,
63
 [α]D +54.0 (c 1.0 in CHCl3) for (R)-232); CSP-HPLC: Chiralcel 
OD (99:1 hexane:i-PrOH, 1.0 mL min
–1
) (S)-232 6.5 min, (R)-232 7.8 min. 
Lab Book Reference: GG4/45/1 
 
tert-Butyl 3-chloropropyl-pyridin-2-ylmethyl-carbamate 245 
 
Using general procedure I: NaBH(OAc)3 (5.9 g, 28 mmol, 1.4 eq.), 3-
chloropropylamine hydrochloride 244 (2.6 g, 20 mmol, 1.0 eq.) and 2-
pyridinecarboxaldehyde 243 (2.14 g, 1.9 mL, 20 mmol, 1.eq.) in 1,2-dichloroethane (80 
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mL), then di-tert-butylcarbonate (4.36 g, 20 mmol, 1.0 eq.) in CH2Cl2 (30 mL) gave the 
crude product. Purification by flash column chromatography on silica with 90:10 
CH2Cl2-Et2O as eluent gave N-Boc chloro-propylamine 245 (1.8 g, 32%) as a colourless 
oil, RF (90:10 CH2Cl2-Et2O) 0.2; IR (ATR) 2976, 1690 (C=O), 1409, 1366, 1245, 1159, 
754 cm
‒1
; 
1
H NMR (400 MHz, CDCl3) (50:50 mixture of rotamers) 8.54 (s, 0.5H, Ar), 
8.53 (s, 0.5H, Ar), 7.67 (dd, J = 7.5, 7.5 Hz, 0.5H, Ar), 7.66 (dd, J = 7.5, 7.5 Hz, 0.5H, 
Ar), 7.33-7.23 (m, 1H, Ar), 7.19 (d, J = 5.0 Hz, 0.5H, Ar), 7.18 (d, J = 5.0 Hz, 0.5H, 
Ar), 4.58 (s, 1H, NCH2), 4.54 (s, 1H, NCH2), 3.61-3.37 (m, 4H, NCH2 + CH2Cl), 2.11-
1.91 (m, 2H, CH2), 1.51 (s, 4.5H, CMe3), 1.39 (s, 4.5H, CMe3); 
13
C NMR (100.6 MHz, 
CDCl3) (mixture of rotamers) δ 158.6 (ipso-Ar), 158.2 (ipso-Ar), 155.8 (C=O), 155.6 
(C=O), 149.1 (Ar), 136.8 (Ar), 136.6 (Ar), 122.2 (Ar), 122.1 (Ar), 121.7 (Ar), 120.6 
(Ar), 80.1 (CMe3), 53.3 (NCH2), 52.4 (NCH2), 45.5 (NCH2), 45.0 (NCH2), 42.5 
(CH2Cl), 42.3 (CH2Cl), 31.3 (CH2), 28.4 (CMe3); MS (ESI) m/z 285 [(M + H)
+
, 20], 229 
(100); HRMS (ESI) m/z calcd for C14H21
35
ClN2O2 (M + H)
+
 285.1364, found 285.1356 
(+3.0 ppm error). 
Lab Book Reference: GG6/44/1 
 
2-Pyridin-2-ylpyrrolidine-1-carboxylic acid tert-butyl ester (R)-211 
 
(Table 4.3, Entry 3) 
Using general procedure J: s-BuLi (0.2 mL of a 1.3 M solution in hexanes, 0.26 mmol, 
1.3 eq.), N-Boc chloro-propylamine 245 (57 mg, 0.2 mmol, 1.0 eq.) and (+)-sparteine 
surrogate (50 mg, 0.26 mmol, 1.3 eq.) in toluene (2 mL) gave the crude product. 
Purification by flash column chromatography on silica with 50:50 CH2Cl2-Et2O as 
eluent gave recovered starting material 245 (24 mg, 42%) and pyrrolidine (R)-211 (29 
mg, 58%, 60:40 er by CSP-HPLC) as a colourless oil, RF (80:20 CH2Cl2-Et2O) 0.1; 
1
H 
NMR (400 MHz, CDCl3) (65:35 mixture of rotamers) δ 8.58-8.50 (m, 1H, Ar), 7.64 (dd, 
J = 7.5, 7.5 Hz, 1H, Ar), 7.22-7.09 (m, 2H, Ar), 5.02 (br d, J = 5.5 Hz, 0.35H, NCH), 
4.88 (dd, J = 8.0, 4.5 Hz, 0.65H, Ar), 3.72-3.45 (m, 2H, NCH), 2.47-2.22 (m, 1H, CH), 
2.13-1.82 (m, 3H, CH), 1.46 (s, 3.15H, CMe3), 1.20 (s, 5.85H, CMe3);
 13
C NMR (100.6 
MHz, CDCl3) (mixture of rotamers) δ 163.7 (ipso-Ar), 154.5 (C=O), 149.2 (Ar), 148.9 
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(Ar), 136.4 (Ar), 136.2 (Ar), 121.5 (Ar), 120.1 (Ar), 119.6 (Ar), 79.3 (CMe3), 62.8 
(NCH), 62.1 (NCH), 47.4 (NCH2), 47.0 (NCH2), 34.2 (CH2), 28.4 (CMe3), 28.1 (CMe3), 
23.7 (CH2), 23.2 (CH2); CSP-HPLC: Chiralcel AD-H (90:10 hexane:i-PrOH, 1.0 mL 
min
–1
) (R)-211 3.8 min, (S)-211 6.7 min. Spectroscopic data consistent with those 
reported in the literature.
30
 
Lab Book Reference: GG6/46/1 
 
(Table 4.3, Entry 4) 
Using general procedure J: s-BuLi (0.2 mL of a 1.3 M solution in hexanes, 0.26 mmol, 
1.3 eq.), N-Boc chloro-propylamine 245 (57 mg, 0.2 mmol, 1.0 eq.) and (+)-sparteine 
surrogate (50 mg, 0.26 mmol, 1.3 eq.) in Et2O (2 mL) gave the crude product. 
Purification by flash column chromatography on silica with 50:50 CH2Cl2-Et2O as 
eluent gave recovered starting material 245 (24 mg, 42%) and pyrrolidine (R)-211 (29 
mg, 58%, 62:38 er by CSP-HPLC) as a colourless oil, CSP-HPLC: Chiralcel AD-H 
(90:10 hexane:i-PrOH, 1.0 mL min
–1
) (R)-211 3.8 min, (S)-211 6.7 min. 
Lab Book Reference: GG6/47/1 
 
2-Pyridin-2-ylpyrrolidine-1-carboxylic acid tert-butyl ester (S)-211 
 
(Table 4.3, Entry 1) 
Using general procedure J: s-BuLi (0.2 mL of a 1.3 M solution in hexanes, 0.26 mmol, 
1.3 eq.), N-Boc chloro-propylamine 245 (57 mg, 0.2 mmol, 1.0 eq.) and (‒)-sparteine 
(60 μL, 0.26 mmol, 1.3 eq.) in toluene (2 mL) gave the crude product. Purification by 
flash column chromatography on silica with 50:50 CH2Cl2-Et2O as eluent gave 
pyrrolidine (S)-211 (41 mg, 82%, 51:49 er by CSP-HPLC) as a colourless oil, CSP-
HPLC: Chiralcel AD-H (90:10 hexane:i-PrOH, 1.0 mL min
–1
) (R)-211 3.8 min, (S)-211 
6.6 min. 
Lab Book Reference: GG6/48/1 
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(Table 4.3, Entry 2) 
Using general procedure J: s-BuLi (0.2 mL of a 1.3 M solution in hexanes, 0.26 mmol, 
1.3 eq.), N-Boc chloro-propylamine 245 (57 mg, 0.2 mmol, 1.0 eq.) and (‒)-sparteine 
(60 μL, 0.26 mmol, 1.3 eq.) in Et2O (2 mL) gave the crude product. Purification by flash 
column chromatography on silica with 50:50 CH2Cl2-Et2O as eluent gave recovered 
starting material 245 (24 mg, 42%) and pyrrolidine (S)-211 (28 mg, 56%, 50:50 er by 
CSP-HPLC) as a colourless oil, CSP-HPLC: Chiralcel AD-H (90:10 hexane:i-PrOH, 1.0 
mL min
–1
) (R)-211 3.8 min, (S)-211 6.6 min. 
Lab Book Reference: GG6/49/1 
 
tert-Butyl 3-chloropropyl-pyridin-3-ylmethyl-carbamate 246 
 
Using general procedure I: NaBH(OAc)3 (5.9 g, 28 mmol, 1.4 eq.), 3-
chloropropylamine hydrochloride 244 (2.6 g, 20 mmol, 1.0 eq.) and  3-
pyridinecarboxaldehyde (2.14 g, 1.9 mL, 20 mmol, 1.eq.) in 1,2-dichloroethane (80 
mL), then di-tert-butylcarbonate (4.36 g, 20 mmol, 1.0 eq.) in CH2Cl2 (30 mL) gave the 
crude product. Purification by flash column chromatography on silica with 70:30 
CH2Cl2-Et2O as eluent gave N-Boc propylamine 246 (2.2 g, 39%) as a colourless oil, RF 
(70:30 CH2Cl2-Et2O) 0.2; IR (ATR) 2975, 1685 (C=O), 1411, 1365, 1248, 1158, 773 
cm
‒1
; 
1
H NMR (400 MHz, CDCl3) 8.60-8.47 (m, 2H, Ar), 7.68-.7.51 (m, 1H, Ar), 7.32-
7.26 (m, 1H, Ar), 4.46 (s, 2H, NCH2), 3.54 (br s, 2H, NCH2), 3.44-3.24 (m, 2H, CH2Cl), 
2.08-1.88 (m, 2H, CH2), 1.49 (br s, 9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) (mixture 
of rotamers) δ 155.8 (C=O), 155.3 (C=O), 149.0 (Ar), 148.8 (Ar), 135.4 (Ar), 134.7 
(Ar), 133.8 (ipso-Ar), 123.4 (Ar), 80.4 (CMe3), 48.9 (NCH2), 48.0 (NCH2), 44.7 
(NCH2), 44.1 (NCH2), 42.2 (CH2Cl), 31.1 (CH2), 28.3 (CMe3); MS (ESI) m/z 285 [(M + 
H)
+
, 100], 229 (500); HRMS (ESI) m/z calcd for C14H21ClN2O2 (M + H)
+
 285.1364, 
found 285.1361 (+1.0 ppm error). 
Lab Book Reference: GG6/58/1 
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2-Pyridin-3-ylpyrrolidine-1-carboxylic acid tert-butyl ester (R)-247  
 
(Table 4.4, Entry 3) 
Using general procedure J: s-BuLi (0.2 mL of a 1.3 M solution in hexanes, 0.26 mmol, 
1.3 eq.), N-Boc chloro-propylamine 246 (57 mg, 0.2 mmol, 1.0 eq.) and (+)-sparteine 
surrogate (50 mg, 0.26 mmol, 1.3 eq.) in toluene (2 mL) gave the crude product. 
Purification by flash column chromatography on silica with 70:30 CH2Cl2-Et2O as 
eluent gave pyrrolidine (R)-247 (15 mg, 30%, 65:35 er by CSP-HPLC) as a colourless 
oil, RF (70:30 CH2Cl2-Et2O) 0.4; 
1
H NMR (400 MHz, CDCl3) (65:35 mixture of 
rotamers) δ 8.51-8.41 (m, 2H, Ar), 7.49 (d, J = 8.0 Hz, 1H, Ar), 7.23 (dd, J = 8.0, 
5.0Hz, 1H, Ar), 4.95 (br s, 0.35H, NCH), 4.77 (br s, 0.65H, Ar), 3.68-3.44 (m, 2H, 
NCH), 2.44-2.23 (m, 1H, CH), 1.98-1.75 (m, 3H, CH), 1.44 (s, 3.15H, CMe3), 1.18 (s, 
5.85H, CMe3);
 13
C NMR (100.6 MHz, CDCl3) (mixture of rotamers) δ 154.2 (C=O), 
148.0 (Ar), 147.7 (Ar), 147.2 (Ar), 140.3 (Ar), 133.2 (ipso-Ar), 133.0 (ipso-Ar), 123.2 
(Ar), 79.6 (CMe3), 59.1 (NCH), 58.7 (NCH), 47.2 (NCH2), 47.0 (NCH2), 35.8 (CH2), 
34.5 (CH2), 28.4 (CMe3), 28.1 (CMe3), 23.5 (CH2), 23.2 (CH2); CSP-HPLC: Chiralcel 
AD-H (80:20 hexane:i-PrOH, 0.7 mL min
–1
) (S)-247 5.8 min, (R)-247 6.6 min and 
recovered starting material 246 (31 mg, 54%). Spectroscopic data consistent with those 
reported in the literature.
56
  
Lab Book Reference: GG6/59/1 
 
(Table 4.4, Entry 4) 
Using general procedure J: s-BuLi (0.2 mL of a 1.3 M solution in hexanes, 0.26 mmol, 
1.3 eq.), N-Boc chloro-propylamine 246 (57 mg, 0.2 mmol, 1.0 eq.) and (+)-sparteine 
surrogate (50 mg, 0.26 mmol, 1.3 eq.) in Et2O (2 mL) gave the crude product. 
Purification by flash column chromatography on silica with 70:30 CH2Cl2-Et2O as 
eluent gave pyrrolidine (R)-247 (25 mg, 50%, 64:36 er by CSP-HPLC) as a colourless 
oil, CSP-HPLC: Chiralcel AD-H (80:20 hexane:i-PrOH, 0.7 mL min
–1
) (S)-247 5.8 min, 
(R)-247 6.6 min and recovered starting material 246 (13 mg, 23%). 
Lab Book Reference: GG6/60/1 
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2-Pyridin-3-ylpyrrolidine-1-carboxylic acid tert-butyl ester (S)-247 
 
(Table 4.3, Entry 1) 
Using general procedure J: s-BuLi (0.2 mL of a 1.3 M solution in hexanes, 0.26 mmol, 
1.3 eq.), N-Boc chloro-propylamine 246 (57 mg, 0.2 mmol, 1.0 eq.) and (‒)-sparteine 
(60 μL, 0.26 mmol, 1.3 eq.) in toluene (2 mL) gave the crude product. Purification by 
flash column chromatography on silica with 70:30 CH2Cl2-Et2O as eluent gave 
pyrrolidine (S)-247 (18 mg, 36%, 53:47 er by CSP-HPLC) as a colourless oil, CSP-
HPLC: Chiralcel AD-H (80:20 hexane:i-PrOH, 0.7 mL min
–1
) (S)-247 5.8 min, (R)-247 
6.6 min and recovered starting material 246 (23 mg, 40%). 
Lab Book Reference: GG6/63/1 
 
(Table 4.4, Entry 2) 
Using general procedure J: s-BuLi (0.2 mL of a 1.3 M solution in hexanes, 0.26 mmol, 
1.3 eq.), N-Boc chloro-propylamine 246 (57 mg, 0.2 mmol, 1.0 eq.) and (‒)-sparteine 
(60 μL, 0.26 mmol, 1.3 eq.) in Et2O (2 mL) gave the crude product. Purification by flash 
column chromatography on silica with 70:30 CH2Cl2-Et2O as eluent gave pyrrolidine 
(S)-247 (35 mg, 70%, 51:49 er by CSP-HPLC) as a colourless oil, CSP-HPLC: 
Chiralcel AD-H (80:20 hexane:i-PrOH, 0.7 mL min
–1
) (S)-247 5.8 min, (R)-247 6.6 min 
and recovered starting material 246 (13 mg, 23%). 
Lab Book Reference: GG6/64/1 
 
2,5-Dimethyl-2-phenylpyrrolidine-1-carboxylic acid tert-butyl ester (2R,5R)-249 
and (2R,5S)-250 
 
(Table 4.6, Entry 2) 
Using general procedure K: s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq.), pyrrolidine (R)-232 (131 mg, 0.5 mmol, 1.0 eq., 98:2 er) and (+)-sparteine 
surrogate (126 mg, 0.65 mmol, 1.3 eq.) in Et2O (3.5 mL) at 40 °C under Ar for 30 min. 
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Then, Me2SO4 (126 mg, 100 μL, 1.0 mmol, 2.0 eq.), saturated NH4Cl(aq) (5 mL), Et2O 
(5 mL) and extraction with Et2O (3 × 5 mL) gave the crude product. Purification by 
flash column chromatography on silica with 90:10 petrol-Et2O as eluent gave an 81:19 
mixture (by 
1
H NMR spectroscopy of the amines) of pyrrolidines (2R,5R)-249 and 
(2R,5S)-250 (114 mg, 82%) as a colourless oil, IR (CHCl3) 2928, 1648 (C=O), 1369, 
1147, 746 cm
1
;
 
 
1
H NMR (400 MHz, CDCl3) (mixture of rotamers) δ 7.38-7.27 (m, 
3.5H, Ph), 7.24-7.13 (m, 1.5H, Ph), 4.36-4.08 (m, 1H, NCH), 2.29-2.02 (m, 2H, CH), 
1.97-1.88 (m, 1H, CH), 1.84 (s, 0.3H, Me), 1.81-1.67 (m, 2.4H, Me), 1.64-1.51 (m, 2H, 
Me + CH), 1.50-1.37 (m, 4H, Me + CMe3), 1.37-1.21 (m, 1.6H, Me), 1.14 (s, 0.7H, 
CMe3), 1.09 (s, 5H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) (mixture of rotamers) δ 
154.2 (C=O 2R,5S), 153.8 (C=O 2R,5R), 153.1 (C=O2R,5R), 148.4 (ipso-Ph 2R,5R), 148.2 
(ipso-Ph 2R,5S), 147.5 (ipso-Ph 2R,5R), 128.1 (Ph 2R,5R), 128.0 (Ph 2R,5S), 127.8 (Ph 2R,5R), 
127.7 (Ph 2R,5S), 125.9 (Ph 2R,5S), 125.8 (Ph 2R,5S), 125.7 (Ph 2R,5R), 125.0 (Ph 2R,5R), 124.7 
(Ph 2R,5R), 78.9 (CMe3 2R,5S), 78.8 (CMe3 2R,5R), 66.6 (NC 2R,5R), 66.4 (NC 2R,5S), 66.1 (NC 
2R,5R), 65.8 (NC 2R,5S), 55.8 (NCH 2R,5S), 55.6 (NCH 2R,5S), 54.8 (NCH 2R,5R), 54.7 (NCH 
2R,5R), 43.4 (CH2 2R,5R), 42.8 (CH2 2R,5S), 42.6 (CH2 2R,5R), 42.0 (CH2 2R,5S), 30.3 (CH2 
2R,5R), 29.9 (CH2 2R,5R), 28.6 (CMe3 2R,5S), 28.5 (CMe3 2R,5R), 28.4 (CH2 2R,5S), 28.2 (CH2 
2R,5S), 28.1 (CMe3 2R,5S), 28.0 (CMe3 2R,5R), 23.7 (Me 2R,5R), 23.6 (Me 2R,5R), 21.5 (Me 
2R,5S), 21.2 (Me 2R,5R), 20.9 (Me 2R,5S), 20.3 (Me 2R,5R); MS (ESI) m/z 298 [(M + Na)
+
, 
80], 276 [(M + H)
+
, 30], 220 (100); HRMS (ESI) m/z calcd for C17H25NO2 (M + H)
+
 
276.1958, found 276.1945 (+4.9 ppm error). 
Lab Book Reference: GG4/15/1 
 
(Table 4.6, Entry 1) 
Using general procedure K: s-BuLi (0.4 mL of a 1.3 M solution in hexanes, 0.52 mmol, 
1.3 eq.), pyrrolidine (R)-232 (104 mg, 0.4 mmol, 1.0 eq., 98:2 er) and (+)-sparteine 
surrogate (101 mg, 0.52 mmol, 1.3 eq.) in Et2O (2.8 mL) at 78 °C under Ar for 1 h. 
Then, Me2SO4 (101 mg, 76 μL, 0.8 mmol, 2.0 eq.), saturated NH4Cl(aq) (4 mL), Et2O (4 
mL) and extraction with Et2O (3 × 4 mL) gave the crude product. Purification by flash 
column chromatography on silica with 90:10 petrol-Et2O as eluent gave an 87:13 
mixture (by 
1
H NMR spectroscopy of the amines) of pyrrolidines (2R,5R)-249 and 
(2R,5S)-250 (49 mg, 45%) as a colourless oil and recovered starting material (R)-232 
(45 mg, 43%) as a white solid. 
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Lab Book Reference: GG4/65/1 
 
2,5-Dimethyl-2-phenylpyrrolidine-1-carboxylic acid tert-butyl ester (2S,5R)-250 
and (2S,5S)-249 
 
(Table 4.7, Entry 2) 
Using general procedure K: s-BuLi (0.4 mL of a 1.3 M solution in hexanes, 0.52 mmol, 
1.3 eq.), pyrrolidine (S)-232 (104 mg, 0.4 mmol, 1.0 eq., 98:2 er) and (+)-sparteine 
surrogate (101 mg, 0.52 mmol, 1.3 eq.) in Et2O (2.8 mL) at 40 °C under Ar for 30 min. 
Then, Me2SO4 (101 mg, 76 μL, 0.8 mmol, 2.0 eq.), saturated NH4Cl(aq) (4 mL), Et2O (4 
mL) and extraction with Et2O (3 × 4 mL) gave the crude product. Purification by flash 
column chromatography on silica with 90:10 petrol-Et2O as eluent gave a 94:6 mixture 
(by 
1
H NMR spectroscopy of the amines) of pyrrolidines (2S,5R)-250 and (2S,5S)-249 
(94 mg, 85%) as a colourless oil, [α]D 103.0 (c 1.0 in CHCl3); IR (CHCl3) 2961, 2928, 
1649 (C=O), 1367, 1146, 1071, 1015 cm
1
;
 1
H NMR (400 MHz, CDCl3) (65:35 mixture 
of rotamers) δ 7.32-7.25 (m, 2H, Ph), 7.22-7.13 (m, 3H, Ph), 4.37-4.27 (m, 0.65H, 
NCH), 4.25-4.14 (m, 0.35H, NCH), 2.31-2.16 (m, 1H, CH), 2.05-1.86 (m, 2H, CH), 
1.95 (s, 1H, Me), 1.84 (s, 2H, Me), 1.48 (s, 3.15H, CMe3), 1.46-1.35 (m, 1H, Me), 1.33 
(d, J = 6.0 Hz, 2H, Me), 1.28 (d, J = 6.0 Hz, 1H, Me), 1.31-1.17 (m, 1H, CH), 1.14 (s, 
5.85H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) (mixture of rotamers) δ 154.2 (C=O), 
153.5 (C=O), 148.2 (ipso-Ph), 146.5 (ipso-Ph), 128.0 (Ph), 127.7 (Ph), 125.9 (Ph), 
125.8 (Ph), 124.7 (Ph), 78.9 (CMe3), 78.8 (CMe3 2S,5S), 66.4 (NC), 65.8 (NC), 55.8 
(NCH), 55.7 (NCH), 42.8 (CH2), 42.6 (CH2), 42.0 (CH2), 28.6 (CMe3), 28.4 (CH2), 28.2 
(CH2), 28.1 (CMe3), 21.5 (Me), 20.9 (Me); MS (ESI) m/z 298 [(M + Na)
+
, 80], 276 [(M 
+ H)
+
, 30], 220 (100); HRMS (ESI) m/z calcd for C17H25NO2 (M + H)
+
 276.1958, found 
276.1950 (+3.0 ppm error) and recovered starting material (S)-232 (15 mg, 14%) as a 
white solid. 
Lab Book Reference: GG4/68/1 
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(Table 4.6, Entry 1) 
Using general procedure K: s-BuLi (0.4 mL of a 1.3 M solution in hexanes, 0.52 mmol, 
1.3 eq.), pyrrolidine (S)-232 (104 mg, 0.4 mmol, 1.0 eq., 98:2 er) and (+)-sparteine 
surrogate (101 mg, 0.52 mmol, 1.3 eq.) in Et2O (2.8 mL) at 78 °C under Ar for 1 h. 
Then, Me2SO4 (101 mg, 76 μL, 0.8 mmol, 2.0 eq.), saturated NH4Cl(aq) (4 mL), Et2O (4 
mL) and extraction with Et2O (3 × 4 mL) gave the crude product. Purification by flash 
column chromatography on silica with 90:10 petrol-Et2O as eluent gave a 92:8 mixture 
(by 
1
H NMR spectroscopy of the amines) of pyrrolidines (2S,5R)-250 and (2S,5S)-249 
(56 mg, 51%) as a colourless oil and recovered starting material (S)-232 (42 mg, 40%) 
as a white solid. 
Lab Book Reference: GG4/67/1 
 
2,5-Dimethyl-2-phenylpyrrolidine-1-carboxylic acid tert-butyl ester (2R,5S)-250 
and (2R,5R)-249 
 
(Table 4.6, Entry 3) 
Using general procedure K: s-BuLi (0.4 mL of a 1.3 M solution in hexanes, 0.52 mmol, 
1.3 eq.), pyrrolidine (R)-232 (104 mg, 0.4 mmol, 1.0 eq., 98:2 er) and ()-sparteine (122 
mg, 0.52 mmol, 1.3 eq.) in Et2O (2.8 mL) at 78 °C under Ar for 1 h. Then, Me2SO4 
(101 mg, 76 μL, 0.8 mmol, 2.0 eq.), saturated NH4Cl(aq) (4 mL), Et2O (4 mL) and 
extraction with Et2O (3 × 4 mL) gave the crude product. Purification by flash column 
chromatography on silica with 90:10 petrol-Et2O as eluent gave a 98:2 mixture (by 
1
H 
NMR spectroscopy of the amines) of pyrrolidines (2R,5S)-250 and (2R,5R)-249 (50 mg, 
45%) as a colourless oil, [α]D +86.0 (c 1.0 in CHCl3) and recovered starting material 
(R)-232 (55 mg, 53%) as a white solid. 
Lab Book Reference: GG4/92/1 
 
(Table 4.6, Entry 4) 
Using general procedure K: s-BuLi (0.2 mL of a 1.3 M solution in hexanes, 0.26 mmol, 
1.3 eq.), pyrrolidine (R)-232 (52 mg, 0.2 mmol, 1.0 eq., 98:2 er) and ()-sparteine (61 
mg, 0.26 mmol, 1.3 eq.) in Et2O (1.4 mL) at 40 °C under Ar for 30 min. Then, Me2SO4 
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(50 mg, 40 μL, 0.4 mmol, 2.0 eq.), saturated NH4Cl(aq) (2 mL), Et2O (2 mL) and 
extraction with Et2O (3 × 2 mL) gave the crude product. Purification by flash column 
chromatography on silica with 90:10 petrol-Et2O as eluent gave a 91:9 mixture (by 
1
H 
NMR spectroscopy of the amines) of pyrrolidines (2R,5S)-250 and (2R,5R)-249 (53 mg, 
96%) as a colourless oil. 
Lab Book Reference: GG4/50/1 
 
(Scheme 4.48) 
Using general procedure K: s-BuLi (0.37 mL of a 1.3 M solution in hexanes, 0.48 
mmol, 1.3 eq.), pyrrolidine (R)-232 (96 mg, 0.37 mmol, 1.0 eq., 98:2 er) and TMEDA 
(56 mg, 70 μL, 0.48 mmol, 1.3 eq.) in Et2O (2.6 mL) at 78 °C under Ar for 30 min. 
Then, Me2SO4 (91 mg, 70 μL, 0.74 mmol, 2.0 eq.), saturated NH4Cl(aq) (4 mL), Et2O (4 
mL) and extraction with Et2O (3 × 4 mL) gave the crude product. Purification by flash 
column chromatography on silica with 90:10 petrol-Et2O as eluent gave a 60:40 mixture 
(by 
1
H NMR spectroscopy of the amines) of pyrrolidines (2R,5S)-250 and (2R,5R)-249 
(52 mg, 51%) as a colourless oil and recovered starting material (R)-232 (40 mg, 42%) 
as a white solid. 
Lab Book Reference: GG3/97/1 
 
2,5-Dimethyl-2-phenylpyrrolidine-1-carboxylic acid tert-butyl ester (2R*,5R*)-249 
and (2R*,5S*)-250 
 
(Table 4.5, Entry 1) 
s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 1.3 eq.) was added dropwise 
to a stirred solution of pyrrolidine rac-232 (131 mg, 0.5 mmol, 1.0 eq.) in THF (3.5 mL) 
at 40 °C under Ar. The resulting solution was stirred at 40 °C for 30 min. Then, 
Me2SO4 (126 mg, 100 μL, 1.0 mmol, 1.0 eq.) was added. The resulting solution was 
stirred at 40 °C for 10 min and then allowed to warm to rt over 1 h. Then, saturated 
NH4Cl(aq) (5 mL) and Et2O (5 mL) were added and the two layers were separated. The 
aqueous layer was extracted with Et2O (3 × 5 mL) and the combined organic layers 
were dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
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Purification by flash column chromatography on silica with 90:10 petrol-Et2O as eluent 
gave an undetermined mixture of pyrrolidines (2R*,5R*)-249 and (2R*,5S*)-250 (112 
mg, 81%) as a colourless oil, RF (90:10 petrol-Et2O) 0.2. 
Lab Book Reference: GG4/7/1 
 
(Table 4.5, Entry 2) 
Using general procedure K: s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq.), pyrrolidine rac-232 (131 mg, 0.5 mmol, 1.0 eq.) and TMEDA (75 mg, 100 μL, 
0.65 mmol, 1.3 eq.) in THF (3.5 mL) at 40 °C under Ar for 30 min. Then, Me2SO4 
(126 mg, 100 μL, 1.0 mmol, 1.0 eq.), saturated NH4Cl(aq) (5 mL), Et2O (5 mL) and 
extraction with Et2O (3 × 5 mL) gave the crude product. Purification by flash column 
chromatography on silica with 90:10 petrol-Et2O as eluent gave an undetermined 
mixture of pyrrolidines (2R*,5R*)-249 and (2R*,5S*)-250 (128 mg, 93%) as a 
colourless oil. 
Lab Book Reference: GG4/8/1 
 
(Table 4.5, Entry 3) 
Using general procedure K: s-BuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq.), pyrrolidine rac-232 (131 mg, 0.5 mmol, 1.0 eq.) and TMEDA (75 mg, 100 μL, 
0.65 mmol, 1.3 eq.) in Et2O (3.5 mL) at 40 °C under Ar for 30 min. Then, Me2SO4 
(126 mg, 100 μL, 1.0 mmol, 1.0 eq.), saturated NH4Cl(aq) (5 mL), Et2O (5 mL) and 
extraction with Et2O (3 × 5 mL) gave the crude product. Purification by flash column 
chromatography on silica with 90:10 petrol-Et2O as eluent gave an undetermined 
mixture of pyrrolidines (2R*,5R*)-249 and (2R*,5S*)-250 (124 mg, 90%) as a 
colourless oil. 
Lab Book Reference: GG4/14/1 
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(2R,5R)-2,5-Dimethyl-2-phenylpyrrolidine (2R,5R)-251 and (2R,5S)-252 
 
(from reaction in Table 4.6, Entry 1) 
Using general procedure L: TFA (114 mg, 76 μL, 1.0 mmol, 10.0 eq.) and an unknown 
mixture of pyrrolidines (2R,5R)-249 and (2R,5S)-250 (27 mg, 0.1 mmol, 1.0 eq.) in 
CH2Cl2 (1 mL) gave an 87:13 mixture (by 
1
H NMR spectroscopy) of pyrrolidines 
(2R,5R)-251 and (2R,5S)-252 (13 mg, 74%) as a yellow oil, IR (CHCl3) 3361 (NH), 
2917, 2882, 1425, 1354, 1241, 1120, 691 cm
1
; 
1
H NMR (400 MHz, CDCl3) δ 7.54-
7.48 (m, 2H, Ph), 7.36-7.30 (m, 2H, Ph), 7.24-7.19 (m, 1H, Ph), 3.52 (ddq, J = 6.5, 6.5, 
6.5 Hz, 0.87H, NCH 2R,5R), 3.23 (ddq, J = 6.5, 6.5, 6.5 Hz, 0.13H, NCH 2R,5S), 2.22-1.82 
(m, 4H, CH + NH), 1.50 (s, 0.39H, Me), 1.44 (s, 2.61H, Me), 1.43-1.35 (m, 1H, CH), 
1.25 (d, J = 6.5 Hz, 0.39H, Me), 1.23 (d, J = 6.5 Hz, 2.61H, Me); 
13
C NMR (100.6 
MHz, CDCl3) δ 150.0 (ipso-Ph 2R,5R), 128.1 (Ph 2R,5R), 126.1 (Ph 2R,5R), 126.0 (Ph 2R,5R), 
125.3 (Ph 2R,5S), 65.5 (NC 2R,5R), 54.0 (NCH 2R,5S), 53.2 (NCH 2R,5R), 40.5 (CH2 2R,5S), 
40.0 (CH2 2R,5R), 34.2 (CH2 2R,5S), 33.5 (CH2 2R,5R), 32.0 (Me 2R,5S), 30.4 (Me 2R,5R), 21.9 
(Me 2R,5R); MS (ESI) m/z 176 [(M + H)
+
, 100]; HRMS (ESI) m/z calcd for C12H17N (M 
+ H)
+
 176.1434, found 176.1438 (2.1 ppm error). 
Lab Book Reference: GG4/71/1 
 
(from reaction in Table 4.6, Entry 2) 
Using general procedure L: TFA (114 mg, 76 μL, 1.0 mmol, 10.0 eq.) and an unknown 
mixture of pyrrolidines (2R,5R)-249 and (2R,5S)-250 (27 mg, 0.1 mmol, 1.0 eq.) in 
CH2Cl2 (1 mL) gave an 81:19 mixture (by 
1
H NMR spectroscopy) of pyrrolidines 
(2R,5R)-251 and (2R,5S)-252 (13 mg, 74%) as a yellow oil. 
Lab Book Reference: GG4/86/1 
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(2S,5R)-2,5-Dimethyl-2-phenylpyrrolidine (2S,5R)-252 and (2S,5S)-251 
 
(from reaction in Table 4.7, Entry 2) 
Using general procedure L: TFA (114 mg, 76 μL, 1.0 mmol, 10.0 eq.) and an unknown 
mixture of pyrrolidines (2S,5R)-249 and (2S,5S)-250 (27 mg, 0.1 mmol, 1.0 eq.) in 
CH2Cl2 (1 mL) gave a 94:6 mixture (by 
1
H NMR spectroscopy) of pyrrolidines (2S,5R)-
252 and (2S,5S)-251 (11 mg, 63%), IR (CHCl3) 3290 (NH), 2915, 1425, 1353, 1240, 
1121, 1012, 745, 692 cm
1
; 
1
H NMR (400 MHz, CDCl3) (for (2S,5R)-252) δ 7.54-7.48 
(m, 2H, Ph), 7.36-7.30 (m, 2H, Ph), 7.24-7.19 (m, 1H, Ph), 3.52 (ddq, J = 6.5, 6.5, 6.5 
Hz, 0.06H, NCH 2S,5S), 3.23 (ddq, J = 6.5, 6.5, 6.5 Hz, 0.94H, NCH 2S,5R), 2.22 (dt, J = 
12.5, 7.5 Hz, 1H, CH), 2.14-2.01 (m, 1H, CH + NH), 2.01-1.82 (m, 2H, CH2), 1.50 (s, 
2.82H, Me), 1.49-1.39 (m, 1.18H, CH + Me), 1.25 (d, J = 6.5 Hz, 2.82H, Me), 1.23 (d, J 
= 6.5 Hz, 0.18H, Me); 
13
C NMR (100.6 MHz, CDCl3) δ 149.1 (ipso-Ph), 128.1 (Ph), 
126.0 (Ph), 125.3 (Ph), 65.7 (NC), 54.0 (NCH), 40.5 (CH2), 34.2 (CH2), 32.0 (Me), 21.9 
(Me); MS (ESI) m/z 176 [(M + H)
+
, 100]; HRMS (ESI) m/z calcd for C12H17N (M + H)
+
 
176.1434, found 176.1438 (2.1 ppm error). 
Lab Book Reference: GG4/74/1 
 
(from reaction in Table 4.7, Entry 1) 
Using general procedure L: TFA (114 mg, 76 μL, 1.0 mmol, 10.0 eq.) and an unknown 
a mixture of pyrrolidines (2S,5R)-250 and (2S,5S)-249 (27 mg, 0.1 mmol, 1.0 eq.) in 
CH2Cl2 (1 mL) gave a 92:8 mixture (by 
1
H NMR spectroscopy) of pyrrolidines (2S,5R)-
252 and (2S,5S)-251 (5 mg, 28%). 
Lab Book Reference: GG4/73/1 
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(2R,5S)-2,5-Dimethyl-2-phenylpyrrolidine (2R,5S)-252 and (2R,5R)-251 
 
(from reaction in Table 4.6, Entry 3) 
Using general procedure L: TFA (114 mg, 76 μL, 1.0 mmol, 10.0 eq.) and an unknown 
mixture of pyrrolidines (2R,5S)-250 and (2R,5R)-249 (27 mg, 0.1 mmol, 1.0 eq.) in 
CH2Cl2 (1 mL) gave a 98:2 mixture (by 
1
H NMR spectroscopy) of pyrrolidines (2R,5S)-
252 and (2R,5R)-251 (12 mg, 74%). 
Lab Book Reference: GG4/95/1 
 
(from reaction in Table 4.6, Entry 4) 
Using general procedure L: TFA (148 mg, 48 μL, 1.3 mmol, 10.0 eq.) and a mixture of 
pyrrolidines (2R,5S)-250 and (2R,5R)-249 (35 mg, 0.13 mmol, 1.0 eq.) in CH2Cl2 (1 
mL) gave a 91:9 mixture (by 
1
H NMR spectroscopy) of pyrrolidines (2R,5S)-252 and 
(2R,5R)-251 (13 mg, 57%). 
Lab Book Reference: GG4/53/1 
 
(Scheme 4.48) 
Using general procedure L: TFA (74 mg, 48 μL, 0.64 mmol, 10.0 eq.) and an unknown 
mixture of pyrrolidines (2R,5S)-250 and (2R,5R)-249 (18 mg, 0.065 mmol, 1.0 eq.) in 
CH2Cl2 (0.65 mL) gave a 60:40 mixture (by 
1
H NMR spectroscopy) of pyrrolidines 
(2R,5S)-252 and (2R,5R)-251 (10 mg, 83%). 
Lab Book Reference: GG4/70/1 
 
2,5-Dimethyl-2-phenylpyrrolidine (2R*,5R*)-251 and (2R*,5S*)-252 
 
(Scheme 4.46) 
Using general procedure L: TFA (114 mg, 76 μL, 0.64 mmol, 10.0 eq.) and an unknown 
mixture of pyrrolidines (2R*,5R*)-249 and (2R*,5S*)-250 (30 mg, 0.11 mmol, 1.0 eq.) 
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in CH2Cl2 (0.3 mL) gave a 55:45 mixture (by 
1
H NMR spectroscopy) of pyrrolidines 
(2R*,5R*)-251 and (2R*,5S*)-252 (10 mg, 92%). 
Lab Book Reference: GG4/47/1 
 
Attempted synthesis of 2,2,5-trimethyl-5-phenylpyrrolidine-1-carboxylic acid tert-
butyl ester 255 
 
(Scheme 4.53) 
s-BuLi (0.24 mL of a 1.3 M solution in hexanes, 0.31 mmol, 1.3 eq.) was added 
dropwise to a stirred solution of an undetermined mixture of pyrrolidines (2R*,5R*)-
249 and (2R*,5S*)-250 (62 mg, 0.24 mmol, 1.0 eq.) and TMEDA (36 mg, 50 μL, 0.31 
mmol, 1.3 eq.) in THF (1.7 mL) at 30 °C under Ar. The resulting solution was stirred 
at 30 °C for 1 h. Then, Me2SO4 (60 mg, 45 μL, 0.48 mmol, 2.0 eq.) was added. The 
resulting solution was stirred at 30 °C for 10 min and then allowed to warm to rt over 
1 h. Then, saturated NH4Cl(aq) (5 mL) and Et2O (5 mL) were added and the two layers 
were separated. The aqueous layer was extracted with Et2O (3 × 5 mL) and the 
combined organic layers were dried (MgSO4) and evaporated under reduced pressure to 
give the crude product. The 
1
H NMR spectrum of the crude product showed only 
starting material and therefore purification was not attempted. 
Lab Book Reference: GG4/21/1 
 
Attempted synthesis of 2-(hydroxydiphenylmethyl)-2,5-dimethyl-5-
phenylpyrrolidine-1-carboxylic acid tert-butyl ester 256 
 
(Scheme 4.53) 
s-BuLi (0.3 mL of a 1.3 M solution in hexanes, 0.39 mmol, 1.3 eq.) was added dropwise 
to a stirred solution of an undetermined mixture of pyrrolidines (2R*,5R*)-249 and 
(2R*,5S*)-250 (75 mg, 0.24 mmol, 1.0 eq.) and TMEDA (45 mg, 60 μL, 0.39 mmol, 1.3 
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eq.) in THF (2.1 mL) at 30 °C under Ar. The resulting solution was stirred at 30 °C 
for 1 h. Then, a solution of benzophenone (109 mg, 0.6 mmol, 2.0 eq.) in THF (1 mL) 
was added. The resulting solution was stirred at 30 °C for 10 min and then allowed to 
warm to rt over 1 h. Then, saturated NH4Cl(aq) (5 mL) and Et2O (5 mL) were added and 
the two layers were separated. The aqueous layer was extracted with Et2O (3 × 5 mL) 
and the combined organic layers were dried (MgSO4) and evaporated under reduced 
pressure to give the crude product. The 
1
H NMR spectrum of the crude product showed 
only starting material and therefore purification was not attempted. 
Lab Book Reference: GG4/25/1 
 
2-Methyl-2,5-diphenylpyrrolidine-1-carboxylic acid tert-butyl ester (2S,5S)-253 
and (2S,5R)-254 
 
(Table 4.8, Entry 1) 
Using general procedure M: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), pyrrolidine (S)-232 (261 mg, 1.0 mmol, 1.0 eq., 98:2 er) and (+)-sparteine 
surrogate (252 mg, 1.3 mmol, 1.3 eq.) in Et2O (7 mL), then ZnCl2 (0.6 mL of a 1.0 M 
solution in Et2O, 0.6 mmol, 0.6 eq.), bromobenzene (204 mg, 140 μL, 1.3 mmol, 1.3 
eq.), t-Bu3PHBF4 (14.5 mg, 0.05 mmol, 0.05 eq.) and Pd(OAc)2 (9 mg, 0.04 mmol, 0.04 
eq.) gave the crude product. Purification by flash column chromatography on silica with 
95:5 petrol-Et2O as eluent gave a 96:4 mixture (by CSP-HPLC) of pyrrolidines (2S,5S)-
253 and (2S,5R)-254 (190 mg, 56%, >99:1 er for (2S,5S)-253 and 98:2 er for (2S,5R)-
254 by CSP-HPLC) as a colourless oil, IR (CHCl3) 2929, 2889, 1668 (C=O), 1427, 
1343, 1228, 1144, 1104, 1013, 749, 690 cm
1
;
 1
H NMR (400 MHz, CDCl3) (55:45 
mixture of rotamers) δ 7.38-7.20 (m, 10H, Ph), 5.33 (dd, J = 8.0, 2.5 Hz, 0.55H, NCH), 
5.16 (dd, J = 8.0, 2.5 Hz, 0.45H, NCH), 2.36-2.16 (m, 2H, CH), 2.14 (s, 1.35H, Me), 
2.04 (s, 1.65H, Me), 1.97-1.90 (m, 1H, CH), 1.75-1.63 (m, 1H, CH), 1.18 (s, 4.05H, 
CMe3), 1.16 (s, 4.95H, CMe3);
 13
C NMR (100.6 MHz, CDCl3) (mixture of rotamers) δ 
154.5 (C=O), 153.7 (C=O), 147.9 (ipso-Ph), 146.5 (ipso-Ph), 145.4 (ipso-Ph), 144.2 
(ipso-Ph), 128.4 (Ph), 128.2 (Ph), 128.1 (Ph), 127.9 (Ph), 126.5 (Ph), 126.3 (Ph), 126.2 
(Ph), 126.1 (Ph), 125.5 (Ph), 125.4 (Ph), 125.0 (Ph), 124.9 (Ph), 79.5 (CMe3), 79.1 
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(CMe3), 67.2 (NC), 66.6 (NC), 64.3 (NCH), 64.1 (NCH), 42.5 (CH2), 41.7 (CH2), 31.05 
(CH2), 31.00 (CH2), 28.1 (CMe3), 27.4 (Me), 26.9 (Me); MS (ESI) m/z 360 [(M + Na)
+
, 
50], 338 [(M + H)
+
, 45], 282 (100); HRMS (ESI) m/z calcd for C22H27NO2 (M + H)
+
 
338.2115, found 338.2115 (+0.7 ppm error); CSP-HPLC: Chiralcel AD-H (99:1 
hexane:i-PrOH, 0.7 mL min
–1
) (2S,5R)-254 5.7 min, (2R,5S)-254 7.6 min,  (2R,5R)-253 
9.0 min, (2S,5S)-253 11.8 min. 
Lab Book Reference: GG5/95/1 
 
(Table 4.8, Entry 2) 
Using general procedure M: s-BuLi (0.42 mL of a 1.3 M solution in hexanes, 0.55 
mmol, 1.1 eq.), pyrrolidine (S)-232 (130 mg, 0.5 mmol, 1.0 eq., 94:6 er) and (+)-
sparteine surrogate (107 mg, 0.55 mmol, 1.1 eq.) in Et2O (1.4 mL), then ZnCl2 (0.3 mL 
of a 1.0 M solution in Et2O, 0.3 mmol, 0.6 eq.), bromobenzene (94 mg, 63 μL, 0.6 
mmol, 1.2 eq.), t-Bu3PHBF4 (7.2 mg, 0.025 mmol, 0.05 eq.) and Pd(OAc)2 (4.5 mg, 
0.02 mmol, 0.04 eq.) gave the crude product. Purification by flash column 
chromatography on silica with 95:5 petrol-Et2O as eluent gave a 94:6 mixture (by CSP-
HPLC) of pyrrolidines (2S,5S)-253 and (2S,5R)-254 (65 mg, 38%, >99:1 er for (2S,5S)-
253 and 76:24 er for (2S,5R)-254 by CSP-HPLC) as a colourless oil, CSP-HPLC: 
Chiralcel AD-H (99:1 hexane:i-PrOH, 0.7 mL min
–1
) (2S,5R)-254 5.4 min, (2R,5S)-254 
7.1 min,  (2R,5R)-253 8.2 min, (2S,5S)-253 11.1 min. 
Lab Book Reference: GG6/7/1 
 
(Table 4.8, Entry 3) 
s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 eq.) was added dropwise 
to a stirred solution of pyrrolidine (S)-232 (261 mg, 1.0 mmol, 1.0 eq., 80:20 er) and 
(+)-sparteine surrogate (252 mg, 1.3 mmol, 1.3 eq.) in Et2O (7 mL) at 40 °C under Ar. 
The resulting solution was stirred at 40 °C for 30 min. Then, ZnCl2 (0.6 mL of a 1.0 M 
solution in Et2O, 0.6 mmol, 0.6 eq.) was added and the resulting mixture was stirred at 
40 °C for 30 min. The reaction mixture was allowed to warm to rt over 30 min. Then, 
bromobenzene (204 mg, 140 μL, 1.3 mmol, 1.3 eq.) and a mixture of t-Bu3PHBF4 (19 
mg, 0.0625 mmol, 0.0625 eq.) and Pd(OAc)2 (11 mg, 0.05 mmol, 0.05 eq.) were added. 
The resulting mixture was stirred at rt for 16 h. NH4OH(aq) (0.1 mL) and Et2O (5 mL) 
were added and mixture stirred for 1 h. The solids were removed by filtration through a 
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pad of Celite

 and washed with Et2O (10 mL). The filtrate was washed with 1 M HCl(aq) 
(10 mL) and water (2 × 10 mL), dried (MgSO4) and evaporated under reduced pressure 
to give the crude product. Purification by flash column chromatography on silica with 
95:5 petrol-Et2O as eluent gave an 86:14 mixture (by CSP-HPLC) of pyrrolidines 
(2S,5S)-253 and (2S,5R)-254 (197 mg, 58%, 98:2 er for (2S,5S)-253 and 18:82 er for 
(2S,5R)-254 by CSP-HPLC) as a colourless oil, CSP-HPLC: Chiralcel AD-H (99:1 
hexane:i-PrOH, 0.7 mL min
–1
) (2S,5R)-254 4.9 min, (2R,5S)-254 5.4 min,  (2R,5R)-253 
6.1 min, (2S,5S)-253 8.4 min and recovered starting material (S)-232 (95 mg, 36%) as a 
white solid. 
Lab Book Reference: GG4/61/1 
 
(Scheme 4.56) 
Using general procedure M: s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq.), pyrrolidine (S)-232 (261 mg, 1.0 mmol, 1.0 eq., 98:2 er) and (‒)-sparteine (234 
mg, 1.3 mmol, 1.3 eq.) in Et2O (7 mL), then ZnCl2 (0.6 mL of a 1.0 M solution in Et2O, 
0.6 mmol, 0.6 eq.), bromobenzene (204 mg, 140 μL, 1.3 mmol, 1.3 eq.), t-Bu3PHBF4 
(19 mg, 0.065 mmol, 0.065 eq.) and Pd(OAc)2 (11 mg, 0.05 mmol, 0.05 eq.) gave the 
crude product. Purification by flash column chromatography on silica with 95:5 petrol-
Et2O as eluent gave a 19:81 mixture (by CSP-HPLC) of pyrrolidines (2S,5S)-253 and 
(2S,5R)-254 (190 mg, 56%, 94:6 er for (2S,5S)-253 and >99:1 er for (2S,5R)-254 by 
CSP-HPLC) as a colourless oil, CSP-HPLC: Chiralcel AD-H (99:1 hexane:i-PrOH, 0.7 
mL min
–1
) (2S,5R)-254 5.7 min, (2R,5S)-254 7.6 min,  (2R,5R)-253 9.0 min, (2S,5S)-
253 10.8 min. 
Lab Book Reference: GG4/93/1 
 
2-Methyl-2,5-diphenylpyrrolidine-1-carboxylic acid tert-butyl ester (2R,5R)-253 
and (2R,5S)-254 
 
(Scheme 4.55) 
Using general procedure M: s-BuLi (2.11 mL of a 1.3 M solution in hexanes, 2.75 
mmol, 1.1 eq.), pyrrolidine (R)-232 (653 mg, 2.5 mmol, 1.0 eq., 98:2 er) and ()-
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sparteine (644 mg, 2.75 mmol, 1.1 eq.) in Et2O (7 mL), then ZnCl2 (1.5 mL of a 1.0 M 
solution in Et2O, 1.5 mmol, 0.6 eq.), bromobenzene (471 mg, 310 μL, 3.0 mmol, 1.2 
eq.), t-Bu3PHBF4 (36 mg, 0.125 mmol, 0.05 eq.) and Pd(OAc)2 (22 mg, 0.1 mmol, 0.04 
eq.) gave the crude product. Purification by flash column chromatography on silica with 
95:5 petrol-Et2O as eluent gave a 95:5 mixture (by CSP-HPLC) of pyrrolidines (2R,5R)-
253 and (2R,5S)-254 (502 mg, 60%, >99:1 er for (2R,5R)-253 and 99:1 er for (2R,5S)-
254 by CSP-HPLC), as a colourless oil, CSP-HPLC: Chiralcel AD-H (99:1 hexane:i-
PrOH, 0.7 mL min
–1
) (2S,5R)-254 4.0 min, (2R,5S)-254 5.3 min,  (2R,5R)-253 6.7 min, 
(2S,5S)-253 11.1 min and recovered starting material (R)-232 (208 mg, 32%) as a white 
solid. 
Lab Book Reference: GG6/5/1 
 
2-Methyl-2,5-diphenylpyrrolidine-1-carboxylic acid tert-butyl ester (2R*,5R*)-253 
and (2R*,5S*)-254 
 
(Scheme 4.47) 
s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 eq.) was added dropwise 
to a stirred solution of N-Boc pyrrolidine rac-232 (261 mg, 1.0 mmol, 1.0 eq.) in THF 
(7 mL) at 40 °C under Ar. The resulting solution was stirred at 40 °C for 30 min. 
Then, ZnCl2 (0.6 mL of a 1.0 M solution in Et2O, 0.6 mmol, 0.6 eq.) was added and the 
resulting mixture was stirred at 40 °C for 30 min. The reaction mixture was allowed to 
warm to rt over 30 min. Then, bromobenzene (204 mg, 140 μL, 1.3 mmol, 1.3 eq.) and 
a mixture of 
t
Bu3PHBF4 (19 mg, 0.0625 mmol, 0.0625 eq.) and Pd(OAc)2 (11 mg, 0.05 
mmol, 0.05 eq.) were added. The resulting mixture was stirred at rt for 16 h. NH4OH(aq) 
(0.1 mL) and Et2O (5 mL) were added and mixture stirred for 1 h. The solids were 
removed by filtration through a pad of Celite

 and washed with Et2O (10 mL). The 
filtrate was washed with 1 M HCl(aq) (10 mL) and water (2 × 10 mL), dried (Na2SO4) 
and evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica with 95:5 petrol-Et2O as eluent gave a 64:36 mixture 
(by CSP-HPLC) of pyrrolidines (2R*,5R*)-253 and (2R*,5S*)-254 (140 mg, 42%) as a 
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colourless oil, CSP-HPLC: Chiralcel AD-H (99:1 hexane:i-PrOH, 0.7 mL min
–1
) 
(2S,5R)-254 4.6 min, (2R,5S)-254 5.3 min,  (2R,5R)-253 6.2 min, (2S,5S)-253 8.5 min. 
Lab Book Reference: GG4/46/1 
 
2-Methyl-2,5-diphenylpyrrolidine (2R*,5R*)-293 and (2R*,5S*)-294 
 
Using general procedure L: TFA (205 mg, 137 μL, 1.8 mmol, 10.0 eq.), a 64:36 mixture 
(by CSP-HPLC) of pyrrolidines (2R*,5R*)-253 and (2R*,5S*)-254 (65 mg, 0.2 mmol, 
1.0 eq.) in CH2Cl2 (0.55 mL) gave a 64:36 mixture (by 
1
H NMR spectroscopy) of 
pyrrolidines (2R*,5R*)-293 and (2R*,5S*)-294 (44 mg, 93%) as a colourless oil, 
1
H 
NMR (400 MHz, CDCl3) δ 7.72-7.59 (m, 2H, Ph), 7.57-7.46 (m, 2H, Ph), 7.44-7.33 (m, 
4H, Ph), 7.33-7.25 (m, 2H, Ph), 4.59 (dd, J = 7.5, 7.5 Hz, 0.36H, NCH), 4.31 (dd, J = 
7.5, 7.5 Hz, 0.64H, NCH 2R*,5R*), 2.43-2.12 (m, 4H, CH2), 1.63 (s, 1.92H, Me 2R*,5R*), 
1.62 (s, 1.08H, Me 2R*,5S*); 
13
C NMR (100.6 MHz, CDCl3) δ 150.5 (ipso-Ph 2R*,5S*), 
149.5 (ipso-Ph 2R*,5R*), 143.4 (ipso-Ph 2R*,5S*), 145.5 (ipso-Ph 2R*,5R*), 128.4 (Ph), 128.3 
(Ph), 128.2 (Ph), 128.1 (Ph), 128.0 (Ph), 127.8 (Ph), 126.8 (Ph), 126.7 (Ph), 126.6 (Ph), 
126.0 (Ph), 125.9 (Ph), 125.3 (Ph), 65.3 (NC 2R*,5R*), 64.4 (NC 2R*,5S*), 62.0 (NCH 
2R*,5R*), 61.4 (NCH 2R*,5S*), 40.8 (CH2 2R*,5S*), 40.6 (CH2 2R*,5R*), 34.7 (CH2 2R*,5S*), 34.6 
(CH2 2R*,5R*), 32.0 (Me 2R*,5R*), 30.7 (Me 2R*,5S*). 
Lab Book Reference: GG4/48/1 
 
5-(2-Fluoro-5-methylpyridin-3-yl)-2-methyl-2-phenylpyrrolidine-1-carboxylic acid 
tert-butyl ester (2R,5R)-257 and (2R,5S)-295 
 
(Scheme 4.58) 
Using general procedure M: s-BuLi (0.46 mL of a 1.3 M solution in hexanes, 0.6 mmol, 
1.2 eq.), pyrrolidine (R)-232 (130 mg, 0.5 mmol, 1.0 eq., 98:2 er) and ()-sparteine (140 
mg, 0.6 mmol, 1.2 eq.) in Et2O (1 mL), then ZnCl2 (0.3 mL of a 1.0 M solution in Et2O, 
0.3 mmol, 0.6 eq.), 3-bromo-2-fluoro-5-methylpyridine (190 mg, 0.41 mmol, 0.83 eq.), 
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t-Bu3PHBF4 (7.25 mg, 0.025 mmol, 0.05 eq.) and Pd(OAc)2 (4.5 mg, 0.02 mmol, 0.04 
eq.) gave the crude product. Purification by flash column chromatography on silica with 
99:1-95:5 CH2Cl2-Et2O as eluent gave 97:3 mixture (by 
1
H NMR spectroscopy of the 
amines) of pyrrolidines (2R,5R)-257 and (2R,5S)-295 (100 mg, 66%) as a white solid, 
mp 109-113 °C; RF (99:1 CH2Cl2-Et2O) 0.3; IR (ATR) 2971, 2933, 1695 (C=O), 1444, 
1364, 1165, 1110, 1027, 761, 697 cm
‒1
; 
1
H NMR (400 MHz, CDCl3) (55:45 mixture of 
rotamers) δ 7.91 (br s, 0.45H, Ar), 7.88 (br s, 0.55H, Ar), 7.53 (d, 4JHF = 9.5 Hz, d, J = 
2.0 Hz, 0.45H, Ar), 7.45 (d, 
4
JHF = 9.5 Hz, d, J = 2.5 Hz, 0.55H, Ar), 7.39-7.31 (m, 2H, 
Ph), 7.27-7.21 (m, 3H, Ph), 5.44 (d, J = 8.0 Hz, 0.55H, NCH), 5.34 (d, J = 8.0 Hz, 
0.45H, NCH), 2.35 (s, 3H, ArMe), 2.34-2.26 (m, 0.55H, CH), 2.23-2.15 (m, 0.45H, 
CH), 2.14 (s, 1.35H, Me), 2.13-2.05 (m, 1H, CH), 2.03 (s, 1.65H, Me), 1.77-1.63 (m, 
1H, CH), 1.23 CMe3), 1.18 (s, 4.95H, CMe3);
 13
C NMR (100.6 MHz, CDCl3) (mixture 
of rotamers) δ 159.0 (d, 1JCF = 235.5 Hz, ipso-Ar), 158.9 (d, 
1
JCF = 235.5 Hz, ipso-Ar), 
154.4 (C=O), 153.3 (C=O), 147.1 (ipso-Ph), 145.6 (ipso-Ph), 144.9 (d, 
3
JCF = 14.5 Hz, 
Ar), 144.8 (d, 
3
JCF = 14.5 Hz, Ar), 137.9 (d, 
3
JCF = 5.0 Hz, Ar), 137.7 (d, 
3
JCF = 5.0 Hz, 
Ar), 130.6 (d, 
4
JCF = 4.0 Hz, ipso-Ar), 130.5 (d, 
4
JCF = 4.0 Hz, ipso-Ar), 128.3 (Ph), 
128.0 (Ph), 126.5 (Ph), 126.3 (Ph), 125.9 (d, 
2
JCF = 27.5 Hz, ipso-Ar), 124.9 (Ph), 124.8 
(d, 
2
JCF = 27.5 Hz, ipso-Ar), 124.8 (Ph), 80.1 (CMe3), 79.7 (CMe3), 67.3 (NC), 66.8 
(NC), 58.6 (d, 
3
JCF = 2.5 Hz, NCH), 57.8 (d, 
3
JCF = 1.5 Hz, NCH), 42.4 (CH2), 41.6 
(CH2), 29.0 (CH2), 28.9 (CH2), 28.2 (CMe3), 28.0 (CMe3), 27.6 (Me), 27.2 (Me), 17.8 
(Me), 17.7 (Me); MS (ESI) m/z 393 [(M + Na)
+
, 100], 371 [(M + H)
 +
, 20], 315 (10); 
HRMS (ESI) m/z calcd for C22H27FN2O2 (M + H)
+
 371.2129, found 371.2117 (+3.0 
ppm error). 
Lab Book Reference: GG6/28/1 
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5-(2-Methoxyphenyl)-2-methyl-2-phenylpyrrolidine-1-carboxylic acid tert-butyl 
ester (2R,5R)-258 and (2R,5S)-296 
 
 
X-ray structure of (2R,5R)-258 
(Scheme 4.58) 
Using general procedure M: s-BuLi (0.46 mL of a 1.3 M solution in hexanes, 0.6 mmol, 
1.2 eq.), pyrrolidine (R)-232 (130 mg, 0.5 mmol, 1.0 eq., 98:2 er) and ()-sparteine (140 
mg, 0.6 mmol, 1.2 eq.) in Et2O (1 mL), then ZnCl2 (0.3 mL of a 1.0 M solution in Et2O, 
0.3 mmol, 0.6 eq.), 2-bromo-anisole (77 mg, 0.05 μL, 0.41 mmol, 0.83 eq.), t-
Bu3PHBF4 (7.25 mg, 0.025 mmol, 0.05 eq.) and Pd(OAc)2 (4.5 mg, 0.02 mmol, 0.04 
eq.) gave the crude product. Purification by flash column chromatography on silica with 
85:15 petrol-Et2O as eluent gave a 96:4 mixture (by 
1
H NMR spectroscopy of the 
amines) of pyrrolidines (2R,5R)-258 and (2R,5S)-296 (104 mg, 70%) as a white solid, 
mp 136-139 °C; RF (85:15 petrol-Et2O) 0.3; IR (ATR) 2977, 2942, 1691 (C=O), 1488, 
1372, 1239, 1027, 1027, 756, 701 cm
‒1
; 
1
H NMR (400 MHz, CDCl3) (55:45 mixture of 
rotamers) δ 7.38-7.19 (m, 7H, Ar), 6.98 (dd, J = 7.5, 7.5 Hz, 0.45H, Ar), 6.97 (dd, J = 
7.5, 7.5 Hz, 0.55H, Ar), 6.90 (br d, J = 8.0 Hz, 0.45H, Ar), 6.89 (br d, J = 8.0 Hz, 
0.55H, Ar), 5.63 (d, J = 7.5 Hz, 0.55H, NCH), 5.49 (d, J = 7.5 Hz, 0.45H, NCH), 3.87 
(s, 1.35H, OMe), 3.86 (s, 1.65H, OMe), 2.31-2.02 (m, 2H, CH), 2.17 (s, 1.35H, Me), 
2.08 (s, 1.65H, Me), 1.93-1.80 (m, 1H, CH), 1.66-1.57 (m, 1H,CH), 1.20 (s, 4.05H, 
CMe3), 1.19 (s, 4.95H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) (mixture of rotamers) δ 
156.1 (ipso-Ar), 156.0 (ipso-Ar), 154.4 (C=O), 153.7 (C=O), 147.8 (ipso-Ar), 146.5 
(ipso-Ar), 133.2 (ipso-Ar), 132.0 (ipso-Ar), 128.1 (Ar), 127.8 (Ar), 127.5 (Ar), 127.2 
(Ar), 126.1 (Ar), 126.0 (Ar), 125.8 (Ar), 125.2 (Ar), 125.1 (Ar), 125.0 (Ar), 120.1 (Ar), 
120.0 (Ar), 110.3 (Ar), 110.1 (Ar), 79.4 (CMe3), 78.8 (CMe3), 67.0 (NC), 66.6 (NC), 
59.5 (NCH), 58.8 (NCH), 55.3 (OMe), 55.2 (OMe), 42.3 (CH2), 41.7 (CH2), 29.0 (CH2), 
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28.9 (CH2), 28.1 (CMe3), 28.0 (CMe3), 27.6 (Me), 27.0 (Me); MS (ESI) m/z 390 [(M + 
Na)
+
, 100], 368 [(M + H)
 +
, 25], 312 (25); HRMS (ESI) m/z calcd for C23H29NO3 (M + 
H)
+
 368.2220, found 368.2216 (+0.7 ppm error). 
Crystal structure determination of (2R,5R)-258 
C23H29NO3, M = 367.47, monoclinic, a = 9.88187(15), b = 7.96489(14), c = 13.5877(3) 
Å, β = 98.7072(16)°, U = 1057.14(3) Å3, T = 110.05(10) K, space group P21, Z = 2, 
µ(Mo-Kα) = 0.076 mm-1, 10412 reflection measured, 5412 unique (Rint = 0.0280) which 
were used in calculation. The final R1 was 0.0424 (I≥2σ) and wR2 was 0.0974 (all 
data). 
Lab Book Reference: GG6/30/1 
 
2-Methyl-2-phenyl-5-(pyridin-2-yl)pyrrolidine-1-carboxylic acid tert-butyl ester 
(2R,5R)-259 and (2R,5S)-297 
 
(Scheme 4.58) 
Using general procedure M: s-BuLi (0.46 mL of a 1.3 M solution in hexanes, 0.6 mmol, 
1.2 eq.), pyrrolidine (R)-232 (130 mg, 0.5 mmol, 1.0 eq., 98:2 er) and ()-sparteine (140 
mg, 0.6 mmol, 1.2 eq.) in Et2O (1 mL), then ZnCl2 (0.3 mL of a 1.0 M solution in Et2O, 
0.3 mmol, 0.6 eq.), 2-bromo-pyridine (65 mg, 0.04 μL, 0.41 mmol, 0.83 eq.), t-
Bu3PHBF4 (7.25 mg, 0.025 mmol, 0.05 eq.) and Pd(OAc)2 (4.5 mg, 0.02 mmol, 0.04 
eq.) gave the crude product. Purification by flash column chromatography on silica with 
90:10-80:20 CH2Cl2-Et2O as eluent gave a 97:3 mixture (by 
1
H NMR spectroscopy of 
the amines) of pyrrolidines of (2R,5R)-259 and (2R,5S)-297 (62 mg, 45%) as a white 
solid, mp 72-74 °C; RF (85:15 CH2Cl2-Et2O) 0.3; IR (ATR) 2975, 2946, 1691 (C=O), 
1363, 1154, 1044, 765, 701 cm
‒1
; 
1
H NMR (400 MHz, CDCl3) (55:45 mixture of 
rotamers) δ 8.60-8.54 (m, 1H, Ar), 7.72-7.64 (m, 1H, Ar), 7.38-7.31 (m, 3H, Ph), 7.31-
7.20 (m, 3H, Ar), 7.19-7.12 (m, 1H, Ar), 5.38 (dd, J = 8.5, 2.0 Hz, 0.55H, NCH), 5.23 
(dd, J = 8.5, 2.0 Hz, 0.45H, NCH), 2.38-2.26 (m, 0.55H, CH), 2.25-2.10 (m, 1.45H, 
CH), 2.14 (s, 1.35H, Me), 2.02 (s, 1.65H, Me), 2.01-1.90 (m, 1.55H, CH), 1.89-1.81 (m, 
0.45H, CH),  1.21 (s, 4.05H, CMe3), 1.16 (s, 4.95H, CMe3); 
13
C NMR (100.6 MHz, 
CDCl3) (mixture of rotamers) δ 163.9 (ipso-Ar), 162.5 (ipso-Ar), 154.5 (C=O), 153.5 
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(C=O), 149.2 (Ar), 149.0 (Ar), 147.8 (ipso-Ar), 146.2 (ipso-Ar), 136.4 (Ar), 136.1 (Ar), 
128.2 (Ar), 127.9 (Ar), 126.1 (Ar), 124.9 (Ar), 124.8 (Ar), 121.5 (Ar), 121.4 (Ar), 119.9 
(Ar), 119.6 (Ar), 79.6 (CMe3), 79.3 (CMe3), 67.4 (NC), 66.8 (NC), 65.7 (NCH), 65.4 
(NCH), 42.8 (CH2), 41.8 (CH2), 29.3 (CH2), 29.0 (CH2), 28.2 (CMe3), 28.1 (CMe3), 
27.5 (Me), 27.0 (Me); MS (ESI) m/z 361 [(M + Na)
+
, 30], 339 [(M + H)
 +
, 100], 283 
(10); HRMS (ESI) m/z calcd for C21H26N2O2 (M + H)
+
 339.2067, found 339.2067 (0.0 
ppm error). 
Lab Book Reference: GG6/84/1 
 
2-Methyl-2-phenyl-5-(thiophen-3-yl)pyrrolidine-1-carboxylic acid tert-butyl ester 
(2R,5R)-260 and (2R,5S)-298 
 
(Scheme 4.58) 
Using general procedure M: s-BuLi (0.46 mL of a 1.3 M solution in hexanes, 0.6 mmol, 
1.2 eq.), pyrrolidine (R)-232 (130 mg, 0.5 mmol, 1.0 eq., 98:2 er) and ()-sparteine (140 
mg, 0.6 mmol, 1.2 eq.) in Et2O (1 mL), then ZnCl2 (0.3 mL of a 1.0 M solution in Et2O, 
0.3 mmol, 0.6 eq.), 2-bromo-thiophene (67 mg, 0.04 μL, 0.41 mmol, 0.83 eq.), t-
Bu3PHBF4 (7.25 mg, 0.025 mmol, 0.05 eq.) and Pd(OAc)2 (4.5 mg, 0.02 mmol, 0.04 
eq.) gave the crude product. Purification by flash column chromatography on silica with 
95:5 petrol-EtOAc as eluent gave a 95:5 mixture (by 
1
H NMR spectroscopy of the 
amines) of pyrrolidines (2R,5R)-260 and (2R,5S)-298 (107 mg, 76%) as a colourless oil, 
RF (95:5 petrol-Et2O) 0.2; IR (ATR) 2974, 2932, 1686 (C=O), 1361, 1162, 1080, 1029, 
760, 698 cm
‒1
; 
1
H NMR (400 MHz, CDCl3) (55:45 mixture of rotamers) δ 7.37-7.31 (m, 
2H, Ar), 7.30 (d, J = 3.0 Hz, 0.45H, Ar), 7.28 (d, J = 3.0 Hz, 0.55H, Ar), 7.26-7.19 (m, 
3H, Ar), 7.14-7.10 (m, 0.55H, Ar), 7.09-7.06 (m, 0.45H, Ar), 7.05 (dd, J = 5.0, 1.0 Hz, 
0.55H Ar), 7.02 (dd, J = 5.0, 1.0 Hz, 0.45H Ar), 5.43 (d, J = 7.5 Hz, 0.55H, NCH), 5.26 
(d, J = 7.5 Hz, 0.45H, NCH), 2.27-2.16 (m, 1.45H, CH), 2.15-2.04 (m, 0.55H, CH), 
2.10 (s, 1.35H, Me), 2.01-1.91 (m, 1H, CH), 1.98 (s, 1.65H, Me), 1.28 (s, 4.05H, 
CMe3), 1.18 (s, 4.95H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) (mixture of rotamers) δ 
154.5 (C=O), 153.6 (C=O), 147.8 (ipso-Ar), 146.6 (ipso-Ar), 146.3 (ipso-Ar), 145.5 
(ipso-Ar), 128.2 (Ar), 127.9 (Ar), 126.2 (Ar), 126.1 (Ar), 126.0 (Ar), 125.7 (Ar), 125.4 
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(Ar), 124.9 (Ar), 119.8 (Ar), 119.4 (Ar), 79.5 (CMe3), 79.2 (CMe3), 66.8 (NC), 66.2 
(NC), 60.2 (NCH), 60.0 (NCH), 42.8 (CH2), 42.0 (CH2), 29.9 (CH2), 29.5 (CH2), 28.2 
(CMe3), 28.1 (CMe3), 27.9 (Me), 27.4 (Me); MS (ESI) m/z 366 [(M + Na)
+
, 100], 288 
(10); HRMS (ESI) m/z calcd for C20H25NO2S (M + Na)
+
 366.1498, found 366.1488 
(+2.3 ppm error). 
Lab Book Reference: GG6/81/1 
 
2-Methyl-2-phenyl-5-(1-(triisopropylsilyl)-1H-pyrrol-3-yl)pyrrolidine-1-carboxylic 
acid tert-butyl ester (2R,5R)-261 and (2R,5S)-270 
 
(Scheme 4.58) 
Using general procedure M: s-BuLi (1.38 mL of a 1.3 M solution in hexanes, 1.8 mmol, 
1.2 eq.), pyrrolidine (R)-232 (392 mg, 1.5 mmol, 1.0 eq., 98:2 er) and ()-sparteine (530 
mg, 1.8 mmol, 1.2 eq.) in Et2O (3 mL), then ZnCl2 (0.9 mL of a 1.0 M solution in Et2O, 
0.9 mmol, 0.6 eq.), 3-bromo-N-triisopropylsilyl-pyrrole (363 mg, 0.32 μL, 1.2 mmol, 
0.83 eq.), t-Bu3PHBF4 (22 mg, 0.075 mmol, 0.05 eq.) and Pd(OAc)2 (13 mg, 0.06 
mmol, 0.04 eq.) gave the crude product as a 94:6 mixture (by 
1
H NMR spectroscopy) of 
(2R,5R)-261 and (2R,5S)-270. Purification by flash column chromatography on silica 
with 95:5 petrol-Et2O as eluent gave a 94:6 mixture (by 
1
H NMR spectroscopy) of 
pyrrolidines (2R,5R)-261 and (2R,5S)-270 (411 mg, 71%) as an orange oil, RF (95:5 
petrol-Et2O) 0.1; IR (ATR) 2952, 2874, 1693 (C=O), 1362, 1160, 1099, 1082, 761, 697, 
657 cm
‒1
; 
1
H NMR (400 MHz, CDCl3) (50:50 mixture of rotamers for (2R,5R)-261 and 
75:25 mixture of rotamers for (2R,5S)-270) δ 7.35-7.16 (m, 5H, Ar), 6.74-6.68 (m, 
1.5H, Ar), 6.64 (br s, 0.5H, Ar), 6.24 (dd, J = 2.5, 1.5 Hz, 0.5H, Ar), 6.19 (dd, J = 2.5, 
1.5 Hz, 0.5H, Ar), 5.38 (d, J = 7.5 Hz, 0.47H, NCH), 5.32 (d, J = 6.0 Hz, 0.045H, 
NCH), 5.22 (d, J = 7.5 Hz, 0.47H, NCH), 5.16 (d, J = 6.0 Hz, 0.015H, NCH), 2.35-1.97 
(m, 2H, CH), 2.02 (s, 1.5H, Me), 1.96-1.80 (m, 1.5H, CH), 1.87 (s, 1.5H, Me), 1.70 (dd, 
J = 12.0 6.0 Hz, 0.5H, CH), 1.44 (septet, J = 7.5 Hz, 1.5H, CHMe2), 1.43 (septet, J = 
7.5 Hz, 1.5H, CHMe2), 1.36 (s, 4.5H, CMe3), 1.15 (s, 4.5H, CMe3), 1.14-1.07 (m, 18H, 
CHMe2);
 13
C NMR (100.6 MHz, CDCl3) (mixture of rotamers) δ 154.1 (C=O), 153.9 
(C=O), 148.6 (ipso-Ar), 147.0 (ipso- Ar), 129.9 (ipso-Ar), 128.8 (ipso-Ar), 128.0 (Ar), 
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127.7 (Ar), 125.9 (Ar), 125.7 (Ar), 124.9 (Ar), 124.8 (Ar), 123.8 (Ar), 123.7 (Ar), 121.6 
(Ar), 120.8 (Ar), 108.9 (Ar), 108.7 (Ar), 78.7 (CMe3), 78.6 (CMe3), 66.3 (NC), 65.5 
(NC), 58.0 (NCH), 57.4 (NCH), 43.5 (CH2), 43.4 (CH2), 29.8 (CH2), 29.0 (CH2), 28.4 
(CMe3), 28.1 (CMe3), 27.4 (Me), 23.8 (Me), 17.8 (Me), 11.7 (SiCH), 11.6 (SiCH); MS 
(ESI) m/z 505 [(M + Na)
+
, 100], 483 [(M + H)
 +
, 60], 427 (5); HRMS (ESI) m/z calcd 
for C29H46N2O2Si (M + H)
+
 483.3401, found 483.3389 (+2.4 ppm error) and recovered 
starting material (R)-232 (115 mg, 29%) as a white solid. 
Lab Book Reference: GG6/56/1 
 
2-Methyl-2-phenyl-5-(1-triisopropylsilyl-pyrrol-3-yl)pyrrolidine-1-carboxylic acid 
tert-butyl ester (2R,5S)-270 and (2R,5R)-261 
 
(Scheme 4.61) 
Using general procedure M: s-BuLi (0.46 mL of a 1.3 M solution in hexanes, 0.6 mmol, 
1.2 eq.), pyrrolidine (R)-232 (130 mg, 0.5 mmol, 1.0 eq., 98:2 er) and (+)-sparteine 
surrogate (116 mg, 0.6 mmol, 1.2 eq.) in Et2O (1 mL), then ZnCl2 (0.3 mL of a 1.0 M 
solution in Et2O, 0.3 mmol, 0.6 eq.), 3-bromo-N-triisopropylsilyl-pyrrole (124 mg, 0.11 
μL, 0.41 mmol, 0.83 eq.), t-Bu3PHBF4 (7.25 mg, 0.025 mmol, 0.05 eq.) and Pd(OAc)2 
(4.5 mg, 0.02 mmol, 0.04 eq.) gave the crude product as a 74:26 mixture (by 
1
H NMR 
spectroscopy) of (2R,5S)-270 and (2R,5R)-261. Purification by flash column 
chromatography on silica with 95:5 petrol-Et2O as eluent gave a 70:30 mixture (by 
1
H 
NMR spectroscopy) of pyrrolidines (2R,5S)-270 and (2R,5R)-261 (111 mg, 56%) as an 
orange oil, RF (95:5 petrol-Et2O) 0.1; IR (ATR) 2947, 2868, 1684 (C=O), 1363, 1158, 
1098, 883, 761, 691, 657 cm
‒1
; 
1
H NMR (400 MHz, CDCl3) (75:25 mixture of rotamers 
for (2R,5S)-270 and 50:50 mixture of rotamers for (2R,5R)-261) δ 7.34-6.98 (m, 6H, 
Ar), 6.79-6.62 (m, 1H, Ar), 6.36 (br s, 0.52H, Ar), 6.29 (br s, 0.18H, Ar), 6.24 (dd, J = 
2.5, 1.5 Hz, 0.15H, Ar), 6.19 (dd, J = 2.5, 1.5 Hz, 0.15H, Ar), 5.38 (d, J = 7.5 Hz, 
0.15H, NCH), 5.32 (d, J = 6.0 Hz, 0.52H, NCH), 5.22 (d, J = 7.5 Hz, 0.15H, NCH), 
5.16 (d, J = 6.0 Hz, 0.18H, NCH), 2.40-1.67 (m, 7H, CH2 + Me), 1.50-1.34 (m, 3H, 
CHMe2), 1.36 (s, 1.35H, CMe3), 1.29-1.03 (m, 25.65H, CHMe2 + CMe3);
 13
C NMR 
(100.6 MHz, CDCl3) (mixture of rotamers) δ 154.1 (C=O 2R,5R), 154.0 (C=O 2R,5S), 153.9 
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(C=O 2R,5S), 148.9 (ipso-Ar 2R,5S), 148.6 (ipso-Ar 2R,5R), 147.0 (ipso-Ar 2R,5R), 129.9 (ipso-
Ar 2R,5R), 128.8 (ipso-Ar 2R,5R), 128.0 (Ar 2R,5R), 127.9 (Ar 2R,5S), 127.7 (Ar 2R,5R), 127.5 
(Ph 2R,5S), 125.9 (Ar 2R,5R), 125.7 (Ar 2R,5R), 125.6 (Ar 2R,5S), 125.5 (Ar 2R,5S), 124.9 (Ar 
2R,5R), 124.8 (Ar 2R,5R), 123.8 (Ar 2R,5R), 123.7 (Ar 2R,5R), 123.3 (ipso-Ar 2R,5S), 123.2 
(ipso-Ar 2R,5S), 121.7 (Ar 2R,5S), 121.6 (Ar 2R,5R), 120.8 (Ar 2R,5R), 109.9 (Ar 2R,5S), 109.7 
(Ar 2R,5S), 108.9 (Ar 2R,5R), 108.7 (Ar 2R,5R), 78.8 (CMe3 2R,5S), 78.7 (CMe3 2R,5R), 78.6 
(CMe3 2R,5R), 78.5 (CMe3 2R,5S), 66.7 (NC 2R,5S), 66.3 (NC 2R,5R), 66.0 (NC 2R,5S), 65.5 
(NC 2R,5R), 58.0 (NCH 2R,5R), 57.4 (NCH 2R,5R), 56.8 (NCH 2R,5S), 55.9 (NCH 2R,5S), 45.1 
(CH2 2R,5S), 43.5 (CH2 2R,5R), 43.4 (CH2 2R,5R), 40.8 (CH2 2R,5S), 29.8 (CH2 2R,5R), 29.7 (CH2 
2R,5S), 29.6 (CH2 2R,5S), 29.0 (CH2 2R,5R), 28.5 (CMe3 2R,5S) 28.4 (CMe3 2R,5R), 28.1 (CMe3 
2R,5R), 28.0 (CMe3 2R,5S) 27.4 (Me 2R,5R), 24.0 (Me 2R,5S), 23.8 (Me 2R,5S), 20.8 (Me 2R,5S), 
17.8 (Me 2R,5S), 11.7 (SiCH 2R,5R), 11.6 (SiCH 2R,5S); MS (ESI) m/z 505 [(M + Na)
+
, 100], 
483 [(M + H)
 +
, 20]; HRMS (ESI) m/z calcd for C29H46N2O2Si (M + H)
+
 483.3401, 
found 483.3388 (2.5 ppm error) and recovered starting material (R)-232 (51 mg, 39%) 
as a white solid. 
Lab Book Reference: GG6/57/1 
 
2-Fluoro-5-methyl-3-(5-methyl-5-phenylpyrrolidin-2-yl)pyridine (2R,5R)-262 and 
(2S,5R)-299 
 
(Scheme 4.59) 
Using general procedure L: TFA (57 mg, 38 μL, 0.5 mmol, 10.0 eq.) and an unknown 
mixture of pyrrolidines (2R,5R)-257 and (2R,5S)-295 (18 mg, 0.05 mmol, 1.0 eq.) in 
CH2Cl2 (0.5 mL) gave a 97:3 mixture (by 
1
H NMR spectroscopy) of pyrrolidines 
(2R,5R)-262 and (2S,5R)-299 (12 mg, 89%) as a yellow oil, IR (ATR) 3348 (NH), 2965, 
2928, 2870, 1445, 1235, 762, 700 cm
1
; 
1
H NMR (400 MHz, CDCl3) δ 7.93-7.84 (m, 
2H, Ar), 7.49 (dd, J = 7.5, 1.5 Hz, 2H, Ar), 7.37 (dd, J = 7.5, 7.5 Hz, 2H, Ar), 7.25 (tt, J 
= 7.5, 1.5 Hz, 1H, Ph), 4.74 (dd, J = 7.5, 7.5 Hz, 0.03H, NCH), 4.46 (dd, J = 7.5, 7.5 
Hz, 0.97H, NCH), 2.35 (s, 3H, ArMe), 2.32-2.23 (m, 2H, CH), 2.19-1.98 (m, 2H, CH + 
NH), 1.85-1.65 (m, 1H, CH), 1.57 (s, 3H, Me); 
13
C NMR (100.6 MHz, CDCl3) δ 159.7 
(d, 
1
JCF = 237.0 Hz, ipso-Ar), 149.9 (ipso-Ph), 144.7 (d, 
3
JCF = 14.5 Hz, Ar), 139.1 (d, 
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3
JCF = 6.0 Hz, Ar), 130.1 (d, 
4
JCF = 4.0 Hz, ipso-Ar), 128.4 (Ph), 126.5 (d, 
2
JCF = 29.0 
Hz, ipso-Ar), 126.3 (Ph), 125.0 (Ph), 65.2 (NC), 54.9 (d, 
3
JCF = 3.0 Hz, NCH), 39.7 
(CH2), 32.9 (CH2), 31.7 (Me), 17.6 (Me); MS (ESI) m/z 271 [(M + H)
+
, 100]; HRMS 
(ESI) m/z calcd for C17H19FN2 (M + H)
+
 271.1605, found 271.1608 (0.9 ppm error). 
Lab Book Reference: GG6/34/1 
 
5-(2-Methoxyphenyl)-2-methyl-2-phenylpyrrolidine (2R,5R)-263 and (2R,5S)-300 
 
(Scheme 4.59) 
Using general procedure L: TFA (57 mg, 38 μL, 0.5 mmol, 10.0 eq.) and an unknown 
mixture of pyrrolidines (2R,5R)-258 and (2R,5S)-296 (18 mg, 0.05 mmol, 1.0 eq.) in 
CH2Cl2 (0.5 mL) gave a 96:4 mixture (by 
1
H NMR spectroscopy) of pyrrolidines 
(2R,5R)-263 and (2R,5S)-300 (13 mg, 97%) as a yellow oil, IR (ATR) 3358 (NH), 2962, 
1488, 1462, 1236, 1027, 751, 700 cm
1
; 
1
H NMR (400 MHz, CDCl3) δ 7.57 (dd, J = 
8.0, 1.0 Hz, 2H, Ar), 7.52 (dd, J = 7.5, 1.5 Hz, 1H, Ar), 7.40-7.34 (m, 2H, Ar), 7.27-
7.22 (m, 2H, Ar), 6.98 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H, Ar), 6.89 (dd, J = 8.0, 1.0 Hz, 1H, 
Ar), 4.83 (dd, J = 7.5, 7.5 Hz, 0.04H, NCH), 4.48 (dd, J = 7.5, 7.5 Hz, 0.96H, NCH), 
3.85 (s, 2.88H, OMe), 3.84 (s, 0.12H, OMe), 2.37-2.20 (m, 2H, CH + NH), 2.20-2.04 
(m, 2H, CH), 1.94-1.84 (m, 1H, CH), 1.59 (s, 3H, Me); 
13
C NMR (100.6 MHz, CDCl3) 
δ 157.2 (ipso-Ar), 149.7 (ipso-Ar), 132.6 (ipso-Ar), 128.2 (Ar), 127.7 (Ar), 127.1 (Ar), 
125.9 (Ar), 125.3 (Ar), 120.5 (Ar), 110.4 (Ar), 65.2 (NC), 57.2 (NCH), 55.2 (OMe), 
40.5 (CH2), 32.8 (CH2), 32.0 (Me); MS (ESI) m/z 268 [(M + H)
+
, 100]; HRMS (ESI) 
m/z calcd for C18H21NO (M + H)
+
 268.1696, found 268.1695 (+0.7 ppm error). 
Lab Book Reference: GG6/36/1 
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2-(5-Methyl-5-phenylpyrrolidin-2-yl)pyridine (2R,5R)-264 and (2S,5R)-301 
 
(Scheme 4.59) 
Using general procedure L: TFA (57 mg, 38 μL, 0.5 mmol, 10.0 eq.) and an unknown 
mixture of pyrrolidines (2R,5R)-259 and (2R,5S)-297 (16 mg, 0.05 mmol, 1.0 eq.) in 
CH2Cl2 (0.5 mL) gave an 97:3 mixture (by 
1
H NMR spectroscopy) of pyrrolidines 
(2R,5R)-264 and (2S,5R)-301 (11 mg, 92%) as a yellow oil, IR (ATR) 3304 (NH), 2960, 
2927, 2867, 1443, 1259, 1027, 763, 700 cm
1
; 
1
H NMR (400 MHz, CDCl3) δ 8.57 (dd, J 
= 5.0, 1.0 Hz, 1H, Ar), 7.65 (ddd, J = 7.5, 7.5, 2.0 Hz, 1H, Ar), 7.62-7.59 (m, 1H, Ar), 
7.39-7.29 (m, 3H, Ar), 7.23 (tt, J = 7.5. 1.5 Hz, 1H, Ar), 7.17 (ddd, J = 7.5, 5.0, 1.5 Hz, 
1H, Ar), 4.34 (dd, J = 7.5, 7.5 Hz, 0.95H, NCH), 4.23 (dd, J = 7.5, 7.5 Hz, 0.05H, 
NCH), 2.53 (br s, 1H, NH), 2.34 (ddd, J = 12.0, 7.5, 6.0 Hz, 1H, CH), 2.16 (dddd, J = 
12.0, 7.5, 7.5, 7.5 Hz, 1H, CH), 2.04 (ddd, J = 12.0, 7.5, 7.0 Hz, 1H, CH), 1.93-1.83 (m, 
1H, CH), 1.62 (s, 3H, Me); 
13
C NMR (100.6 MHz, CDCl3) δ 162.9 (ipso-Ar), 149.0 
(ipso-Ar), 148.9 (Ar), 136.4 (Ar), 128.1 (Ar), 126.1 (Ar), 125.5 (Ar), 121.9 (Ar), 121.8 
(Ar), 66.2 (NC), 63.0 (NCH), 40.6 (CH2), 34.4 (CH2), 31.3 (Me); MS (ESI) m/z 239 [(M 
+ H)
+
, 100]; HRMS (ESI) m/z calcd for C16H18N2 (M + H)
+
 239.1543, found 239.1543 
(0.5 ppm error). 
Lab Book Reference: GG6/85/1 
 
2-Methyl-2-phenyl-5-(thiophen-3-yl)pyrrolidine (2R,5R)-265 and (2R,5S)-302 
 
(Scheme 4.59) 
Using general procedure L: TFA (57 mg, 38 μL, 0.5 mmol, 10.0 eq.) and an unknown 
mixture of pyrrolidines (2R,5R)-260 and (2R,5S)-298 (16 mg, 0.05 mmol, 1.0 eq.) in 
CH2Cl2 (0.5 mL) gave a 95:5 mixture (by 
1
H NMR spectroscopy) of pyrrolidines 
(2R,5R)-265 and (2R,5S)-302 (12 mg, 99%) as a yellow oil, IR (ATR) 3357 (NH), 2960, 
2865, 1444, 1074, 780, 762, 700, 645 cm
1
; 
1
H NMR (400 MHz, CDCl3) δ 7.57 (dd, J = 
8.0, 1.5 Hz, 2H, Ar), 7.36 (dd, J = 8.0, 8.0 Hz, 2H, Ar), 7.32 (dd, J = 5.0, 3.0 Hz, 1H, 
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Ar), 7.24 (t, J = 8.0 Hz, 1H, Ph), 7.21-7.19 (m, 1H, Ar), 7.14 (dd, J = 5.0, 1.0 Hz, 1H, 
Ar), 4.62 (dd, J = 7.5, 7.5 Hz, 0.05H, NCH), 4.30 (dd, J = 7.5, 7.5 Hz, 0.95H, NCH), 
2.38-2.28 (m, 1H, CH), 2.21-2.06 (m, 2H, CH), 1.97-1.82 (m, 2H, CH + NH), 1.56 (s, 
3H, Me); 
13
C NMR (100.6 MHz, CDCl3) δ 149.4 (ipso-Ar), 146.2 (ipso-Ar), 128.2 (Ar), 
126.4 (Ar), 126.0 (Ar), 125.9 (Ar), 125.3 (Ar), 120.0 (Ar), 65.3 (NC), 58.0 (NCH), 40.6 
(CH2), 34.0 (CH2), 32.0 (Me); MS (ESI) m/z 244 [(M + H)
+
, 100]; HRMS (ESI) m/z 
calcd for C15H18NS (M + H)
+
 244.1154, found 244.1156 (0.7 ppm error). 
Lab Book Reference: GG6/82/1 
 
2,5-Dimethyl-2,5-diphenylpyrrolidine-1-carboxylic acid tert-butyl ester (2S,5S)-272 
and meso-273 
 
(Table 4.9, Entry 2) 
General procedure N: n-BuLi (110 μL of a 2.5 M solution in hexanes, 0.27 mmol, 1.3 
eq.), an 86:14 mixture of phenyl pyrrolidines (2S,5S)-253 (98:2 er) and (2S,5R)-254 
(82:18 er) (70 mg, 0.21 mmol, 1.0 eq.) in THF (4 mL) at 50 °C under Ar for 3 min. 
Then, Me2SO4 (53 mg, 40 μL, 0.42 mmol, 2.0 eq.) gave the crude product which 
contained a 70:30 mixture (by 
1
H NMR spectroscopy) of (2S,5S)-272 and meso-273. 
Purification by flash column chromatography on silica with 95:5 petrol-Et2O as eluent 
gave pyrrolidine meso-273 (7 mg, 10%) as a colourless oil, RF (95:5 petrol-Et2O) 0.2;
 
IR 
(ATR) 2973, 2928, 1687 (C=O), 1351, 1165, 1061, 760, 696, 554 cm
1
; 
1
H NMR (400 
MHz, CDCl3) (rotamers) δ 7.60-7.46 (m, 4H, Ph), 7.43-7.28 (m, 4H, Ph), 7.26-7.16 (m, 
2H, Ph), 2.44-2.22 (m, 2H, CH), 2.17-2.02 (m, 1H, CH), 1.96 (br s, 4H, Me + CH), 1.89 
(br s, 3H, Me), 1.12 (s, 9H, CMe3);
 13
C NMR (100.6 MHz, CDCl3) (rotamers) δ 153.6 
(C=O), 148.4 (ipso-Ph), 146.9 (ipso-Ph), 127.9 (Ph), 127.7 (Ph), 126.0 (Ph), 125.9 (Ph), 
79.2 (CMe3), 68.2 (NC), 67.5 (NC), 42.0 (CH2), 41.6 (CH2), 28.6 (Me), 28.1 (CMe3), 
25.4 (Me); MS (ESI) m/z 374 [(M + Na)
+
, 100], 352 [(M + H)
 +
, 10], 296 (15); HRMS 
(ESI) m/z calcd for C23H29NO2 (M + H)
+
 352.2271, found 352.2267 (+0.7 ppm error) 
and pyrrolidine (2S,5S)-272 (25 mg, 34%, 97:3 er by CSP-HPLC) as a white solid, mp 
101-103 °C; RF (95:5 petrol-Et2O) 0.2; [α]D 61.9 (c 1.0 in CHCl3); IR (CHCl3) 2931, 
1658 (C=O), 1425, 1343, 1243, 1149, 1039, 843, 689 cm
1
;
 1
H NMR (400 MHz, 
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CDCl3) δ 7.44-7.31 (m, 8H, Ph), 7.26-7.19 (m, 2H, Ph), 2.13-2.02 (m, 2H, CH), 2.07 (s, 
3H, Me), 2.00-1.87 (m, 2H, CH), 1.97 (s, 3H, Me), 1.12 (s, 9H, CMe3); 
13
C NMR 
(100.6 MHz, CDCl3) (rotamers) δ 153.1 (C=O), 148.4 (ipso-Ph), 147.2 (ipso-Ph), 128.2 
(Ph), 127.9 (Ph), 126.0 (Ph), 125.9 (Ph), 125.3 (Ph), 125.0 (Ph), 79.0 (CMe3), 68.5 
(NC), 67.9 (NC), 42.2 (CH2), 41.6 (CH2), 28.1 (CMe3), 26.0 (Me), 25.4 (Me); MS (ESI) 
m/z 374 [(M + Na)
+
, 80], 352 [(M + H)
+
, 100], 296 (80); HRMS (ESI) m/z calcd for 
C23H29NO2 (M + H)
+
 352.2271, found 352.2257 (+3.3 ppm error); CSP-HPLC: 
Chiralcel AD-H (99.5:0.5 hexane:i-PrOH, 0.7 mL min
–1
) (2R,5R)-272 5.2 min, (2S,5S)-
272 8.7 min and recovered starting material (2S,5S)-253 and (2S,5R)-254 (40 mg, 56%) 
as a colourless oil. 
Lab Book Reference: GG4/63 
 
(Table 4.9, Entry 1) 
General procedure N: n-BuLi (90 μL of a 2.5 M solution in hexanes, 0.21 mmol, 1.3 
eq.), an 86:14 mixture of phenyl pyrrolidines (2S,5S)-253 (98:2 er) and (2S,5R)-254 
(82:18 er) (55 mg, 0.16 mmol, 1.0 eq.) in THF (3 mL) at 78 °C under Ar for 1 h. Then, 
Me2SO4 (40 mg, 30 μL, 0.32 mmol, 2.0 eq.) gave the crude product which contained a 
78:22 mixture (by 
1
H NMR spectroscopy) of (2S,5S)-272 and meso-273. Purification by 
flash column chromatography on silica with 95:5 petrol-Et2O as eluent gave pyrrolidine 
meso-273 (4.5 mg, 8%) as a colourless oil, pyrrolidine (2S,5S)-272 (20 mg, 35%, 97:3 
er by CSP-HPLC) as a white solid, CSP-HPLC: Chiralcel AD-H (99.5:0.5 hexane:i-
PrOH, 0.7 mL min
–1
) (2R,5R)-272 5.1 min, (2S,5S)-272 8.7 min and recovered starting 
material (2S,5S)-253 and (2S,5R)-254 (30 mg, 56%) as a colourless oil. 
Lab Book Reference: GG4/64 
 
2,5-Dimethyl-2,5-diphenylpyrrolidine-1-carboxylic acid tert-butyl ester (2R*,5R*)-
272 and meso-273 
 
(Scheme 4.65) 
General procedure N: n-BuLi (0.33 mL of a 2.5 M solution in hexanes, 0.83 mmol, 1.3 
eq.), a 64:36 mixture of (2R*,5R*)-253 and (2R*,5S*)-254 (215 mg, 0.64 mmol, 1.0 
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eq.) in THF (4.5 mL) at 0 °C under Ar for 5 min. Then, Me2SO4 (161 mg, 120 μL, 1.3 
mmol, 2.0 eq.) gave the crude product which contained a 55:45 mixture (by 
1
H NMR 
spectroscopy) of (2R*,5R*)-272 and meso-273. Purification by flash column 
chromatography on silica with 95:5 petrol-Et2O as eluent gave a 50:50 mixture (by 
1
H 
NMR spectroscopy) of (2R*,5R*)-272 and meso-273 (64 mg, 29%) as a colourless oil. 
Lab Book Reference: GG4/28/2 
 
2,5-Dimethyl-2,5-diphenylpyrrolidine-1-carboxylic acid tert-butyl ester (2S,5S)-272 
and meso-273 
 
 
X-ray structure of (2S,5S)-272 
(Table 4.10, Entry 1) 
General procedure O: n-BuLi (70 μL of a 2.5 M solution in hexanes, 0.18 mmol, 1.1 
eq.), a 96:4 mixture of phenyl pyrrolidines (2S,5S)-253 (>99:1 er) and (2S,5R)-254 
(92:8 er) (54 mg, 0.16 mmol, 1.0 eq.) and TMEDA (20 mg, 25 μL, 0.18 mmol, 1.1 eq.) 
in Et2O (1.6 mL) at 30 °C under Ar for 30 min. Then, Me2SO4 (30 mg, 22 μL, 0.24 
mmol, 1.5 eq.) gave the crude product which contained a 91:9 mixture (by 
1
H NMR 
spectroscopy) of (2S,5S)-272 and meso-273. Purification by flash column 
chromatography on silica with 95:5 petrol-Et2O as eluent gave pyrrolidine meso-273 (1 
mg, 2%) as a colourless oil, pyrrolidine (2S,5S)-272 (48 mg, 85%, 99:1 er by CSP-
HPLC) as a white solid, CSP-HPLC: Chiralcel AD-H (99.5:0.5 hexane:i-PrOH, 0.7 mL 
min
–1
) (2R,5R)-272 5.0 min, (2S,5S)-272 8.2 min and recovered starting material (5 mg, 
9%) as a colourless oil. 
Crystal structure determination of (2S,5S)-272 
C23H29NO2, M = 351.47, orthorhombic, a = 8.54159(14), b = 9.92093(16), c = 
23.6875(4) Å, β = 90.00°, U = 2007.30(6) Å3, T = 110.00(10) K, space group P212121, Z 
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= 4, µ(Mo-Kα) = 0.073 mm-1, 28011 reflection measured, 5855 unique (Rint = 0.0353) 
which were used in calculation. The final R1 was 0.0354 (I≥2σ) and wR2 was 0.0933 
(all data). 
Lab Book Reference: GG6/1 
 
(Table 4.10, Entry 2) 
General procedure O: n-BuLi (90 μL of a 2.5 M solution in hexanes, 0.22 mmol, 1.1 
eq.), a 96:4 mixture of phenyl pyrrolidines (2S,5S)-253 (>99:1 er) and (2S,5R)-254 
(92:8 er) (67 mg, 0.2 mmol, 1.0 eq.) and TMEDA (25 mg, 33 μL, 0.22 mmol, 1.1 eq.) in 
Et2O (2 mL) at 30 °C under Ar for 1 h. Then, Me2SO4 (38 mg, 28 μL, 0.3 mmol, 1.5 
eq.) gave the crude product which contained a 90:10 mixture (by 
1
H NMR 
spectroscopy) of (2S,5S)-272 and meso-273. Purification by flash column 
chromatography on silica with 95:5 petrol-Et2O as eluent gave pyrrolidine meso-273 
(2.5 mg, 3%) as a colourless oil and pyrrolidine (2S,5S)-272 (61 mg, 87%, 99:1 er by 
CSP-HPLC) as a white solid, CSP-HPLC: Chiralcel AD-H (99.5:0.5 hexane:i-PrOH, 
0.7 mL min
–1
) (2R,5R)-272 5.0 min, (2S,5S)-272 8.5 min. 
Lab Book Reference: GG6/2 
 
(Scheme 4.68) 
General procedure XO: n-BuLi (44 μL of a 2.5 M solution in hexanes, 0.11 mmol, 1.1 
eq.), a 94:6 mixture of phenyl pyrrolidines (2S,5S)-253 (>99:1 er) and (2S,5R)-254 
(76:24 er) (33 mg, 0.1 mmol, 1.0 eq.) and TMEDA (13 mg, 16 μL, 0.11 mmol, 1.1 eq.) 
in Et2O (1 mL) at 30 °C under Ar for 1 h. Then, Me2SO4 (19 mg, 14 μL, 0.15 mmol, 
1.5 eq.) gave the crude product which contained a 89:11 mixture (by 
1
H NMR 
spectroscopy) of (2S,5S)-272 and meso-273. Purification by flash column 
chromatography on silica with 95:5 petrol-Et2O as eluent gave pyrrolidine (2S,5S)-272 
(31 mg, 88%, 99:1 er by CSP-HPLC) as a white solid, CSP-HPLC: Chiralcel AD-H 
(99.5:0.5 hexane:i-PrOH, 0.7 mL min
–1
) (2R,5R)-272 5.3 min, (2S,5S)-272 9.8 min. 
Lab Book Reference: GG6/11 
 
 
 
Chapter Five: Experimental 
279 
2,5-Dimethyl-2,5-diphenylpyrrolidine-1-carboxylic acid tert-butyl ester (2R,5R)-
272 and meso-273 
 
(Scheme 4.69) 
General procedure O: n-BuLi (44 μL of a 2.5 M solution in hexanes, 0.11 mmol, 1.1 
eq.), a 95:5 mixture of phenyl pyrrolidines (2R,5R)-253 (>99:1 er) and (2R,5S)-254 
(99:1 er) (33 mg, 0.1 mmol, 1.0 eq.) and TMEDA (13 mg, 16 μL, 0.11 mmol, 1.1 eq.) in 
Et2O (1 mL) at 0 °C under Ar for 1 min. Then, Me2SO4 (19 mg, 14 μL, 0.15 mmol, 1.5 
eq.) gave the crude product which contained a 89:11 mixture (by 
1
H NMR 
spectroscopy) of (2R,5R)-272 and meso-273. Purification by flash column 
chromatography on silica with 95:5 petrol-Et2O as eluent gave pyrrolidine (2R,5R)-272 
(30 mg, 85%, 99:1 er by CSP-HPLC) as a white solid, [α]D +60.1 (c 1.8 in CHCl3); 
CSP-HPLC: Chiralcel AD-H (99.5:0.5 hexane:i-PrOH, 0.7 mL min
–1
) (2R,5R)-272 5.2 
min, (2S,5S)-272 10.8 min. 
Lab Book Reference: GG6/16 
 
2,5-Dimethyl-2,5-diphenylpyrrolidine-1-carboxylic acid tert-butyl ester meso-273 
and (2S,5S)-272 
 
(Scheme 4.70) 
General procedure O: n-BuLi (44 μL of a 2.5 M solution in hexanes, 0.11 mmol, 1.1 
eq.), a 81:19 mixture of phenyl pyrrolidines (2S,5R)-254 (>99:1 er) and (2S,5S)-253 
(94:6 er) (33 mg, 0.1 mmol, 1.0 eq.) and TMEDA (13 mg, 16 μL, 0.11 mmol, 1.1 eq.) in 
Et2O (1 mL) at 30 °C under Ar for 1 h. Then, Me2SO4 (19 mg, 14 μL, 0.15 mmol, 1.5 
eq.) gave the crude product which contained an 81:19 mixture (by 
1
H NMR 
spectroscopy) of meso-273 and (2S,5S)-272. Purification by flash column 
chromatography on silica with 95:5 petrol-Et2O as eluent gave pyrrolidine meso-273 (14 
mg, 40%) as colourless oil and pyrrolidine (2S,5S)-272 (3 mg, 8%) as a white solid. 
Lab Book Reference: GG6/17 
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1-tert-Butyl 2-methyl 5-methyl-2,5-diphenylpyrrolidine-1,2-dicarboxylate (2S,5S)-
274 
 
(Scheme 4.73) 
General procedure O: n-BuLi (44 μL of a 2.5 M solution in hexanes, 0.11 mmol, 1.1 
eq.), a 94:6 mixture of phenyl pyrrolidines (2S,5S)-253 (>99:1 er) and (2S,5S)-254 
(76:24 er) (33 mg, 0.1 mmol, 1.0 eq.) and TMEDA (13 mg, 16 μL, 0.11 mmol, 1.1 eq.) 
in Et2O (1 mL) at 30 °C under Ar for 1 h. Then, methyl chloroformate (14 mg, 11 μL, 
0.15 mmol, 1.5 eq.) gave the crude product which contained a 91:9 mixture (by 
1
H 
NMR spectroscopy) of (2S,5S)-274 and (2R,5S)-275. Purification by flash column 
chromatography on silica with 70:30 petrol-Et2O as eluent gave pyrrolidine (2S,5S)-274 
(35 mg, 88%) as white solid, mp 91-93 °C; RF (70:30 petrol-Et2O) 0.2;
 
IR (ATR) 2970, 
2950, 1733 (C=O, CO2Me), 1686 (C=O, Boc), 1387, 1369, 1255, 1161, 1007, 702 cm
1
; 
1
H NMR (400 MHz, CDCl3) (55:45 mixture of rotamers) δ 7.73 (dd, J = 8.5, 1.0 Hz, 
1.1H, Ph), 7.66 (dd, J = 8.5, 1.0 Hz, 0.9H, Ph), 7.43 (t, J = 7.0 Hz, 1H, Ph), 7.40-7.33 
(m, 5H, Ph), 7.32-7.28 (m, 1H, Ph), 7.27-7.20 (m, 1H, Ph), 3.85 (s, 1.35H, OMe), 3.81 
(s, 1.65H, OMe), 2.66 (ddd, J = 12.5, 12.5, 6.5 Hz, 0.55H, CH), 2.49 (ddd, J = 12.5, 
12.5, 6.5 Hz, 0.45H, CH), 2.29 (ddd, J = 12.5, 6.5, 2.0 Hz, 0.55H, CH), 2.20 (ddd, J = 
12.5, 6.5, 2.0 Hz, 0.45H, CH), 2.04 (ddd, J = 12.5, 12.5, 6.5 Hz, 0.45H, CH), 2.03 (ddd, 
J = 12.5, 12.5, 6.5 Hz, 0.55H, CH), 2.01 (s, 1.35H, Me), 1.93-1.77 (m, 1H, CH), 1.89 (s, 
1.65H, Me), 1.32 (s, 4.05H, CMe3), 1.22 (s, 4.95H, CMe3);
 13
C NMR (100.6 MHz, 
CDCl3) (mixture of rotamers) δ 173.3 (C=O, CO2Me), 154.0 (C=O, Boc), 152.7 (C=O, 
Boc), 147.4 (ipso-Ph), 146.0 (ipso-Ph), 139.7 (ipso-Ph), 139.5 (ipso-Ph), 127.9 (Ph), 
127.8 (Ph), 127.7 (Ph), 127.6 (Ph), 127.5 (Ph), 127.2 (Ph), 127.1 (Ph), 127.0 (Ph), 126.1 
(Ph), 126.0 (Ph), 125.8 (Ph), 125.7 (Ph), 80.5 (CMe3), 80.3 (CMe3), 74.5 (NC), 74.3 
(NC), 68.3 (NC), 67.1 (NC), 52.6 (OMe), 52.4 (OMe), 42.7 (CH2), 41.8 (CH2), 38.2 
(CH2), 37.0 (CH2), 28.1 (CMe3), 28.0 (CMe3), 27.7 (Me), 27.1 (Me); MS (ESI) m/z 418 
[(M + Na)
+
, 100], 396 [(M + H)
 +
, 20], 340 (10); HRMS (ESI) m/z calcd for C24H29NO4 
(M + H)
+
 396.2169, found 396.2169 (0.1 ppm error). 
Lab Book Reference: GG6/53/1 
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1-tert-Butyl 2-methyl 5-methyl-2,5-diphenylpyrrolidine-1,2-dicarboxylate (2R,5S)-
275 and (2S,5S)-274 
 
(Scheme 4.74) 
General procedure O: n-BuLi (44 μL of a 2.5 M solution in hexanes, 0.11 mmol, 1.1 
eq.), a 81:19 mixture of phenyl pyrrolidines (2S,5R)-254 (>99:1 er) and (2S,5S)-253 
(94:6 er) (33 mg, 0.1 mmol, 1.0 eq.) and TMEDA (13 mg, 16 μL, 0.11 mmol, 1.1 eq.) in 
Et2O (1 mL) at 30 °C under Ar for 1 h. Then, methyl chloroformate (14 mg, 11 μL, 
0.15 mmol, 1.5 eq.) gave the crude product as a 86:14 mixture (by 
1
H NMR 
spectroscopy) of (2R,5S)-275 and (2S,5S)-274. Purification by flash column 
chromatography on silica with 70:30 petrol-Et2O as eluent gave an 86:14 mixture (by 
1
H NMR spectroscopy) of pyrrolidines (2R,5S)-275 and (2S,5S)-274 (28 mg, 57%) as 
white solid, mp 108-112 °C; RF (70:30 petrol-Et2O) 0.2;
 
IR (ATR) 2985, 2948, 1740 
(C=O), 1679 (C=O), 1362, 1250, 1156, 755, 700 cm
1
; 
1
H NMR (400 MHz, CDCl3) 
(65:35 mixture of rotamers for (2R,5S)-275 and 55:45 mixture of rotamers for (2S,5S)-
274) δ 7.73 (dd, J = 8.5, 1.0 Hz, 0.15H, Ph), 7.66 (dd, J = 8.5, 1.0 Hz, 0.13H, Ph), 7.54 
(d, J = 8.0 Hz, 1.12H, Ph), 7.50 (d, J = 8.0 Hz, 0.6H, Ph), 7.48-7.35 (m, 4H, Ph), 7.35-
7.24 (m, 3H, Ph), 7.23-7.17 (m, 1H, Ph), 3.85 (s, 0.2H, OMe), 3.84-3.69 (s, 1.12H, 
OMe), 3.75 (s, 1.68H, OMe), 2.93-2.73 (m, 1H, CH), 2.66 (ddd, J = 12.5, 12.5, 6.5 Hz, 
0.08H, CH), 2.60 (dd, J = 12.5, 5.5 Hz, 0.56H, CH), 2.54-2.42 (m, 0.36H, CH), 2.14-
1.96 (m, 4.61H, CH + Me), 1.93-1.77 (m, 0.42H, CH + Me), 1.32 (s, 0.58H, CMe3), 
1.25-1.19 (m, 3.38H, CMe3), 1.15 (s, 5.04H, CMe3);
 13
C NMR (100.6 MHz, CDCl3) 
(mixture of rotamers) δ 173.8 (C=O, CO2Me 2R,5S), 173.7 (C=O, CO2Me 2R,5S), 173.3 
(C=O, CO2Me 2S,5S), 154.4 (C=O, Boc 2R,5S), 154.0 (C=O, Boc 2S,5S), 152.7 (C=O, Boc 
2S,5S), 147.4 (ipso-Ph 2S,5S), 147.2 (ipso-Ph 2R,5S), 146.3 (ipso-Ph 2R,5S), 146.0 (ipso-Ph 
2S,5S), 139.6 (ipso-Ph 2R,5S), 139.5 (ipso-Ph 2R,5S), 128.4 (Ph 2R,5S), 128.3 (Ph 2R,5S), 128.0 
(Ph 2R,5S), 127.9 (Ph 2S,5S), 127.8 (Ph 2S,5S), 127.7 (Ph 2R,5S), 127.6 (Ph 2S,5S), 127.5 (Ph 
2R,5S), 127.2 (Ph 2R,5S), 127.1 (Ph 2R,5S), 126.3 (Ph 2R,5S), 126.2 (Ph 2R,5S), 126.0 (Ph 2R,5S), 
125.9 (Ph 2R,5S), 125.8 (Ph 2S,5S), 125.7 (Ph 2S,5S), 125.5 (Ph 2R,5S), 80.5 (CMe3 2S,5S), 80.3 
(CMe3 2S,5S), 80.2 (CMe3 2R,5S), 80.1 (CMe3 2R,5S), 74.5 (NC 2S,5S), 74.4 (br, NC 2R,5S), 74.3 
(NC 2S,5S), 68.4 (NC 2R,5S), 68.3 (NC 2S,5S), 67.6 (NC 2R,5S), 67.1 (NC 2S,5S), 52.7 (OMe 
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2R,5S), 52.5 (OMe 2R,5S), 52.4 (OMe 2S,5S), 43.1 (CH2 2R,5S), 42.7 (CH2 2S,5S), 41.8 (CH2 
2S,5S), 41.7 (CH2 2R,5S), 39.6 (CH2 2R,5S), 38.2 (CH2 2S,5S), 38.1 (CH2 2R,5S), 37.0 (CH2 2S,5S), 
30.3 (Me 2R,5S), 29.7 (Me 2R,5S), 28.1 (CMe3 2S,5S), 28.0 (CMe3 2S,5S), 27.9 (br, CMe3 2R,5S), 
27.7 (Me 2S,5S), 27.1 (Me 2S,5S); MS (ESI) m/z 418 [(M + Na)
+
, 100], 396 [(M + H)
 +
, 5], 
340 (5); HRMS (ESI) m/z calcd for C24H29NO4 (M + H)
+
 396.2169, found 396.2175 
(1.4 ppm error). 
Lab Book Reference: GG6/52/1 
 
1-tert-Butyl 2-methyl 2-(2-methoxyphenyl)-5-methyl-5-phenylpyrrolidine-1,2-
dicarboxylate (2R,5R)-276 
 
(Scheme 4.75) 
General procedure P: n-BuLi (44 μL of a 2.5 M solution in hexanes, 0.11 mmol, 1.1 
eq.), a 96:4 mixture of phenyl pyrrolidines (2R,5R)-258 and (2R,5S)-296 (37 mg, 0.1 
mmol, 1.0 eq.) and TMEDA (13 mg, 16 μL, 0.11 mmol, 1.1 eq.) in Et2O (1 mL), then 
methyl chloroformate (14 mg, 11 μL, 0.15 mmol, 1.5 eq.) gave the crude product. 
Purification by flash column chromatography on silica with 70:30 petrol-Et2O as eluent 
gave pyrrolidine (2R,5R)-276 (16 mg, 38%) as a white solid, mp 131-134 °C; RF (70:30 
petrol-Et2O) 0.2; IR (ATR) 2945, 1731 (C=O, CO2Me), 1697 (C=O, Boc), 1363, 1249, 
1156, 1027, 756, 704 cm
‒1
; 
1
H NMR (400 MHz, CDCl3) (70:30 mixture of rotamers) δ 
7.71 (d, J = 7.5 Hz, 1.4H, Ar), 7.63 (d, J = 7.5 Hz, 0.6H, Ar), 7.37 (dd, J = 7.5, 7.5 Hz, 
2H, Ar), 7.34-7.27 (m, 1H, Ar), 7.26-7.18 (m, 2H, Ar), 7.00 (dd, J = 7.5, 7.5 Hz, 1H, 
Ar), 6.94 (d, J = 8.0 Hz, 1H, Ar), 3.82 (s, 3H, OMe), 3.77 (s, 3H, OMe), 2.77 (ddd, J = 
12.5, 12.5, 6.5 Hz, 0.7H, CH), 2.66-2.52 (m, 1.3H, CH), 2.09-2.02 (m, 1H, CH), 2.00 (s, 
0.9H, Me), 1.93 (s, 2.1H, Me), 1.85 (td, J = 12.5, 6.5 Hz, 1H, CH), 1.31 (s, 2.7H, 
CMe3), 1.17 (s, 6.3H, CMe3);
 13
C NMR (100.6 MHz, CDCl3) (mixture of rotamers) δ 
174.8 (C=O, CO2Me), 173.4 (C=O, CO2Me), 157.4 (ipso-Ar), 157.3 (ipso-Ar), 153.8 
(C=O, Boc), 147.9 (ipso-Ar), 146.4 (ipso-Ar), 128.7 (Ar), 128.4 (ipso-Ar), 128.0 (Ar), 
127.7 (Ar), 125.9 (Ar), 125.7 (Ar), 120.3 (Ar), 111.9 (Ar), 80.2 (CMe3), 73.5 (NC), 67.3 
(NC), 55.5 (OMe), 52.4 (OMe), 52.1 (OMe), 42.8 (CH2), 42.2 (CH2), 35.0 (CH2), 34.5 
(CH2), 28.1 (CMe3), 28.0 (CMe3), 27.9 (Me), 27.3 (Me); MS (ESI) m/z 448 [(M + Na)
+
, 
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60], 426 [(M + H)
+
, 100], 370 (20), 326 (10); HRMS (ESI) m/z calcd for C25H31NO5 (M 
+ H)
+
 426.2275, found 426.2269 (+1.1 ppm error) and recovered starting material (14 
mg, 38%). 
Lab Book Reference: GG6/40/1 
 
1-tert-Butyl 2-methyl 5-methyl-5-phenyl-2-(pyridin-2-yl)pyrrolidine-1,2-
dicarboxylate (2R,5R)-277 and (2S,5R)-303 
 
(Scheme 4.75) 
General procedure P: n-BuLi (70 μL of a 2.5 M solution in hexanes, 0.165 mmol, 1.1 
eq.), a 95:5 mixture of phenyl pyrrolidines (2R,5R)-259 and (2R,5S)-297 (51 mg, 0.15 
mmol, 1.0 eq.) and TMEDA (20 mg, 26 μL, 0.165 mmol, 1.1 eq.) in Et2O (1.5 mL), 
then methyl chloroformate (21 mg, 17 μL, 0.225 mmol, 1.5 eq.) gave the crude product 
which contained a 75:25 mixture (by 
1
H NMR spectroscopy) of (2S,5S)-277 and 
(2S,5R)-303. Purification by flash column chromatography on silica with 90:10 CH2Cl2-
Et2O as eluent gave a 75:25 mixture (by 
1
H NMR spectroscopy) of pyrrolidines 
(2R,5R)-277 and (2S,5R)-303 (18 mg, 35%) as a yellow oil, RF (90:10 CH2Cl2-Et2O) 
0.2; IR (ATR) 2977, 1740 (C=O, CO2Me), 1683 (C=O, Boc), 1361, 1249, 1159, 757, 
699 cm
‒1
; 
1
H NMR (400 MHz, CDCl3) (75:25 mixture of rotamers for (2R,5R)-277 and 
60:40 mixture of rotamers for (2S,5R)-303) δ 8.69-8.70 (m, 1H, Ar), 7.84-7.69 (m, 2H, 
Ar), 7.69-7.46 (m, 1H, Ar), 7.40-7.28 (m, 2H, Ar), 7.26-7.13 (m, 3H, Ar), 3.85 (s, 0.3H, 
OMe), 3.82 (s, 0.45H, OMe), 3.80 (s, 0.57H, OMe), 3.75 (s, 1.68H, OMe), 2.34 (dd, J = 
12.5, 5.5 Hz, 0.65H, CH), 3.05-2.94 (m, 0.35H, CH), 2.79-2.47 (m, 1H, CH), 2.13-1.94 
(m, 4H, Me + CH), 1.87-1.66 (m, 1H, CH), 1.32 (s, 0.9H, CMe3), 1.26 (s, 1.35H, 
CMe3), 1.19 (s, 1.71H, CMe3), 1.11 (s, 5.04H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) 
(mixture of rotamers) δ 173.4 (C=O, CO2Me), 172.9 (C=O, CO2Me), 158.9 (ipso-Ar), 
158.6 (ipso-Ar), 154.4 (C=O, Boc), 154.1 (C=O, Boc), 148.3 (Ar), 148.0 (Ar), 147.6 
(ipso-Ar), 136.2 (Ar), 136.1 (Ar), 128.0 (Ar), 127.8 (Ar), 127.7 (Ar), 126.0 (Ar), 125.6 
(Ar), 125.4 (Ar), 124.1 (Ar), 122.6 (Ar), 122.4 (Ar), 122.2 (Ar), 80.4 (CMe3), 80.2 
(CMe3), 75.5 (NC), 75.4 (NC), 68.2 (NC), 67.3 (NC), 52.8 (OMe), 52.7 (OMe), 43.9 
(CH2), 42.9 (CH2), 42.2 (CH2), 36.6 (CH2), 35.7 (CH2), 34.8 (CH2), 28.1 (CMe3), 28.0 
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(CMe3), 27.9 (CMe3), 23.1 (Me), 22.8 (Me); MS (ESI) m/z 419 [(M + Na)
+
, 60], 397 
[(M + H)
+
, 100]; HRMS (ESI) m/z calcd for C23H28N2O4 (M + H)
+
 397.2122, found 
397.2121 (+0.8 ppm error) and recovered starting material (17 mg, 33%). 
Lab Book Reference: GG6/95/1 
 
1-tert-Butyl 2-methyl 5-methyl-5-phenyl-2-(1-(triisopropylsilyl)-1H-pyrrol-3-
yl)pyrrolidine-1,2-dicarboxylate (2R,5R)-278 
 
(Scheme 4.75) 
General procedure P: n-BuLi (44 μL of a 2.5 M solution in hexanes, 0.11 mmol, 1.1 
eq.), a 94:6 mixture of phenyl pyrrolidines (2R,5R)-261 and (2R,5S)-270 (48 mg, 0.1 
mmol, 1.0 eq.) and TMEDA (13 mg, 16 μL, 0.11 mmol, 1.1 eq.) in Et2O (1 mL), then 
methyl chloroformate (14 mg, 11 μL, 0.15 mmol, 1.5 eq.) gave the crude product which 
contained a 98:2 mixture (by 
1
H NMR spectroscopy) of (2R,5R)-278 and 
diastereoisomer (2R,5S). Purification by flash column chromatography on silica with 
80:20 petrol-Et2O as eluent gave pyrrolidine (2R,5R)-278 (28 mg, 52%) as a yellow oil, 
RF (80:20 petrol-Et2O) 0.2; IR (ATR) 2947, 2868, 1739 (C=O, CO2Me), 1698 (C=O, 
Boc), 1361, 1161, 1107, 1088, 691, 657 cm
‒1
; 
1
H NMR (400 MHz, CDCl3) (55:45 
mixture of rotamers) δ 7.71 (d, J = 7.5 Hz, 0.9H, Ar), 7.66 (d, J = 7.5 Hz, 1.1H, Ar), 
7.34 (dd, J = 7.5, 7.5 Hz, 2H, Ar), 7.24-7.17 (m, 1H, Ar), 6.77 (dd, J = 2.0, 2.0 Hz, 
0.45H, Ar), 6.73 (d, J = 2.5 Hz, 1H, Ar), 6.70 (dd, J = 2.5, 2.5 Hz, 0.55H, Ar), 6.33 (dd, 
J = 2.5, 1.5 Hz, 0.45H, Ar), 6.31 (dd, J = 2.5, 2.5 Hz, 0.55H, Ar), 3.83 (s, 1.65H, OMe), 
3.81 (s, 1.35H, OMe), 2.45-2.34 (m, 0.45H, CH), 2.30-2.00 (m, 3.55H, CH), 1.95 (s, 
1.65H, Me), 1.81 (s, 1.35H, Me), 1.45 (septet, J = 7.5 Hz, 1.35H, CHMe2), 1.43 (septet, 
J = 7.5 Hz, 1.65H, CHMe2), 1.35 (s, 4.95H, CMe3), 1.19 (s, 4.05H, CMe3), 1.16-1.08 
(m, 18H, CHMe2);
 13
C NMR (100.6 MHz, CDCl3) (mixture of rotamers) δ 174.3 (C=O, 
CO2Me), 174.1 (C=O, CO2Me), 153.4 (C=O, Boc), 152.7 (C=O, Boc), 148.0 (ipso-Ar), 
146.5 (ipso-Ar), 127.8 (Ar), 127.6 (Ar), 126.4 (ipso-Ar), 126.1 (Ar), 125.9 (ipso-Ar), 
125.8 (Ar), 125.7 (Ar), 123.4 (Ar), 123.1 (Ar), 123.0 (Ar), 122.8 (Ar), 110.7 (Ar), 110.5 
(Ar), 79.8 (CMe3), 79.4 (CMe3), 70.6 (NC), 69.9 (NC), 67.9 (NC), 66.7 (NC), 52.4 
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(OMe), 52.1 (OMe), 43.3 (CH2), 42.2 (CH2), 37.7 (CH2), 36.3 (CH2), 28.2 (CMe3), 28.0 
(CMe3), 27.9 (Me), 27.5 (Me), 17.9 (CHMe2), 17.8 (CHMe2), 11.7 (SiCH); MS (ESI) 
m/z 563 [(M + Na)
+
, 90], 541 [(M + H)
+
, 100], 485 (15); HRMS (ESI) m/z calcd for 
C31H48N2O4Si (M + H)
+
 541.3456, found 541.3456 (+2.4 ppm error) and recovered 
starting material (22 mg, 45%). 
Lab Book Reference: GG6/39/1 
 
ReactIR™ monitoring of the lithiation of di-substituted N-Boc pyrrolidine (S)-232 
at 78 °C 
 
Et2O (10 mL) was added to a flask equipped with a stirrer bar and ReactIR™ probe at rt 
under Ar. After cooling to 78 °C, a solution of (+)-sparteine surrogate (252 mg, 1.3 
mmol, 1.3 eq.) in Et2O (2 mL) was added followed by a solution of di-substituted N-
Boc pyrrolidine (S)-232 (261 mg, 1.0 mmol, 1.0 eq.) in Et2O (2 mL). The solution was 
stirred for 5 min (to verify the stability of the readout on ReactIR™). Then, s-BuLi (1.0 
mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 eq.) was added dropwise. The 
solution was stirred at 78 °C for 50 min. For di-substituted N-Boc pyrrolidine (S)-232, 
two peaks at 1711 cm
1
 and 1694 cm
1
 were observed and assigned to νC=O in the two 
rotamers (S)-232a and (S)-232b. After addition of s-BuLi, a new peak at 1627 cm
1
 was 
observed which was assigned to νC=O in the lithiated intermediate. After a lithiation time 
of 2 min, complete lithiation of di-substituted N-Boc pyrrolidine (S)-232b to give the 
lithiated intermediate and di-substituted N-Boc pyrrolidine (S)-232a was observed. 
Lab Book Reference: GG6/14 
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ReactIR™ monitoring of the lithiation of di-substituted N-Boc pyrrolidine (S)-232  
at 40 °C 
 
Et2O (10 mL) was added to a flask equipped with a stirrer bar and ReactIR™ probe at rt 
under Ar. After cooling to 40 °C, a solution of (+)-sparteine surrogate (252 mg, 1.3 
mmol, 1.3 eq.) in Et2O (2 mL) was added followed by a solution of di-substituted N-
Boc pyrrolidine (S)-232 (261 mg, 1.0 mmol, 1.0 eq.) in Et2O (2 mL). The solution was 
stirred for 5 min (to verify the stability of the readout on ReactIR™). Then, s-BuLi (1.0 
mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 eq.) was added dropwise. The 
solution was stirred at 40 °C for 40 min. For di-substituted N-Boc pyrrolidine (S)-232, 
two peaks at 1711 cm
1
 and 1695 cm
1
 were observed and assigned to νC=O in the two 
rotamers (S)-232a and (S)-232b. After addition of s-BuLi, a new peak at 1627 cm
1
 was 
observed which was assigned to νC=O in the lithiated intermediate. After a lithiation time 
of 5 min, complete lithiation of di-substituted N-Boc pyrrolidine (S)-232a and (S)-232b 
to give the lithiated intermediate was observed. 
Lab Book Reference: GG6/13 
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ReactIR™ monitoring of the lithiation of tri-substituted N-Boc pyrrolidine 
(2S,5S)-253 at 78 °C 
 
Et2O (12 mL) was added to a flask equipped with a stirrer bar and ReactIR™ probe at rt 
under Ar. After cooling to 78 °C, a solution of TMEDA (128 mg, 160 µL, 1.1 mmol, 
1.1 eq.) was added followed by a solution of tri-substituted N-Boc pyrrolidine (2S,5S)-
253 (337 mg, 1.0 mmol, 1.0 eq.) in Et2O (2 mL). The solution was stirred for 5 min (to 
verify the stability of the readout on ReactIR™). Then, n-BuLi (0.44 mL of a 2.5 M 
solution in hexanes, 1.1 mmol, 1.1 eq.) was added dropwise. The solution was stirred at 
78 °C for 15 min. For di-substituted N-Boc pyrrolidine (2S,5S)-253, two peaks at 1701 
cm
1
 and 1695 cm
1
 were observed and assigned to νC=O in the two rotamers (2S,5S)-
253a and (2S,5S)-253b. After addition of n-BuLi, a new peak at 1631 cm
1
 was 
observed which was assigned to νC=O in the lithiated intermediate. After a lithiation time 
of 1 min, complete lithiation of di-substituted N-Boc pyrrolidine (2S,5S)-253b to give 
the lithiated intermediate and di-substituted N-Boc pyrrolidine (2S,5S)-253a was 
observed. 
Lab Book Reference: GG6/12 
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ReactIR™ monitoring of the lithiation of tri-substituted N-Boc pyrrolidine 
(2S,5S)-253 at 30 °C 
 
Et2O (12 mL) was added to a flask equipped with a stirrer bar and ReactIR™ probe at rt 
under Ar. After cooling to 30 °C, a solution of TMEDA (89 mg, 110 µL, 0.77 mmol, 
1.1 eq.) was added followed by a solution of tri-substituted N-Boc pyrrolidine (2S,5S)-
253 (240 mg, 0.7 mmol, 1.0 eq.) in Et2O (2 mL). The solution was stirred for 5 min (to 
verify the stability of the readout on ReactIR™). Then, n-BuLi (0.31 mL of a 2.5 M 
solution in hexanes, 0.77 mmol, 1.1 eq.) was added dropwise. The solution was stirred 
at 78 °C for 11 min. For di-substituted N-Boc pyrrolidine (2S,5S)-253, two peaks at 
1709 cm
1
 and 1699 cm
1
 were observed and assigned to νC=O in the two rotamers 
(2S,5S)-253a and (2S,5S)-253b. After addition of n-BuLi, a new peak at 1627 cm
1
 was 
observed which was assigned to νC=O in the lithiated intermediate. After a lithiation time 
of 7 min, complete lithiation of di-substituted N-Boc pyrrolidine (2S,5S)-253a and 
(2S,5S)-253b to give the lithiated intermediate was observed. 
Lab Book Reference: GG6/15 
 
 
Abbreviations 
289 
Abbreviations 
aq.  Aqueous 
Boc  t-Butoxycarbonyl 
bp Boiling point 
br Broad 
cm
1
 Wavenumber 
CSP Chiral Stationary Phase 
δ Chemical shift 
d Doublet 
dd Doublet doublet 
ddd Doublet doublet doublet 
dddd Doublet doublet doublet doublet 
ddddd Doublet doublet doublet doublet doublet 
dq Double quartet 
dr Diastereomeric ratio 
er Enantiomeric ratio 
E
+ 
Electrophile 
ESI Electrospray ionisation 
eq. Equivalent(s) 
Et Ethyl 
Et2O Diethyl ether 
Abbreviations 
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g Gram(s) 
h Hour(s) 
HPLC High Performance Liquid Chromatography 
HRMS High resolution mass spectrometry 
Hz Hertz 
IR Infra-red 
J Coupling constant in Hz 
µL Microlitres 
m Multiplet 
M Molar 
M
+
 Molecular ion 
Me Methyl 
mg Milligrams 
min Minute(s) 
mL Millilitre(s) 
mmol Millimole(s) 
mp Melting point 
MS Mass spectrometry 
m/z Mass to charge ratio 
NMR Nuclear Magnetic Resonance 
Petrol Petroleum ether (fraction which boils at 40-60 °C) 
Abbreviations 
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Ph Phenyl 
ppm Parts per million 
q Quartet 
quin Quintet 
RF Retention factor 
rt Room temperature 
s Singlet 
(+)-sp. surr. (+)-Sparteine surrogate 
t Triplet 
tt Triplet triplet 
TBME tert-Butyl methyl ether 
THF Tetrahydrofuran 
TMEDA N,N,N,N-tetramethylethylenediamine 
 
  
Bibliography 
292 
Bibliography 
 
 (1) Morita, Y.; Tokuyama, H.; Fukuyama, T. Org. Lett. 2005, 7, 4337. 
 (2) Ashcroft, C. P.; Hellier, P.; Pettman, A.; Watkinson, S. Org. Process Res. Dev. 
2010, 15, 98. 
 (3) Manfré, F.; Pulicani, J. P. Tetrahedron: Asymmetry 1994, 5, 235. 
 (4) Beak, P.; Lee, W.-K. Tetrahedron Lett. 1989, 30, 1197. 
 (5) Barker, G.; O’Brien, P.; Campos, K. R. Org. Lett. 2010, 12, 4176. 
 (6) Beak, P.; Lee, W. K. J. Org. Chem. 1990, 55, 2578. 
 (7) Beak, P.; Lee, W. K. J. Org. Chem. 1993, 58, 1109. 
 (8) Berkheij, M.; van der Sluis, L.; Sewing, C.; den Boer, D. J.; Terpstra, J. W.; 
Hiemstra, H.; Iwema Bakker, W. I.; van den Hoogenband, A.; van Maarseveen, J. H. 
Tetrahedron Lett. 2005, 46, 2369. 
 (9) Robinson, S. P.; Sheikh, N. S.; Baxter, C. A.; Coldham, I. Tetrahedron Lett. 
2010, 51, 3642. 
 (10) Kerrick, S. T.; Beak, P. J. Am. Chem. Soc. 1991, 113, 9708. 
 (11) Beak, P.; Kerrick, S. T.; Wu, S.; Chu, J. J. Am. Chem. Soc. 1994, 116, 3231. 
 (12) Dearden, M. J.; Firkin, C. R.; Hermet, J.-P. R.; O'Brien, P. J. Am. Chem. Soc. 
2002, 124, 11870. 
 (13) Stead, D.; O'Brien, P.; Sanderson, A. Org. Lett. 2008, 10, 1409. 
 (14) Beak, P.; Basu, A.; Gallagher, D. J.; Park, Y. S.; Thayumanavan, S. Acc. Chem. 
Res. 1996, 29, 552. 
 (15) Mitchell, E. A.; Peschiulli, A.; Lefevre, N.; Meerpoel, L.; Maes, B. U. W. Chem. 
Eur. J. 2012, 18, 10092. 
 (16) Coutts, S. J.; Kelly, T. A.; Snow, R. J.; Kennedy, C. A.; Barton, R. W.; Adams, 
J.; Krolikowski, D. A.; Freeman, D. M.; Campbell, S. J.; Ksiazek, J. F.; Bachovchin, 
W. W. J. Med. Chem. 1996, 39, 2087. 
 (17) Chackalamannil, S.; Davies, R. J.; Asberom, T.; Doller, D.; Leone, D. J. Am. 
Chem. Soc. 1996, 118, 9812. 
 (18) Hoffmann, R. W. Chem. Rev. 1989, 89, 1841. 
 (19) Guerrero, C. A.; Sorensen, E. J. Org. Lett. 2011, 13, 5164. 
Bibliography 
293 
 (20) Pizzuti, M. G.; Minnaard, A. J.; Feringa, B. L. Org. Biomol. Chem. 2008, 6, 
3464. 
 (21) Trapella, C.; Pela, M.; Del Zoppo, L.; Calo, G.; Camarda, V.; Ruzza, C.; 
Cavazzini, A.; Costa, V.; Bertolasi, V.; Reinscheid, R. K.; Salvadori, S.; Guerrini, R. 
J. Med. Chem. 2011, 54, 2738. 
 (22) Xiong, H.; Frietze, W.; Andisik, D. W.; Ernst, G. E.; Palmer, W. E.; Hinkley, L.; 
Varnes, J. G.; Albert, J. S.; Veale, C. A. Tetrahedron Lett. 2010, 51, 6741. 
 (23) Watson, R. T.; Gore, V. K.; Chandupatla, K. R.; Dieter, R. K.; Snyder, J. P. J. 
Org. Chem. 2004, 69, 6105. 
 (24) Dieter, R. K.; Chen, N. J. Org. Chem. 2006, 71, 5674. 
 (25) Murakami, S.; Takemoto, T.; Shimizu, Z. J. Pharm. Soc. Jpn. 1953, 73, 1026. 
 (26) Liniger, M.; Estermann, K.; Altmann, K.-H. J. Org. Chem. 2013, 78, 11066. 
 (27) Deng, X.; Mani, N. S. Tetrahedron: Asymmetry 2005, 16, 661. 
 (28) Bilke, J. L.; Moore, S. P.; O’Brien, P.; Gilday, J. Org. Lett. 2009, 11, 1935. 
 (29) Klapars, A.; Campos, K. R.; Waldman, J. H.; Zewge, D.; Dormer, P. G.; Chen, 
C.-y. J. Org. Chem. 2008, 73, 4986. 
 (30) Barker, G.; McGrath, J. L.; Klapars, A.; Stead, D.; Zhou, G.; Campos, K. R.; 
O’Brien, P. J. Org. Chem. 2011, 76, 5936. 
 (31) Rayner, P. J.; O’Brien, P.; Horan, R. A. J. J. Am. Chem. Soc. 2013, 135, 8071. 
 (32) Bennie, L. S.; Kerr, W. J.; Middleditch, M.; Watson, A. J. B. Chem. Comm. 
2011, 47, 2264. 
 (33) Gallagher, D. J.; Beak, P. J. Org. Chem. 1995, 60, 7092. 
 (34) Kizirian, J.-C.; Caille, J.-C.; Alexakis, A. Tetrahedron Lett. 2003, 44, 8893. 
 (35) Kizirian, J.-C.; Cabello, N.; Pinchard, L.; Caille, J.-C.; Alexakis, A. Tetrahedron 
2005, 61, 8939. 
 (36) Cabello, N.; Kizirian, J.-C.; Gille, S.; Alexakis, A.; Bernardinelli, G.; Pinchard, 
L.; Caille, J.-C. Eur. J. Org. Chem. 2005, 2005, 4835. 
 (37) Carbone, G.; O’Brien, P.; Hilmersson, G. r. J. Am. Chem. Soc. 2010, 132, 
15445. 
 (38) Barker, G.; O’Brien, P.; Campos, K. R. ARKIVOC 2011, v, 217. 
 (39) Dieter, R. K.; Oba, G.; Chandupatla, K. R.; Topping, C. M.; Lu, K.; Watson, R. 
T. J. Org. Chem. 2004, 69, 3076. 
 (40) Husmann, R.; Jörres, M.; Raabe, G.; Bolm, C. Chem. Eur. J. 2010, 16, 12549. 
Bibliography 
294 
 (41) Bauer, J. O.; Stiller, J.; Marqués-López, E.; Strohfeldt, K.; Christmann, M.; 
Strohmann, C. Chem. Eur. J. 2010, 16, 12553. 
 (42) Jentzsch, K. I.; Min, T.; Etcheson, J. I.; Fettinger, J. C.; Franz, A. K. J. Org. 
Chem. 2011, 76, 7065. 
 (43) Coldham, I.; Copley, R. C. B.; Haxell, T. F. N.; Howard, S. Org. Lett. 2001, 3, 
3799. 
 (44) Ashweek, N. J.; Coldham, I.; Haxell, T. F. N.; Howard, S. Org. Biomol. Chem. 
2003, 1, 1532. 
 (45) Gross, K. M. B.; Jun, Y. M.; Beak, P. J. Org. Chem. 1997, 62, 7679. 
 (46) Metallinos, C.; Xu, S. Org. Lett. 2009, 12, 76. 
 (47) Coldham, I.; Dufour, S.; Haxell, T. F. N.; Howard, S.; Vennall, G. P. Angew. 
Chem. Int. Ed. 2002, 41, 3887. 
 (48) Coldham, I.; Dufour, S.; Haxell, T. F. N.; Vennall, G. P. Tetrahedron 2005, 61, 
3205. 
 (49) Coldham, I.; Patel, J. J.; Sanchez-Jimenez, G. Chem. Comm. 2005, 3083. 
 (50) Coldham, I.; Dufour, S.; Haxell, T. F. N.; Patel, J. J.; Sanchez-Jimenez, G. J. 
Am. Chem. Soc. 2006, 128, 10943. 
 (51) Beak, P.; Anderson, D. R.; Curtis, M. D.; Laumer, J. M.; Pippel, D. J.; 
Weisenburger, G. A. Acc. Chem. Res. 2000, 33, 715. 
 (52) Bates, R. B.; Kroposki, L. M.; Potter, D. E. J. Org. Chem. 1972, 37, 560. 
 (53) Clayden, J.; Yasin, S. A. New Journal of Chemistry 2002, 26, 191. 
 (54) Bartlett, P. D.; Friedman, S.; Stiles, M. J. Am. Chem. Soc. 1953, 75, 1771. 
 (55) Basu, A.; Thayumanavan, S. Angew. Chem. Int. Ed. 2002, 41, 716. 
 (56) Campos, K. R.; Klapars, A.; Waldman, J. H.; Dormer, P. G.; Chen, C.-y. J. Am. 
Chem. Soc. 2006, 128, 3538. 
 (57) Gawley, R. E.; Eddings, D. B.; Santiago, M.; Vicic, D. A. Org. Biomol. Chem. 
2006, 4, 4285. 
 (58) Gawley, R. E.; Hart, G. C.; Bartolotti, L. J. J. Org. Chem. 1989, 54, 175. 
 (59) Coldham, I.; O’Brien, P.; Patel, J. J.; Raimbault, S.; Sanderson, A. J.; Stead, D.; 
Whittaker, D. T. E. Tetrahedron: Asymmetry 2007, 18, 2113. 
 (60) Bailey, W. F.; Beak, P.; Kerrick, S. T.; Ma, S.; Wiberg, K. B. J. Am. Chem. Soc. 
2002, 124, 1889. 
 (61) Stead, D.; Carbone, G.; O’Brien, P.; Campos, K. R.; Coldham, I.; Sanderson, A. 
J. Am. Chem. Soc. 2010, 132, 7260. 
Bibliography 
295 
 (62) Firth, J. D.; O’Brien, P. unpublished results. 
 (63) Sheikh, N. S.; Leonori, D.; Barker, G.; Firth, J. D.; Campos, K. R.; Meijer, A. J. 
H. M.; O’Brien, P.; Coldham, I. J. Am. Chem. Soc. 2012. 
 (64) Phillips, H. Journal of the Chemical Society, Transactions 1925, 127, 2552. 
 (65) Andersen, K. K. Tetrahedron Lett. 1962, 3, 93. 
 (66) Satoh, T.; Oohara, T.; Yamakawa, K. Tetrahedron Lett. 1988, 29, 4093. 
 (67) Satoh, T.; Sato, T.; Oohara, T.; Yamakawa, K. J. Org. Chem. 1989, 54, 3973. 
 (68) Thomas, E. W.; Rynbrandt, R. H.; Zimmermann, D. C.; Bell, L. T.; Muchmore, 
C. R.; Yankee, E. W. J. Org. Chem. 1989, 54, 4535. 
 (69) Arrowsmith, J. E.; Greengrass, C. W. Tetrahedron Lett. 1982, 23, 357. 
 (70) Herak, J. J.; Vinković, M.; Mandić, Z.; Lukić, I.; Tomić, M.; Kovačević, M. 
Tetrahedron: Asymmetry 1994, 5, 1605. 
 (71) Rayner, P. PhD Thesis, University of York 2013. 
 (72) Brown, D. S.; Charreau, P.; Hansson, T.; Ley, S. V. Tetrahedron 1991, 47, 
1311. 
 (73) Emerson, D. W.; Craig, A. P.; Potts, I. W. J. Org. Chem. 1967, 32, 102. 
 (74) Trost, B. M. Chem. Rev. 1978, 78, 363. 
 (75) Trost, B. M. Acc. Chem. Res. 1978, 11, 453. 
 (76) Reich, H. J.; Wollowitz, S. J. Am. Chem. Soc. 1982, 104, 7051. 
 (77) Beak, P.; Zajdel, W. J. J. Am. Chem. Soc. 1984, 106, 1010. 
 (78) Hodgson, D. M.; Kloesges, J. Angew. Chem. Int. Ed. 2010, 49, 2900. 
 (79) Bredt, J. Justus Liebigs Annalen der Chemie 1924, 437, 1. 
 (80) Shea, K. J. Tetrahedron 1980, 36, 1683. 
 (81) Beak, P.; Wu, S.; Yum, E. K.; Jun, Y. M. J. Org. Chem. 1994, 59, 276. 
 (82) Park, Y. S.; Beak, P. Tetrahedron 1996, 52, 12333. 
 (83) Park, Y. S.; Weisenburger, G. A.; Beak, P. J. Am. Chem. Soc. 1997, 119, 10537. 
 (84) Faibish, N. C.; Park, Y. S.; Lee, S.; Beak, P. J. Am. Chem. Soc. 1997, 119, 
11561. 
 (85) Clayden, J.; Lemiègre, L.; Pickworth, M. Tetrahedron: Asymmetry 2008, 19, 
2218. 
 (86) Park, Y. S.; Boys, M. L.; Beak, P. J. Am. Chem. Soc. 1996, 118, 3757. 
 (87) Kondo, Y.; Kojima, S.; Sakamoto, T. J. Org. Chem. 1997, 62, 6507. 
 (88) Tomooka, K.; Nakazaki, A.; Nakai, T. J. Am. Chem. Soc. 1999, 122, 408. 
 (89) Still, W. C.; Sreekumar, C. J. Am. Chem. Soc. 1980, 102, 1201. 
Bibliography 
296 
 (90) Gawley, R. E.; Narayan, S.; Vicic, D. A. J. Org. Chem. 2005, 70, 328. 
 (91) Ohwada, T.; Okamoto, I.; Shudo, K.; Yamaguchi, K. Tetrahedron Lett. 1998, 
39, 7877. 
 (92) Seel, S.; Thaler, T.; Takatsu, K.; Zhang, C.; Zipse, H.; Straub, B. F.; Mayer, P.; 
Knochel, P. J. Am. Chem. Soc. 2011, 133, 4774. 
 (93) Agbodjan, A. A.; Cooley, B. E.; Copley, R. C. B.; Corfield, J. A.; Flanagan, R. 
C.; Glover, B. N.; Guidetti, R.; Haigh, D.; Howes, P. D.; Jackson, M. M.; Matsuoka, 
R. T.; Medhurst, K. J.; Millar, A.; Sharp, M. J.; Slater, M. J.; Toczko, J. F.; Xie, S. J. 
Org. Chem. 2008, 73, 3094. 
 (94) Slater, M. J.; Amphlett, E. M.; Andrews, D. M.; Bravi, G.; Burton, G.; Cheasty, 
A. G.; Corfield, J. A.; Ellis, M. R.; Fenwick, R. H.; Fernandes, S.; Guidetti, R.; Haigh, 
D.; Hartley, C. D.; Howes, P. D.; Jackson, D. L.; Jarvest, R. L.; Lovegrove, V. L. H.; 
Medhurst, K. J.; Parry, N. R.; Price, H.; Shah, P.; Singh, O. M. P.; Stocker, R.; 
Thommes, P.; Wilkinson, C.; Wonacott, A. J. Med. Chem. 2007, 50, 897. 
 (95) Keana, J. F.; Lee, T. D.; Bernard, E. M. J. Am. Chem. Soc. 1976, 98, 3052. 
 (96) Keana, J. F. W.; Seyedrezai, S. E.; Gaughan, G. J. Org. Chem. 1983, 48, 2644. 
 (97) Einhorn, J.; Einhorn, C.; Ratajczak, F.; Gautier-Luneau, I.; Pierre, J.-L. J. Org. 
Chem. 1997, 62, 9385. 
 (98) Goti, A.; Nannelli, L. Tetrahedron Lett. 1996, 37, 6025. 
 (99) Pache, S.; Botuha, C.; Franz, R.; Kündig, E. P.; Einhorn, J. Helv. Chim. Acta 
2000, 83, 2436. 
 (100) Ikuma, N.; Tamura, R.; Shimono, S.; Kawame, N.; Tamada, O.; Sakai, N.; 
Yamauchi, J.; Yamamoto, Y. Angew. Chem. Int. Ed. 2004, 43, 3677. 
 (101) Haskins, C. M.; Knight, D. W. Chem. Comm. 2002, 2724. 
 (102) Kuznetsov, N. Y.; Kolomnikova, G. D.; Khrustalev, V. N.; Golovanov, D. G.; 
Bubnov, Y. N. Eur. J. Org. Chem. 2008, 5647. 
 (103) Penning, T. D.; Zhu, G.-D.; Gandhi, V. B.; Gong, J.; Liu, X.; Shi, Y.; 
Klinghofer, V.; Johnson, E. F.; Donawho, C. K.; Frost, D. J.; Bontcheva-Diaz, V.; 
Bouska, J. J.; Osterling, D. J.; Olson, A. M.; Marsh, K. C.; Luo, Y.; Giranda, V. L. J. 
Med. Chem. 2008, 52, 514. 
 (104) Burgess, L. E.; Meyers, A. I. J. Org. Chem. 1992, 57, 1656. 
 (105) Higashiyama, K.; Inoue, H.; Takahashi, H. Tetrahedron 1994, 50, 1083. 
 (106) Manescalchi, F.; Nardi, A. R.; Savoia, D. Tetrahedron Lett. 1994, 35, 2775. 
 (107) Brinner, K. M.; Ellman, J. A. Org. Biomol. Chem. 2005, 3, 2109. 
Bibliography 
297 
 (108) Reddy, L. R.; Prashad, M. Chem. Comm. 2010, 46, 222. 
 (109) Rajender Reddy, L.; Das, S. G.; Liu, Y.; Prashad, M. J. Org. Chem. 2010, 75, 
2236. 
 (110) Leemans, E.; Mangelinckx, S.; De Kimpe, N. Chem. Comm. 2010, 46, 3122. 
 (111) Pablo, Ó.; Guijarro, D.; Yus, M. J. Org. Chem. 2013, 78, 9181. 
 (112) Ozawa, F.; Hayashi, T. J. Organomet. Chem. 1992, 428, 267. 
 (113) Wu, S.; Lee, S.; Beak, P. J. Am. Chem. Soc. 1996, 118, 715. 
 (114) Hayashi, T.; Konishi, M.; Kobori, Y.; Kumada, M.; Higuchi, T.; Hirotsu, K. J. 
Am. Chem. Soc. 1984, 106, 158. 
 (115) Netherton, M. R.; Fu, G. C. Org. Lett. 2001, 3, 4295. 
 (116) Van Betsbrugge, J.; Tourwé, D.; Kaptein, B.; Kierkels, H.; Broxterman, R. 
Tetrahedron 1997, 53, 9233. 
 (117) Kano, T.; Sakamoto, R.; Mii, H.; Wang, Y.-G.; Maruoka, K. Tetrahedron 2010, 
66, 4900. 
 (118) Foschi, F.; Landini, D.; Lupi, V.; Mihali, V.; Penso, M.; Pilati, T.; Tagliabue, A. 
Chem. Eur. J. 2010, 16, 10667. 
 (119) Tayama, E.; Kimura, H. Angew. Chem. Int. Ed. 2007, 46, 8869. 
 (120) Zhou, L.; Chen, J.; Tan, C. K.; Yeung, Y.-Y. J. Am. Chem. Soc. 2011, 133, 
9164. 
 (121) Farid, U.; Wirth, T. Angew. Chem. Int. Ed. 2012, 51, 3462. 
 (122) Xiao, D.; Lavey, B. J.; Palani, A.; Wang, C.; Aslanian, R. G.; Kozlowski, J. A.; 
Shih, N.-Y.; McPhail, A. T.; Randolph, G. P.; Lachowicz, J. E.; Duffy, R. A. 
Tetrahedron Lett. 2005, 46, 7653. 
 (123) Sheikh, N. S.; Leonori, D.; Barker, G.; Firth, J. D.; Campos, K. R.; Meijer, A. J. 
H. M.; O’Brien, P.; Coldham, I. J. Am. Chem. Soc. 2012, 134, 5300. 
 (124) Beng, T. K.; Woo, J. S.; Gawley, R. E. J. Am. Chem. Soc. 2012, 134, 14764. 
 (125) Coindet, C.; Comel, A.; Kirsch, G. Tetrahedron Lett. 2001, 42, 6101. 
 (126) Huang, J.; O’Brien, P. Tetrahedron Lett. 2005, 46, 3253. 
 (127) Li, X.; Leonori, D.; Sheikh, N. S.; Coldham, I. Chem. Eur. J. 2013, 19, 7724. 
 (128) Graser, M.; Kopacka, H.; Wurst, K.; Müller, T.; Bildstein, B. Inorg. Chim. Acta 
2013, 401, 38. 
 (129) Burchat, A. F.; Chong, J. M.; Nielsen, N. J. Organomet. Chem. 1997, 542, 281. 
 (130) Dieter, R. K.; Li, S. J. Org. Chem. 1997, 62, 7726. 
Bibliography 
298 
 (131) Doherty, S.; Knight, J. G.; McRae, A.; Harrington, R. W.; Clegg, W. Eur. J. 
Org. Chem. 2008, 2008, 1759. 
 (132) Wu, T. R.; Chong, J. M. J. Am. Chem. Soc. 2006, 128, 9646. 
 (133) Hajipour, A. R.; Falahati, A. R.; Ruoho, A. E. Tetrahedron Lett. 2006, 47, 2717. 
 (134) Hajipour, A. R.; Mallakpour, S. E.; Afrousheh, A. Tetrahedron 1999, 55, 2311. 
 (135) Sinha, M. K.; Reany, O.; Yefet, M.; Botoshansky, M.; Keinan, E. Chem. Eur. J. 
2012, 18, 5589. 
 (136) Wykypiel, W.; Lohmann, J.-J.; Seebach, D. Helv. Chim. Acta 1981, 64, 1337. 
 (137) Vechorkin, O.; Proust, V. r.; Hu, X. J. Am. Chem. Soc. 2009, 131, 9756. 
 (138) Amat, M.; P rez, M.; Minaglia, A. T.; Bosch, J. J. Org. Chem. 2008, 73, 6920. 
 (139) Barluenga, J.; Foubelo, F.; Fañanás, F. J.; Yus, M. Tetrahedron 1989, 45, 2183. 
 
